Elizabeth J. Shpall, M.D.
Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine
About Dr. Elizabeth J. Shpall
Elizabeth Shpall, MD, is a nationally recognized expert in stem cell transplantation. She currently is the Director of the Cell Therapy Laboratory and Director of the Cord Blood Bank at the University of Texas MD Anderson Cancer Center. She also serves as Professor and Chair ad interim of the Department of Stem Cell Transplantation and Cellular Therapy and holds the Howard and Lee Smith Chair in Cancer Research. Dr. Shpall's research covers a range of applications, among them: leukemia, lymphoma treatment, anti-tumor immunity enhancement and tissue repair. Many of her studies address the safety and efficacy of stem cell transplantation for patients.
Dr. Shpall has provided unparalleled leadership in the area of umbilical cord blood collection, banking and transplantation. Under her watch, the Cord Blood Bank at MD Anderson has collected over 140,000 cord blood units from voluntary donations since its establishment in April 2005, coordinating these efforts with several hospitals in Houston. The Stem Cell Transplant Program has transplanted more than 400 patients with cord blood using novel strategies such as ex vivo expansion of the cord blood cells before infusion, to make it work better in patients.
Dr. Shpall’s influence is felt beyond the Texas Medical Center. She was the founding president and current Board member of the Foundation Accreditation of Cell Therapy (FACT) established in an organization that accredits stem cell transplantation programs and ensures quality management plans and standard operating procedures. She is a past president of the American Society of Blood and Marrow Transplantation (ASBMT).
Dr. Shpall's academic career started with an undergraduate degree from Brown University in 1976. She completed her medical degree at the University of Cincinnati College of Medicine in 1980 before becoming a resident at Beth Israel Medical Center in New York for three years. From 1983 through 1985, she was a fellow in the Department of Neoplastic Diseases at Mount Sinai Medical Center in New York, serving as chief fellow in her final year.
Before coming to MD Anderson in 2002, she was an associate professor and director of the Cord Blood Bank at the University of Colorado Health Sciences Center, a program she started. From 1986 to 1990, she was an assistant professor at the Duke University Medical Center.
She has authored or co-authored nearly 700 research articles, abstracts, editorials and book chapters during her career in addition to speaking throughout the world at conferences and symposia. She holds two patents resulting from her research efforts.
Dr. Shpall has been honored with numerous awards for her academic and research work at MD Anderson. These include the R. Lee Clark prize for Excellence-Clinical Faculty, the President’s Recognition for Faculty Excellence Award and the Otis W. and Pearl L. Walters Faculty Achievement Award in Clinical Research.
Present Title & Affiliation
Primary Appointment
Director, Manufacturing & Clinical Operations, Department of Institute for Cell Therapy Discovery & Innovation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Department Chair ad interim, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas
Director, Cell Therapy Laboratory, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas
Howard Foster Smith and Lee Dennis Smith Chair for Cancer Research, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas
Director, Cord Blood Bank, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas
Professor of Medicine, Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1980 | University of Cincinnati College of Medicine, Cincinnati, Ohio, US, MD |
| 1976 | Brown University, Providence, Rhode Island, US, BA Equivalent in Biology and French |
Postgraduate Training
| 1984-1985 | Clinical Fellowship, Mount Sinai Medical Center, New York, New York |
| 1980-1983 | Clinical Residency, Beth Israel Hospital, New York, New York |
Licenses & Certifications
| 2022 | Basic Life Support (BLS) |
| 2021 | Drug Enforcement Administration (DEA) |
| 2002 | Texas Medical License (TMB) |
| 1987 | American Board of Medical Oncology (Recertification grandfathered and not required) |
| 1983 | American Board of Internal Medicine (Recertification grandfathered and not required) |
Experience & Service
Faculty Academic Appointments
Professor, University of Colorado Health Sciences Center, Denver, Colorado, 1996 - 2002
Associate Professor, University of Colorado Health Sciences Center, Denver, Colorado, 1990 - 1996
Assistant Professor, Duke University Medical Center, Durham, North Carolina, 1986 - 1990
Instructor, Mount Sinai Medical Center, New York, New York, 1985 - 1986
Administrative Appointments/Responsibilities
Medical Director, Department of Cell Therapy Laboratory, Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2002 - 2014
Director, Department of Cell Processing and Cryopreservation Laboratory, University of Colorado, Denver, Colorado, 1997 - 2002
Associate Director, Department of Bone Marrow Transplant Program, University of Colorado Health Sciences Center, Denver, Colorado, 1990 - 2002
Director, Department of Stem Cell Engineering Laboratories and Apheresis Unit, The University of Texas MD Anderson Cancer Center, Denver, Colorado, 1990 - 2002
Director, Department of Cryopreservation Laboratory, Duke University Medical Center, Durham, North Carolina, 1988 - 1990
Other Professional Positions
Member, Foundation for the Accreditation of Cellular Therapies (FACT) Board of Directors, Omaha, Nebraska, 1998 - 2011
Extramural Institutional Committee Activities
Member, MDA 2021-11 Inquiry Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, Thesis Advisory Committee CPRIT TRIUMPH Postdoctoral Fellowship Program, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, Thesis Advisory Committee Mecit Kaplan, The University of Texas MD Anderson Cancer Center, 2023 - Present
Co-Chairman, Cancer Center Support Grant-Stem Cell Transplantation and Regenerative Medicine Program, The University of Texas MD Anderson Cancer Center, 2018 - Present
Co-Chair, Search Committee, Department of Lymphoma-Myeloma, The University of Texas MD Anderson Cancer Center, 2018 - 2019
Member, Annual DoCM Faculty Recognition and Award Program Nomination Reviews, The University of Texas MD Anderson Cancer Center, 2017 - 2017
Member, Faculty Promotion and Tenure Advisory Council, The University of Texas MD Anderson Cancer Center, 2015 - 2018
Member, Human Embryonic & Induced Pluripotent Stem Cell Oversight (HEIPSCRO), The University of Texas MD Anderson Cancer Center, 2014 - Present
Member, Steering Committee for the Society of Hematologic Oncology (SOHO), The University of Texas MD Anderson Cancer Center, 2013 - Present
Chairman, Clinical Research Committee (CRC) #2, The University of Texas MD Anderson Cancer Center, 2012 - 2014
Member, Professional Liability Committee (PLC), The University of Texas MD Anderson Cancer Center, 2012 - 2013
Chair, Search Committee, Chairman Department GYN-Oncology, The University of Texas MD Anderson Cancer Center, 2012 - 2013
Chairman, Search Committee Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 2011 - 2012
Member, Promotion and Tenure Committee, The University of Texas MD Anderson Cancer Center, 2010 - 2013
Member, The Multidisciplinary Research Advisory Committee (MRAC), The University of Texas MD Anderson Cancer Center, 2010 - 2011
Member, Women Faculty Programs Departmental Liaison, The University of Texas MD Anderson Cancer Center, 2010 - 2023
Quality Officer and Member, Department of Stem Cell Transplantation and Cellular Therapy, Ongoing Professional Practice Evaluation (OPPE) Committee, The University of Texas MD Anderson Cancer Center, 2009 - 2012
Member, Annual DoCM Faculty Recognition and Award Program Nomination Reviews, The University of Texas MD Anderson Cancer Center, 2008 - 2008
Member, Institutional Review Board (IRB) #1, The University of Texas MD Anderson Cancer Center, 2008 - 2009
Member, American Society of Clinical Oncology Young Investigators Award Oversight Committee, The University of Texas MD Anderson Cancer Center, 2008 - 2009
Member, Tissue Transplantation Committee, The University of Texas MD Anderson Cancer Center, 2007 - 2008
Member, Cancer Center Support Grant- Immunology Program, The University of Texas MD Anderson Cancer Center, 2007 - Present
Chairman, Cord Blood Bank Steering Committee, The University of Texas MD Anderson Cancer Center, 2004 - Present
Member, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2004 - 2007
Member, GMP Cell Therapy Laboratory Steering Committee, The University of Texas MD Anderson Cancer Center, 2003 - Present
Member, Search Committee, Chairman Department General Internal Medicine, The University of Texas MD Anderson Cancer Center, 2003 - 2004
Member, Search Committee, Chairman Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, 2003 - 2004
Editorial Activities
Editorial Board, Cytotherapy, 2019 - 2022
Editorial Board, Cytotherapy, 2014 - Present
Editorial Board, Treatment Strategies-Hematology, 2011 - 2014
Editorial Board, Blood, 2004 - 2014
Editorial Board, Biology of Blood and Bone Marrow Transplantation, 1997 - Present
Editorial Board, Cytokines in Hematology/Oncology, 1993 - 2000
Editorial Board, Cancer Research, Therapy and Control, 1991 - 2000
Honors & Awards
| 2020 - 2021 | E. Donnall Thomas Award, The American Society of Transplantation and Cellular Therapy |
| 2018 | 2018 Jaap de Graeff Visiting Teaching Professor, Leids Universitair Medisch Centrum |
| 2018 - 2023 | Association of American Physicians |
| 2017 | Women Who Conquer Cancer Mentorship Award, American Society of Clinical Oncology (ASCO) |
| 2017 | Daniel Drake Award, University of Cincinnati College of Medicine |
| 2016 - 2017 | The R. Lee Clark Prize for Excellence-Clinical Faculty, MD Anderson Cancer Center |
| 2014 - 2015 | President's Recognition for Faculty Excellence Award, MD Anderson Cancer Center |
| 2010 - 2011 | The Otis W. and Pearl L. Walters Faculty Achievement Award in Clinical Research, MD Anderson Cancer Center |
| 2009 - 2010 | The Irwin H. Krakoff Award for Excellence in Clinical Research, MD Anderson Cancer Center |
| 2007 - 2008 | Clinical Physician, Texas Federation of Business and Professional Women's Club (BPW) |
| 2001 - 2023 | Best Doctor in America, America's Top Doctor |
| 1989 | ACS Career Development Award |
| 1987 | ACS Institutional Research Grant Award, Institutional Research Grant Award |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2019. CAR-T cell therapy: the MD Anderson CARTOX Program. Conference. CAR-T cell therapy: the MD Anderson CARTOX Program. Houston, TX, US.
- 2017. CARTOX Algorithm. Conference. CARTOX Algorithm. Houston, TX, US.
- 2017. MD Anderson CARTOX Program. Conference. MD Anderson CARTOX Program. Houston, TX, US.
- 2013. Immunotherapy in CLL- Studies. Conference. Immunotherapy in CLL- Studies. Houston, TX, US.
- 2013. Cellular Immunotherapy: ready for prime time?. Conference. Cellular Immunotherapy: ready for prime time?. Houston, TX, US.
- 2012. Novel Strategies in Stem Cell Transplantation. Conference. Novel Strategies in Stem Cell Transplantation. Houston, TX, US.
- 2012. Novel Allogeneic SCT Strategies in AML. Conference. Novel Allogeneic SCT Strategies in AML. Houston, TX, US.
- 2011. Cord Blood Banking and Transplantation. Conference. Cord Blood Banking and Transplantation. Houston, TX, US.
Regional Presentations
- 2024. Evolving Trends in Mesenchymal Stem Cell based Therapies. Invited. 2nd Annual Stem Cell Transplant & Cellular Therapy Symposium. Phoenix, Arizona, US.
- 2023. Diagnosis grading and management of CAR-T Toxicities. Conference. Inaugural Stem Cell Transplant and Cell Therapy Symposium. Scottsdale, AZ, US.
- 2017. Car T cells—a New Breakthrough on Cancer Research. Conference. Car T cells—a New Breakthrough on Cancer Research. Houston, US.
- 2014. FACT Strategic Planning Retreat. Conference. FACT Strategic Planning Retreat. Chicago, IL, US.
- 2014. Fucosylated Infused Cord Blood Unit Using Reagent. Conference. Fucosylated Infused Cord Blood Unit Using Reagent. Washington, DC, US.
- 2014. SCT Program and Plans for allogeneic transplants. Conference. SCT Program and Plans for allogeneic transplants. Phoenix, AZ, US.
- 2013. HPDSC Advisory Board Meeting. Conference. HPDSC Advisory Board Meeting. Newark, NJ, US.
- 2013. FACT Inspection. Conference. FACT Inspection. Seattle, WA, US.
- 2013. ASBMT Strategic Planning Retreat. Conference. ASBMT Strategic Planning Retreat. Chicago, IL, US.
- 2013. 4 HRSA Cord Blood Strategy Meeting. Conference. 4 HRSA Cord Blood Strategy Meeting. DC, WA, US.
- 2013. FACT Strategic Planning Retreat. Conference. FACT Strategic Planning Retreat. Chicago, IL, US.
- 2012. ASBMT/CIBMTR/NMDP Leadership Meeting. Conference. ASBMT/CIBMTR/NMDP Leadership Meeting. Minneapolis, MN, US.
- 2012. BMT Field and Society Strategic Plans. Conference. BMT Field and Society Strategic Plans. New York, NY, US.
- 2012. Perspectives on Cord Blood Biology and Clinical Applications. Conference. Perspectives on Cord Blood Biology and Clinical Applications. New York, NY, US.
- 2012. Targeting Risk for Graft Versus Host Disease. Conference. Targeting Risk for Graft Versus Host Disease. San Diego, CA, US.
- 2011. ASBMT and NMDP Meeting. Conference. ASBMT and NMDP Meeting. Minneapolis, MN, US.
- 2011. Expand Donor Population. Conference. Expand Donor Population. Chicago, IL, US.
- 2011. Enhance Engraftment. Conference. Enhance Engraftment. Chicago, IL, US.
- 2011. FACT Cord Blood Inspection and Accreditation Workshop. Conference. FACT Cord Blood Inspection and Accreditation Workshop. Omaha, NE, US.
- 2010. Cord Blood Stem Cell Expansion. Conference. Cord Blood Stem Cell Expansion. Orlando, FL, US.
- 2010. NMDP Cord Blood Advisory Group Meeting. Conference. NMDP Cord Blood Advisory Group Meeting. Minneapolis, MN, US.
- 2010. Cord Blood Bank Site Visit. Conference. Cord Blood Bank Site Visit. New York, NY, US.
- 2010. Council CBU Engraftment Session. Conference. Council CBU Engraftment Session. Minneapolis, MN, US.
- 2010. FDA Project with Phase II study of Cord Blood Expansion. Conference. FDA Project with Phase II study of Cord Blood Expansion. Rockville, MD, US.
- 2010. CLLGRP Advisory Board Meeting. Conference. CLLGRP Advisory Board Meeting. Barcelona, ES.
- 2010. Netcord-NMPD Cord Blood Advisory Group Meeting. Conference. Netcord-NMPD Cord Blood Advisory Group Meeting. San Francisco, CA, US.
- 2009. NMPD Cord blood Committee Meeting. Conference. NMPD Cord blood Committee Meeting. Minneapolis, MS, US.
- 2009. Joint Optimal Donors and GVHD SOSS Committee meeting. Conference. Joint Optimal Donors and GVHD SOSS Committee meeting. Arlington, VA, US.
- 2009. NMDP Network Engagement Workshop. Conference. NMDP Network Engagement Workshop. Chicago, IL, US.
- 2009. Netcord Strategic Planning Retreat. Conference. Netcord Strategic Planning Retreat. Barcelona, ES.
- 2009. FACT Inspection. Conference. FACT Inspection. Tel Aviv, IL.
- 2008. FACT Inspection. Conference. FACT Inspection. New York, NY, US.
- 2008. Texas Vaccine Center Meeting. Conference. Texas Vaccine Center Meeting. Dallas, TX, US.
- 2008. HRSA and NMDP. Conference. HRSA and NMDP. Cincinnati, OH, US.
- 2008. Stem Cell Bills. Conference. Stem Cell Bills. Austin, TX, US.
- 2008. Cord blood PO1. Conference. Cord blood PO1. Bethesda, MD, US.
- 2008. Advisory Council Blood Stem Cell Meeting. Conference. Advisory Council Blood Stem Cell Meeting. Reagan, DC.
- 2008. Netcord Board of Directors. Conference. Netcord Board of Directors. Florence, IT.
- 2008. Cord Blood Registry. Conference. Cord Blood Registry. Tucson, AZ, US.
- 2008. FACT Inspection. Conference. FACT Inspection. San Diego, CA, US.
- 2008. CBR Overview/Outline of related Donation Structure. Conference. CBR Overview/Outline of related Donation Structure. Tucson, AZ, US.
- 2007. Cord Blood Demonstration Project. Conference. Cord Blood Demonstration Project. Washington, DC, US.
- 2007. FACT Inspection. Conference. FACT Inspection. Durham, NC, US.
- 2007. NMDP Cord Blood Committee Meeting. Conference. NMDP Cord Blood Committee Meeting. Minneapolis, MN, US.
- 2007. stem cell transplantations and immune reconstitution. Conference. stem cell transplantations and immune reconstitution. London.
- 2007. GVHD scientific advisory board meeting. Conference. GVHD scientific advisory board meeting. Baltimore, MD, US.
- 2007. Stem Cell Bills. Conference. Stem Cell Bills. Austin, TX, US.
- 2007. Testified at FDA re: Proposed Cord Blood Licensing regulations. Conference. Testified at FDA re: Proposed Cord Blood Licensing regulations. Washington, DC, US.
- 2007. Netcord- Executive Committee meeting. Conference. Netcord- Executive Committee meeting. Lyon, US.
- 2007. FACT Inspection. Conference. FACT Inspection. Leiden, NL.
- 2006. StemEx Pivotal Study Investigator Meeting. Conference. StemEx Pivotal Study Investigator Meeting. Newark, NJ, US.
- 2006. Netcord Strategic Planning Retreat. Conference. Netcord Strategic Planning Retreat. Düsseldorf, US.
- 2006. Cellerant Advisory Board. Conference. Cellerant Advisory Board. San Francisco, CA, US.
- 2005. Cord Expansion Study. Conference. Cord Expansion Study. Thousand Oaks, CA, US.
- 2005. FACT Inspection, Carolinas. Conference. FACT Inspection, Carolinas. Durham, NC, US.
- 2005. Stem Cell Bills. Conference. Stem Cell Bills. Austin, TX, US.
- 2004. FACT Inspection. Conference. FACT Inspection. Besancon, US.
- 2004. Consultant for Transplant Trials. Conference. Consultant for Transplant Trials. Wisconsin, US.
- 2003. Celtrans Advisory Board Meeting. Conference. Celtrans Advisory Board Meeting. Missoula, MT, US.
- 2003. FACT Inspection. Conference. FACT Inspection. Seattle, WA, US.
- 2000. FACT Inspection. Conference. FACT Inspection. Fairfax, VA, US.
- 1998. FACT Inspection. Conference. FACT Inspection. Los Angeles, CA, US.
- 1998. FACT Inspection. Conference. FACT Inspection. Lubbock, TX, US.
- 1998. FACT Inspection. Conference. FACT Inspection. Philadelphia, PA, US.
- 1997. FACT Inspection. Conference. FACT Inspection. Chicago, IL, US.
National Presentations
- 2024. The Facts About FACT. Invited. 5th Annual ASTCT Leadership Course. Washington, DC, US.
- 2024. Hematopoietic Biology & Transplantation. Invited. 5th Annual ASTCT Leadership Course. Washington, DC, US.
- 2024. Karl G. Blume Memorial Lectureship. Invited. 2024 Stanford BMT-CT Symposium. Stanford, California, US.
- 2023. How I chose an Alternative Donor. Invited. ASTCT Clinical Education Conference. Virtual, US.
- 2022. Quality Improvement: Blood Drop. Conference. Quality Improvement: Blood Drop. New Orleans, LA, US.
- 2022. ASTCT Corporate Council Meeting. Conference. ASTCT Corporate Council Meeting. Phoenix, AZ, US.
- 2022. 2022 Tandem Meetings l Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR. Conference. 2022 Tandem Meetings l Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR. Salt Lake City, UT, US.
- 2021. Cellular Immunotherapy in the Real World: Toxicity. Conference. ASTCT, CIBMTR, and NMDP. virutal, US.
- 2021. Management of CAR-T cell infusion-related cytokine release syndrome. Conference. Brazilian Bone Marrow and Cellular Therapy Society. Brazil (virtual), US.
- 2021. Cord Blood Expansion-Biology and Techniques. Conference. ASGCT, US.
- 2021. Management of Toxicity of Immune Cell Therapy. Conference. AACR, US.
- 2021. Cord Blood: Forerunners and New Horizons. Conference. American Society for Transplantation and Cellular Therapy (ASTCT). Virtual, US.
- 2019. The Future of Cell Therapy. Conference. Beth Israel Deaconess Midical Center. Boston, MA, US.
- 2019. Engineering of Cord Blood Grafts:Fucosylation. Conference. Cord Blood Connect. Miami, FL, US.
- 2019. How We Did It - MD Anderson Experience. Conference. MSK Clinical Application of CAR T Cells 2019. New York, NY, US.
- 2019. CAR-T Experience: Managing Toxicity and Maintaining Efficacy. Conference. Banner MD Anderson Cancer Center at University of Arizona. Phoenix, AZ, US.
- 2019. Toxicity and Management of CAR T-cells. Conference. 9th Annual Clinical Hematology & Oncology Conference. San Diego, CA, US.
- 2018. Guidelines for Implementing Institutional Protocols. Conference. National Comprehensive Cancer Network. Philadelphia, PA, US.
- 2018. Clinical Updates in Use of Umbilical Cord Blood Treatments: Shifting the Paradigm in Blood & Marrow Transplantation. Conference. BMT Tandem. Salt Lake City, UT, US.
- 2017. Gene Expression Profiling Is a Strong Predictor of Clinical Outcomes in Newly Diagnosed Multiple Myeloma. Conference. Blood. Atlanta, US.
- 2017. CS1-Specific Chimeric Antigen Receptor Drives Cord Blood NK Cell Maturation and Expansion In Vivo. Conference. Blood. Atlanta, US.
- 2017. Interim Results of a Phase 2 Clinical Trial Using Mb-IL21 Ex Vivo Expanded NK Cells to Enhance Graft Versus Leukemia Effect for Patients with Myeloid Malignancies after Haploidentical Transplantation. Conference. Blood. Atlanta, US.
- 2017. Large-Scale, Bioreactor-Generated Expansion of Umbilical Cord Blood Tissue-Derived Mesenchymal Stromal Cells for Clinical Use. Conference. Blood. Atlanta, US.
- 2017. Graft Failure Post Allogeneic Stem Cell Transplant: Conditioning Regimen Improves Engraftment and Survival. Conference. Blood. Atlanta, US.
- 2017. Hiv Specific T Cells Generated from HIV Naive Adult and Cord Blood Donors Target a Range of Novel Viral Epitopes: Implications for a Cure Strategy after Allogeneic HSCT and CBT. Conference. Blood. Atlanta, US.
- 2017. A Randomized Phase III Trial of Busulfan + Melphalan Vs Melphalan Alone for Multiple Myeloma. Conference. Blood. Atlanta, US.
- 2017. Randomized Phase II Trial of Combination Idiotype Vaccine and Adoptive Cell Transfer of Costimulated Autologous T Cells in Patients with Multiple Myeloma Post-Autotransplantation. Conference. Blood. Atlanta, US.
- 2017. Gemcitabine/Clofarabine/Busulfan: A New Myeloablative Reduced-Toxicity Conditioning Regimen with High Activity for Allogeneic Stem-Cell Transplant (alloSCT) in Aggressive Lymphomas. Conference. Blood. Atlanta, US.
- 2017. Interim Results of a Phase 2 Clinical Trial Using Mb-IL21 Ex Vivo Expanded NK Cells to Enhance Graft Versus Leukemia Effect for Patients with Myeloid Malignancies after Haploidentical Transplantation. Conference. Blood. Atlanta, US.
- 2017. The Prognostic Impact of Minimal Residual Disease on Risk of Progression and Progression Free Survival in Acute Myeloid Leukemia. Conference. Blood. Atlanta, US.
- 2017. Post-Transplant Cyclophosphamide Improves Progression Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients with Prior CTLA-4 or PD-1 Blockade. Conference. Blood. Atlanta, US.
- 2017. Cord Blood NK Cells Engineered to Express a Humanized CD123-Targeted Chimeric Antigen Receptor (CAR) and IL-15 As Off-the-Shelf Therapy for Acute Myeloid Leukemia. Conference. Blood. Atlanta, US.
- 2017. The FACTS of CARTOX: What are the Standards for Institutions Offering Immune Effector Cells?. Conference. Blood. Atlanta, GA, US.
- 2017. Allogeneic Transplantation for TP53+ AML: Prognostic Factors for Survival. Conference. Blood. Atlanta, US.
- 2017. Evaluation of T Cell Compartment By Mass Cytometry Reveals Distinct Patterns of Expression of Exhaustion Markers in Chronic Lymphocytic Leukemia. Conference. Blood. Atlanta, US.
- 2017. Exploring the Cord Blood T Cell Compartment with Mass Cytometry Reveals the Existence of Memory CD4, CD8 and Regulatory T Cell Pools in the Fetal Period. Conference. Blood. Atlanta, US.
- 2017. The TGF-β/SMAD Signaling Pathway As a Mediator of NK Cell Dysfunction and Immune Evasion in Myelodysplastic Syndrome. Conference. Blood. Atlanta, US.
- 2017. NK Cell Diversity Influences Outcomes after Cord Blood Transplantation. Conference. Blood. Atlanta, US.
- 2017. Early Maintenance with Tyrosine Kinase Inhibitors Post Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Improves Survival in Ph+ Acute Lymphoblastic Leukemia (ALL) Patients. Conference. Blood. Atlanta, US.
- 2017. Shortening the Time to Manufacture CAR+ T Cells with Sleeping Beauty System Supports T-Cell Engraftment and Anti-Tumor Effects in Patients with Refractory CD19+ Tumors. Conference. Blood. Atlanta, US.
- 2017. Cord Blood Transplantation. Conference. Texas Transplantation Society's 30th Annual Scientific Meeting. Galveston, TX, US.
- 2017. Mesenchymal stem cells. Conference. TrialNet. Denver, CO, US.
- 2017. What would be the services that cord blood banks need to offer if a transplant centre looks for advanced applications. Conference. Netcord, US.
- 2015. Expansion and Enhanced Homing of Cord Blood. Conference. 2015 BMT Tandem Meeting. San Diego, CA, US.
- 2014. The future of cord blood and other cellular therapies. Conference. Celgene. Warren, NJ, US.
- 2014. Cord Blood Transplantation. Conference. BMT Tandem Scientific Meeting. Dallas, TX, US.
- 2013. Hematopoietic Stem Cell Transplantation for AML. Conference. 55th ASH Annual Meeting and Exposition. New Orleans, LA, US.
- 2013. Cord Blood Physician's Conference to Establish Guidelines for Optimal Conduct of Cord Blood. Conference. NMDP. Minneapolis, MN, US.
- 2012. Ex-Vivo Expansion Technology to improve engraftment and reduce graft failure rate. Conference. World Cord Blood Congress. Boston, MT, US.
- 2012. Virus and Tumor Specific Cord Blood- Derived T Cells for Patients after Cord Blood Transplantation. Conference. 10th Annual Intl Cord Blood Symposium. San Francisco, CA, US.
- 2012. The Future of Cord Blood Transplantation. Conference. 18th ISCT Annual Meeting. Seattle, WA, US.
- 2012. Clinical Cellular Therapy. Conference. BMT Tandem meeting. San Diego, CA, US.
- 2011. Mesenchymal Stem Cell Based Cord Blood Expansion Leads to Rapid Engraftment of Platelets. Conference. Cord Blood Forum, Inc. San Francisco, CA, US.
- 2010. Graft Failure and Engraftment in Cord Blood Transplantation. Conference. BMT Tandem Meeting. Orlando, FL, US.
- 2009. Cord Blood Stem Cell Expansion. Conference. 51st ASH Annual Meeting and Exposition. New Orleans, LA, US.
- 2009. Improving Outcomes in Cord Blood Transplant: Research & Practice. Conference. 22nd Annual Council Meeting. Minneapolis, MN, US.
- 2009. Cord Blood Banking and Transplantation Current Status and Future Directions. Conference. BMT Tandem Scientific Meeting. Tampa, FL, US.
- 2008. Cord Blood Transplantation and Graft Engineering. Conference. International Society of Cell Therapy. Miami, FL, US.
- 2008. Overview of Stem Cell Therapy Cord Blood Therapy. Conference. RSNA. Chicago, IL, US.
- 2007. Cord Blood Expansion with Mesenchymal Stem Cells. Conference. 5th, International Umbilical Cord Blood Transplantation Symposium. Los Angeles, CA, US.
- 2006. Cord Blood Future Directions. Conference. International Society of Cell Therapy (ISCT) Six annual Somatic Therapy Symposium. Bethesda, MD.
- 2006. The role of fetal cord blood in the African American Population. Conference. Annual Convention & Scientific Assembly for National Medical Association. Dallas, TX, US.
- 2006. Cellular Therapy Workshop. Conference. ISCT Conference. Berlin.
- 2006. Cord Blood Transplantation. Conference. 4th, Annual Singapore Society of Hematology. Singapore, US.
- 2005. Title not provided. Conference. Board Review in Hematology and Medical Oncology, US.
- 2005. Umbilical Cord Blood. Conference. 3rd, Annual National Umbilical Cord Blood Transplantation Symposium. Los Angeles, CA, US.
- 2005. Title not provided. Conference. Canadian Hematology Society, US.
- 2005. Title not provided. Conference. Represented MDACC at Texas Legislature re: Stem Cell Bills. Austin, TX, US.
- 2004. Cord Blood Transplantation. Conference. 2nd, Annual Intl Umbilical Cord Blood Transplantation Symposium. Los Angeles, CA, US.
- 2004. Title not provided. Conference. Texas Transplant Institute. San Antonio, TX, US.
- 2004. Title not provided. Conference. BMT Tandem Meeting. Orlando, FL, US.
- 2003. Title not provided. Conference. ASH Conference. San Diego, CA, US.
- 2003. Title not provided. Conference. FACT University of Nebraska Medical Center, US.
- 2003. Title not provided. Conference. Celtrans Advisory Board Meeting. Missoula, MT, US.
- 2003. Title not provided. Conference. Stanford University 8th Biennial National Symposium on Hematopoietic Cell Transplantation,. Palo Alto, CA, US.
- 2003. Umbilical Cord Transplant Symposium. Conference. International Conference. Duarte, CA, US.
- 2003. Title not provided. Conference. Tandem BMT Meeting. Keystone, CO, US.
- 2002. Clinical Development of StemEx, Status of Phase I Study. Conference. American Society of Hematology, 44th Annual Meeting and Exposition. Philadelphia, PA, US.
- 2002. Title not provided. Conference. University of Utah Symposium on Stem Cell Transplantation Cord Blood Transplantation and Expansion, US.
- 2002. High-Dose Therapy for Breast Cancer Patients. Conference. The Stanford University 8th Biennial National Symposium on Hematopoietic Cell Transplantation. Palo Alto, CA, US.
- 2002. Cord Blood Expansion Experience. Conference. Gamida Cell. Washington, DC, US.
- 2002. Cord Blood Expansion Experience. Conference. Gamida Cell Meeting on Cord Blood Expansion. Washington, US.
- 2002. Dendritic Cell Therapy for Breast Cancer Patients. Conference. Miltenyi Dendritic Cell Meeting. Denver, CO, US.
- 2002. Cord Blood Transplantation. Conference. MD Anderson Blood and Marrow Transplantation Faculty Conference. Houston, TX, US.
- 2002. The Future of Dendritic Cell Therapy. Conference. COBE-Gambro Laboratories Seminar on Dendrtic Cell Therapy. Lakewood, CO, US.
- 2001. The Clinical Use of Expanded Cord Blood Progenitors. Conference. 5th International Symposium on In Utero Stem Cell Transplantation and Gene Therapy. Reno, NV, US.
- 2001. Latest Data In Cord Blood Transplantation. Conference. Meeting of the Northern Colorado Cancer Group. Ft. Collins, CO, US.
- 2001. Cord Blood Banking and Transplantation in the United States. Conference. International Symposium on Stem Cells: Biotechnology, and Clinical Applications. Twain, US.
- 2001. Cord Blood Banking – Collection Facilities. Conference. Annual Meeting of the International Society of Hematotherapy and Graft Engineering (ISHAGE). San Diego, CA, US.
- 2001. Cord Blood Transplantation. Conference. Annual Meeting of the International Society of Hematotherapy and Graft Engineering (ISHAGE. Quebec City, US.
- 2001. University of Colorado Cord Blood Transplant Studies. Conference. StemCyte Advisory Committee Meeting. San Francisco, CA, US.
- 2001. Current Status and Future Directions of the University of Colorado Cord Blood Bank. Conference. Netcord Meeting. New York, NY, US.
- 2001. History and Current Status of the Foundation for the Accreditation of Hematopoietic Cell Therapy. Conference. BMT Tandem Meeting. Orlando, FL, US.
- 2000. Transplantation of Adult and Pediatric Cancer Patients with Cord Blood Progenitors Expanded Ex Vivo. Conference. 42nd, Annual Meeting of the American Society of Hematology. Orlando, FL, US.
- 2000. Cord Blood Banking – Collection Facilities. Conference. Netcord-New York Blood Center Seminar on Cord Bank Inspections. New York, NY, US.
- 2000. High-Dose Therapy for Breast Cancer Patients. Conference. The Stanford University 7th, Biennial National Symposium on Hematopoietic Cell Transplantation. Palo Alto, CA, US.
- 2000. Cord Blood Transplantation. Conference. 13th, International Symposium on Treatment of Leukemia and Cancer. New York, NY, US.
- 2000. Stem Cell Processing, Expansion and Selection. Conference. Tandem Meetings of the International Bone Marrow Transplant Registry/American Society of Blood and Marrow Transplantation. Anaheim, CA, US.
- 2000. High-Dose Therapy for Breast Cancer. Conference. Scripps Clinic Symposium on Cancer Therapy. La Jolla, CA, US.
- 2000. High-Dose Therapy for Breast Cancer Patients. Conference. American Cancer Society. San Diego, CA, US.
- 1999. The Status of Breast Cancer Treatment and Transplantation. Conference. Blue Cross Blue Shield Policy Forum. Los Angeles, CA, US.
- 1999. A Randomized Trial of Stem Cell Purging for Breast Cancer Patients with Stage II/III, 10+ Node Disease. Conference. American Society of Clinical Oncology Breast Cancer Intergroup Meeting. Atlanta, GA, US.
- 1999. Preservation and Transplantation of Fetal Cord Blood. Conference. University of Colorado Immunology Department Symposium. Keystone, CO, US.
- 1999. Dendritic Cell Vaccines in the Post-Transplant Setting. Conference. Southwest Oncology Group Meeting. Phoenix, AZ, US.
- 1999. Future Directions in Hematopoietic Cell Therapy for Breast Cancer Patients. Conference. Dana Farber Cancer Center Medical Grand Rounds. Boston, MA, US.
- 1999. Bone Marrow Transplantation for Solid Tumors Other than Breast Cancer. Conference. Tandem Meetings of the International Bone Marrow Transplant Registry/American Society of Blood and Marrow Transplantation. Keystone, CO, US.
International Presentations
- 2023. The case for CAR T cells. Conference. EBMT. Paris, US.
- 2023. Cord derived MSC for ARDS/Covid 19. Conference. EBMT. Paris, US.
- 2019. Cord Blood Derived MSC, Exosomes, and Regenerative Medicine. Conference. ISCT 2019 Conference Melburne, AU.
- 2019. Ex-vivo expansion of cord blood stem cells. Conference. 45th EBMT Annual Meeting, DE.
- 2018. cord blood derived stem cells for immunotherapy and regenerative medicine. Conference. World Advanced Therapies and Regenerative Medicine. London, GB.
- 2018. GVHD treatment with cell therapy. Conference. XXVI International Symposium of Transfusion Medicine and Cell. Sao Paulo, BR.
- 2018. Cord blood expansion for transplant. Conference. XXVI International Symposium of Transfusion Medicine and Cell. Sao Paulo, BR.
- 2018. Cord blood transplantation and cellular therapy. Conference. Astellas. Sapporo, JP.
- 2018. Cord Blood Derived transplantation and cellular therapy for the future. Conference. 9th International Symposium Haploidentical Stem Cell Transplantation. Rehovot, IL.
- 2017. The future of cord blood transplantation and cellular therapy. Conference. China Medical University Hospital. Taipei, TW.
- 2014. Cord Blood Then and Now. Conference. International Society for Cellular Therapy. Paris, FR.
- 2014. Special Lecture: Cord Blood Transplant: Past, present and future. Conference. The Medal Group Corporation, TW.
- 2014. Kian Ang memorial lecture. Conference. The Medal Group Corporation, TW.
- 2014. Acute Myeloid Leukemia-II. Conference. The Medal Group Corporation, TW.
- 2014. Cord Blood Transplant; Past, Present and future. Conference. The Medal Group Corporation, TW.
- 2014. Post Transplant Therapies for AML. Conference. The Medal Group Corporation, TW.
- 2014. Novel strategies for enhanced engraftment and adaptive therapy following cord blood transplantation: MD Anderson experience. Conference. Weizmann Institute of Science, IL.
- 2013. Cord Blood Banking. Conference. ESH European School of Haematology. Monte-Carlo, MC.
- 2013. NK Cellular Therapy for CLL. Conference. iWCll Scientific Board and Programme Committee. Cologne, DE.
- 2013. Novel Approaches Using MSC's. Conference. 19th ISCT Annual Meeting. Auckland, NZ.
- 2012. Cord Blood Expansion. Conference. Nobel conference Hematopoietic Stem Cells: From Basic Science to Regenerative Medicine. Stockholm, SE.
- 2012. Expansion of Cord Blood-derived Stem Cells in Co-cultures with MSCs. Conference. ESH-EHA Scientific Workshop on Anti-Inflammatory & Immune Modulatory properties of MSCs. Cannes Mandelieu, FR.
- 2012. Cord Blood Transplantation. Conference. 38th Annual Meeting of the European Group for Blood and Marrow Transplantation. Geneva, CH.
- 2011. Anti-leukemia NK cells. Conference. ESH European School of Haematology. Rome, IT.
- 2011. Ex Vivo Expansion of CB Cells: Is still a possible option. Conference. ESH European School of Haematology. Rome, IT.
- 2011. Challenges in Stem Cell Mobilization. Conference. The Medal Group Corporation. Bangkok, TH.
- 2011. Reduced Intensity Conditioning Transplant in AML and role of post-transplant maintenance therapy. Conference. The Medal Group Corporation. Bangkok, TH.
- 2011. Updated Results on Cord Blood vs MUD Transplant. Conference. The Medal Group Corporation. Singapore, SG.
- 2011. Current Chemotherapy Protocols and Their Impact on Invasive Fungal Infections. Conference. The Medal Group Corporation. Singapore, SG.
- 2010. Transplantation Dreaming. Conference. 15th Congress of EHA, European Alliance for Therapy of CLL. Barcelona, ES.
- 2010. Overview of Cell and BioBanking, and Good Manufacturing Practice (GMP). Conference. 14th Congress of EHA & American Society of Hematology. Barcelona, ES.
- 2010. In Vitro Cord Blood HSC Expansion. Conference. First International conference on Hematopoietic Stem Cell Transplantation Focus on Alternative Donors. Sao Paulo, BR.
- 2010. Cord Blood Banking. Conference. First International Conference on Hemaopoietic Stem Cell Transplantation Focus on Alternative Donors. Sao Paulo, BR.
- 2010. Cord Blood Transplantation. Conference. Cord Blood Transplantation. Taipei, TW.
- 2010. Overcoming Challenges in Cord Blood Transplant and Cord Blood Banking. Conference. National University Cancer Institute. Singapore, SG.
- 2010. Role of Transplant in CLL. Conference. First International Hematologic Malignancies Conference"Bridging the Gap 2010". Singapore, SG.
- 2009. Mesenchymal Stem Cell Based Cord Expansion Trail Cell Working Group at EBMT. Conference. EBMT 35 Annual Meeting of the European Group for Blood & Marrow Transplantation. Goteborg, SE.
- 2009. The Future of Cord Blood Transplantation. Conference. Annual International conference Sheba. Israel, IL.
- 2008. Current Status of Umbilical Cord Blood Transplantation: Biology, Banking and Clinical Practice,. Conference. AABB Annual Meeting & TXPO 2008. Montreal, CA.
- 2008. MSC and Cord Blood expansion. Conference. International ESH-EHA Scientific Workshop Biology and Clinical Applications of Mesenchymal Stem Cells. Paris De Gaulle, FR.
- 2007. The Mesenchymal Cells. Conference. Biology and Clinical Applications of Cord Blood Cells,International workshop. Paris, FR.
- 2006. Cord Blood Mesenchymal Stem Cells Co-Cultures. Conference. Biology and Clinical Applications of Mesenchymal Stem Cells, International workshop. Mandeliu La Napoule, FR.
- 2004. Cord Blood Transplantation. Conference. 8th,Tokyo Intl Symposium on Cord Blood Transplantation. Tokyo, JP.
- 2004. Title not provided. Conference. EBMT Conference. Barcelona, ES.
- 2002. The Ex Vivo Expansion of Cord Blood. Conference. International Society of Cell Therapy (ISCT. Barcelona, ES.
- 2002. Evaluation of Clinical Transplant Facilities. Conference. Seminar on Joint Accreditation Committee of ISCT and EBMT. Barcelona, ES.
- 2001. Cord Blood Banking and Ex Vivo Expansion. Conference. Israeli Symposium on Tissue Banking (EABT) – Eilat, IL.
- 2000. Cord Blood Transplantation. Conference. Forum on Canadian National Policy for Stem Cell Transplantation. Ottawa, CA.
- 2000. Cord Blood Transplantation” and “Transplants for Non-Hodgkin’s Lymphoma. Conference. South American Symposium on Bone Marrow Transplantation. Curitiba, BR.
- 2000. The Ex Vivo Expansion of Cord Blood. Conference. Eurocord International Symposium on Stem Cell Transplantation. Paris, FR.
- 2000. The University of Colorado Experience with Expanded Cord Blood”. Conference. Tokyo 5th International Symposium of Cord Blood Transplantation. Tokyo, JP.
- 2000. Breast Cancer: Who should go to transplant. Conference. Annual Meeting of the Canadian Bone Marrow Transplant Group. Quebec, CA.
- 1999. University of Colorado Cord Blood Banking and Transplant Experience. Conference. Netcord International Meeting on Cord Blood Banking and Transplantation. Dusseldorf, DE.
- 1999. The Ex Vivo Expansion of Cord Blood for the Clinic. Conference. Eurocord Meeting on Stem Cell Transplantation. Annency, FR.
Formal Peers
- 2022. Board of Directors Meeting. Invited. Minneapolis, MN, US.
- 2022. Mesenchymal Stem Cell (MSC)-Based Therapy for the Clinic. Invited. Rehovot, IL.
- 2022. Chair, Scientific Advisory Board. Invited. Chicago, IL, US.
- 2021. What to do with the cord blood "sleeping" inventory: practical perspectives. Invited. Virtual, US.
- 2021. Cord Blood: Forerunners and New Horizons. Invited. New York, NY, US.
- 2018. The management of CAR T cell toxicities. Invited. Leiden, DE.
- 2018. Cord blood expansion and cellular therapy. Invited. Leiden, DE.
- 2017. CAR-T cells: A new breakthrough in cancer research. Invited. Houston, US.
- 2017. Cord Blood Transplantation. Invited. Vancouver, CA.
- 2017. Harnessing the immune system to treat hematological malignancies. Invited. Columbus, OH, US.
- 2014. Novel strategies for enhanced engraftment and adoptive therapy following cord. Invited, IL.
- 2013. The Future of Cord Blood Cell Therapy. Invited. Minneapolis, MN, US.
- 2013. Umbilical cord blood cell expansion platforms. Invited. Columbus, OH, US.
- 2011. ASBMT Corporate Council Meeting. Invited. Phoenix, AZ, US.
- 2010. Advances in Umbilical Cord Blood Transplantation. Invited. New York, NY, US.
- 2009. Umbilical Cord Blood Banking and Transplantation. Invited. Indian Wells, CA, US.
- 2009. Future of Cord Blood Transplantation. Invited. Miami, FL, US.
- 2008. Roundtable on Clinical Endpoints for Phase III Trials in Acute GVHD. Invited. Baltimore, MD, US.
- 2008. Cord Blood Transplant Grant. Invited. Washington, DC, US.
- 2006. Cord Blood Expansion. Invited. Seattle, WA, US.
- 2006. Cord Blood Transplantation and Expansion. Invited. Salt Lake City, UT, US.
- 2004. Cord Blood Transplantation. Invited. San Antonio, US.
- 2002. High-Dose Therapy for Breast Cancer Patients. Invited. Palo Alto, CA, US.
- 2000. Cord Blood Banking Collection Facilities. Invited. New York, NY, US.
- 2000. High-Dose Therapy for Breast Cancer Patients. Invited. Los Angeles, CA, US.
- 2000. High-Dose Therapy for Breast Cancer. Invited. La Jolla, CA, US.
- 1999. Future Directions in Hematopoietic Cell Therapy for Breast Cancer Patients. Invited. Boston, MA, US.
Grant & Contract Support
| Date: | 2026 - 2031 |
| Title: | Advancing TGFâ-Resistant CAR-NK Cell Therapy for Acute Myeloid Leukemia |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | GRANT14505169 |
| Date: | 2024 - 2029 |
| Title: | TROP2-Directed CAR-NK Cells for the Immunotherapy of Pancreatic Cancer |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | R01# (GRANT13900291) |
| Date: | 2024 - 2029 |
| Title: | Transplantation of T and B cell depleted lung cells for the treatment of IPF patients |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | R61/R33# |
| Date: | 2024 - 2025 |
| Title: | NO TITLE PROVIDED |
| Funding Source: | NIH |
| Role: | Major User |
| ID: | 1S10OD036354-01 |
| Date: | 2023 - 2025 |
| Title: | A Novel Transplant Conditioning Regimen to Enhance Anti-leukemia Immunity |
| Funding Source: | NIH/NCI |
| Role: | Other Significant Contributor |
| Date: | 2023 - 2028 |
| Title: | Ex Vivo Engineering of Platelets and platelet progenitor cells from cord blood for the treatment of thrombocytopenia |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | 2 R01CA061508 |
| Date: | 2023 - 2028 |
| Title: | The University of Texas MD Anderson Cancer Center SPORE in Ovarian Cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| Date: | 2023 - 2028 |
| Title: | SIK2 enhances PARP inhibitor sensitivity in ovarian cancer |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 1 P50 CA281701-01 |
| Date: | 2022 - 2023 |
| Title: | Priority Project 3: B-Cell MoonShot (NHL) |
| Funding Source: | UTMDACC |
| Role: | CO-I |
| Date: | 2021 - 2023 |
| Title: | Next Generation Cellular Therapies in Myelodysplastic and Acute Myeloid Leukemia |
| Funding Source: | UTMDACC/AML Moonshot |
| Role: | CO-I |
| Date: | 2021 - 2023 |
| Title: | Translational development of AFM24-loaded, CAR-like NK cells for pancreatic cancer therapy |
| Funding Source: | UTMDACC/PDAC Moonshot |
| Role: | CO-I |
| Date: | 2021 - 2023 |
| Title: | Harnessing Innate Immunity with CAR-NK |
| Funding Source: | UTMDACC/CLL Moonshot |
| Role: | CO-I |
| Date: | 2021 - 2023 |
| Title: | NK Cell Immunotherapy for colorectal cancer |
| Funding Source: | UTMDACC/CRC Moonshot |
| Role: | CO-I |
| Date: | 2021 - 2023 |
| Title: | Novel Natural killer Cell Based Therapies for High-Risk Multiple Myeloma |
| Funding Source: | UTMDACC/HRMM Moonshot |
| Role: | CO-I |
| Date: | 2021 - 2023 |
| Title: | Next Generation Engineered NK Cells for Lymphoma Patients after CAR19 T Cell Failure |
| Funding Source: | UTMDACC/NHL-B-Cell Moonshot |
| Role: | CO-I |
| Date: | 2020 - 2022 |
| Title: | Pancreatic Moonshot Flagship Project |
| Funding Source: | UTMDACC |
| Role: | CO-I |
| Date: | 2020 - 2025 |
| Title: | SPORE in Brain Cancer: Off-the-shelf Genetically Engineered Natural Killer Therapy for Glioblastoma |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 5P50CA127001-14 |
| Date: | 2020 - 2022 |
| Title: | Colorectal Cancer Research Moonshot Project |
| Funding Source: | UTMDACC |
| Role: | CO-I |
| Date: | 2019 - 2026 |
| Title: | Bispecific NK Engager (AFM13) combined with cord blood-derived NK cells for refractory Hodgkin and other CD30+ lymphomas |
| Funding Source: | Affimed |
| Role: | CO-I |
| Date: | 2019 |
| Title: | National Cord Blood Inventory (DHHS/HRSA) |
| Funding Source: | Cord Blood Bank Protocol |
| Role: | PI |
| ID: | HHSH75R60219C0004 |
| Date: | 2019 - 2023 |
| Title: | SPORE University of Texas M.D. Anderson Cancer Center-Leukemia |
| Funding Source: | NIH/NCI |
| Role: | Program Director/Principal Investigator |
| ID: | 5P50CA100632-20 |
| Date: | 2019 - 2023 |
| Title: | ACT Moonshot Cell Therapy Project |
| Funding Source: | UTMDACC |
| Role: | Co-PI |
| Date: | 2019 |
| Title: | National Cord Blood Inventory (DHHS/HRSA) |
| Funding Source: | Cord Blood Bank Protocol |
| Role: | PI |
| ID: | HHSH75R60219C0004 |
| Date: | 2019 |
| Title: | National Cord Blood Inventory (DHHS/HRSA) |
| Funding Source: | Cord Blood Bank Protocol |
| Role: | PI |
| ID: | HHSH75R60219C0004 |
| Date: | 2019 - 2020 |
| Title: | CCSG Administrative Supplement for Cell-based Immunotherapies |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | P30CA016672 |
| Date: | 2019 - 2025 |
| Title: | Cancer Center Support Grant |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | P30 CA166745 |
| Date: | 2019 - 2025 |
| Title: | Stem Cell and Cellular Therapy Research Program |
| Funding Source: | NIH/CCSG |
| Role: | Project Leader |
| ID: | 5P30 CA016672 |
| Date: | 2019 - 2022 |
| Title: | Cancer Center Support (CORE) Grant |
| Funding Source: | NIH/CCSG |
| Role: | CO-I |
| ID: | 3 P30 CA016672-41S8 |
| Date: | 2019 - 2023 |
| Title: | Tailoring CAR-based Immunotherapy Strategies to T Cell Lymphoma |
| Funding Source: | BCM/Stand Up to Cancer (SU2C) |
| Role: | CO-I |
| ID: | 6438 |
| Date: | 2018 - 2025 |
| Title: | Novel Cord Blood Derived Cellular Therapies |
| Funding Source: | NIH/NCI |
| Role: | Program Leader |
| ID: | 5P01CA148600-11 |
| Date: | 2017 - 2021 |
| Title: | Blood Derived NK Cells, 6555-18 |
| Funding Source: | Leukemia and Lymphoma Society |
| Role: | Co-PI |
| Date: | 2017 - 2022 |
| Title: | Glioblastoma Moonshot Project |
| Funding Source: | UTMDACC |
| Role: | CO-I |
| Date: | 2017 - 2022 |
| Title: | HRMM Moonshot Project |
| Funding Source: | UTMDACC |
| Role: | CO-I |
| Date: | 2016 - 2019 |
| Title: | Preclinical studies to Optimize the NK cell-AFM13 product for clinical use; perform scale-up and validations studies; obtain FDA and IRB approval; conduct a phase I-II clinical trial |
| Funding Source: | Affimed |
| Role: | CO-I |
| Date: | 2016 - 2021 |
| Title: | The CXCL12-CXCR-STAT3 Pathway and Regulation of the CLL Immune Microenvironment |
| Funding Source: | CLL Global Foundation |
| Role: | PI |
| ID: | FP000000429 |
| Date: | 2016 - 2024 |
| Title: | Hematopoietic Progenitor Cells - Cord Blood |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| ID: | 5R01CA061508-25 |
| Date: | 2016 - 2021 |
| Title: | Acute Myeloid Leukemia in the Immunosuppressed Microenvironment - Project 2: Immunotherapy for AML Using Off-the-Shelf and Engineered Cord Blood-Derived Natural Killer Cells |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | CO-I |
| ID: | RP160693 |
| Date: | 2016 - 2021 |
| Title: | Off-the-shelf engineered NK cells for the treatment of AML |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 5 R01 CA211044-05 |
| Date: | 2016 - 2019 |
| Title: | Targeting Cytomegalvirus as a Novel for Immunotherapy of Glioblastoma Multiforme |
| Funding Source: | Gateway Foundation |
| Role: | CO-I |
| Date: | 2016 - 2018 |
| Title: | Enhanced homing of hematopoietic stem cells to marrow with enforced endothelial protein C receptor signaling and fucosylation |
| Funding Source: | SNIF |
| Role: | PI |
| Date: | 2016 - 2025 |
| Title: | The TMC Regenerative Medicine Studies, MSC Cardiology and Brain Studies |
| Funding Source: | UTMDACC/TMC |
| Role: | PI |
| Date: | 2015 - 2018 |
| Title: | Strategic Alliance- Cytomx CAR NK Cells-Project 1 |
| Funding Source: | CYTOMX |
| Role: | Co-PI |
| ID: | RCTS 00051908 |
| Date: | 2015 - 2023 |
| Title: | CLL Moonshot Flagship Project |
| Funding Source: | UTMDACC |
| Role: | PI |
| Date: | 2015 - 2023 |
| Title: | Priority Project 3: Allogeneic Genetically Engineered Natural Killer Therapy forGlioblastoma (GBM) |
| Funding Source: | UTMDACC/GBM |
| Role: | CO-I |
| Date: | 2015 - 2020 |
| Title: | Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke |
| Funding Source: | Duke University |
| Role: | PI |
| ID: | 16012290 |
| Date: | 2015 - 2019 |
| Title: | Role of the Gastrointestinal Microbiome in Cancer Patient Care |
| Funding Source: | MRP-UTMDACC |
| Role: | PI |
| ID: | 13015245/ 2015-13015245-Y1 |
| Date: | 2015 - 2018 |
| Title: | A Phase I/II Clinical Trial to Investigate Fucosylated Tregs in Prevention of GVHD |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| Date: | 2015 - 2018 |
| Title: | Novel Correlative Studies for Ongoing MD Anderson Eltrombopag Trials |
| Funding Source: | Novartis |
| Role: | PI |
| Date: | 2015 - 2016 |
| Title: | Immunotherapy for CLL Using Off-the-Shelf Cord Blood-Derived Natural Killer Cells |
| Funding Source: | Katz Foundation |
| Role: | PI |
| Date: | 2014 - 2023 |
| Title: | A Phase II Trial of Mesenchymal Stem Cells for Treatment of Acute Respiratory Distress |
| Funding Source: | Katz Foundation |
| Role: | PI |
| Date: | 2014 - 2016 |
| Title: | Immune Reconstitution during Ibrutinib Therapy |
| Funding Source: | Pharmacyclics |
| Role: | CO-I |
| Date: | 2014 - 2017 |
| Title: | Investigation of ex vivo fucosylation to enhance the efficacy of adoptive T cell immunotherapy |
| Funding Source: | Leukemia and Lymphoma Society |
| Role: | CO-I |
| ID: | P-TRP-1997-14 |
| Date: | 2014 - 2017 |
| Title: | The role of regulatory T cells in ALS |
| Funding Source: | Methodist Hospital Research Institute |
| Role: | CO-I |
| ID: | 12967 |
| Date: | 2014 - 2017 |
| Title: | CMV Adoptive T cell Therapy for GBM patients |
| Funding Source: | The GBM Moonshot |
| Role: | CO-I |
| Date: | 2014 - 2018 |
| Title: | CMV Adoptive T cell Therapy |
| Funding Source: | Rose Foundation |
| Role: | CO-I |
| Date: | 2014 - 2023 |
| Title: | MDS/AML Moonshot Cell Therapy Project |
| Funding Source: | UTMDACC |
| Role: | CO-I |
| Date: | 2014 - 2016 |
| Title: | All-in-One Purification and Engineering of Therapeutic Cell Systems |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 5R21EB017384-02 |
| Date: | 2014 - 2017 |
| Title: | Fucosylated Regulatory T Cells Prevent Graft Versus Host Disease |
| Funding Source: | Katz Foundation |
| Role: | PI |
| ID: | 12054 |
| Date: | 2014 - 2016 |
| Title: | Curative cell-based therapies for chronic lymphocytic leukemia (CLL) |
| Funding Source: | Sister Institution Network Fund Grant |
| Role: | CO-I |
| Date: | 2013 - 2015 |
| Title: | Phase 1 Study of Umbilical Cord Blood-Derived T Cells in Malignant B Cells |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 5R01FD004369-02 |
| Date: | 2013 - 2017 |
| Title: | NiCord® Sickle Cell Pilot Study |
| Funding Source: | Gamida Cell Ltd |
| Role: | PI |
| Date: | 2013 - 2017 |
| Title: | NO TITLE PROVIDED |
| Funding Source: | Gamida Cell Ltd. NiCord® Sickle Cell Pilot Study |
| Role: | PI |
| Date: | 2013 - 2016 |
| Title: | Project 3: Target GD2+ BCSCs using T-cells expressing GD2-specific chimeric antigen receptors (CARs) |
| Funding Source: | Institutional Support, Multidisciplinary Research |
| Role: | CO-I |
| Date: | 2013 - 2018 |
| Title: | Cord Blood Cells Ex Vivo Expanded with MPCs (Clinical Supply) |
| Funding Source: | Mesoblast, Inc |
| Role: | PI |
| ID: | 00000783 |
| Date: | 2013 - 2018 |
| Title: | Cord Blood Cells Ex Vivo Expanded with MPC's (Clinical) |
| Funding Source: | Mesoblast, Inc |
| Role: | PI |
| ID: | 00000572 |
| Date: | 2012 - 2016 |
| Title: | Activation and expansion of NK cells in chronic lymphocytic leukemia (CLL) for adoptive therapy |
| Funding Source: | CLL Global Research Foundation |
| Role: | PI |
| ID: | 12114776 |
| Date: | 2012 - 2015 |
| Title: | CD19-Specific T-Cell Therapy after Cord Blood Transplantation |
| Funding Source: | Food and Drug Administration (FDA) |
| Role: | CO-I |
| ID: | 1439 |
| Date: | 2012 - 2017 |
| Title: | Imaging T cells by positron emission tomography |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 5R01CA163587-04 |
| Date: | 2011 - 2017 |
| Title: | Improving Cord Blood Transplantation |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | 5 P01 CA148600-06 |
| Date: | 2011 - 2017 |
| Title: | Improving Cord Blood Transplantation (Core A) |
| Funding Source: | NIH/NCI |
| Role: | Core Leader |
| ID: | 1 P01 CA148600-10 |
| Date: | 2011 - 2017 |
| Title: | Improving Cord Blood Transplantation (PP-1) |
| Funding Source: | NIH/NCI |
| Role: | Project Leader |
| ID: | 1 P01 CA148600-10 |
| Date: | 2011 - 2023 |
| Title: | Novel Cord Blood Derived Cellular Therapies (Core C) |
| Funding Source: | NIH/NCI |
| Role: | Core Co-Investigator |
| ID: | 1 P01 CA148600-11 |
| Date: | 2011 - 2016 |
| Title: | MIRA-Cellular Therapy for Cancer GMP Core 2 |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| ID: | RP110619 (RP110553C2) |
| Date: | 2011 - 2016 |
| Title: | Adoptive Immunotherapy With NK Cells Expanded Ex Vivo For Treatment of Hematopoietic Malignancies |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | CO-I |
| ID: | RP110553-P3 |
| Date: | 2010 - 2017 |
| Title: | SPORE in Human Cancers for the Years 2008 and 2009 (PP-1) |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| ID: | 5P50 CA142509-05 |
| Date: | 2010 - 2014 |
| Title: | Improving Cord Blood Expansion and Homing for Patients with Cancer |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| ID: | RP100469-01 |
| Date: | 2010 - 2013 |
| Title: | Cord Blood Natural Killer Cells for Patients with Cancer |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| ID: | HIRP100430-01 |
| Date: | 2010 - 2012 |
| Title: | Cord Blood Banking |
| Funding Source: | National Marrow Donor Program |
| Role: | PI |
| ID: | 19146 |
| Date: | 2010 - 2012 |
| Title: | Validation of Stem Cell Potency Assays |
| Funding Source: | NMDP Collaborative Agreement |
| Role: | PI |
| ID: | 19146 01 |
| Date: | 2010 - 2011 |
| Title: | Ex vivo Expansion of Cord Blood Natural Killer cells for CLL Therapy |
| Funding Source: | CLL Global Research Foundation |
| Role: | PI |
| ID: | LAB02-630 |
| Date: | 2009 - 2011 |
| Title: | Improving Survivial of Cord Blood Transplant Patients, Baylor College of Medicine-MD Anderson Multi-Institutional Research Project |
| Funding Source: | BCM-MDACC MRP |
| Role: | PI |
| ID: | U54HL081007-05 |
| Date: | 2009 - 2011 |
| Title: | Cord Blood Collection for Translational Research |
| Funding Source: | American Stem Cell, Inc. (ASC) |
| Role: | PI |
| ID: | LS2009-00027280EB |
| Date: | 2009 - 2012 |
| Title: | Immune reconstitution after cord blood transplantation |
| Funding Source: | NIH/NHLBI |
| Role: | CO-I |
| ID: | 5R01HL091749-04 |
| Date: | 2008 - 2010 |
| Title: | Extracorporeal Thermo-ablation of Circulating Cancer Cells/Stem Cells Using Targe |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | IR43 CA 132420-01 |
| Date: | 2008 - 2012 |
| Title: | Cord Blood Expansion on Meseynchymal Stem Cells |
| Funding Source: | Angioblast Systems Inc |
| Role: | PI |
| ID: | CS2008-00023693JW |
| Date: | 2008 - 2011 |
| Title: | Activation and Expansion of Chronic lymphocytic leukemia (CLL) specific T-cells |
| Funding Source: | CLL Global Research Foundation |
| Role: | CO-I |
| ID: | CS2007-00021455RG |
| Date: | 2008 - 2014 |
| Title: | Activation & Expansion of CLL specific T-cells to study the immune reconstitution following Infusion of CD3/CD28 bead- activated and expaned T cells in patients with chronic lymphocytic leukemia following alemtuzumab based therapy |
| Funding Source: | CLL Global Research Foundation |
| Role: | CO-I |
| Date: | 2007 - 2012 |
| Title: | Translational Development of Novel Vaccine Therapies |
| Funding Source: | Leukemia and Lymphoma Society |
| Role: | Core D Leader |
| ID: | 7262-08-04-06-061-32 |
| Date: | 2007 - 2013 |
| Title: | Adoptive Immunotherapy After Umbilical Cord Blood Transplant |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 5R01CA124782-05 |
| Date: | 2007 - 2009 |
| Title: | Ex Vivo Expansion to Improve Survival following cord Blood Transplantation |
| Funding Source: | Carl C. Anderson Sr. & Marie Jo Anderson Charitable Foundation |
| Role: | PI |
| Date: | 2007 - 2009 |
| Title: | Ex Vivo Expansion to Improve Survival following cord Blood Transplantation |
| Funding Source: | Gillson-Longenbaugh Foundation |
| Role: | PI |
| ID: | HL087365 |
| Date: | 2007 - 2012 |
| Title: | Cord blood expansion with a copper chelator and a primitive cytokine regimen |
| Funding Source: | Gamida Cell |
| Role: | PI |
| ID: | CS2006-00018273AB |
| Date: | 2007 - 2011 |
| Title: | Enhancing the efficacy of CD19-Specific Cord Blood-Derived T Cells |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | R01CA120956 |
| Date: | 2007 - 2011 |
| Title: | Cardiovascular Cell Therapy Research Network |
| Funding Source: | NHLBI |
| Role: | CO-I |
| ID: | HL087365-01 |
| Date: | 2006 - 2021 |
| Title: | Cord Blood Bank Protocol |
| Funding Source: | Department of Health and Human Services, Health Resources and Services Administration |
| Role: | PI |
| ID: | HSHH234200737001C |
| Date: | 2006 - 2028 |
| Title: | National Cord Blood Inventory |
| Funding Source: | Department of Health and Human Services, Health Resources and Services Administration (DHHS/HRSA) |
| Role: | PI |
| ID: | HSHH250201000011C |
| Date: | 2006 - 2010 |
| Title: | Expansion of hematopoietic progenitor cells for transplantation in patients with hematologic malignancies |
| Funding Source: | The Katz Foundation |
| Role: | PI |
| ID: | 1260603 |
| Date: | 2006 - 2016 |
| Title: | Cord Blood Expansion on Mesenchymal Stem Cells |
| Funding Source: | Viacell |
| Role: | PI |
| ID: | CS2006-00015733 |
| Date: | 2006 - 2007 |
| Title: | The Propagation and Evaluation of Umbilical Cord Blood-Derived Megakaryoccyte Progenitors |
| Funding Source: | JP McCarthy Foundation Grant |
| Role: | Project Leader |
| Date: | 2006 - 2010 |
| Title: | Cord Blood Banking |
| Funding Source: | Cockrell Foundation |
| Role: | PI |
| Date: | 2005 - 2011 |
| Title: | UTMDACC SPORE in Breast Cancer (PP-3) |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | 5P50CA116199-05 |
| Date: | 2005 - 2010 |
| Title: | Specialized Center for Cell Based Therapy |
| Funding Source: | NIH |
| Role: | Project Leader |
| ID: | U54#HL081030-01 |
| Date: | 2005 - 2007 |
| Title: | Induction of CTLs against CTCL by dendritic cells loaded with amplified tumor RNA |
| Funding Source: | Ladies Leukemia League |
| Role: | CO-I |
| Date: | 2005 - 2007 |
| Title: | Induction of CTLs against CTCL by dendritic cells loaded with amplified tumor RNA |
| Funding Source: | Dermatology Research |
| Role: | CO-I |
| Date: | 2005 - 2008 |
| Title: | The Expansion, Transduction and Molecular Imaging and of Porcine Marrow-Derived Mesenchymal Stem Cells |
| Funding Source: | Texas Heart Institute |
| Role: | PI |
| ID: | LS2006-00016055-01 |
| Date: | 2004 - 2007 |
| Title: | MD Anderson Multi-Institutional Research |
| Funding Source: | MDACC |
| Role: | PI |
| ID: | MD Anderson Multi-Institutional Research |
| Date: | 2004 - 2007 |
| Title: | A Novel Autograft Purging Strategy for CML |
| Funding Source: | NCI |
| Role: | CO-I |
| ID: | R21CA108137-01 |
| Date: | 2003 - 2005 |
| Title: | Strategies for effective ex vivo priming of cutaneous T-cell lymphoma -specific cytotoxic T lymphocytes by autologous dendritic cells pulsed with whole tumor cells |
| Funding Source: | Dermatology Foundation |
| Role: | CO-I |
| Date: | 2002 - 2005 |
| Title: | Ex vivo Expanded Cord Blood Cells |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | NIH-NHLBI; RO1 # CA88878 |
| Date: | 2002 - 2007 |
| Title: | Human Hematopoietic Precursor Cells |
| Funding Source: | NHLBI |
| Role: | CO-I |
| ID: | HL61382-07 |
| Date: | 1999 - 2015 |
| Title: | NIH SPORE in Ovarian Cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-Leader-Project 5 |
| ID: | 5P50 CA83639-15 |
| Date: | 1997 - 2016 |
| Title: | Therapy of Chronic Myelogenous Leukemia (CML)- Core E |
| Funding Source: | NIH/NCI |
| Role: | Core Leader-Core E |
| ID: | 5P01CA49696-25 |
| Date: | 1997 - 2016 |
| Title: | The Therapy of CML, Project 2 |
| Funding Source: | NIH/NCI |
| Role: | CO-I |
| ID: | PO1 CA49639 |
| Title: | SPORE in Brain Cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 2 P50CA127001-01 |
Selected Publications
Peer-Reviewed Articles
- Smallbone P, Cao K, Saliba RM, Carmarzzi Y, Al-Atrash G, Alvarez M, Rondon G, Fingrut WB, Aljawai YM, Olson AL, Alousi AM, Chen GL, Tanner MR, Zou J, Ramdial JL, Champlin RE, Shpall EJ, Oran B. Reduced relapse in high risk acute myeloid leukemia and myelodysplastic neoplasms with permissive HLA-DPB1 mismatches and post-transplant cyclophosphamide. Leukemia, 2026. e-Pub 2026. PMID: 41803402.
- Lin P, Acharya S, Reyes-Silva F, Basar R, Uprety N, Moreno Rueda LY, Lin P, Gilbert AL, Banerjee PP, Fang D, Zhang C, Nunez Cortes AK, Melo Garcia L, Daher M, Muniz-Feliciano L, Deyter GM, Woods V, Rawal S, Li P, Jones CM, Shrestha R, Qazilbash MH, Patel KK, Lee HC, Champlin RE, Marin D, Shpall EJ, Orlowski RZ, Rezvani K. CD70-Targeting CAR NK Cells Overcome BCMA Downregulation and Improve Survival in High-risk Multiple Myeloma Models. Blood Cancer Discov 7(2):234-249, 2026. e-Pub 2026. PMID: 41144785.
- Mehta RS, Aljawai YM, Kebriaei P, Cao K, Zou J, Carmazzi Y, Rondon G, Oran B, Popat U, Rezvani K, Champlin RE, Shpall EJ. Development and explainable AI-driven characterization of a prognostic model for haploidentical transplantation outcomes. NPJ Digit Med, 2026. e-Pub 2026. PMID: 41772139.
- Pasvolsky O, Marcoux C, Milton DR, Haider AA, Tanner MR, Bashir Q, Srour S, Saini N, Smallbone P, Lin P, Ramdial J, Nieto Y, Mohamedi AH, Siddiqui UR, Jamil A, Tang G, Aljawai Y, Lee HC, Patel KK, Kebriaei P, Thomas SK, Orlowski RZ, Champlin RE, Shpall EJ, Qazilbash MH. Results of delayed or salvage autologous hematopoietic stem cell transplantation for multiple myeloma. Bone Marrow Transplant 61(3):294-302, 2026. e-Pub 2026. PMID: 41350936.
- Smallbone P, Mendt M, Sackstein R, Tanner MR, Kaur I, Basar R, Rafei H, Daher M, Overman B, Al-Atrash G, Alousi AM, Bashir Q, Hosing CM, Im JS, Kebriaei P, Banerjee P, Patel KP, Zou J, Cao K, Khouri I, Mehta R, Molldrem J, Nieto Y, Oran B, Popat UR, Qazilbash MH, Rondon G, Saini N, Srour S, Champlin RE, Rezvani K, Shpall EJ, Olson A. Ex vivo mesenchymal progenitor cell-based cord blood cell expansion and exofucosylation to enhance transplant engraftment. Cytotherapy 28(3):102010, 2026. e-Pub 2026. PMID: 41396090.
- Mehta RS, Aljawai YM, Kebriaei P, Rondon G, Fingrut W, Smallbone P, Oran B, Olson A, Champlin RE, Shpall EJ. Modeling donor age and type trade-offs for personalized selection in allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide prophylaxis. Leukemia 40(3):502-510, 2026. e-Pub 2026. PMID: 41526616.
- Olson A, Li YE, Basar R, Banerjee P, Kaur I, Abueg G, Sylejmani M, Uprety N, Shrestha R, Silva FR, Page V, Champlin RE, Kontoyiannis DP, Chemaly RF, Shpall EJ, Moore L, Gaber OA, Rezvani K, Abudayyeh A. Role of BK Virus CTLs in the Treatment of BK Virus-Associated Nephropathy in Kidney-Transplant and Hematopoietic Cell Transplant Recipients. Transpl Infect Dis:e70178, 2026. e-Pub 2026. PMID: 41645606.
- Subramanian, N, Garcia Pleitez, H, Nguyen, D, Milton, D, Kebriaei, P, Shpall, E, Cheng, L, Lu, J, Jin, S, Wu, CC, Sheth, RA, Ferrajoli, A, Hanzelka, KM, Kroll, M, Rojas Hernandez, CM. Automated natural language processing to identify venous thromboembolism from diagnostic imaging reports. Blood Vessels, Thrombosis and Hemostasis 3(1), 2026. e-Pub 2026.
- Senapati, J, Croden, J, Garcia-Manero, G, Takahashi, K, Daver, N, Kadia, TM, Borthakur, G, Short, NJ, Jabbour, EJ, Haddad, FG, Marvin-Peek, J, Abbas, HA, Bose, P, Tang, G, Loghavi, S, Shpall, E, Ramdial, JL, Popat, UR, Champlin, RE, Ravandi-Kashani, F, Kantarjian, HM, DiNardo, C. Outcomes of therapy-related non-core binding factor acute myeloid leukemia with venetoclax-based therapies. HemaSphere 10(2), 2026. e-Pub 2026. PMID: 41694734.
- Subramanian N, Garcia Pleitez H, Nguyen D, Milton DR, Kebriaei P, Shpall E, Cheng L, Lu J, Jin S, Wu CC, Sheth RA, Ferrajoli A, Toale KM, Kroll MH, Rojas-Hernandez CM. Automated natural language processing to identify venous thromboembolism from diagnostic imaging reports. Blood Vessel Thromb Hemost 3(1):100122, 2026. e-Pub 2026. PMID: 41503124.
- Senapati J, Croden J, Garcia-Manero G, Takahashi K, Daver NG, Kadia TM, Borthakur G, Short NJ, Jabbour E, Haddad F, Marvin-Peek J, Abbas HA, Bose P, Tang G, Loghavi S, Shpall EJ, Ramdial J, Popat UR, Champlin RE, Ravandi F, Kantarjian HM, Dinardo CD. Outcomes of therapy-related non-core binding factor acute myeloid leukemia with venetoclax-based therapies. Hemasphere 10(2):e70317, 2026. e-Pub 2026. PMID: 41694734.
- Haider AA, Marcoux C, Milton DR, Tanner MR, Bashir Q, Smallbone P, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Tang G, Mohamedi AH, Siddiqui UR, Aljawai Y, Kebriaei P, Lee HC, Ye C, Patel KK, Thomas SK, Orlowski RZ, Champlin RE, Shpall EJ, Qazilbash MH, Pasvolsky O. Lenalidomide maintenance after delayed or salvage autologous stem cell transplantation. Leuk Lymphoma:1-9, 2026. e-Pub 2026. PMID: 41608977.
- Fan C, Hayase T, Chang CC, Glover IK, Flores II, McDaniel LK, Ortega MR, Sanchez CA, El-Himri RK, Brown AN, Karmouch JL, Jamal MA, Ahmed SS, Halsey TM, Jin Y, Tsai WB, Prasad R, Enkhbayar A, Mohammed A, Schmiester M, Damania AV, Ajami NJ, Wargo JA, Peterson CB, Rondon G, Al-Juhaishi T, Alousi AM, Molldrem JJ, Champlin RE, Shpall EJ, Martens E, Arias CA, Jenq RR, Hayase E. Fecal carbohydrate-degrading bacteria are associated with reduced incidence of lower gastrointestinal GVHD. Blood Adv, 2026. e-Pub 2026. PMID: 41558030.
- Nieto Y, Ward JF, Hofstetter W, Rice D, Karam JA, Pisters L, Vauthey JN, Shah A, Lin JK, Johns AC, Araujo J, Tu SM, Wang J, Li J, Abudayyeh A, Thall PF, Bassett R, Barnett M, Gulbis A, Shigle TL, Ramdial J, Popat U, Qazilbash M, Jones RB, Andersson BS, Shpall EJ, Sheikh I, Pagliaro L, Campbell MT. High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors. Clin Cancer Res 32(2):300-311, 2026. e-Pub 2026. PMID: 40853903.
- Greenbaum U, Hashmi H, Elsawy M, Kim S, Moskop A, Oloyede T, Awan FT, Bachanova V, Badar T, Bar M, Barba P, Beitinjaneh AM, Cashen A, Dholaria B, Farooq U, Foglesong J, Ganguly S, Hematti P, Hill LC, Jain MD, Jain T, Kebriaei P, Kittai AS, Locke FL, Lulla PD, McGuirk JP, Mead E, Mussetti A, Nishihori T, Olson AL, Pennisi M, Perales MA, Geethakumari PR, Riedell PA, Saber W, Shouval R, Shpall EJ, Magalhaes-Silverman M, Strouse C, Turtle CJ, Vallurupalli A, Wudhikarn K, Pasquini MC, Ahmed S, Sorror M. New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma. Blood Adv 10(1):217-227, 2026. e-Pub 2026. PMID: 40811818.
- Mehta RS, Aljawai YM, Kebriaei P, Hosing C, Olson A, Oran B, Popat U, Rondon G, Rezvani K, Champlin RE, Shpall EJ. Re-Evaluating Donor Selection Priorities for Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide. JCO Oncol Pract:OP2500675, 2026. e-Pub 2026. PMID: 41529219.
- Kim K, Shah R, Ayers A, Ahmed S, Claret L, Strati P, Nair R, Nze C, Ramdial J, Torres J, Shpall EJ, Fayad LE, Nastoupil LJ, Westin JR, Flowers CR, Neelapu SS, Chihara D. Clinical trial access after CAR T-cell therapy failure in relapsed/refractory large B-cell lymphoma. Br J Haematol, 2026. e-Pub 2026. PMID: 41521615.
- Oran B, Thall P, Alousi A, Al-Atrash G, Mehta R, Marin D, Kebriaei P, Popat U, Bassett R, Bashir Q, Im J, Olson A, Jewell J, Smallbone P, Shpall E, Champlin R. Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single center. Haematologica 111(1):149-157, 2026. e-Pub 2026. PMID: 40702903.
- Marcoux C, Milton DR, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Saeed A, Haider AA, Ramdial J, Irfan S, YagoNieto, Tang G, Aljawai Y, Kebriaei P, Lee HC, Patel KK, Thomas SK, Orlowski RZ, Champlin RE, Shpall EJ, Qazilbash MH, Pasvolsky O. Post-Transplant Outcomes in IgD Multiple Myeloma: A Propensity Score-Matched Analysis. Transplant Cell Ther, 2025. e-Pub 2025. PMID: 41421540.
- Kalluri, VS, Smaglo, BG, Mahadevan, KK, Kirtley, ML, McAndrews, KM, Mendt Vilchez, MC, Yang, S, Maldonado, AS, Sugimoto, H, Salvatierra De Aranguren, M, Solis Soto, LM, Haymaker, CL, Finch, RA, Gagea Iurascu, M, Fluty, AC, Ludtke, SJ, Lee, JJ, Jain, A, Varadhachary, GR, Shroff, R, Maitra, A, Shpall, E, Pant, S, Kalluri, R. Engineered exosomes with KrasG12D specific siRNA in pancreatic cancer. Nature communications 16(1), 2025. e-Pub 2025. PMID: 41027940.
- Goulart H, Ravandi F, Short NJ, Jain N, Daver N, Kadia TM, DiNardo C, Borthakur G, Takahashi K, Pemmaraju N, Haddad FG, Montalban Bravo G, Alvarado Y, Issa GC, Bataller A, Pierce S, Loghavi S, Tang G, Wang SA, Thakral B, Shpall E, Champlin R, Khouri I, Kebriaei P, Garcia-Manero G, Sasaki K, Jabbour EJ, Senapati J. Clinical Outcomes of Adult Patients With Newly Diagnosed Mixed Phenotype Acute Leukemia. JCO Precis Oncol 9:e2500494, 2025. e-Pub 2025. PMID: 41370732.
- Biederstadt A, Basar R, Park JM, Uprety N, Shrestha R, Reyes Silva F, Dede M, Watts J, Acharya S, Xiong D, Liu B, Daher M, Rafei H, Banerjee P, Li P, Islam S, Fan H, Shanley M, Jin J, Kumar B, Woods V, Lin P, Tiberti S, Nunez Cortes AK, Jiang XR, Biederstadt I, Zhang P, Li Y, Rawal S, Liu E, Muniz-Feliciano L, Deyter GM, Shpall EJ, Fowlkes NW, Chen K, Rezvani K. Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency. Cancer Cell 43(11):2069-2088.e11, 2025. e-Pub 2025. PMID: 40845844.
- Strati P, Brandt A, Lionel AC, Henderson J, Westin JR, Adkins S, Shpall EJ, Kebriaei P, Ramdial J, Saini N, Ahmed S, Flowers C, Neelapu SS, Hildebrandt MAT. Germline determinants of toxicity and efficacy in patients with large B-cell lymphoma treated with CAR T-cell therapy. J Immunother Cancer 13(10), 2025. e-Pub 2025. PMID: 41067879.
- Pasvolsky O, Shimony S, Saliba RM, Marcoux C, Ledesma C, Rondon G, Tewari P, Ragoonanan D, Short NJ, Jabbour E, Gooptu M, Ho VT, Soiffer RJ, Antin JH, Koreth J, Cutler CS, Paolino JD, Duncan CN, Lehmann LE, DeAngelo DJ, Jain N, Champlin R, Shpall E, Luskin MR, Kebriaei P. Allogeneic Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults With Acute Lymphoblastic Leukemia-A Retrospective, Dual-Center Study. Am J Hematol 101(1):16-25, 2025. e-Pub 2025. PMID: 41051170.
- Short NJ, Loghavi S, Yilmaz M, Karrar O, Kim K, Dinardo CD, Kadia TM, Maroun M, Borthakur G, Issa GC, Jabbour J, Oran B, Shpall EJ, Popat U, Patel KP, Routbort M, Konopleva M, Ravandi F, Kantarjian H, Daver N. Long-term outcomes in FLT3-mutated acute myeloid leukemia after frontline hypomethylating agent, venetoclax and a FLT3 inhibitor. Haematologica, 2025. e-Pub 2025. PMID: 41035402.
- Marcoux C, Milton DR, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Patel A, Khan HN, Ramdial J, Nieto Y, Tang G, Haider A, Aljawai Y, Kebriaei P, Lee HC, Ye C, Patel KK, Thomas SK, Orlowski RZ, Champlin RE, Shpall EJ, Qazilbash MH, Pasvolsky O. Outcomes of Patients With Multiple Myeloma With deletion 1p Following Autologous Stem Cell Transplant. Transplant Cell Ther 31(10):804.e1-804.e9, 2025. e-Pub 2025. PMID: 40752590.
- Kawedia JD, Handy VW, Myers AL, Gulbis AM, Mehta R, Champlin RE, Shpall EJ, Nieto Y, Andersson BS, Popat UR. Seizure Prophylaxis and its Impact on Busulfan Pharmacokinetics and Dosing in a Novel Timed Sequential Protocol: MD Anderson Experience. Transplant Cell Ther 31(9):709.e1-709.e10, 2025. e-Pub 2025. PMID: 40514011.
- Brehm V, Wang Z, Rocha L, Jones B, Jenq RR, Chang CC, Cheng GS, Hsu J, Sharifi H, Yanik G, Luna L, Waqar A, Zaveri J, Dickey BF, Bashoura L, Shpall EJ, Zinter M, O'Dwyer D, Champlin RE, Chen G, Alousi A, Paczesny S, Peterson CB, Sheshadri A. Inflammatory Markers and Microbiome Dysbiosis in Hematopoietic Cell Transplant Recipients with Lung Graft-versus-Host Disease. Transplant Cell Ther 31(9):668.e1-668.e12, 2025. e-Pub 2025. PMID: 40543709.
- Shafat T, Khawaja F, Jiang Y, Daher M, Febres-Aldana A, Shigle TL, Rondon G, Champlin R, Bhatti M, Spallone A, Olson A, Ariza-Heredia EJ, Chen G, Rezvani K, Shpall EJ, Chemaly RF. The interplay between Epstein-Barr Virus and Cytomegalovirus reactivation following allogeneic hematopoietic cell transplantation in the era of primary CMV prophylaxis. Clin Microbiol Infect 31(12):2063-2072, 2025. e-Pub 2025. PMID: 40865766.
- Arora S, Jen WY, Yilmaz M, Deshmukh I, Senapati J, Loghavi S, Issa GC, Short NJ, Kadia TM, DiNardo CD, Borthakur G, Jabbour J, Pemmaraju N, Andreeff M, Takahashi K, Bhalla K, Popat U, Shpall EJ, Oran B, Abbas HA, Garcia-Manero G, Ravandi F, Kantarjian H, Daver N. Outcomes of patients with newly diagnosed acute myeloid leukemia with FLT3-tyrosine kinase domain mutations: Prognostic implications of NPM1 co-mutation. Cancer 131(16):e70032, 2025. e-Pub 2025. PMID: 40782343.
- Mehta RS, Aljawai YM, Kebriaei P, Olson A, Oran B, Rondon G, Rezvani K, Champlin RE, Shpall EJ. The Impact of Isolated HLA-DQB1 Mismatch and Donor Age in Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide. Transplant Cell Ther 31(11):920.e1-920.e14, 2025. e-Pub 2025. PMID: 40819683.
- Senapati, J, Kantarjian, HM, Kadia, TM, Kekedjian, J, Borthakur, G, Daver, N, DiNardo, C, Jabbour, EJ, Bose, P, Short, NJ, Yilmaz, M, Jain, N, Pemmaraju, N, Abbas, HA, Issa, GC, Maiti, A, Bravo, GM, Deshmukh, I, Shpall, E, Kebriaei, P, Popat, UR, Loghavi, S, Thakral, B, Tang, G, Haddad, FG, Alvarado, Y, Manero, GG, Ravandi-Kashani, F. Contemporary outcomes of octa-nonagenarians with newly diagnosed acute myeloid leukemia. Cancer 131(16), 2025. e-Pub 2025. PMID: 40772501.
- Aljawai YM, Ramdial JL, Smallbone P, Chen GL, Kebriaei P, Pasvolsky O, Popat UR, Oran B, Rezvani K, Champlin RE, Shpall EJ, Mehta RS. Comparative Outcomes of HCT with Post-Transplant Cyclophosphamide in Older Adults: The Impact of Donor Type. Blood Adv 9(20):5201-5206, 2025. e-Pub 2025. PMID: 40795211.
- Smallbone P, Shigle TL, Paslovsky O, Hosing C, Alousi A, Bashir Q, Aljawai Y, Ramdial J, Popat U, Champlin R, Shpall EJ, Oran B. Maintenance therapy with oral decitabine plus cedazuridine after allogeneic stem cell transplantation for myelodysplastic syndrome. Haematologica 110(8):1798-1807, 2025. e-Pub 2025. PMID: 40013380.
- Saliba RM, Niemann M, Srour SA, Greenbaum U, Alzahrani KK, Carmazzi Y, Rondon G, Rezvani K, Daher M, Li D, Ma Q, Tanner MR, Cao K, Shpall EJ, Champlin RE, Spierings E, Zou J. Molecular Disparity of HY Antigen Affects Chronic Graft-Versus-Host Disease and Relapse in Female-to-Male Stem Cell Transplants. Transplant Cell Ther 31(11):903-915, 2025. e-Pub 2025. PMID: 40714365.
- Uryu H, Saeki K, Haeno H, Kapadia CD, Furudate K, Nangalia J, Spencer Chapman M, Zhao L, Hsu JI, Zhao C, Chen S, Tanaka T, Li Z, Ogata S, Hanache S, Yang H, DiNardo C, Daver N, Pemmaraju N, Jain N, Ravandi F, Zhang J, Song X, Thompson E, Tang H, Little L, Gumbs C, Orlowski RZ, Qazilbash M, Bhalla K, Colla S, Kantarjian H, Kanagal-Shamanna R, Bueso-Ramos C, Nakada D, Al-Atrash G, Molldrem J, Futreal PA, Shpall E, Goodell M, Garcia-Manero G, Takahashi K. Clonal evolution of hematopoietic stem cells after autologous stem cell transplantation. Nat Genet 57(7):1695-1707, 2025. e-Pub 2025. PMID: 40596442.
- Aljawai YM, Ramdial JL, Rondon G, Smallbone P, Kebriaei P, Popat UR, Oran B, Rezvani K, Champlin RE, Shpall EJ, Mehta RS. Outcomes of Haploidentical vs Mismatched Unrelated Donor HCT with Post-Transplant Cyclophosphamide Prophylaxis. Blood Adv 9(15):4023-4036, 2025. e-Pub 2025. PMID: 40517414.
- Lontos K, Saliba RM, Kanagal-Shamanna R, Ozcan G, Ramdial JL, Chen GL, Kadia TM, Short NJ, Daver NG, Kantarjian HM, Marin D, Kebriaei P, Popat UR, Champlin RE, Shpall EJ, Oran B. TP53 Mutant Variant Allele Frequency and Cytogenetics Determine Prognostic Groups in MDS/AML for Transplantation. Blood Adv 9(11):2845-2854, 2025. e-Pub 2025. PMID: 39853269.
- Rafei H, Basar R, Acharya S, Hsu YS, Liu P, Zhang D, Bohn T, Liang Q, Mohanty V, Upadhyay R, Li P, Phadatare P, Dede M, Xiong D, Fan H, Jones CM, Kunz S, Daher M, Nunez Cortes AK, Shanley M, Liu B, Moseley SM, Zhang C, Fang D, Banerjee P, Uprety N, Li Y, Shrestha R, Wan X, Shen H, Woods V, Gilbert AL, Rawal S, Dou J, Tan Y, Park JM, Reyes Silva F, Biederstadt A, Kaplan M, Jiang XR, Biederstadt I, Kumar B, Tiberti S, Moore M, Jin J, Yang RZ, Muniz-Feliciano L, Rosemore S, Lin P, Deyter GM, Fowlkes NW, Jain AK, Marin D, Maitra A, Chen K, Bopp T, Shpall EJ, Rezvani K. CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells. Nature 643(8073):1076-1086, 2025. e-Pub 2025. PMID: 40468083.
- Senapati J, Loghavi S, Garcia-Manero G, Tang G, Kadia T, Short NJ, Abbas HA, Arani N, DiNardo CD, Borthakur G, Pemmaraju N, Oran B, Shpall E, Popat U, Champlin R, Pierce S, Arora S, Issa G, Yilmaz M, Patel K, Takahashi K, Montalban-Bravo G, Hammond D, Haddad FG, Ravandi F, Kantarjian HM, Daver NG. Clinical interrogation of TP53 aberrations and its impact on survival in patients with myeloid neoplasms. Haematologica 110(6):1304-1315, 2025. e-Pub 2025. PMID: 39665206.
- Nieto Y, Banerjee P, Kaur I, Basar R, Li Y, Daher M, Rafei H, Kerbauy LN, Kaplan M, Marin D, Griffin L, Barnett M, Bassett R, Uprety N, Shrestha R, Silva FR, Islam S, Ganesh C, Borneo Z, Ramdial J, Ramirez A, Hosing C, Alousi A, Popat U, Qazilbash M, Ahmed S, Iyer S, Sainz TP, Vega F, Fowlkes NW, Alexis K, Emig M, Harstrick A, Overesch A, Shpall EJ, Rezvani K. Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial. Nat Med 31(6):1987-1993, 2025. e-Pub 2025. PMID: 40186077.
- Pasvolsky O, Abid MB, Milton DR, Tanner MR, Bashir Q, Srour S, Saini N, Jatoi A, Khan HN, Lin P, Ramdial J, Nieto Y, Tang G, Siddiqui U, Aljawai Y, Kebriaei P, Lee HC, Patel KK, Gaballa MR, Thomas SK, Orlowski RZ, Champlin RE, Shpall EJ, Qazilbash MH. Outcomes of patients with multiple myeloma undergoing autologous transplant with suboptimal pretransplant response. Br J Haematol 206(6):1730-1736, 2025. e-Pub 2025. PMID: 40159289.
- Pasvolsky O, Marcoux C, Milton DR, Rafaeli N, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Tang G, Mohamedi AH, Deen AF, Aljawai Y, Lee HC, Patel KK, Becnel MR, Kebriaei P, Thomas SK, Orlowski RZ, Champlin R, Shpall EJ, Qazilbash MH. Outcomes of Multiple Myeloma Patients With Prior Solid Tumors Undergoing Autologous Transplantation. Transplant Cell Ther 31(8):565.e1-565.e9, 2025. e-Pub 2025. PMID: 40383197.
- Senapati J, Loghavi S, Marvin-Peek J, Garcia-Manero G, Kadia TM, Borthakur G, Daver N, Short NJ, Jain N, Issa GC, Haddad F, Hammond D, Chien K, Tang G, Thakral B, Montalban-Bravo G, Pemmaraju N, Bazinet A, Swaminathan M, Pierce S, Abbas HA, Reville P, Popat U, Shpall E, Champlin R, Jabbour E, Ravandi F, Kantarjian HM, DiNardo CD. Clinico-Genomic Interrogation of Secondary-Type Acute Myeloid Leukemia: Response and Outcomes to Contemporary Therapies. Am J Hematol 100(5):758-769, 2025. e-Pub 2025. PMID: 39921561.
- Shouval R, Strouse C, Kim S, Oloyede T, Ahmed S, Awan FT, Luan D, Bachanova V, Badar T, Bar M, Barba P, Beitinjaneh AM, Cashen A, Dholaria B, Elsawy M, Ganguly S, Geethakumari PR, Greenbaum U, Hashmi H, Hill LC, Jain MD, Jain T, Kebriaei P, Kittai AS, Locke FL, Lulla PD, Mead E, McGuirk JP, Mussetti A, Nishihori T, Olson AL, Pennisi M, Perales MA, Riedell PA, Saber W, Mirza AS, Magalhaes-Silverman M, Shpall EJ, Sorror M, Wudhikarn K, Turtle CJ, Moskop A, Pasquini MC. Cytokine release syndrome and neurotoxicity following CD19 CAR-T in B-cell lymphoma. Transplant Cell Ther 31(7):419-433, 2025. e-Pub 2025. PMID: 40288610.
- Saha S, Rehman L, Rehman A, Darbaniyan F, Weber DM, Becnel M, Gaballa MR, Thomas SK, Lee HC, Chang CC, Arora R, Menges M, Corallo S, Davila ML, Locke FL, Tanner MR, Neelapu SS, Shpall EJ, Flowers CR, Orlowski RZ, Jenq RR, Jain MD, Peterson C, Hansen DK, Saini NY, Patel KK. Longitudinal analysis of gut microbiome and metabolome correlates of response and toxicity with idecabtagene vicleucel. Blood Adv 9(14):3429-3440, 2025. e-Pub 2025. PMID: 40198765.
- Alkhunaizi M, Soto F, Leung CH, Bhan N, Bashoura L, Dickey BF, Sharifi H, Cheng GS, Yanik G, Rondon G, Saliba R, Chen G, Al-Atrash G, Hosing C, Kebriaei P, Popat UR, Shpall EJ, Champlin RE, Li L, Alousi AM, Sheshadri A. Restrictive Ventilatory Defect Following Hematopoietic Stem Cell Transplant Is Associated With Increased Mortality. Transplant Cell Ther 31(4):255.e1-255.e10, 2025. e-Pub 2025. PMID: 39921208.
- Nieto Y, Ramdial J, Valdez B, Thall PF, Bassett R, Barnett M, Srour S, Hosing C, Alousi A, Qazilbash M, Popat U, Gulbis A, Shigle TL, Ahmed S, Guillermo Pacheco M, Champlin R, Shpall EJ, Andersson BS. Enhancement of High-Dose Chemotherapy and Autologous SCT with the PARP Inhibitor Olaparib for Refractory Lymphoma. Clin Cancer Res 31(6):975-982, 2025. e-Pub 2025. PMID: 39804167.
- Pasvolsky O, Marcoux C, Wang Z, Milton DR, Pal B, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Tang G, Syed N, Aljawai Y, Lee HC, Patel KK, Becnel MR, Ye C, Kebriaei P, Thomas SK, Orlowski RZ, Champlin RE, Shpall EJ, Qazilbash MH. Outcomes of Standard-Risk Multiple Myeloma Patients Who Undergo Upfront Autologous Hematopoietic Stem Cell Transplantation. Transplant Cell Ther 31(3):166.e1-166.e9, 2025. e-Pub 2025. PMID: 39746546.
- Meraz, I, Majidi, M, Song, R, Meng, F, Gao, L, Wang, Q, Wang, J, Shpall, E, Roth, JA. NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model. eLife 13, 2025. e-Pub 2025. PMID: 39932765.
- Senapati, J, Kantarjian, HM, Haddad, FG, Short, NJ, Borthakur, G, Kanagal Shamanna, R, Tang, G, Jabbour, EJ, DiNardo, C, Daver, N, Montalban Bravo, G, Shah, V, Alousi, AM, Shpall, E, Popat, UR, Garcia-Manero, G, Ravandi-Kashani, F, Kadia, TM. Outcomes of Patients With Treated Secondary Acute Myeloid Leukemia. American journal of hematology 100(2):249-259, 2025. e-Pub 2025. PMID: 39718824.
- Meraz IM, Majidi M, Song R, Meng F, Gao L, Wang Q, Wang J, Shpall EJ, Roth JA. NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model. eLife 13:RP98258, 2025. e-Pub 2025.
- Alkhunaizi M, Soto-Lanza F, Leung CH, Bhan N, Bashoura L, Dickey BF, Sharifi H, Cheng G, Yanik GA, Rondon G, Saliba R, Chen G, Al-Atrash G, Hosing C, Kebriaei P, Popat UR, Shpall EJ, Champlin RE, Li L, Alousi AM, Sheshadri A. Restrictive Ventilatory Defects Following Hematopoietic Stem Cell Transplant Are Associated With Increased Mortality. Transplant Cell Ther. e-Pub 2025.
- Melo Garcia, L, Gangadharan, A, Banerjee, PP, Li, YE, Zeng, A, Rafei, H, Lin, P, Kumar, B, Acharya, S, Daher, M, Muniz-Feliciano, L, Deyter, GM, Dominguez, G, Park, JM, Reyes Silva, F, Nunez Cortes, AK, Basar, R, Uprety, N, Shanley, M, Kaplan, M, Liu, E, Shpall, E, Rezvani, K. Overcoming CD226-related immune evasion in acute myeloid leukemia with CD38 CAR-engineered NK cells. Cell Reports 44(1), 2025. e-Pub 2025. PMID: 39754720.
- Melo Garcia L, Gangadharan A, Banerjee P, Li Y, Zeng AGX, Rafei H, Lin P, Kumar B, Acharya S, Daher M, Muniz-Feliciano L, Deyter GM, Dominguez G, Park JM, Reyes Silva F, Nunez Cortes AK, Basar R, Uprety N, Shanley M, Kaplan M, Liu E, Shpall EJ, Rezvani K. Overcoming CD226-related immune evasion in acute myeloid leukemia with CD38 CAR-engineered NK cells. Cell Rep 44(1):115122, 2025. e-Pub 2025. PMID: 39754720.
- Marcoux C, Pasvolsky O, Milton DR, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Tang G, Lee HC, Patel KK, Kebriaei P, Ahmed A, Aljawai Y, Thomas SK, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Real-World Outcomes of Upfront Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma With Deletion 17p. Transplant Cell Ther 31(1):12.e1-12.e10, 2025. e-Pub 2025. PMID: 39448031.
- Grefe M, Trujillo-Ocampo A, Clinton J, He H, Yu L, Li D, Ma Q, Shpall EJ, Molldrem JJ, Im JS. Cord blood-derived iNK T cells as a platform for allogeneic CAR T cell therapy. Front Immunol 16:1621260, 2025. e-Pub 2025. PMID: 40519924.
- Bashir Q, Konopleva M, Abueg G, Ramdial J, Hosing C, Srour SA, Alousi A, Popat UR, Nieto Y, Alatrash G, Champlin RE, Shpall EJ, Qazilbash M, Pemmaraju N. Tagraxofusp maintenance post-hematopoietic stem cell transplantation provides long-term survival and manageable safety for a patient with blastic plasmacytoid dendritic cell neoplasm. Leuk Res Rep 24:100518, 2025. e-Pub 2025. PMID: 40612021.
- Pasvolsky, O, Ghanem, S, Milton, D, Rauf, M, Tanner, MR, Bashir, Q, Srour, S, Saini, N, Lin, P, Ramdial, JL, Nieto, Y, Tang, G, Aljawai, YM, Khan, HN, Kebriaei, P, Lee, HC, Patel, K, Thomas, SK, Weber, DM, Orlowski, R, Shpall, E, Champlin, RE, Qazilbash, MH. Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant. Blood cancer journal 14(1), 2024. e-Pub 2024. PMID: 38199987.
- Pasvolsky O, Marcoux C, Milton DR, Pal B, Tanner MR, Bashir Q, Srour S, Lee J, Saini N, Lin P, Ramdial J, Nieto Y, Tang G, Aljawai Y, Kebriaei P, Becnel MR, Lee HC, Patel KK, Thomas SK, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Optimal infused CD34(+) cell dose in multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation. Blood Cancer J 14(1):189, 2024. e-Pub 2024. PMID: 39482325.
- Prasad R, Rehman A, Rehman L, Darbaniyan F, Blumenberg V, Schubert ML, Mor U, Zamir E, Schmidt S, Hayase T, Chia-Chi C, McDaniel LK, Flores I, Strati P, Nair R, Chihara D, Fayad LE, Ahmed S, Iyer SP, Wang ML, Jain P, Nastoupil LJ, Westin JR, Arora R, Turner JG, Khawaja F, Wu R, Dennison JB, Menges M, Hidalgo-Vargas M, Reid KM, Davila ML, Dreger P, Korell F, Schmitt A, Tanner MR, Champlin RE, Flowers CR, Shpall EJ, Hanash S, Neelapu SS, Schmitt M, Subklewe M, Fahrmann J, Stein-Thoeringer C, Elinav E, Jain MD, Hayase E, Jenq RR, Saini NY. Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy. Blood, 2024. e-Pub 2024. PMID: 39441941.
- Senapati J, Kantarjian HM, Bazinet A, Reville P, Short NJ, Daver N, Borthakur G, Bataller A, Jabbour E, DiNardo C, Haddad F, Sasaki K, Popat U, Oran B, Alousi AM, Loghavi S, Shpall E, Garcia-Manero G, Ravandi F, Kadia TM. Lower intensity therapy with cladribine/low dose cytarabine/venetoclax in older patients with acute myeloid leukemia compares favorably with intensive chemotherapy among patients undergoing allogeneic stem cell transplantation. Cancer 130(19):3333-3343, 2024. e-Pub 2024. PMID: 38809547.
- Ramdial J, Lin R, Thall PF, Valdez BC, Hosing C, Srour S, Popat U, Qazilbash M, Alousi A, Barnett M, Gulbis A, Shigle TL, Shpall EJ, Andersson BS, Nieto Y. High activity of the new myeloablative regimen of gemcitabine/clofarabine/busulfan for allogeneic transplant for aggressive lymphomas. Bone Marrow Transplant, 2024. e-Pub 2024. PMID: 39341929.
- Rahman ZA, Othman T, Saliba RM, Vanegas YAM, Mohty R, Ledesma C, Rondon G, Jain N, Jabbour E, Pullarkat V, Alkhateeb HB, Kantarjian HM, Greipp PT, Nakamura R, Kharfan-Dabaja MA, Champlin RE, Forman SJ, Shpall EJ, Litzow MR, Foran JM, Aldoss I, Koller PB, Kebriaei P. A Multicenter Analysis of Allogeneic Transplant Outcomes in Adults with Philadelphia-like B-cell Acute Lymphoblastic Leukemia in First Complete Remission. Transplant Cell Ther 30(12):1197-1205, 2024. e-Pub 2024. PMID: 39332807.
- Angelidakis G, Chemaly RF, Sahasrabhojane PV, Morado-Aramburo O, Jiang Y, Bhatti MM, Shpall E, Hosing C, Jain P, Mahadeo KM, Khawaja F, Elhajj P, Wargo JA, Jenq RR, Ajami NJ, Kebriaei P, Ariza-Heredia EJ. Humoral Immunity and Antibody Responses against Diphtheria, Tetanus, and Pneumococcus after Immune Effector Cell Therapies: A Prospective Study. Vaccines (Basel) 12(9), 2024. e-Pub 2024. PMID: 39340100.
- Hayase E, Hayase T, Mukherjee A, Stinson SC, Jamal MA, Ortega MR, Sanchez CA, Ahmed SS, Karmouch JL, Chang CC, Flores II, McDaniel LK, Brown AN, El-Himri RK, Chapa VA, Tan L, Tran BQ, Xiao Y, Fan C, Pham D, Halsey TM, Jin Y, Tsai WB, Prasad R, Glover IK, Enkhbayar A, Mohammed A, Schmiester M, King KY, Britton RA, Reddy P, Wong MC, Ajami NJ, Wargo JA, Shelburne S, Okhuysen PC, Liu C, Fowler SW, Conner ME, Katsamakis Z, Smith N, Burgos da Silva M, Ponce DM, Peled JU, van den Brink MRM, Peterson CB, Rondon G, Molldrem JJ, Champlin RE, Shpall EJ, Lorenzi PL, Mehta RS, Martens EC, Alousi AM, Jenq RR. Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host disease. Cell Host Microbe 32(9):1621-1636.e6, 2024. e-Pub 2024. PMID: 39214085.
- Kumar B, Singh A, Basar R, Uprety N, Li Y, Fan H, Cortes AKN, Kaplan M, Acharya S, Shaim H, Xu AC, Wu M, Ensley E, Fang D, Banerjee PP, Garcia LM, Tiberti S, Lin P, Rafei H, Munir MN, Moore M, Shanley M, Mendt M, Kerbauy LN, Liu B, Biederstadt A, Gokdemir E, Ghosh S, Kundu K, Reyes-Silva F, Jiang XR, Wan X, Gilbert AL, Dede M, Mohanty V, Dou J, Zhang P, Liu E, Muniz-Feliciano L, Deyter GM, Jain AK, Rodriguez-Sevilla JJ, Colla S, Garcia-Manero G, Shpall EJ, Chen K, Abbas HA, Rai K, Rezvani K, Daher M. BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML. Sci Transl Med 16(764):eadp0004, 2024. e-Pub 2024. PMID: 39259809.
- Angelidakis G, Chemaly RF, Sahasrabhojane PV, Morado-Aramburo O, Jiang Y, Bhatti MM, Shpall E, Hosing C, Jain P, Mahadeo KM, Khawaja F, Elhajj P, Wargo JA, Jenq RR, Ajami NJ, Kebriaei P, Ariza-Heredia EJ. Humoral Immunity and Antibody Responses against Diphtheria, Tetanus, and Pneumococcus after Immune Effector Cell Therapies: A Prospective Study. Vaccines 12(9):1070, 2024. e-Pub 2024.
- Marcoux CM, Alousi AM, Im J, Hill LC, Smallbone P, Popat U, Hosing C, Kebriaei P, Olson A, Mehta R, Chen G, Qazilbash M, Shpall E, Champlin RC, Saliba RM. Gastrointestinal involvement refines prognosis in minnesota standard risk acute graft-vs.-host disease. Bone Marrow Transplant, 2024. e-Pub 2024. PMID: 39187601.
- Mehta RS, Ramdial JL, Kebriaei P, Champlin RE, Popat UR, Rezvani K, Shpall EJ. Haploidentical versus HLA-matched sibling donor HCT with PTCy prophylaxis: HLA factors and donor age considerations. Blood Adv, 2024. e-Pub 2024. PMID: 39167765.
- Sharifi H, Bertini CD, Alkhunaizi M, Hernandez MP, Musa Z, Borges C, Turk I, Bashoura L, Dickey BF, Cheng GS, Yanik GA, Galban C, Guo HH, Godoy M, Reinhardt J, Hoffman E, Castro M, Rondon G, Alousi A, Champlin RE, Shpall EJ, Lu Y, Peterson SW, Datta K, Nicolls M, Hsu JL, Sheshadri A. CT strain metrics allow for earlier diagnosis of bronchiolitis obliterans syndrome after hematopoietic cell transplant. Blood Adv 8(19):5156-5165, 2024. e-Pub 2024. PMID: 39163616.
- Shanley M, Daher M, Dou J, Li S, Basar R, Rafei H, Dede M, Gumin J, Pantaleomicronn Garciotaa J, Nunez Cortes AK, He S, Jones CM, Acharya S, Fowlkes NW, Xiong D, Singh S, Shaim H, Hicks SC, Liu B, Jain A, Zaman MF, Miao Q, Li Y, Uprety N, Liu E, Muniz-Feliciano L, Deyter GM, Mohanty V, Zhang P, Evans SE, Shpall EJ, Lang FF, Chen K, Rezvani K. Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD. Cancer Cell 42(8):1450-1466.e11, 2024. e-Pub 2024. PMID: 39137729.
- Pasvolsky O, Marcoux C, Dai J, Milton DR, Tanner MR, Syed N, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Tang G, Aljawai Y, Lee HC, Gaballa MR, Patel KK, Kebriaei P, Thomas SK, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Trends in Outcomes After Upfront Autologous Transplant for Multiple Myeloma over Three Decades. Transplant Cell Ther 30(8):772.e1-772.e11, 2024. e-Pub 2024. PMID: 38852784.
- Yeh J, Pasvolsky O, Saliba RM, Figgins B, Wang C, Fang Z, Ahmed S, Yilmaz M, Daver N, Ravandi F, DiNardo C, Short NJ, Kadia T, Al-Atrash G, Daher M, Costa DM, Popat U, Champlin R, Shpall E, Oran B. Efficacy and Safety of Gilteritinib versus Sorafenib as Post-Transplant Maintenance in Patients With FLT3-ITD Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk, 2024. e-Pub 2024. PMID: 39183099.
- Shaffer BC, Gooptu M, DeFor TE, Maiers M, Bolanos-Meade J, Abboud R, Briggs AD, Khimani F, Modi D, Newcomb R, Shpall EJ, Bupp C, Spellman SR, Stefanski HE, Shaw BE, Auletta JJ, Devine SM, Jimenez Jimenez AM, Al Malki MM. Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors. J Clin Oncol 42(28):3277-3286, 2024. e-Pub 2024. PMID: 39018507.
- He H, Vedia RA, Lu S, Li Q, Cox KR, St John L, Sergeeva A, Clise-Dwyer K, Alatrash G, Shpall EJ, Ma Q, Molldrem JJ. Hu8F4-CAR T cells with mutated Fc spacer segment improve target specificity and mediate anti-leukemia activity in vivo. Cytotherapy 26(11):1331-1340, 2024. e-Pub 2024. PMID: 39033444.
- Milutinovic B, Mahalingam R, Mendt M, Arroyo L, Seua A, Dharmaraj S, Shpall EJ, Heijnen CJ. Intranasally administered MSC-derived extracellular vesicles reverse cisplatin-induced cognitive impairment. Int. J. Mol. Sci 24(14):11862, 2024. e-Pub 2024. PMID: 37511623.
- Saengboon S, Ciurea SO, Popat UR, Ramdial JL, Bashir Q, Alousi AM, Chen J, Rondon G, Olson AL, Im JS, Hosing C, Shpall EJ, Champlin RE, Srour SA. Long-term outcomes after haploidentical stem cell transplantation for hematologic malignancies. Blood Adv 8(12):3237-3245, 2024. e-Pub 2024. PMID: 38607399.
- Acharya S, Basar R, Daher M, Rafei H, Li P, Uprety N, Ensley E, Shanley M, Kumar B, Banerjee PP, Melo Garcia L, Lin P, Mohanty V, Kim KH, Jiang X, Pan Y, Li Y, Liu B, Nunez Cortes AK, Zhang C, Fathi M, Rezvan A, Montalvo MJ, Cha SL, Reyes-Silva F, Shrestha R, Guo X, Kundu K, Biederstadt A, Muniz-Feliciano L, Deyter GM, Kaplan M, Jiang XR, Liu E, Jain A, Roszik J, Fowlkes NW, Solis Soto LM, Raso MG, Khoury JD, Lin P, Vega F, Varadarajan N, Chen K, Marin D, Shpall EJ, Rezvani K. CD28 costimulation augments CAR signaling in NK cells via the LCK/CD3Z/ZAP70 signaling axis. Cancer Discov 14(10):1879-1900, 2024. e-Pub 2024. PMID: 38900051.
- Febres-Aldana A, Khawaja F, Morado-Aramburo O, Shigle TL, Rondon G, Sassine J, Spallone A, Srinivasan K, Ramdial J, Alousi A, Champlin R, Chen G, Daher M, Rezvani K, Ariza-Heredia EJ, Shpall EJ, Chemaly RF. Mortality in recipients of allogeneic haematopoietic cell transplantation in the era of cytomegalovirus primary prophylaxis: a single-centre retrospective experience. Clin Microbiol Infect 30(6):803-809, 2024. e-Pub 2024. PMID: 38460821.
- Uryu H, Saeki K, Haeno H, Kapadia CD, Furudate K, Nangalia J, Chapman MS, Zhao L, Hsu JI, Zhao C, Chen S, Tanaka T, Li Z, Yang H, DiNardo C, Daver N, Pemmaraju N, Jain N, Ravandi F, Zhang J, Song X, Thompson E, Tang H, Little L, Gumbs C, Orlowski RZ, Qazilbash M, Bhalla K, Colla S, Kantarjian H, Shamanna RK, Ramos CB, Nakada D, Futreal PA, Shpall E, Goodell M, Garcia-Manero G, Takahashi K. Clonal evolution of hematopoietic stem cells after cancer chemotherapy. bioRxiv, 2024. e-Pub 2024. PMID: 38826462.
- Pasvolsky O, Wang Z, Milton DR, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Tang G, Kebriaei P, Aljawai Y, Khan HN, Lee HC, Ye C, Patel KK, Thomas SK, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation. Blood Cancer J 14(1):82, 2024. e-Pub 2024. PMID: 38760362.
- Pasvolsky, O, Pasyar, S, Bassett Jr, R, Khan, HN, Tanner, MR, Bashir, Q, Srour, S, Saini, N, Lin, P, Ramdial, JL, Nieto, Y, Lee, HC, Patel, K, Kebriaei, P, Thomas, SK, Weber, DM, Orlowski, R, Shpall, E, Champlin, RE, Qazilbash, MH. Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation. Cancer 130(9):1663-1672, 2024. e-Pub 2024. PMID: 38127583.
- Jallouk AP, Kui N, Sun R, Westin JR, Steiner RE, Nair R, Nastoupil LJ, Fayad LE, Zaki AA, Hawkins M, Adkins S, Noorani M, Das K, Henderson J, Shpall EJ, Kebriaei P, Ramdial J, Flowers CR, Neelapu SS, Ahmed S, Strati P. Effect of delayed cell infusion in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy. Haematologica 109(5):1460-1468, 2024. e-Pub 2024. PMID: 38031807.
- Pasvolsky O, Saliba RM, Popat UR, Alousi A, Mehta R, Yeh J, Al-Atrash G, Adeel M, Ramdial J, Marin D, Rondon G, Kebriaei P, Champlin R, Daver N, Dinardo C, Short NJ, Shpall EJ, Oran B. Azacitidine Post-transplant Maintenance Improves Disease Progression in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome. Clin Lymphoma Myeloma Leuk 24(5):e196-e204, 2024. e-Pub 2024. PMID: 38403505.
- Khouri, IF, Alzahrani, K, Kantarjian, HM, Milton, D, Gulbis, A, Sasaki, K, Jain, N, Short, NJ, Kadia, TM, Daher, M, Rafei, H, Im, JS, Marin, D, Olson, AL, Popat, UR, Qazilbash, MH, Ramdial, JL, Rondon, G, Srour, S, Kebriaei, P, Shpall, E, Champlin, RE, Jabbour, EJ. Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation. American journal of hematology 99(5):836-843, 2024. e-Pub 2024. PMID: 38400519.
- Ciurea, SO, Kongtim, P, Srour, S, Chen, J, Soebbing, D, Shpall, E, Rezvani, K, Nakkula, RJ, Thakkar, A, Troy, EC, Cash, AA, Behbehani, GK, Cao, K, Schafer, JR, Champlin, RE, Lee, DA. Results of a phase I trial with Haploidentical mbIL-21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML. American journal of hematology 99(5):890-899, 2024. e-Pub 2024. PMID: 38444268.
- Ahmed, S, Bashir, Q, Bassett Jr, R, Ullah, F, Aung, FM, Valdez, B, Alousi, AM, Hosing, C, Kebriaei, P, Khouri, IF, Marin, D, Nieto, Y, Olson, AL, Oran, B, Qazilbash, MH, Rezvani, K, Mehta, RS, Shpall, E, Ciurea, SO, Andersson, BS, Champlin, RE, Popat, UR. Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation. American journal of hematology 99(4):562-569, 2024. e-Pub 2024. PMID: 38314663.
- Pille M, Avila JM, Park SH, Le CQ, Xue H, Haerynck F, Saxena L, Lee C, Shpall EJ, Bao G, Vandekerckhove B, Davis BR. Gene editing-based targeted integration for correction of Wiskott-Aldrich syndrome. Mol Ther Methods Clin Dev 32(1):101208, 2024. e-Pub 2024. PMID: 38414825.
- Marcoux, C, Saliba, RM, Wallis, W, Khazal, SJ, Ragoonanan, D, Rondon, G, Tewari, P, Popat, UR, Oran, B, Olson, AL, Bashir, Q, Qazilbash, MH, Alousi, AM, Hosing, C, Nieto, Y, Al-Atrash, G, Marin, D, Rezvani, K, Khouri, IF, Srour, S, Champlin, RE, Shpall, E, Kebriaei, P. Incidence and risk factors of early onset VOD/SOS differ in younger vs older adults after stem cell transplantation. Blood Advances 8(5):1128-1136, 2024. e-Pub 2024. PMID: 38266155.
- Alzahrani K, Pasvolsky O, Wang Z, Milton DR, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Lee HC, Patel KK, Manasanch EE, Kebriaei P, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin R, Qazilbash MH. Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantation. Br J Haematol 204(5):1944-1952, 2024. e-Pub 2024. PMID: 38448009.
- Marin D, Li Y, Basar R, Rafei H, Daher M, Dou J, Mohanty V, Dede M, Nieto Y, Uprety N, Acharya S, Liu E, Wilson J, Banerjee P, Macapinlac HA, Ganesh C, Thall PF, Bassett R, Ammari M, Rao S, Cao K, Shanley M, Kaplan M, Hosing C, Kebriaei P, Nastoupil LJ, Flowers CR, Moseley SM, Lin P, Ang S, Popat UR, Qazilbash MH, Champlin RE, Chen K, Shpall EJ, Rezvani K. Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19(+) B cell tumors: a phase 1/2 trial. Nat Med 30(3):772-784, 2024. e-Pub 2024. PMID: 38238616.
- Curran KJ, Nikiforow S, Bachier C, Hsu YM, Maloney DG, Maus MV, McCarthy PL, Porter DL, Shi PA, Shpall EJ, William B, Wacker K, Warkentin P, Heslop HE. Robust Quality Infrastructure is Key to Safe and Effective Delivery of Immune Effector Cells: How FACT-Finding Can Help. Blood Adv 8(4):1053-1061, 2024. e-Pub 2024. PMID: 37467016.
- Molldrem J, He H, Vedia R, Lu S, Li Q, Cox K, St John L, Sergeeva A, Clise-Dwyer K, Alatrash G, Shpall E, Ma Q. Hu8F4-CAR T cells with mutated Fc spacer segment improve target-specificity and mediate anti-leukemia activity in vivo. Res Sq, 2024. e-Pub 2024. PMID: 38464203.
- Yalniz FF, Greenbaum U, Pasvolsky O, Milton DR, Kanagal-Shamanna R, Ramdial J, Srour S, Mehta R, Alousi A, Popat UR, Nieto Y, Kebriaei P, Al-Atrash G, Oran B, Hosing C, Ahmed S, Champlin RE, Shpall EJ, Qazilbash MH, Bashir Q. Characteristics and outcomes of patients with multiple myeloma who developed therapy-related acute myeloid leukemia and myelodysplastic syndrome following autologous cell transplantation. Transplant Cell Ther 30(2):205.e1-205.e12, 2024. e-Pub 2023. PMID: 37437764.
- Nieto, Y, Banerjee, PP, Kaur, I, Kim, KH, Fang, D, Thall, PF, Griffin, L, Barnett, M, Basar, R, Hosing, C, Ramdial, JL, Srour, S, Daher, M, Marin, D, Jiang, X, Chen, K, Champlin, RE, Shpall, E, Rezvani, K. Ex Vivo Expanded Cord Blood Natural Killer Cells Combined with Rituximab and High-Dose Chemotherapy and Autologous Stem Cell Transplantation for B Cell Non-Hodgkin Lymphoma. Transplantation and Cellular Therapy 30(2):203.e1-203.e9, 2024. e-Pub 2024. PMID: 38042257.
- Laskowitz, D, Troy, JD, Poehlein, E, Bennett, ER, Shpall, E, Wingard, JR, Freed, B, Belagaje, SR, Khanna, A, Jones, W, Volpi, JJ, Marrotte, E, Kurtzberg, J. A Randomized, Placebo-Controlled, Phase II Trial of Intravenous Allogeneic Non-HLA Matched, Unrelated Donor, Cord Blood Infusion for Ischemic Stroke. Stem Cells Translational Medicine 13(2):125-136, 2024. e-Pub 2024. PMID: 38071749.
- Kan P, Srinivasan VM, Gumin J, Garcia R, Chen SR, Johnson JN, Collins DE, Chen MM, Ledbetter D, Huse J, Luna ZAE, Robledo A, Vasandani V, Rao A, Singh SK, Shpall EJ, Fueyo J, Gomez-Manzano C, Lang FF. Development of a Rabbit Human Glioblastoma Model for Testing of Endovascular Selective Intra-Arterial Infusion (ESIA) of Novel Stem Cell-Based Therapeutics. Neuro Oncol 26(1):127-136, 2024. e-Pub 2024. PMID: 37603323.
- Saliba RM, Kanakry CG, Gadalla S, Kebriaei P, Rezvani K, Champlin RE, Shpall EJ, Weisdorf D, Mehta RS. Effect of donor age in patients with acute myeloid leukemia undergoing haploidentical hematopoietic cell transplantation vary by conditioning intensity and recipient age. Am J Hematol 99(1):38-47, 2024. e-Pub 2023. PMID: 37850688.
- Bachar-Lustig, E, Lask, A, Eidelstein, Y, Or-Geva, N, Gidron-Budovsky, R, Nathansohn-Levy, B, Eyrich, M, Liu, WH, Dang, G, Miranda, KC, Ramirez, A, Kaur, I, Rezvani, K, Shpall, E, Champlin, RE, Nagler, A, Shimoni, A, Barnees-Kagan, S, Reisner, Y. Generation of Non-Alloreactive Antiviral Central Memory CD8 Human Veto T Cells for Cell Therapy. Transplantation and Cellular Therapy 30(1):71.e1-71.e13, 2024. e-Pub 2024. PMID: 37890590.
- Marinos A, Ramdial J, Khawaja F, Saliba RM, Shigle TL, Alousi AM, Rondon G, Chen J, Ledesma C, Champlin RE, Daher M, Chen G, Marin D, Rezvani K, Shpall EJ, Chemaly RF. Hematopoietic cell transplantation can be safely performed after COVID-19. Bone Marrow Transplant 58(12):1410-1412, 2023. e-Pub 2023. PMID: 37726490.
- Pasvolsky O, Ghanem S, Milton DR, Masood A, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Lee HC, Patel KK, Kebriaei P, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Outcomes of Autologous Stem Cell Transplant in Patients with Ultra High-Risk Multiple Myeloma. Transplant Cell Ther 29(12):757-762, 2023. e-Pub 2023. PMID: 37673125.
- Joseph J, Srour SA, Milton DR, Ramdial JL, Saini NY, Olson AL, Bashir Q, Oran B, Alousi AM, Hosing C, Qazilbash MH, Kebriaei P, Shpall EJ, Champlin RE, Popat UR. Transplant Outcomes of Myelofibrosis with Busulfan and Fludarabine Myeloablative Conditioning. Transplant Cell Ther S2666-6367(23):01553-1, 2023. e-Pub 2023. PMID: 37742746.
- Pasvolsky, O, Bassett Jr, R, Ghanem, S, Cuglievan, B, Tewari, P, Hosing, C, Srour, S, Ramdial, JL, Mahadeo, KM, Khazal, SJ, Petropoulos, D, Popat, UR, Qazilbash, MH, Kebriaei, P, Champlin, RE, Shpall, E, Nieto, Y. Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant. BMC cancer 23(1), 2023. e-Pub 2023. PMID: 38124057.
- Strati P, Jallouk A, Deng Q, Li X, Feng L, Sun R, Adkins S, Johncy S, Cain T, Steiner RE, Ahmed S, Chihara D, Fayad LE, Padmanabhan Iyer S, Horowitz SB, Nastoupil LJ, Nair R, Hassan A, Daoud T, Hawkins M, Rodriguez MA, Shpall EJ, Ramdial JL, Kebriaei P, Hong DS, Westin JR, Neelapu SS, Green MR. A Phase I Study of Prophylactic Anakinra to Mitigate ICANS in Patients with Large B-cell Lymphoma. Blood Adv 7(21):6785-6789, 2023. e-Pub 2023. PMID: 37389847.
- Kadia TM, Ravandi F, Molica M, Bataller A, Borthakur G, Daver N, Jabbour E, DiNardo CD, Pemmaraju N, Jain N, Ferrajoli A, Ylimaz M, Bose P, Tidwell RS, Marx KR, Rausch CR, Kanagal-Shamanna R, Wang S, Islam R, Champlin R, Shpall E, Konopleva M, Garcia-Manero G, Kantarjian H. Phase II study of cladribine, idarubicin, and ara-C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia. Am J Hematol 98(11):1711-1720, 2023. e-Pub 2023. PMID: 37635400.
- Alkhaldi H, Reinhardt A, Barnett M, Kundu S, Hosing C, Ramdial J, Saini N, Srour S, Alousi A, Kebriaei P, Popat U, Qazilbash M, Champlin R, Shpall EJ, Gulbis A, Shigle TL, Dabaja B, Pinnix C, Ahmed S, Steiner R, Andersson BS, Nieto Y. High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma. Transplant Cell Ther 29(11):690-694, 2023. e-Pub 2023. PMID: 37607645.
- Popat UR, Pasvolsky O, Bassett R, Mehta RS, Olson AL, Chen J, Alousi AM, Al-Atrash G, Bashir Q, Gulbis AM, Hosing CM, Im JS, Kebriaei P, Khouri IF, Marin DC, Nieto Y, Oran B, Saini NY, Shigle TL, Srour SA, Ramdial JL, Rezvani K, Qazilbash MH, Andersson BS, Champlin RE, Shpall EJ. Myeloablative Fractionated Busulfan for Allogeneic Stem Cell Transplant in Older Patients or Patients with Comorbidities. Blood Adv 7(20):6196-6205, 2023. e-Pub 2023. PMID: 37611156.
- Pasvolsky O, Milton DR, Masood A, Sami SS, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Saeed A, Lee HC, Patel KK, Kebriaei P, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Single-agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experience. Am J Hematol 98(10):1571-1578, 2023. e-Pub 2023. PMID: 37461327.
- Mehta RS, Ali H, Dai Y, Yao B, Overman B, Ratanatharathorn V, Gill S, Socié G, Anderson K, Cahn JY, Mujeebuddin A, Champlin R, Shpall E, Holtan SG, Alousi A. A prospective phase 2 clinical trial of a C5a complement inhibitor for acute GVHD with lower GI tract involvement. Bone Marrow Transplant 58(9):991-999, 2023. e-Pub 2023. PMID: 37202544.
- Carter BZ, Mak PY, Muftuoglu M, Tao W, Ke B, Pei J, Bedoy AD, Ostermann LB, Nishida Y, Isgandarova S, Sobieski M, Nguyen N, Powell RT, Martinez-Moczygemba M, Stephan C, Basyal M, Pemmaraju N, Boettcher S, Ebert BL, Shpall EJ, Wallner B, Morgan RA, Karras GI, Moll UM, Andreeff M. Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cells. Blood 142(12):1056-1070, 2023. e-Pub 2023. PMID: 37339579.
- Bazinet A, Kantarjian H, Arani N, Popat U, Bataller A, Sasaki K, DiNardo CD, Daver N, Yilmaz M, Abbas HA, Short NJ, Issa G, Jabbour E, Pierce SA, Chen J, Garcia R, Konopleva M, Garcia-Manero G, Alousi A, Shpall EJ, Champlin RE, Borthakur G, Ravandi F, Kadia T. Evolving trends and outcomes in older patients with acute myeloid leukemia including allogeneic stem cell transplantation. Am J Hematol 98(9):1383-1393, 2023. e-Pub 2023. PMID: 37334870.
- Richard-Carpentier G, Rausch CR, Sasaki K, Hammond D, Morita K, Takahashi K, Tang G, Kanagal-Shamanna R, Bhalla K, Dinardo CD, Borthakur G, Pemmaraju N, Shpall EJ, Alousi A, Daver NG, Garcia-Manero G, Konopleva MY, Ravandi F, Kantarjian HM, Kadia TM. Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2). Haematologica 108(9):2331-2342, 2023. e-Pub 2023. PMID: 36951163.
- Pasvolsky O, Marcoux C, Milton DR, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Lee HC, Patel KK, Kebriaei P, Tewari P, Crawford-Suber L, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Outcomes of young adults (aged ≤ 40 years) with newly diagnosed multiple myeloma after up-front autologous stem cell transplant. Br J Haematol 202(4):866-873, 2023. e-Pub 2023. PMID: 37376789.
- Li L, Mohanty V, Dou J, Huang Y, Banerjee PP, Miao Q, Lohr JG, Vijaykumar T, Frede J, Knoechel B, Muniz-Feliciano L, Laskowski TJ, Liang S, Moyes JS, Nandivada V, Basar R, Kaplan M, Daher M, Liu E, Li Y, Acharya S, Lin P, Shanley M, Rafei H, Marin D, Mielke S, Champlin RE, Shpall EJ, Chen K, Rezvani K. Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering. Sci Adv 9(30):eadd6997, 2023. e-Pub 2023. PMID: 37494448.
- Short NJ, Ong F, Ravandi F, Nogueras-Gonzalez G, Kadia TM, Daver N, DiNardo CD, Konopleva M, Borthakur G, Oran B, Al-Atrash G, Mehta R, Jabbour EJ, Yilmaz M, Issa GC, Maiti A, Champlin RE, Kantarjian H, Shpall EJ, Popat U. Impact of Type of Induction Therapy on Outcomes in Older Adults with AML after Allogeneic Stem Cell Transplantation. Blood Adv 7(14):3573-3581, 2023. e-Pub 2023. PMID: 37104058.
- Milutinovic, B, Mahalingam, R, Mendt Vilchez, MC, Arroyo, LD, Seua, AV, Dharmaraj, S, Shpall, E, Heijnen, CJ. Intranasally Administered MSC-Derived Extracellular Vesicles Reverse Cisplatin-Induced Cognitive Impairment. International journal of molecular sciences 24(14):11862, 2023. e-Pub 2023. PMID: 37511623.
- Tsimberidou AM, Guenther K, Andersson BS, Mendrzyk R, Alpert A, Wagner C, Nowak A, Aslan K, Satelli A, Richter F, Kuttruff-Coqui S, Schoor O, Fritsche J, Coughlin Z, Mohamed AS, Sieger K, Norris B, Ort R, Beck J, Vo HH, Hoffgaard F, Ruh M, Backert L, Wistuba II, Fuhrmann D, Ibrahim NK, Morris VK, Kee BK, Halperin DM, Nogueras-Gonzalez GM, Kebriaei P, Shpall EJ, Vining D, Hwu P, Singh H, Reinhardt C, Britten CM, Hilf N, Weinschenk T, Maurer D, Walter S. Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-In-Human Clinical Trial in Patients with Advanced Metastatic Cancer. Cancer Immunol Res 11(7):925-945, 2023. e-Pub 2023. PMID: 37172100.
- Strati P, Pasvolsky O, Feng L, Xu G, Tewari SO, Varghese J, Ow K, Santiago M, Al Zaki A, Jallouk A, Neelapu SS, Kebriaei P, Shpall EJ, Ahmed S. ASCT vs CART for Patients with Relapsed LBCL in PR: Role of TMTV. Blood Adv 7(11):2586-2589, 2023. e-Pub 2023. PMID: 36745104.
- Ostrin EJ, Rider NL, Alousi AM, Irajizad E, Li L, Peng Q, Kim ST, Bashoura L, Arain MH, Noor LZ, Patel N, Mehta R, Popat UR, Hosing C, Jenq RR, Rondon G, Hanash SM, Paczesny S, Shpall EJ, Champlin RE, Dickey BF, Sheshadri A. A Nasal Inflammatory Cytokine Signature Is Associated with Early Graft-versus-Host Disease of the Lung after Allogeneic Hematopoietic Cell Transplantation: Proof of Concept. Immunohorizons 7(6):421-430, 2023. e-Pub 2023. PMID: 37289498.
- Mehta RS, Ramdial J, Marin D, Alousi A, Kanakry CG, Champlin RE, Rezvani K, Shpall EJ, Page K, Gadalla SM, Kebriaei P, Weisdorf D. Impact of Donor Age in Haploidentical-PTCy Versus MUD-PTCy HCT in AML patients. Transplant Cell Ther 29(6):377.e1-377.e7, 2023. e-Pub 2023. PMID: 36990221.
- Meraz IM, Majidi M, Fang B, Meng F, Gao L, Shao R, Song R, Li F, Lissanu Y, Chen H, Ha MJ, Wang Q, Wang J, Shpall E, Jung SY, Haderk F, Gui P, Riess JW, Olivas V, Bivona TG, Roth JA. 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib. Commun Biol 6(1):509, 2023. e-Pub 2023. PMID: 37169941.
- Marcoux C, Marin D, Ramdial J, AlAtrash G, Alousi AM, Oran B, Kebriaei P, Popat UR, Rezvani K, Champlin RE, Shpall EJ, Mehta RS. Younger Haploidentical Donor Versus Older Matched Unrelated Donor for Patients With AML/MDS. Am J Hematol 98(5):712-719, 2023. e-Pub 2023. PMID: 36734029.
- Wang XS, Srour SA, Mendoza T, Whisenant M, Subbiah I, Gonzalez E, Kamal M, Shen SE, Cleeland C, Kebriaei P, Rezvani K, Neelapu S, Ahmed S, Shpall E. Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy. Br J Haematol 201(4):738-746, 2023. e-Pub 2023. PMID: 36733986.
- Meraz IM, Majidi M, Fang B, Meng F, Gao L, Shao R, Song R, Li F, Lissanu Y, Chen H, Ha MJ, Wang Q, Wang J, Shpall E, Jung SY, Haderk F, Gui P, Riess JW, Olivas V, Bivona TG, Roth JA. 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib. Commun Biol 6(1):509, 2023. e-Pub 2023. PMID: 37169940.
- Pasvolsky O, Milton DR, Rauf M, Ghanem S, Masood A, Mohamedi AH, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Tang G, Lee HC, Patel KK, Kebriaei P, Thomas SK, Weber DM, Orlowski RZ, Rezvani K, Champlin R, Shpall EJ, Lin P, Qazilbash MH. Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients. Blood Cancer J 13(1):68, 2023. e-Pub 2023. PMID: 37137874.
- Zou J, Kongtim P, Oran B, Srour SA, Greenbaum U, Carmazzi Y, Rondon G, Ciurea SO, Ma Q, Shpall EJ, Champlin RE, Cao K. Molecular disparity of HLA-DPB1 is associated with the development of subsequent solid cancer after allogeneic hematopoietic stem cell transplantation. Cancer 129(8):1205-1216, 2023. e-Pub 2023. PMID: 36738229.
- Afrough A, Alsfeld LC, Milton DR, Delgado R, Popat UR, Nieto Y, Kebriaei P, Oran B, Saini N, Srour S, Hosing C, Cheema FH, Ahmed S, Manasanch EE, Lee HC, Kaufman GP, Patel KK, Weber DM, Orlowski RZ, Pinnix CC, Dabaja BS, Thomas SK, Champlin RE, Shpall EJ, Qazilbash MH, Bashir Q. Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma. Transplant Cell Ther 29(4):264.e1-264.e9, 2023. e-Pub 2023. PMID: 35605883.
- Jallouk AP, Gouni S, Westin J, Feng L, Mistry H, Steiner RE, James J, Noorani M, Horowitz S, Puebla-Osorio N, Fayad LE, Iyer SP, Hawkins M, Flowers CR, Ahmed S, Nastoupil LJ, Kebriaei P, Shpall EJ, Neelapu SS, Nieto Y, Strati P. Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response. Haematologica 108(4):1163-1167, 2023. e-Pub 2023. PMID: 36384251.
- Mehta RS, Marin D, Alousi A, Kanakry CG, Champlin RE, Rezvani K, Shpall EJ, Page K, Gadalla SM, Weisdorf D, Kebriaei P. Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type. Blood Adv 7(8):1594-1603, 2023. e-Pub 2023. PMID: 36630564.
- Pasvolsky O, Gaballa MR, Milton DR, Masood A, Sami SS, Tanner MR, Bashir Q, Srour S, Saini N, Ramdial J, Nieto Y, Tang G, Lin P, Lee HC, Patel KK, Kebriaei P, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Translocation (4;14): The MD Anderson Cancer Center Experience: Transplant in t(4;14) MM. Transplant Cell Ther 29(4):260.e1-260.e6, 2023. e-Pub 2023. PMID: 36646323.
- Stein-Thoeringer CK, Saini NY, Zamir E, Blumenberg V, Schubert ML, Mor U, Fante MA, Schmidt S, Hayase E, Hayase T, Rohrbach R, Chang CC, McDaniel L, Flores I, Gaiser R, Edinger M, Wolff D, Heidenreich M, Strati P, Nair R, Chihara D, Fayad LE, Ahmed S, Iyer SP, Steiner RE, Jain P, Nastoupil LJ, Westin J, Arora R, Wang ML, Turner J, Menges M, Hidalgo-Vargas M, Reid K, Dreger P, Schmitt A, Müller-Tidow C, Locke FL, Davila ML, Champlin RE, Flowers CR, Shpall EJ, Poeck H, Neelapu SS, Schmitt M, Subklewe M, Jain MD, Jenq RR, Elinav E. A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy. Nat Med 29(4):906-916, 2023. e-Pub 2023. PMID: 36914893.
- Mehta RS, Cao K, Saliba RM, Al-Atrash G, Alousi AM, Lontos K, Marcoux C, Carmazzi Y, Rondon G, Bashir Q, Hosing CM, Kebriaei P, Khouri I, Marin D, Nieto Y, Oran B, Popat UR, Qazilbash MH, Ramdial J, Rezvani K, Champlin RE, Shpall EJ. HLA Factors Versus Non-HLA Factors for Haploidentical Donor Selection. Transplant Cell Ther 29(3):189-198, 2023. e-Pub 2023. PMID: 36470579.
- Alkhunaizi M, Patel B, Bueno L, Bhan N, Ahmed T, Arain MH, Saliba R, Rondon G, Dickey BF, Bashoura L, Ost DE, Li L, Wang S, Shpall E, Champlin RE, Mehta R, Popat UR, Hosing C, Alousi AM, Sheshadri A. Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell Transplantation. Transplant Cell Ther 29(3):204.e1-204.e7, 2023. e-Pub 2023. PMID: 36503180.
- Ngo-Huang A, Ombres R, Saliba RM, Szewczyk N, Adekoya L, Soones TN, Ferguson J, Fontillas RC, Gulbis AM, Hosing C, Kebriaei P, Lindsay R, Marin DC, Mehta RS, Alousi AM, Srour S, Oran B, Olson AL, Qazilbash MH, Rivera Z, Champlin RE, Shpall EJ, Popat UR. Enhanced Recovery Stem-Cell Transplantation: Multidisciplinary Efforts to Improve Outcomes in Older Adults Undergoing Hematologic Stem-Cell Transplant. JCO Oncol Pract 19(3):OP2200520, 2023. e-Pub 2023. PMID: 36626703.
- Ngo-Huang A, Ombres R, Saliba RM, Szewczyk N, Adekoya L, Soones TN, Ferguson J, Fontillas RC, Gulbis AM, Hosing C, Kebriaei P, Lindsay R, Marin DC, Mehta RS, Alousi AM, Srour S, Oran B, Olson AL, Qazilbash MH, Rivera Z, Champlin RE, Shpall EJ, Popat UR. Enhanced Recovery Stem-Cell Transplantation: Multidisciplinary Efforts to Improve Outcomes in Older Adults Undergoing Hematopoietic Stem-Cell Transplant. JCO Oncol Pract 19(3):e417-e427, 2023. e-Pub 2023. PMID: 36626702.
- Pasvolsky O, Saliba RM, Ledesma C, Popat UR, Alousi A, Olson A, Oran B, Hosing C, Bashir Q, Qazilbash MH, Short NJ, Ravandi F, Champlin R, Shpall EJ, Kebriaei P. Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remission. Am J Hematol 98(2):E35-E37, 2023. e-Pub 2023. PMID: 36502492.
- Nieto Y, Pasvolsky O, Bassett R, Ghanem S, Cuglievan B, Tewari P, Hosing C, Sr S, Ramdial J, Mahadeo K, Khazal S, Petropoulos D, Popat U, Qazilbash M, Kebriaei P, Champlin R, Shpall E. Characteristics and Outcomes of Children, Adolescents and Young Adults with Relapsed/Refractory Non-Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant. Res Sq, 2023. e-Pub 2023. PMID: 36798261.
- Cherng HJ, Xu G, Feng L, Steiner R, Fayad L, Strati P, Nair R, Nastoupil LJ, Lee HJ, Neelapu SS, Flowers CR, Rodriguez M, Wang M, Hagemeister F, Pinnix CC, Ramdial J, Srour S, Nieto Y, Rezvani K, Champlin R, Kebriaei P, Westin J, Macapinlac HA, Shpall E, Ahmed S. Positron emission tomography derived metrics in relapsed or refractory large B-cell lymphoma with residual disease before autologous stem cell transplant. Br J Haematol 200(1):35-44, 2023. e-Pub 2023. PMID: 36068929.
- Jenq R, Hayase E, Hayase T, Mukherjee A, Stinson S, Jamal M, Ortega M, Sanchez C, Ahmed S, Karmouch J, Chang CC, Flores I, McDaniel L, Brown A, El-Himri R, Chapa V, Tan L, Tran B, Pham D, Halsey T, Jin Y, Tsai WB, Prasad R, Glover I, Ajami N, Wargo J, Shelburne S, Okhuysen P, Liu C, Fowler S, Conner M, Peterson C, Rondon G, Molldrem JJ, Champlin R, Shpall E, Lorenzi P, Mehta R, Martens E, Alousi A. Bacteroides ovatus alleviates dysbiotic microbiota-induced intestinal graft-versus-host disease. Res Sq, 2023. e-Pub 2023. PMID: 36778495.
- Damron, EP, Qazilbash, MH, Fang, PQ, Wu, SY, Dabaja, BS, Rondon, G, Hosing, C, Champlin, RE, Bashir, Q, Shpall, E, Knafl, M, Lee, HC, Manasanch, EE, Patel, K, Thomas, SK, Orlowski, R, Weber, DM, Pinnix, CC, Gunther, J. Radiation Therapy Can Be Safely Incorporated into Pretransplantation Treatment Regimens for Patients with Multiple Myeloma. Transplant Cell Ther 29(1):37.e1-37.e7, 2023. e-Pub 2023. PMID: 37753818.
- Imahashi N, Basar R, Huang Y, Wang F, Baran N, Banerjee PP, Lu J, Nunez Cortes AK, Uprety N, Ensley E, Muniz-Feliciano L, Laskowski TJ, Moyes JS, Daher M, Mendt M, Kerbauy LN, Shanley M, Li L, FLWI L, Shaim H, Li Y, Konopleva M, Green M, Wargo J, Shpall EJ, Chen K, Rezvani K. Activated B cells suppress T-cell function through metabolic competition. J Immunother Cancer 10(12), 2022. e-Pub 2022. PMID: 36543374.
- Schwabkey ZI, Wiesnoski DH, Chang CC, Tsai WB, Pham D, Ahmed SS, Hayase T, Ortega Turrubiates MR, El-Himri RK, Sanchez CA, Hayase E, Frenk Oquendo AC, Miyama T, Halsey TM, Heckel BE, Brown AN, Jin Y, Raybaud M, Prasad R, Flores I, McDaniel L, Chapa V, Lorenzi PL, Warmoes MO, Tan L, Swennes AG, Fowler S, Conner M, McHugh K, Graf T, Jensen VB, Peterson CB, Do KA, Zhang L, Shi Y, Wang Y, Galloway-Pena JR, Okhuysen PC, Daniel-MacDougall CR, Shono Y, Burgos da Silva M, Peled JU, van den Brink MRM, Ajami N, Wargo JA, Reddy P, Valdivia RH, Davey L, Rondon G, Srour SA, Mehta RS, Alousi AM, Shpall EJ, Champlin RE, Shelburne SA, Molldrem JJ, Jamal MA, Karmouch JL, Jenq RR. Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment. Sci Transl Med 14(671):eabo3445, 2022. e-Pub 2022. PMID: 36383683.
- Fahrmann JF, Saini NY, Chia-Chi C, Irajizad E, Strati P, Nair R, Fayad LE, Ahmed S, Lee HJ, Iyer S, Steiner R, Vykoukal J, Wu R, Dennison JB, Nastoupil L, Jain P, Wang M, Green M, Westin J, Blumenberg V, Davila M, Champlin R, Shpall EJ, Kebriaei P, Flowers CR, Jain M, Jenq R, Stein-Thoeringer CK, Subklewe M, Neelapu SS, Hanash S. A polyamine-centric, blood-based metabolite panel predictive of poor response to CAR-T cell therapy in large B cell lymphoma. Cell Rep Med 3(11):100720, 2022. e-Pub 2022. PMID: 36384092.
- Pasvolsky O, Milton DR, Rauf M, Tanner MR, Bashir Q, Srour S, Tang G, Saini N, Ramdial J, Masood A, Nieto Y, Lee HC, Patel KK, Kebriaei P, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Lenalidomide-Based Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Patients with High-Risk Multiple Myeloma. Transplant Cell Ther 28(11):752.e1-752.e6, 2022. e-Pub 2022. PMID: 35940528.
- Strati P, Jallouk AP, Sun R, Choi J, Das K, Cherng HJ, Ahmed S, Lee HJ, Iyer SP, Nair R, Nastoupil LJ, Steiner RE, Huff CD, Yu Y, Mistry H, Pulsifer B, Noorani M, Saini N, Shpall EJ, Kebriaei P, Flowers CR, Westin JR, Hildebrandt MAT, Neelapu SS. Impact of conditioning chemotherapy on lymphocyte kinetics and outcomes in LBCL patients treated with CAR T-cell therapy. Leukemia 36(11):2669-2677, 2022. e-Pub 2022. PMID: 36127509.
- Short NJ, Macaron W, Kadia T, Dinardo C, Issa GC, Daver N, Wang S, Jorgensen J, Nguyen D, Bidikian A, Patel KP, Loghavi S, Konopleva M, Yilmaz M, Jabbour E, Maiti A, Abbas HA, Shpall E, Popat U, Al-Atrash G, Pierce S, Kantarjian HM, Ravandi F. Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD-negative remission. Am J Hematol 97(11):E408-E411, 2022. e-Pub 2022. PMID: 36054774.
- Singh H, Srour SA, Milton DR, McCarty J, Dai C, Gaballa MR, Ammari M, Olivares S, Huls H, De Groot E, Marin D, Petropoulos D, Olson AL, Anderlini P, Im JS, Khouri I, Hosing CM, Rezvani K, Champlin RE, Shpall EJ, Cooper LJN, Kebriaei P. Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignancies. Front Immunol 13:1032397, 2022. e-Pub 2022. PMID: 36439104.
- Ragoonanan D, Bhar S, Mohan G, Beltramo F, Khazal SJ, Hurley C, Andersen C, Margossian S, Neelapu SS, Shpall E, Gutierrez C, Tewari P, Shoberu B, Talleur A, McCall D, Nunez C, Cuglievan B, Tambaro FP, Petropoulos D, Abdel-Azim H, Mahadeo KM. A multicenter study of ICU resource utilization in pediatric, adolescent and young adult patients post CAR-T therapy. Front Oncol 12:1022901, 2022. e-Pub 2022. PMID: 36353531.
- Zou J, Kongtim P, Srour SA, Greenbaum U, Schetelig J, Heidenreich F, Baldauf H, Moore B, Saengboon S, Carmazzi Y, Rondon G, Ma Q, Rezvani K, Shpall EJ, Champlin RE, Ciurea SO, Cao K. Donor selection for KIR alloreactivity is associated with superior survival in haploidentical transplant with PTCy. Front Immunol 13:1033871, 2022. e-Pub 2022. PMID: 36311784.
- Mehta RS, Saliba RM, Rondon G, Al-Atrash G, Bashir Q, Hosing CM, Kebriaei P, Khouri I, Nieto Y, Oran B, Popat UR, Qazilbash MH, Ramdial J, Srour SA, Champlin RE, Rezvani K, Shpall EJ, Alousi AM. Post-Transplantation Cyclophosphamide vs Tacrolimus and Methotrexate Graft-versus-Host Disease Prophylaxis For HLA-Matched Donor Transplantation. Transplant Cell Ther 28(10):695.e1-695.e10, 2022. e-Pub 2022. PMID: 35902049.
- Popat UR, Andersson BS, Bassett R, Kawedia J, Valdez BC, Alousi AM, Al-Atrash G, Bashir Q, Hosing CM, Im JS, Kebriaei P, Marin D, Nieto Y, Oran B, Olson A, Qazilbash MH, Srour SA, Shpall EJ, Champlin RE, Mehta RS. A myeloablative fractionated busulfan conditioning regimen with post-transplant cyclophosphamide in HLA-matched and haploidentical transplantation: results of a phase II study. Haematologica 107(10):2496-2500, 2022. e-Pub 2022. PMID: 35770531.
- Li Y, Basar R, Wang G, Liu E, Moyes JS, Li L, Kerbauy LN, Uprety N, Fathi M, Rezvan A, Banerjee PP, Muniz-Feliciano L, Laskowski TJ, Ensley E, Daher M, Shanley M, Mendt M, Acharya S, Liu B, Biederstädt A, Rafei H, Guo X, Melo Garcia L, Lin P, Ang S, Marin D, Chen K, Bover L, Champlin RE, Varadarajan N, Shpall EJ, Rezvani K. KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape. Nat Med 28(10):2133-2144, 2022. e-Pub 2022. PMID: 36175679.
- Pasvolsky, O, Milton, D, Rauf, M, Ghanem, S, Masood, A, Mohamedi, A, Tanner, MR, Bashir, Q, Srour, S, Saini, N, Ramdial, JL, Nieto, Y, Tang, G, Lee, HC, Patel, K, Kebriaei, P, Thomas, SK, Weber, DM, Orlowski, R, Shpall, E, Champlin, RE, Lin, P, Qazilbash, MH. MM-403 Impact of Clonal Plasma Cells in Autografts on the Outcome of High-Risk Multiple Myeloma Patients Undergoing Autologous Hematopoietic Stem Cell Transplant. Clinical Lymphoma, Myeloma and Leukemia 22:S421-S422, 2022. e-Pub 2022. PMID: 36164172.
- Saengboon, S, Ramdial, JL, Saini, N, Olson, AL, Im, J, Hosing, C, Popat, UR, Shpall, E, Champlin, RE, Srour, S. AML-528 Long-Term Outcomes After Haploidentical Stem Cell Transplantation (Haplo-SCT) for Hematologic Malignancies. Clinical Lymphoma, Myeloma and Leukemia 22:S259-S260, 2022. e-Pub 2022. PMID: 36163857.
- Hayase E, Hayase T, Jamal MA, Miyama T, Chang CC, Ortega MR, Ahmed SS, Karmouch JL, Sanchez CA, Brown AN, El-Himri RK, Flores II, McDaniel LK, Pham D, Halsey T, Frenk AC, Chapa VA, Heckel BE, Jin Y, Tsai WB, Prasad R, Tan L, Veillon L, Ajami NJ, Wargo JA, Galloway-Peña J, Shelburne S, Chemaly RF, Davey L, Glowacki RWP, Liu C, Rondon G, Alousi AM, Molldrem JJ, Champlin RE, Shpall EJ, Valdivia RH, Martens EC, Lorenzi PL, Jenq RR. Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host disease. Cell 185(20):3705-3719.e14, 2022. e-Pub 2022. PMID: 36179667.
- Kumar B, Afshar-Kharghan V, Mendt M, Sackstein R, Tanner MR, Popat U, Ramdial J, Daher M, Jimenez J, Basar R, Melo Garcia L, Shanley M, Kaplan M, Wan X, Nandivada V, Reyes Silva F, Woods V, Gilbert A, Gonzalez-Delgado R, Acharya S, Lin P, Rafei H, Banerjee PP, Shpall EJ. Engineered cord blood megakaryocytes evade killing by allogeneic T-cells for refractory thrombocytopenia. Front Immunol 13:1018047, 2022. e-Pub 2022. PMID: 36203567.
- Saini NY, Swoboda DM, Greenbaum U, Ma J, Patel RD, Devashish K, Das K, Tanner MR, Strati P, Nair R, Fayad L, Ahmed S, Lee HJ, Iyer SP, Steiner R, Jain N, Nastoupil L, Loghavi S, Tang G, Bassett RL, Jain P, Wang M, Westin JR, Green MR, Sallman DA, Padron E, Davila ML, Locke FL, Champlin RE, Garcia-Manero G, Shpall EJ, Kebriaei P, Flowers CR, Jain MD, Wang F, Futreal AP, Gillis N, Neelapu SS, Takahashi K. Clonal hematopoiesis is associated with increased risk of severe neurotoxicity in axicabtagene ciloleucel therapy of large B-cell lymphoma. Blood Cancer Discov 3(5):385-393, 2022. e-Pub 2022. PMID: 35533245.
- Saini, N, Swoboda, DM, Greenbaum, U, Ma, J, Patel, R, Devashish, K, Das, K, Tanner, MR, Strati, P, Nair, R, Fayad, LE, Ahmed, S, Lee, HJ, Iyer, SP, Steiner, RE, Jain, N, Nastoupil, L, Loghavi, S, Tang, G, Bassett Jr, R, Jain, P, Wang, M, Westin, JR, Green, M, Sallman, D, Padron, E, Davila, ML, Locke, FL, Champlin, RE, Garcia-Manero, G, Shpall, E, Kebriaei, P, Flowers, CR, Jain, MD, Wang, F, Futreal, A, Gillis, NK, Neelapu, SS, Takahashi, K. Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma. Blood Cancer Discovery 3(5):385-393, 2022. e-Pub 2022. PMID: 35533245.
- Andersson BS, Thall PF, Ma J, Valdez BC, Bassett R, Chen J, Ahmed S, Alousi A, Bashir Q, Ciurea S, Gulbis A, Cool R, Kawedia J, Hosing C, Kebriaei P, Kornblau S, Myers A, Oran B, Rezvani K, Shah N, Shpall E, Parmar S, Popat UR, Nieto Y, Champlin RE. A randomized phase III study of pretransplant conditioning for AML/MDS with fludarabine and once daily IV busulfan ± clofarabine in allogeneic stem cell transplantation. Bone Marrow Transplant 57(8):1295-1303, 2022. e-Pub 2022. PMID: 35610308.
- Sheikh IN, Alqahtani S, Ragoonanan D, Tewari P, Petropoulos D, Mahadeo KM, Popat U, Shpall EJ, Khazal S. Post-Transplant Cyclophosphamide after Matched Sibling and Unrelated Donor Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Myeloid Leukemia. Int J Mol Sci 23(15), 2022. e-Pub 2022. PMID: 35955881.
- Mehta RS, Saliba RM, Hayase E, Jenq RR, Abraham S, Rashid A, Rondon G, Al-Atrash G, Bashir Q, Hosing CM, Kebriaei P, Khouri I, Marin D, Nieto Y, Olson A, Oran B, Popat UR, Qazilbash MH, Ramdial J, Srour S, Champlin RE, Rezvani K, Shpall EJ, Alousi AM. Mycophenolate Mofetil: A Friend or a Foe with Post-Transplantation Cyclophosphamide and Tacrolimus Prophylaxis in HLA-Matched Donors?. Transplant Cell Ther 28(8):500.e1-500.e10, 2022. e-Pub 2022. PMID: 35662592.
- Alatrash G, Saberian C, Bassett R, Thall PF, Ledesma C, Lu Y, Daher M, Valdez BC, Kawedia J, Popat U, Mehta R, Oran B, Nieto Y, Olson A, Anderlini P, Marin D, Hosing C, Alousi AM, Shpall EJ, Rondon G, Chen J, Qazilbash M, Champlin RE, Kebriaei P. Vorinostat Combined with Busulfan, Fludarabine, and Clofarabine Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia: Long-Term Study Outcomes. Transplant Cell Ther 28(8):501.e1-501.e7, 2022. e-Pub 2022. PMID: 35618218.
- Saliba RM, Srour SA, Greenbaum U, Ma Q, Carmazzi Y, Moller M, Wood J, Ciurea SO, Kongtim P, Rondon G, Li D, Saengboon S, Alousi AM, Rezvani K, Shpall EJ, Cao K, Champlin RE, Zou J. SIRPα Mismatch Is Associated With Relapse Protection and Chronic Graft-Versus-Host Disease After Related Hematopoietic Stem Cell Transplantation for Lymphoid Malignancies. Front Immunol 13:904718, 2022. e-Pub 2022. PMID: 35874659.
- Gaballa MR, Ma J, Rauf M, Bassett R, Pasvolsky O, Tanner MR, Bashir Q, Srour SA, Saini N, Ramdial J, Nieto Y, Murphy R, Rezvani K, Tang G, Lin P, Lee HC, Patel KK, Ullah MR, Kaufman GP, Manasanch EE, Kebriaei P, Thomas SK, Weber DM, Shpall EJ, Champlin RE, Orlowski RZ, Qazilbash MH. KRD vs. VRD as induction before autologous hematopoietic progenitor cell transplantation for high-risk multiple myeloma. Bone Marrow Transplant 57(7):1142-1149, 2022. e-Pub 2022. PMID: 35523847.
- Steiner RE, Banchs J, Koutroumpakis E, Becnel M, Gutierrez C, Strati P, Pinnix CC, Feng L, Rondon G, Claussen C, Palaskas N, Karimzad K, Ahmed S, Neelapu S, Shpall E, Wang M, Vega F, Wesin J, Nastoupil LJ, Deswal A. Cardiovascular events in patients treated with chimeric antigen receptor T-cell therapy for aggressive B-cell lymphoma. Haematologica 107(7):1555-1566, 2022. e-Pub 2022. PMID: 34758610.
- Mehta RS, Saliba RM, Ghanem S, Alousi AM, Rondon G, Anderlini P, Al-Atrash G, Bashir Q, Hosing CM, Im JS, Kebriaei P, Khouri I, Marin D, Nieto Y, Olson A, Oran B, Popat UR, Qazilbash MH, Ramdial J, Saini N, Srour SA, Champlin RE, Rezvani K, Shpall EJ. Haploidentical vs Matched Unrelated vs Matched Sibling Donor HCT with Post-Transplantation Cyclophosphamide. Transplant Cell Ther 28(7):395.e1-395.e11, 2022. e-Pub 2022. PMID: 35513252.
- Afrough A, Pasvolsky O, Ma J, Srour S, Bashir Q, Saini N, Hosing C, Popat UR, Kebriaei P, Delgado R, Ullah MR, Murphy R, Manasanch EE, Lee HC, Kaufman GP, Patel KK, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Impact of Induction With VCD Versus VRD on the Outcome of Patients With Multiple Myeloma After an Autologous Hematopoietic Stem Cell Transplantation. Transplant Cell Ther 28(6):307.e1-307.e8, 2022. e-Pub 2022. PMID: 35331973.
- Li A, Marten KL, Nguyen D, Basom R, Rondon G, Jin S, Young E, Amos CI, Lee SJ, Davis C, Garcia DA, Champlin R, Shpall E, Kebriaei P, Hernandez CR. External validation of the HIGH-2-LOW model: A predictive score for venous thromboembolism after allogeneic transplant. AM J Hematol 97(6):740-748, 2022. e-Pub 2022. PMID: 35266218.
- Zaki AA, Feng L, Watson G, Ahmed S, Mistry H, Nastoupil LJ, Hawkins M, Nair R, Iyer SP, Lee HJ, Steiner RE, Flowers CE, Shpall EJ, Kebriaei P, Neelapu S, Westin JR, Strati P. Day 30 SUVmax Predicts Progression in Lymphoma Patients Achieving PR/SD After CAR T-cell Therapy. Blood Adv 6(9):2867-2871, 2022. e-Pub 2022. PMID: 35015825.
- Lachowiez CA, Reville PK, Kantarjian H, Jabbour E, Borthakur G, Daver N, Loghavi S, Furudate K, Xiao L, Pierce S, Short NJ, Maiti A, Yilmaz M, Sasaki K, Takahashi K, Konopleva M, Pemmaraju N, Popat U, Shpall E, Garcia-Manero G, Ravandi F, DiNardo CD, Kadia TM. Venetoclax combined with induction chemotherapy in patients with newly diagnosed acute myeloid leukaemia: a post-hoc, propensity score-matched, cohort study. Lancet Haematol 9(5):e305-e-360, 2022. e-Pub 2022. PMID: 35483396.
- Akin S, Hosing C, Khouri IF, Ahmed S, Alousi A, Fowler NH, Joseph J, Truxillo J, Ramdial J, Maadani F, Rondon G, Daher M, Im JS, Steiner RE, Westin JR, Iyer SP, Dabaja BS, Anderlini P, Popat UR, Qazilbash MH, Flowers CR, Shpall EJ, Champlin RC, Nieto Y, Srour SA. Autologous Stem Cell Transplantation for Large B-cell Lymphoma with Secondary Central Nervous System Involvement. Blood Adv 6(7):2267-2274, 2022. e-Pub 2022. PMID: 35008100.
- Nieto Y, Gruschkus S, Valdez BC, Jones RB, Anderlini P, Hosing C, Popat U, Qazilbash M, Kebriaei P, Alousi A, Saini N, Srour S, Rezvani K, Ramdial J, Barnett M, Gulbis A, Shigle TL, Ahmed S, Iyer S, Lee H, Nair R, Parmar S, Steiner R, Dabaja B, Pinnix C, Gunther J, Cuglievan B, Mahadeo K, Khazal S, Chuang H, Champlin R, Shpall EJ, Andersson BS. Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis. Haematologica 107(4):899-908, 2022. e-Pub 2022. PMID: 33951890.
- Zou J, Kongtim P, Oran B, Kosmoliaptsis V, Carmazzi Y, Ma J, Li L, Rondon G, Srour S, Copley HC, Partlow D, Ciurea SO, Greenbaum U, Ma Q, Shpall EJ, Champlin RE, Cao K. Refined HLA-DPB1 mismatch with molecular algorithms predicts outcomes in hematopoietic stem cell transplantation. Haematologica 107(4):844-856, 2022. e-Pub 2022. PMID: 34435482.
- Nieto Y, Gruschkus S, Valdez BC, Jones RB, Anderlini P, Hosing C, Popat U, Qazilbash M, Kebriaei P, Alousi A, Saini N, Srour S, Rezvani K, Ramdial J, Barnett M, Gulbis A, Shigle TL, Ahmed S, Iyer S, Lee H, Nair R, Parmar S, Steiner R, Dabaja B, Pinnix C, Gunter J, Cuglievan B, Mahadeo K, Khazal S, Chuang H, Champlin R, Shpall EJ, Andersson BS. Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis. Haematologica 107(4):899-908, 2022. e-Pub 2022. PMID: 33951890.
- Qazilbash MH, Saini NY, Cha SC, Wang Z, Stadtmauer EA, Baladandayuthapani B, Lin H, Tross B, Honhar M, Rao SS, Kim K, Popescu M, Szymura S, Zhang T, Anderson A, Bashir Q, Shpall EJ, Orlowski RZ, Levine BL, Kerr N, Garfall A, Cohen A, Vogl DT, Dengel K, June CH, Champlin R, Kwak LW. A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myeloma. Blood 139(9):1289-1301, 2022. e-Pub 2022. PMID: 34521108.
- Gaballa MR, Ma J, Tanner MR, Al-Juhaishi T, Bashir Q, Srour SA, Saini NY, Ramdial JL, Nieto Y, Murphy R, Rezvani K, Tang G, Lee HC, Patel KK, Kaufman GP, Manasanch EE, Ullah MR, Kebriaei P, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Real-world long-term outcomes in multiple myeloma with VRD induction, Mel200-conditioned auto-HCT, and lenalidomide maintenance. Leuk Lymphoma 63(3):710-721, 2022. e-Pub 2022. PMID: 34686083.
- Shimizu Y, Gumin J, Gao F, Hossain A, Shpall EJ, Kondo A, Parker Kerrigan BC, Yang J, Ledbetter D, Fueyo J, Gomez-Manzano C, Lang FF. Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma. J Neurosurg 136(3):757-767, 2022. e-Pub 2022. PMID: 34450587.
- Gaballa MR, Banerjee P, Milton DR, Jiang X, Ganesh C, Khazal S, Nandivada V, Islam S, Kaplan M, Daher M, Basar R, Alousi A, Mehta R, Alatrash G, Khouri I, Oran B, Marin D, Popat U, Olson A, Tewari P, Jain N, Jabbour E, Ravandi F, Kantarjian H, Chen K, Champlin R, Shpall E, Rezvani K, Kebriaei P. Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia. Blood 139(12):1908-1919, 2022. e-Pub 2022. PMID: 34914826.
- Meraz IM, Majidi M, Shao R, Meng F, Ha MJ, Shpall E, Roth JA. TUSC2 immunogene enhances efficacy of chemo-immuno combination on KRAS/LKB1 mutant NSCLC in humanized mouse model. Commun Biol 5(1):167, 2022. e-Pub 2022. PMID: 35210547.
- Bashir Q, Milton DR, Popat UR, Kebriaei P, Hosing C, Khouri IF, Rezvani K, Nieto Y, Oran B, Srour SA, Saini NY, Olson AL, Ahmed S, Al-Atrash G, Rondon G, Konopleva MY, Champlin RE, Shpall EJ, Qazilbash MH, Pemmaraju N. Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN). Bone Marrow Transplant 57(1):51-56, 2022. e-Pub 2022. PMID: 34629467.
- Oran B, Champlin RE, Wang F, Tanaka T, Saliba RM, Al-Atrash G, Garcia-Manero G, Kantarjian H, Cao K, Shpall EJ, Alousi AM, Mehta RS, Popat U, Futreal A, Takahashi K. Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation. Leukemia 36(1):257-262, 2022. e-Pub 2022. PMID: 34135465.
- Oran B, Champlin RE, Wang F, Tanaka T, Saliba RM, Al-Atrash G, Garcia-Manero G, Kantarjian H, Cao K, Shpall EJ, Alousi AM, Mehta RS, Popat U, Futreal A, Takahashi K. Correction to: Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation. Leukemia 36(1):298, 2022. e-Pub 2022. PMID: 34876697.
- Short NJ, Venugopal S, Qiao W, Kadia TM, Ravandi F, Macaron W, Dinardo CD, Daver N, Konopleva M, Borthakur G, Shpall EJ, Popat U, Champlin RE, Mehta R, Al-Atrash G, Oran B, Jabbour E, Garcia-Manero G, Issa GC, Montalban-Bravo G, Yilmaz M, Maiti A, Kantarjian H. Impact of frontline treatment approach on outcomes in patients with secondary AML with prior hypomethylating agent exposure. J Hematol Oncol 15(1):12, 2022. e-Pub 2022. PMID: 35093134.
- Ciurea SO, Kongtim P, Soebbing D, Trikha P, Behbehani G, Rondon G, Olson A, Bashir Q, Gulbis AM, Indreshpal K, Rezvani K, Shpall EJ, Bassett R, Cao K, Martin AS, Devine S, Horowitz M, Pasquini M, Lee DA, Champlin RE. Decrease post-transplant relapse using donor-derived expanded NK-cells. Leukemia 36(1):155-164, 2022. e-Pub 2022. PMID: 34312462.
- Yeh J, Whited L, Saliba RM, Rondon G, Banchs J, Shpall E, Champlin R, Popat U. Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide era. Blood Adv 5(24):5599-5607, 2021. e-Pub 2021. PMID: 34592759.
- Srour SA, Milton DR, Bashir Q, Nieto Y, Saini N, Daher M, Ramdial J, Im J, Hosing C, Delgado R, Manasanch E, Lee HC, Thomas S, Kaufman G, Patel K, Popat U, Weber D, Orlowski R, Shpall E, Champlin RE, Qazilbash MH. Melphalan dose intensity for autologous stem cell transplantation in multiple myeloma. Haematologica 106(12):3211-3214, 2021. e-Pub 2021. PMID: 34407606.
- Mehta RS, Saliba RM, Alsfeld LC, Jorgensen JL, Wang SA, Anderlini P, Al-Atrash G, Bashir Q, Ciurea SO, Hosing CM, Im JS, Kebriaei P, Khouri I, Marin D, Nieto Y, Olson A, Oran B, Popat UR, Qazilbash MH, Ramdial J, Rondon G, Saini N, Srour SA, Rezvani K, Shpall EJ, Champlin RE, Alousi AM. Bone Marrow versus Peripheral Blood Grafts for Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide. Transplant Cell Ther 27(12):1003.e1-1003.e13, 2021. e-Pub 2021. PMID: 34537419.
- Szewczyk NA, Ngo-Huang A, Soones TN, Adekoya LM, Fontillas RC, Ferguson JK, Gale-Capps HE, Kurse BC, Lindsay RJ, Ombres R, Rivera ZR, Gulbis AM, Neumann JL, Braveman BH, Marin D, Shigle TL, Whited L, Wallis WD, Sullivan H, Cao L, Champlin RE, Shpall E, Popat UR. Feasibility and Implementation of a Multimodal Supportive Care Program to Improve Outcomes in Older Patients Undergoing Allogeneic Stem Cell Transplantation. Transplant Cell Ther 27(12):1008-1014, 2021. e-Pub 2021. PMID: 34537421.
- Patel R, Ma J, Bashir Q, Delgado R, Rondon G, Popat UR, Hosing CM, Nieto Y, Kebriaei P, Alousi AM, Daher M, Mehta R, Srour S, Weber DM, Thomas SK, Lee HC, Patel KK, Orlowski RZ, Shpall ES, Champlin RE, Saini N, Qazilbash MH. Black multiple myeloma patients undergoing upfront autologous stem cell transplant have similar survival outcomes compared to Whites: A propensity-score matched analysis. Am J Hematol 96(12):E455-E457, 2021. e-Pub 2021. PMID: 34559916.
- Whisenant MS, Srour SA, Williams LA, Subbiah I, Griffin D, Ponce D, Kebriaei P, Neelapu SS, Shpall E, Ahmed S, Wang XS. The Unique Symptom Burden of Patients Receiving CAR T-Cell Therapy. Semin Oncol Nurs 37(6):151216, 2021. e-Pub 2021. PMID: 34629213.
- Hare J, DeLeon PG, Pool K, Reioux D, Fontenot M, Champlin RE, Eaton EN, Marin D, Rezvani K, Shpall EJ, Wilson JM, Hosing C. Optimal umbilical cord blood collection, processing and cryopreservation methods for sustained public cord blood banking. Cytotherapy 23(11):1029-1035, 2021. e-Pub 2021. PMID: 34247985.
- Wang XS, Srour SA, Whisenant M, Subbiah IM, Chen TH, Ponce D, Gonzalez AG, Kamal M, Mendoza T, Cleland CS, Kebriaei P, Neelapu SS, Rezvani K, Ahmed S, Shpall E. Patient-Reported Symptom and Functioning Status during the First 12 Months after Chimeric Antigen Receptor T Cell Therapy for Hematologic Malignancies. Transplant Cell Ther 27(11):930.e1-930.e10, 2021. e-Pub 2021. PMID: 34265479.
- Mehta RS, Bassett R, Chen J, Valdez BC, Kawedia J, Alousi AM, Anderlini P, Al-Atrash G, Bashir Q, Ciurea SO, Hosing CM, Im JS, Kebriaei P, Khouri I, Marin D, Nieto Y, Olson A, Oran B, Qazilbash MH, Ramdial J, Saini N, Srour SA, Rezvani K, Shpall EJ, Andersson BS, Champlin RE, Popat UR. Myeloablative Fractionated Busulfan With Fludarabine in Older Patients: Long Term Disease-Specific Outcomes of a Prospective Phase II Clinical Trial. Transplant Cell Ther 27(11):913.e1-913.e12, 2021. e-Pub 2021. PMID: 34329753.
- Shpall EJ, Rezvani K. Cord blood expansion has arrived. Blood 138(16):1381-1382, 2021. e-Pub 2021. PMID: 34673952.
- Sassine J, Khawaja F, Shigle TL, Handy V, Foolad F, Aitken SL, Jiang Y, Champlin R, Shpall E, Rezvani K, Ariza-Heredia EJ, Chemaly RF. Refractory and Resistant Cytomegalovirus After Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era. Clin Infect Dis 73(8):1346-1354, 2021. e-Pub 2021. PMID: 33830182.
- Al Feghali KA, Fang P, Gule-Monroe M, Milgrom S, Khoury JD, Gunther JR, Sheu T, Nair R, Ahmed S, Steiner R, Strati P, Shpall EJ, Nieto YL, Hosing C, Nastoupil LJ, Westin JR, Neelapu SS, Fowler N, Flowers C, Pinnix CC, Dabaja BS. Prognostic value of disease distribution in secondary central nervous system diffuse large B cell lymphoma treated with radiation therapy. Leuk Lymphoma 62(10):2400-2407, 2021. e-Pub 2021. PMID: 33942701.
- Venugopal S, Shoukier M, Konopleva M, Dinardo CD, Ravandi F, Short NJ, Andreeff M, Borthakur G, Daver N, Pemmaraju N, Sasaki K, Montalban-Bravo G, Marx KR, Pierce S, Popat UR, Shpall EJ, Kanagal-Shamanna R, Garcia-Manero G, Kantarjian HM, Kadia TM. Outcomes in patients with newly diagnosed TP53-mutated acute myeloid leukemia with or without venetoclax-based therapy. Cancer 127(19):3541-3551, 2021. e-Pub 2021. PMID: 34182597.
- Saliba RM, Greenbaum U, Ma Q, Srour SA, Carmazzi Y, Li L, Oran B, Moller M, Wood J, Ciurea SO, Kongtim P, Rondon G, Partlow D, Li D, Rezvani K, Shpall EJ, Cao K, Champlin RE, Zou J. Mismatch in SIRPα, a regulatory protein in innate immunity, is associated with chronic GVHD in hematopoietic stem cell transplantation. Blood Adv 5(17):3407-3417, 2021. e-Pub 2021. PMID: 34495313.
- S Mehta R, Torres Cabala CA, DiNardo CD, Daver N, Dabaja B, Rezvani K, Champlin RE, Shpall E, Duvic M. Post-transplantation donor-derived Sezary syndrome in a patient with A91V PRF1 variant hemophagocytic lymphohistiocytosis. Am J Hematol 96(9):E350-E353, 2021. e-Pub 2021. PMID: 34096089.
- Olson A, Lin R, Marin D, Rafei H, Bdaiwi MH, Thall PF, Basar R, Abudayyeh A, Banerjee P, Aung FM, Kaur I, Abueg G, Rao S, Chemaly R, Mulanovich V, Al-Atrash G, Alousi AM, Andersson BS, Anderlini P, Bashir Q, Castro KM, Daher M, Galvan IM, Hosing C, Im JS, Jones RB, Kebriaei P, Khouri I, Mehta R, Molldrem J, Nieto Y, Oran B, Popat U, Qazilbash M, Rondon G, Saini N, Spencer B, Srour S, Washington D, Barnett M, Champlin, RE, Shpall EJ, Rezvani K. Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation. J Clin Oncol 39(24):2710-2719, 2021. e-Pub 2021. PMID: 33929874.
- Yalniz FF, Saliba RM, Greenbaum U, Ramdial J, Popat U, Oran B, Alousi A, Olson A, Alatrash G, Marin D, Rezvani K, Hosing C, Im J, Mehta R, Qazilbash M, Joseph JJ, Rondon G, Kanagal-Shamanna R, Shpall E, Champlin R, Kebriaei P. Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Myeloid Leukemia. Transplant Cell Ther 27(8):689-695, 2021. e-Pub 2021. PMID: 34023569.
- Basar R, Uprety N, Ensley E, Daher M, Klein K, Martinez F, Aung F, Shanley M, Hu B, Gokdemir E, Nunez Cortes AK, Mendt M, Reyes Silva F, Acharya S, Laskowski T, Muniz-Feliciano L, Banerjee PP, Li Y, Li S, Melo Garcia L, Lin P, Shaim H, Yates SG, Marin D, Kaur I, Rao S, Mak D, Lin A, Miao Q, Dou J, Chen K, Champlin RE, Shpall EJ, Rezvani K. Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapy. Cell Rep 36(3):109432, 2021. e-Pub 2021. PMID: 34270918.
- Kerbauy LN, Marin ND, Kaplan M, Banerjee PP, Berrien-Elliott MM, Becker-Hapak M, Basar R, Foster M, Garcia Melo L, Neal CC, McClain E, Daher M, Nunez Cortes AK, Desai S, Inng Lim FW, Mendt MC, Schappe T, Li L, Shaim H, Shanley M, Ensley EL, Uprety N, Wong P, Liu E, Ang SO, Cai R, Nandivada V, Mohanty V, Miao Q, Shen Y, Baran N, Fowlkes NW, Chen K, Muniz-Feliciano L, Champlin RE, Nieto YL, Koch J, Treder M, Fischer W, Okamoto OK, Shpall EJ, Fehniger TA, Rezvani K. Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood-Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies. Clin Cancer Res 27(13):3744-3756, 2021. e-Pub 2021. PMID: 33986022.
- Shaim H, Shanley M, Basar R, Daher M, Gumin J, Zamler DB, Uprety N, Wang F, Huang Y, Gabrusiewicz K, Miao Q, Dou J, Alsuliman A, Kerbauy LN, Acharya S, Mohanty V, Mendt M, Li S, Lu J, Wei J, Fowlkes NW, Gokdemir E, Ensley EL, Kaplan M, Kassab C, Li L, Ozcan G, Banerjee PP, Shen Y, Gilbert AL, Jones CM, Bdiwi M, Nunez-Cortes AK, Liu E, Yu J, Imahashi N, Muniz-Feliciano L, Li Y, Hu J, Draetta G, Marin D, Yu D, Mielke S, Eyrich M, Champlin RE, Chen K, Lang FF, Shpall EJ, Heimberger AB, Rezvani K. Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells. J Clin Invest 131(14), 2021. e-Pub 2021. PMID: 34138753.
- Greenbaum U, Strati P, Saliba RM, Torres J, Rondon G, Nieto Y, Hosing C, Srour SA, Westin J, Fayad LE, Lee HJ, Iyer SP, Nair R, Nastoupil LJ, Parmar S, Rodriguez MA, Samaniego F, Steiner RE, Wang M, Pinnix CC, Flowers CR, Tummala S, Ramdial JL, Yalniz FF, Hawkins M, Rezvani K, Champlin RE, Shpall EJ, Neelapu SS, Kebriaei P, Ahmed S. CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicity. Blood Adv 5(14):2799-2806, 2021. e-Pub 2021. PMID: 34264268.
- Greenbaum U, Ramdial JL, Olson A, Nieto Y, Strati P, Ahmed S, Neelapu SS, Tummala S, Chi L, Shpall EJ, Kebriaei P. Prolonged neurotoxicity in a lymphoma patient after CD19-directed CAR T-cell therapy: A case report and brief review of the literature. Adv Cell Gene Ther 4(3):e104, 2021. e-Pub 2021.
- Strati P, Ahmed S, Furqan F, Fayad LE, Lee HJ, Iyer SP, Nair R, Nastoupil L, Parmar S, Rodriguez MA, Samaniego F, Steiner RE, Wang ML, Pinnix CC, Horowitz SB, Feng L, Sun R, Claussen CM, Hawkins M, Johnson N, Singh P, Mistry H, Johncy S, Adkins S, Kebriaei P, Shpall EJ, Green MR, Flowers C, Westin J, Neelapu SS. Prognostic Impact of Corticosteroids on Efficacy of Chimeric Antigen Receptor T-cell Therapy in Large B-cell Lymphoma. Blood 137(23):3272-3276, 2021. e-Pub 2021. PMID: 33534891.
- Mehta RS, Bassett R, Rondon G, Overman BJ, Popat UR, Hosing CM, Rezvani K, Qazilbash MH, Anderlini P, Jones RB, Kebriaei P, Marin D, Khouri IF, Oran B, Ciurea SO, Kondo K, Couriel DR, Shpall EJ, Champlin RE, Alousi AM. Randomized phase II trial of extracorporeal phototherapy and steroids vs. steroids alone for newly diagnosed acute GVHD. Bone Marrow Transplant 56(6):1316-1324, 2021. e-Pub 2021. PMID: 33398094.
- Saberian C, Amaria RN, Najjar AM, Radvanyi LG, Haymaker CL, Forget MA, Bassett RL, Faria SC, Glitza IC, Alvarez E, Parshottam S, Prieto V, Lizée G, Wong MK, McQuade JL, Diab A, Yee C, Tawbi HA, Patel S, Shpall EJ, Davies MA, Hwu P, Bernatchez C. Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma. J Immunother Cancer 9(5), 2021. e-Pub 2021. PMID: 34021033.
- Oran B, Saliba RM, Mehta RS, Alousi AM, Marin D, Valdez BC, Chen J, Bashir Q, Ciurea SO, Olson AL, Hosing C, Kebriaei P, Rezvani K, Shpall EJ, Champlin RE, Andersson BS, Popat UR. Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndrome. Cancer 127(10):1598-1605, 2021. e-Pub 2021. PMID: 33471943.
- Mendt M, Daher M, Basar R, Shanley M, Kumar B, Wei Inng FL, Acharya S, Shaim H, Fowlkes N, Tran JP, Gokdemir E, Uprety N, Nunez-Cortes AK, Ensley E, Mai T, Kerbauy LN, Melo-Garcia L, Lin P, Shen Y, Mohanty V, Lu J, Li S, Nandivada V, Wang J, Banerjee P, Reyes-Silva F, Liu E, Ang S, Gilbert A, Li Y, Wan X, Gu J, Zhao M, Baran N, Muniz-Feliciano L, Wilson J, Kaur I, Gagea M, Konopleva M, Marin D, Tang G, Chen K, Champlin R, Rezvani K, Shpall EJ. Metabolic Reprogramming of GMP Grade Cord Tissue Derived Mesenchymal Stem Cells Enhances Their Suppressive Potential in GVHD. Front Immunol 12:631353, 2021. e-Pub 2021. PMID: 34017325.
- Joseph J, Ma J, Hennawy F, Abdulrazzaq MN, Saini N, Patel RD, Hosing CM, Alousi AM, Anderlini P, Popat UR, Qazilbash MH, Shpall EJ, Srour S, Kebriaei P, Bashir Q, Nastoupil LJ, Westin JR, Rondon G, Champlin RE, Andersson BS, Nieto Y, Muzzafar T, Ahmed S. Impact of Cell of Origin Classification on Survival Outcomes after Autologous Transplantation in Relapsed/Refractory Diffuse Large B Cell Lymphoma. Transplant Cell Ther 27(5):404.e1-404.e5, 2021. e-Pub 2021. PMID: 33965178.
- Ahmed S, Bashir Q, Bassett R, Poon MC, Valdez B, Konoplev S, Alousi AM, Andersson BS, Ciurea S, Hosing C, Jones R, Kebriaei P, Khouri I, Kim S, Nieto Y, Olson A, Oran B, Parmar S, Qazilbash MH, Rezvani K, Shah N, Shpall EJ, Champlin R, Popat U. Eltrombopag for Post-Transplantation Thrombocytopenia: Results of Phase II Randomized, Double-Blind, Placebo-Controlled Trial. Transplant Cell Ther 27(5):430.e1-430.e7, 2021. e-Pub 2021. PMID: 33965187.
- Greenbaum U, Klein K, Martinez F, Song J, Thall PF, Ramdial JL, Knape C, Aung FM, Scroggins J, Knopfelmacher A, Mulanovich V, Borjan J, Adachi J, Muthu M, Leung C, Medina MC, Champlin R, Olson A, Alousi A, Rezvani K, Shpall EJ. High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients. Front Immunol 12:675679, 2021. e-Pub 2021. PMID: 33995420.
- Srour SA, Saliba RM, Bashir Q, Popat UR, Ahmed S, Mehta RS, Delgado R, Rondon G, Parmar S, Kebriaei P, Hosing C, Manasanch EE, Lee HC, Patel KK, Orlowski RZ, Shpall E, Champlin RE, Qazilbash MH, Nieto Y. Influence of Overlapping Genetic Abnormalities on Treatment Outcomes of Multiple Myeloma. Transplant Cell Ther 27(3):243.e1-243.e6, 2021. e-Pub 2021. PMID: 33781521.
- Mehta RS, Saliba RM, Jan A, Shigle TL, Wang E, Nieto Y, Ciurea SO, Oran B, Im J, Olson A, Marin D, Qazilbash M, Khouri I, Rondon G, Anderlini P, Rezvani K, Popat U, Kebriaei P, Shpall E, Champlin R, Alousi A. Vedolizumab for Steroid Refractory Lower Gastrointestinal Tract Graft-Versus-Host Disease. Transplant Cell Ther 27(3):272.e1-272.e5, 2021. e-Pub 2021. PMID: 33781539.
- Greenbaum U, Klein K, Martinez F, Song J, Thall PF, Ramdial JL, Knape C, Aung FM, Scroggins J, Knopfelmacher A, Mulanovich V, Borjan J, Adachi J, Muthu M, Leung C, Medina MC, Champlin R, Olson A, Alousi A, Rezvani K, Shpall EJ. High levels of common cold coronavirus antibodies in convalescent plasma are associated with improved survival in COVID-19 patients. medRxiv, 2021. e-Pub 2021. PMID: 33758890.
- Liu E, Ang SOT, Kerbauy L, Basar R, Kaur I, Kaplan M, Li L, Tong Y, Daher M, Ensley EL, Uprety N, Nunez Cortes AK, Yang RZ, Li Y, Shaim H, Reyes Silva F, Lin P, Mohanty V, Acharya S, Shanley M, Muniz-Feliciano L, Banerjee PP, Chen K, Champlin RE, Shpall EJ, Rezvani K. GMP-Compliant Universal Antigen Presenting Cells (uAPC) Promote the Metabolic Fitness and Antitumor Activity of Armored Cord Blood CAR-NK Cells. Front Immunol 12:626098, 2021. e-Pub 2021. PMID: 33717142.
- Daher M, Basar R, Gokdemir E, Baran N, Uprety N, Nunez Cortes AK, Mendt M, Kerbauy LN, Banerjee PP, Shanley M, Imahashi N, Li L, FLWI L, Fathi M, Rezvan A, Mohanty V, Shen Y, Shaim H, Lu J, Ozcan G, Ensley E, Kaplan M, Nandivada V, Bdiwi M, Acharya S, Xi Y, Wan X, Mak D, Liu E, Jiang XR, Ang S, Muniz-Feliciano L, Li Y, Wang J, Kordasti S, Petrov N, Varadarajan N, Marin D, Brunetti L, Skinner RJ, Lyu S, Silva L, Turk R, Schubert MS, Rettig GR, McNeill MS, Kurgan G, Behlke MA, Li H, Fowlkes NW, Chen K, Konopleva M, Champlin RE, Shpall EJ, Rezvani K. Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells. Blood 137(5):624-636, 2021. e-Pub 2021. PMID: 32902645.
- Ragoonanan D, Khazal SJ, Mejia R, Ewing L, Durand JB, Bashoura L, Tayar J, Dailey Garnes N, Petropoulos D, Tewari P, Bhatti M, Ahmad AH, Cortes J, Razvi S, McBeth K, Swinford R, Shoberu B, Waseemuddin W, Chi L, Gill JB, Zaky W, Daw N, Gutierrez C, Tereffe W, Kebriaei P, Rezvani K, Shpall EJ, Champlin RE, Mahadeo KM. Case Discussion and Literature Review: Cancer Immunotherapy, Severe Immune-Related Adverse Events, Multi-Inflammatory Syndrome, and Severe Acute Respiratory Syndrome Coronavirus 2. Front Oncol 11(11):625707, 2021. e-Pub 2021. PMID: 33614514.
- Olson AL, Saliba RM, Oran B, Chen J, Alousi A, Ahmed S, Bashir Q, Ciurea SO, Hosing C, Seon Im J, Kebriaei P, Khouri IF, Mehta R, Nieto Y, Parmar S, Rezvani K, Shah N, Shpall E, Srour SA, Qazilbash M, Andersson BS, Champlin R, Popat UR. Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia. Acta Haematol 144(1):74-81, 2021. e-Pub 2021. PMID: 32604096.
- Srinivasan VM, Gumin J, Camstra KM, Collins DE, Chen MM, Shpall EJ, Parker Kerrigan BC, Johnson JN, Chen SR, Fueyo J, Gomez-Manzano C, Lang FF, Kan P. Endovascular Selective Intra-Arterial Infusion of Mesenchymal Stem Cells Loaded With Delta-24 in a Canine Model. Neurosurgery 88(1):E102-E113, 2021. e-Pub 2021. PMID: 33231254.
- Saliba RM, Veltri L, Rondon G, Chen J, Al-Atrash G, Alousi A, Martinez C, Augustine L, Hosing CM, Oran B, Rezvani K, Shpall EJ, Kebriaei P, Khouri IF, Popat U, Champlin RE, Ciurea SO. Impact of graft composition on outcomes of haploidentical bone marrow stem cell transplantation. Haematologica 106(1):269-274, 2021. e-Pub 2021. PMID: 32107328.
- Maus MV, Alexander S, Bishop MR, Brudno JN, Callahan C, Davila ML, Diamonte C, Dietrich J, Fitzgerald JC, Frigault MJ, Fry TJ, Holter-Chakrabarty JL, Komanduri KV, Lee DW, Locke FL, Maude SL, McCarthy PL, Mead E, Neelapu SS, Neilan TG, Santomasso BD, Shpall EJ, Teachey DT, Turtle CJ, Whitehead T, Grupp SA. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events. J Immunother Cancer 8(2):e001511, 2020. e-Pub 2020. PMID: 33335028.
- Politikos I, Davis E, Nhaissi M, Wagner JE, Brunstein CG, Cohen S, Shpall EJ, Milano F, Scaradavou A, Barker JN. Guidelines for Cord Blood Unit Selection. Biol Blood Marrow Transplant 26(12):2190-2196, 2020. e-Pub 2020. PMID: 32736011.
- Janku F, Park H, Call SG, Madwani K, Oki Y, Subbiah V, Hong DS, Naing A, Velez-Bravo VM, Barnes TG, Hagemeister FB, Falchook GS, Karp DD, Wheler JJ, Piha-Paul SA, Garrido-Laguna I, Shpall EJ, Fayad LE, Neelapu SS, Meric-Bernstam F, Kurzrock R, Fanale MA. Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma. Clin Cancer Res 26(21):5579-5587, 2020. e-Pub 2020. PMID: 33055173.
- Yuan B, El Dana F, Ly S, Yan Y, Ruvolo V, Shpall EJ, Konopleva M, Andreeff M, Battula VL. Bone marrow stromal cells induce an ALDH+ stem cell-like phenotype and enhance therapy resistance in AML through a TGF-β-p38-ALDH2 pathway. PLoS One 15(11):e0242809, 2020. e-Pub 2020. PMID: 33253299.
- Srour SA, Kongtim P, Rondon G, Chen J, Petropoulos D, Ramdial J, Popat U, Kebriaei P, Qazilbash M, Shpall EJ, Champlin RE, Ciurea SO. Haploidentical transplants for patients with relapse after the first allograft. Am J Hematol 95(10):1187-1192, 2020. e-Pub 2020. PMID: 32619033.
- Srinivasan VM, Gumin J, Camstra KM, Chen SR, Johnson JN, Shimizu Y, Parker Kerrigan BC, Shpall EJ, Lang FF, Kan P. Microcatheter delivery of neurotherapeutics: compatibility with mesenchymal stem cells. J Neurosurg 6(4):1-9, 2020. e-Pub 2020. PMID: 31491769.
- Abudayyeh A, Lin H, Abdelrahim M, Rondon G, Andersson BS, Martinez CS, Page VD, Tarrand JJ, Kontoyiannis DP, Marin D, Oran B, Olson A, Jones R, Popat U, Champlin RE, Chemaly RF, Shpall EJ, Rezvani K. Development and Validation of a Risk Assessment Tool for BKPyV Replication in Allogeneic Stem Cell Transplant Recipients. Transpl Infect Dis 22(5):e13395, 2020. e-Pub 2020. PMID: 32602954.
- Basar R, Uprety N, Ensley E, Daher M, Klein K, Martinez F, Aung F, Shanley M, Hu B, Gokdemir E, Mendt M, Silva FR, Acharya S, Laskowski T, Muniz-Feliciano L, Banerjee P, Li Y, Li S, Garcia LM, Lin P, Shaim H, Yates SG, Marin D, Kaur I, Rao S, Mak D, Lin A, Miao Q, Dou J, Chen K, Champlin R, Shpall EJ, Rezvani K. Generation of glucocorticoid resistant SARS-CoV-2 T-cells for adoptive cell therapy. bioRxiv, 2020. e-Pub 2020. PMID: 32995792.
- Strati P, Nastoupil LJ, Westin J, Fayad LE, Ahmed S, Fowler NH, Hagemeister FB, Lee HJ, Iyer SP, Nair R, Parmar S, Rodriguez MA, Samaniego F, Steiner RE, Wang M, Pinnix CC, Adkins S, Claussen CM, Martinez CS, Hawkins MC, Johnson NA, Singh P, Mistry HE, Horowitz S, George S, Feng L, Kebriaei P, Shpall EJ, Neelapu SS, Tummala S, Chi TL. Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphoma. Blood Adv 4(16):3943-3951, 2020. e-Pub 2020. PMID: 32822484.
- Khatua S, Cooper LJN, Sandberg DI, Ketonen L, Johnson JM, Rytting ME, Liu DD, Meador H, Trikha P, Nakkula RJ, Behbehani GK, Ragoonanan D, Gupta S, Kotrotsou A, Idris T, Shpall EJ, Rezvani K, Colen R, Zaky W, Lee DA, Gopalakrishnan V. Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymoma. Neuro Oncol 22(8):1214-1225, 2020. e-Pub 2020. PMID: 32152626.
- Popat U, Mehta RS, Bassett R, Kongtim P, Chen J, Alousi AM, Anderlini P, Ciurea S, Hosing C, Jones R, Kebriaei P, Khouri I, Lindsay R, Nieto Y, Olson A, Oran B, Qazilbash MH, Rondon G, Shpall EJ, Verstovsek S, Andersson BS, Champlin RE. Optimizing the Conditioning Regimen for HCT in Myelofibrosis: Long-term Results of a Prospective Phase II Clinical Trial. Biol Blood Marrow Transplant 26(8):1439-1445, 2020. e-Pub 2020. PMID: 32438043.
- Basar R, Daher M, Uprety N, Gokdemir E, Alsuliman A, Ensley E, Ozcan G, Mendt M, Hernandez Sanabria M, Kerbauy LN, Nunez Cortes AK, Li L, Banerjee PP, Muniz-Feliciano L, Acharya S, Fowlkes NW, Lu J, Li S, Mielke S, Kaplan M, Nandivada V, Bdaiwi M, Kontoyiannis AD, Li Y, Liu E, Ang S, Marin D, Brunetti L, Gundry MC, Turk R, Schubert MS, Rettig GR, McNeill MS, Kurgan G, Behlke MA, Champlin R, Shpall EJ, Rezvani K. Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cells. Blood Adv 4(14):3357-3367, 2020. e-Pub 2020. PMID: 32717029.
- Weathers SP, Penas-Prado M, Pei BL, Ling X, Kassab C, Banerjee P, Bdiwi M, Shaim H, Alsuliman A, Shanley M, de Groot JF, O'Brien BJ, Harrison R, Majd N, Kamiya-Matsuoka C, Fuller GN, Huse JT, Chi L, Rao G, Weinberg JS, Lang FF, Sawaya R, Shpall EJ, Rezvani K, Heimberger AB. Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial. Clin Cancer Res 26(14):3565-3577, 2020. e-Pub 2020. PMID: 32299815.
- Oran B, Garcia-Manero G, Saliba RM, Alfayez M, Al-Atrash G, Ciurea SO, Jabbour EJ, Mehta RS, Popat UR, Ravandi F, Alousi AM, Kadia TM, Konopleva M, DiNardo CD, Rezvani K, Shpall EJ, Sharma P, Kantarjian HM, Champlin RE, Daver N. Posttransplantation cyclophosphamide improves transplantation outcomes in patients with AML/MDS who are treated with checkpoint inhibitors. Cancer 126(10):2193-2205, 2020. e-Pub 2020. PMID: 32125707.
- Yalniz FF, Patel KP, Bashir Q, Marin D, Ahmed S, Alousi AM, Chen J, Ciurea SO, Rezvani K, Popat UR, Shpall EJ, Champlin RE, Oran B. Significance of minimal residual disease monitoring by real-time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomes. Cancer 126(10):2183-2192, 2020. e-Pub 2020. PMID: 32101640.
- Kebriaei P, Hayes J, Daly A, Uberti J, Marks DI, Soiffer R, Waller EK, Burke E, Skerrett D, Shpall E, Martin PJ. A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease. Biol Blood Marrow Transplant 26(5):835-844, 2020. e-Pub 2020. PMID: 31505228.
- Varma A, Abraham SC, Mehta RS, Saini NY, Honhar M, Rashid M, Chen J, Srour SA, Bashir Q, Rondon G, Oran B, Hosing CM, Nieto Y, Kebriaei P, Alousi AM, Ahmed S, Marin D, Khouri IF, Ciurea SO, Qazilbash MH, Rezvani K, Anderlini P, Andersson BS, Shpall EJ, Champlin RE, Popat UR. Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity. Blood Adv 4(7):1296-1306, 2020. e-Pub 2020. PMID: 32236526.
- Varma A, Sui D, Milton DR, Tang G, Saini N, Hasan O, Mukherjee A, Joseph JJ, Bashir Q, Rondon G, Srour S, Popat UR, Hosing CM, Nieto Y, Kebriaei P, Alousi AM, Ahmed S, Mehta R, Khouri IF, Ahmed H, Iyer S, Weber DM, Thomas SK, Manasanch E, Lee HC, Patel K, Ciurea SO, Shpall EJ, Orlowski RZ, Champlin RE, Qazilbash MH. Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after Autologous Hematopoietic Stem Cell Transplantation: Propensity Score Matched Analysis. Biol Blood Marrow Transplant 26(4):665-671, 2020. e-Pub 2020. PMID: 31881283.
- Varma A, Sui D, Milton DR, Tang G, Saini N, Hasan O, Mukherjee A, Joseph JJ, Bashir Q, Rondon G, Srour S, Popat UR, Hosing CM, Nieto Y, Kebriaei P, Alousi AM, Ahmed S, Mehta R, Khouri IF, Ahmed H, Iyer S, Weber DM, Thomas SK, Manasanch E, Lee HC, Patel K, Ciurea SO, Shpall EJ, Orlowski RZ, Champlin RE, Qazilbash MH. Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after Autologous Hematopoietic Stem Cell Transplantation: Propensity Score Matched Analysis. Biol Blood Marrow Transplant 26(4):665-671, 2020. e-Pub 2020. PMID: 31881283.
- Ballen K, Logan BR, Chitphakdithai P, Kuxhausen M, Spellman SR, Adams A, Drexler RJ, Duffy M, Kemp A, King R, Babic A, Delaney C, Karanes C, Kurtzberg J, Petz L, Scaradavou A, Shpall EJ, Smith C, Confer DL, Miller JP. Unlicensed Umbilical Cord Blood Units Provide a Safe and Effective Graft Source for a Diverse Population: A Study of 2456 Umbilical Cord Blood Recipients. Biol Blood Marrow Transplant 26(4):745-757, 2020. e-Pub 2020. PMID: 31756539.
- Srour S, Singh H, McCarty J, de Groot E, Huls H, Rondon G, Qazilbash MH, Ciurea SO, Bardelli G, Buck J, Alousi A, Nieto Y, Rezvani K, Marin D, Popat U, Hosing C, Shpall EJ, Wierda WG, Kantargian H, Champlin R, Cooper L, Kebriaei P. Long-term outcomes of Sleeping Beauty generated CD19specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas. Blood 135(11):862-865, 2020. e-Pub 2020. PMID: 31961918.
- Liu E, Marin D, Banerjee P, Macapinlac HA, Thompson P, Basar R, Nassif Kerbauy L, Overman B, Thall P, Kaplan M, Nandivada V, Kaur I, Nunez Cortes A, Cao K, Daher M, Hosing C, Cohen EN, Kebriaei P, Mehta R, Neelapu S, Nieto Y, Wang M, Wierda W, Keating M, Champlin R, Shpall EJ, Rezvani K. Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors. N Engl J Med 382(6):545-553, 2020. e-Pub 2020. PMID: 32023374.
- Kongtim P, Hasan O, Perez JMR, Varma A, Wang SA, Patel KP, Chen J, Rondon G, Srour S, Bashir Q, Qazilbash M, Mehta R, Shpall EJ, Alousi A, Khouri I, Kebriaei P, Popat U, Champlin RR, Ciurea SO. Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 26(1):197-203, 2020. e-Pub 2020. PMID: 31518645.
- Parker Kerrigan BC, Ledbetter D, Kronowitz M, Phillips L, Gumin J, Hossain A, Yang J, Mendt M, Singh S, Cogdell D, Ene C, Shpall E, Lang FF. RNAi technology targeting the FGFR3-TACC3 fusion breakpoint: an opportunity for precision medicine. Neurooncol Adv 2(1):vdaa132, 2020. e-Pub 2020. PMID: 33241214.
- Li L, Chen H, Marin D, Xi Y, Miao Q, Lv J, Banerjee PP, Shaim H, Daher M, Basar R, Imahashi N, Jimenez J, Hu B, Mehta RS, Kerbauy LN, Kaplan M, Mendt M, Ozcan G, Gokdemir E, Hernandez Sanabria M, Li Y, Chen K, Wang J, Muniz-Feliciano L, Zhao WL, Champlin RE, Shpall EJ, Rezvani K. A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation. Blood Adv 3(23):4117-4130, 2019. e-Pub 2019. PMID: 31821460.
- Oran, B, Champlin, RE, Wang, F, Jeyakumar, N, Garcia-Manero, G, Kantarjian, HM, Saliba, RM, Cao, K, Shpall, E, Alousi, AM, Mehta, RS, Popat, UR, Futreal, A, Takahashi, K. Donor Clonal Hematopoiesis Increases Risk of Acute Graft Versus Host Disease after Matched Related Transplantation in AML and MDS Patients. Blood 134(1), 2019. e-Pub 2019. PMID: 31723997.
- Kansagra AJ, Frey NV, Bar M, Laetsch TW, Carpenter PA, Savani BN, Heslop HE, Bollard CM, Komanduri KV, Gastineau DA, Chabannon C, Perales MA, Hudecek M, Aljurf M, Andritsos L, Barrett JA, Bachanova V, Bonini C, Ghobadi A, Gill SI, Hill JA, Kenderian S, Kebriaei P, Nagler A, Maloney D, Liu HD, Shah NN, Kharfan-Dabaja MA, Shpall EJ, Mufti GJ, Johnston L, Jacoby E, Bazarbachi A, DiPersio JF, Pavletic SZ, Porter DL, Grupp SA, Sadelain M, Litzow MR, Mohty M, Hashmi SK. Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT). Bone Marrow Transplant 54(11):1868-1880, 2019. e-Pub 2019. PMID: 31092900.
- Zeng Z, Liu W, Benton CB, Konoplev S, Lu H, Wang RY, Chen J, Shpall E, Baggerly KA, Champlin R, Konopleva M. Proteomic Profiling of Signaling Networks Modulated by G-CSF/Plerixafor/Busulfan-Fludarabine Conditioning in Acute Myeloid Leukemia Patients in Remission or with Active Disease prior to Allogeneic Stem Cell Transplantation. Acta Haematol 142(3):176-184, 2019. e-Pub 2019. PMID: 31112940.
- Alatrash G, Kidwell KM, Thall PF, Di Stasi A, Chen J, Zope M, Crain AK, Champlin RE, Popat U, Shpall EJ, Jones RB, Andersson BS. Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDS. Bone Marrow Transplant 54(8):1245-1253, 2019. e-Pub 2019. PMID: 30532055.
- Meraz IM, Majidi M, Meng F, Shao R, Ha MJ, Neri S, Fang B, Lin SH, Tinkey PT, Shpall EJ, Morris J, Roth JA. An improved patient-derived xenograft humanized mouse model for evaluation of lung cancer immune responses. Cancer Immunol Res 7(8):1267-1279, 2019. e-Pub 2019. PMID: 31186248.
- Alatrash G, Kidwell KM, Thall PF, Di Stasi A, Chen J, Zope M, Crain AK, Champlin RE, Popat U, Shpall EJ, Jones RB, Andersson BS. Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDS. Bone Marrow Transplant 54(8):1245-1253, 2019. e-Pub 2019. PMID: 30532055.
- Abraham, AA, John, TD, Keller, MD, Russell N Cruz, C, Salem, B, Roesch, L, Liu, H, Hoq, F, Grilley, B, Gee, AP, Dave, H, Jacobsohn, DA, Krance, RA, Shpall, E, Martinez, CA, Hanley, PJ, Bollard, CM. Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients. Blood Advances 3(14):2057-2068, 2019. e-Pub 2019. PMID: 31292125.
- Abraham AA, John TD, Keller MD, Cruz CRN, Salem B, Roesch L, Liu H, Hoq F, Grilley BJ, Gee AP, Dave H, Jacobsohn DA, Krance RA, Shpall EJ, Martinez CA, Hanley PJ, Bollard CM. Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients. Blood Adv 3(14):2057-2068, 2019. e-Pub 2019. PMID: 31420367.
- Saini NY, Saliba RM, Rondon G, Maadani F, Popat U, Hosing CM, Oran B, Bashir Q, Olson A, Nieto Y, Alousi A, Kebriaei P, Srour S, Mehta R, Anderlini P, Shpall EJ, Qazilbash MH, Khouri IF, Fayad L, Lee H, Fowler N, Parmar S, Westin J, Hagemeister F, Champlin RE, Ciurea SO. Impact of Donor Type and Melphalan Dose on Allogeneic Transplantation Outcomes for Patients with Lymphoma. Biol Blood Marrow Transplant 25(7):1340-1346, 2019. e-Pub 2019. PMID: 30763728.
- Maymani H, Lin P, Saliba RM, Popat U, Bashir Q, Shah N, Patel K, Parmar S, Kebriaei P, Hosing C, Ciurea S, Andersson B, Shpall E, Champlin R, Srour SA, Qazilbash MH. Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Three Different Conditioning Regimens. Biol Blood Marrow Transplant 25(5):1039-1044, 2019. e-Pub 2019. PMID: 30639822.
- Ghobadi A, Milton DR, Gowda L, Rondon G, Chemaly RF, Hamdi A, Alousi A, Afrough A, Oran B, Ciurea S, Kebriaei P, Popat UR, Qazilbash MH, Shpall EJ, Champlin RE, Bashir Q. HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant. Curr Res Transl Med 67(2):51-55, 2019. e-Pub 2019. PMID: 30683577.
- Galloway-Peña JR, Peterson CB, Malik F, Sahasrabhojane PV, Shah DP, Brumlow CE, Carlin LG, Chemaly RF, Im JS, Rondon G, Felix E, Veillon L, Lorenzi PL, Alousi AM, Jenq RR, Kontoyiannis DP, Shpall EJ, Shelburne SA, Okhuysen PC. Fecal Microbiome, Metabolites, and Stem Cell Transplant Outcomes: A Single-Center Pilot Study. Open Forum Infect Dis 6(5):ofz173, 2019. e-Pub 2019. PMID: 31065565.
- Alatrash G, Qiao N, Zhang M, Zope M, Perakis AA, Sukhumalchandra P, Philips AV, Garber HR, Kerros C, St John LS, Khouri MR, Khong H, Clise-Dwyer K, Miller LP, Wolpe S, Overwijk WW, Molldrem JJ, Ma Q, Shpall EJ, Mittendorf EA. Fucosylation Enhances the Efficacy of Adoptively Transferred Antigen-Specific Cytotoxic T Lymphocytes. Clin Cancer Res 25(8):2610-2620, 2019. e-Pub 2019. PMID: 30647079.
- Barker JN, Kempenich J, Kurtzberg J, Brunstein CG, Delaney C, Milano F, Politikos I, Shpall EJ, Scaradavou A, Dehn J. CD34+ cell content of 126?341 cord blood units in the US inventory: implications for transplantation and banking. Blood Adv 3(8):1267-1271, 2019. e-Pub 2019. PMID: 30995984.
- Veltri L, Rezvani K, Oran B, Mehta R, Rondon G, Kebriaei P, Popat U, Nieto Y, Hosing C, Qazilbash M, Khouri I, Shpall E, Champlin R, Marin D. Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia. Biol Blood Marrow Transplant 25(3):505-514, 2019. e-Pub 2019. PMID: 30308325.
- Kansagra AJ, Frey NV, Bar M, Laetsch TW, Carpenter PA, Savani BN, Heslop HE, Bollard CM, Komanduri KV, Gastineau DA, Chabannon C, Perales MA, Hudecek M, Aljurf M, Andritsos L, Barrett JA, Bachanova V, Bonini C, Ghobadi A, Gill SI, Hill JA, Kenderian S, Kebriaei P, Nagler A, Maloney D, Liu HD, Shah NN, Kharfan-Dabaja MA, Shpall EJ, Mufti GJ, Johnston L, Jacoby E, Bazarbachi A, DiPersio JF, Pavletic SZ, Porter DL, Grupp SA, Sadelain M, Litzow MR, Mohty M, Hashmi SK. Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT). Bone Marrow Transplant 25(3):e76-e85, 2019. e-Pub 2019. PMID: 30576834.
- El Haddad L, Ariza-Heredia E, Shah DP, Jiang Y, Blanchard T, Ghantoji SS, El Chaer F, El-Haddad D, Prayag A, Nesher L, Rezvani K, Shpall E, Chemaly RF. The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients. J Infect Dis 219(6):898-907, 2019. e-Pub 2019. PMID: 30295846.
- Santomasso B, Bachier C, Westin J, Rezvani K, Shpall EJ. The Other Side of CAR T-Cell Therapy: Cytokine Release Syndrome, Neurologic Toxicity, and Financial Burden. Am Soc Clin Oncol Educ Book 39:433-444, 2019. e-Pub 2019. PMID: 31099694.
- Becnel M, Shpall EJ. Current and future status of stem cell expansion. Curr Opin Hematol 25(6):446-451, 2018. e-Pub 2018. PMID: 30239378.
- Popat UR, Mehta RS, Bassett R, Chen J, Valdez BC, Kawedia J, Ahmed S, Alousi AM, Anderlini P, Al-Atrash G, Bashir Q, Ciurea SO, Hosing CM, Im JS, Jones R, Kebriaei P, Khouri I, Marin D, Nieto Y, Olson A, Oran B, Parmar S, Rezvani K, Qazilbash MH, Shah N, Srour SA, Shpall EJ, Champlin RE, Andersson BS. Fludarabine with a higher versus lower dose of myeloablative timed-sequential busulfan in older patients and patients with comorbidities: an open-label, non-stratified, randomised phase 2 trial. Lancet Haematol 5(11):e532-e542, 2018. e-Pub 2018. PMID: 30389035.
- Cao K, Marin D, Sekine T, Rondon G, Zhao W, Smith NT, Daher M, Wang Q, Li L, Saliba RM, Pingali R, Popat U, Hosing C, Olson A, Oran B, Basar R, Mehta RS, Champlin R, Shpall EJ, Rezvani K. Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood Transplantation. Front Immunol 9(OCT):2444, 2018. e-Pub 2018. PMID: 30405633.
- Muftuoglu M, Olson A, Marin D, Ahmed S, Mulanovich V, Tummala S, Chi TL, Ferrajoli A, Kaur I, Li L, Champlin R, Shpall EJ, Rezvani K. Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy. N Engl J Med 379(15):1443-1451, 2018. e-Pub 2018. PMID: 30304652.
- Ogba N, Arwood NM, Bartlett NL, Bloom M, Brown P, Brown C, Budde EL, Carlson R, Farnia S, Fry TJ, Garber M, Gardner RA, Gurschick L, Kropf P, Reitan JJ, Sauter C, Shah B, Shpall EJ, Rosen ST. Chimeric Antigen Receptor T-Cell Therapy. J Natl Compr Canc Netw 16(9):1092-1106, 2018. e-Pub 2018. PMID: 30181421.
- Nieto Y, Thall PF, Ma J, Valdez BC, Ahmed S, Anderlini P, Popat U, Jones RB, Shpall EJ, Hosing C, Qazilbash M, Kebriaei P, Alousi A, Timmons M, Gulbis A, Myers A, Oki Y, Fanale M, Dabaja B, Pinnix C, Milgrom S, Champlin R, Andersson BS. Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin Lymphoma. Biol Blood Marrow Transplant 24(8):1602-1609, 2018. e-Pub 2018. PMID: 29501779.
- Trujillo-Ocampo A, Cho HW, Herrmann AC, Ruiz-Vazquez W, Thornton AB, He H, Li D, Qazilbash MA, Ma Q, Porcelli SA, Shpall EJ, Molldrem J, Im JS. Rapid ex vivo expansion of highly enriched human invariant natural killer T cells via single antigenic stimulation for cell therapy to prevent graft-versus-host disease. Cytotherapy 20(8):1089-1101, 2018. e-Pub 2018. PMID: 30076070.
- Mah A, Viola GM, Ariza Heredia E, Rezvani K, Kebriaei P, Bhatti MM, Han X, Shpall EJ, Mulanovich VE. Graft loss attributed to possible transfusion-transmitted ehrlichiosis following cord blood stem cell transplant. Transpl Infect Dis 20(4):e12899, 2018. e-Pub 2018. PMID: 29668040.
- Ruvolo PP, Ruvolo VR, Burks JK, Qiu Y, Wang RY, Shpall EJ, Mirandola L, Hail N, Zeng Z, McQueen T, Daver N, Post SM, Chiriva-Internati M, Kornblau SM, Andreeff M. Role of MSC-derived galectin 3 in the AML microenvironment. Biochim Biophys Acta Mol Cell Res 1865(7):959-969, 2018. e-Pub 2018. PMID: 29655803.
- Shah MV, Jorgensen JL, Saliba RM, Wang SA, Alousi AM, Andersson BS, Bashir Q, Ciurea SO, Kebriaei P, Marin D, Patel KP, Popat UR, Rezvani K, Rondon G, Shpall EJ, Champlin RE, Oran B. Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia. Biol Blood Marrow Transplant 24(7):1514-1520, 2018. e-Pub 2018. PMID: 29448058.
- Laskowitz DT, Bennett ER, Durham RJ, Volpi JJ, Wiese JR, Frankel M, Shpall E, Wilson JM, Troy J, Kurtzberg J. Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke: Clinical Outcomes from a Phase I Safety Study. Stem Cells Transl Med 7(7):521-529, 2018. e-Pub 2018. PMID: 29752869.
- Andermann TM, Ju P, Ho C, Reddy P, Riches M, Storb R, Teshima T, Brink VD, MRM, Alousi A, Balerman S, Chiusolo P, Clark WB, Holler E, Howard A, Kean LS, Koh AY, McCarthy PL, McCarty JM, Mohty M, Nakamura R, Rezvani K, Segal BH, Shaw BE, Shpall EJ, Sung AD, Weber D, Whangbo J, Wingard JR, Wood WA, Perales MA, Jenq RR, Bhatt AS. The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future. Biol Blood Marrow Transplant 24(7):1322-1340, 2018. e-Pub 2018. PMID: 29471034.
- Kantarjian HM, DiNardo CD, Nogueras-Gonzalez GM, Kadia TM, Jabbour E, Bueso-Ramos CE, O'Brien SM, Konopleva M, Jain NB, Daver NG, Shpall EJ, Champlin RE, Simkins A, Garcia-Manero G, Keating MJ, Huang X, Cortes JE, Pierce SA, Ravandi F, Freireich EJ. Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000. Cancer 124(12):2534-2540, 2018. e-Pub 2018. PMID: 29645075.
- Patel S, Chorvinsky E, Albihani S, Cruz CR, Jones RB, Shpall EJ, Margolis DM, Ambinder RF, Bollard CM. HIV-Specific T Cells Generated from Naive T Cells Suppress HIV In Vitro and Recognize Wide Epitope Breadths. Mol Ther 26(6):1435-1446, 2018. e-Pub 2018. PMID: 29724686.
- Ciurea SO, Shah MV, Saliba RM, Gaballa S, Kongtim P, Rondon G, Chen J, Wallis W, Cao K, Konopleva M, Daver N, Cortes J, Ravandi F, Alousi A, Ahmed S, Popat U, Parmar S, Bashir Q, Betul O, Hosing C, Shpall EJ, Rezvani K, Khouri IF, Kebriaei P, Champlin RE. Haploidentical Transplantation for Older Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome. Biol Blood Marrow Transplant 24(6):1232-1236, 2018. e-Pub 2018. PMID: 28918304.
- Kornblau SM, Ruvolo PP, Wang RY, Battula VL, Shpall EJ, Ruvolo VR, McQueen T, Qui Y, Zeng Z, Pierce S, Jacamo R, Yoo SY, Le PM, Sun J, Hail N, Konopleva M, Andreeff M. Distinct protein signatures of acute myeloid leukemia bone marrow-derived stromal cells are prognostic for patient survival. Haematologica 103(5):810-821, 2018. e-Pub 2018. PMID: 29545342.
- Mendt M, Kamerkar S, Sugimoto H, McAndrews KM, Wu CC, Gagea M, Yang S, Blanko EVR, Peng Q, Ma X, Marszalek JR, Maitra A, Yee C, Rezvani K, Shpall E, LeBleu VS, Kalluri R. Generation and testing of clinical-grade exosomes for pancreatic cancer. JCI Insight 3(8), 2018. e-Pub 2018. PMID: 29669940.
- Shah MY, Ferracin M, Pileczki V, Chen B, Redis R, Fabris L, Zhang X, Ivan C, Shimizu M, Rodriguez-Aguayo C, Dragomir M, Van Roosbroeck K, Almeida MI, Ciccone M, Nedelcu D, Cortez MA, Manshouri T, Calin S, Muftuoglu M, Banerjee PP, Badiwi MH, Parker-Thornburg J, Multani A, Welsh JW, Estecio MR, Ling H, Tomuleasa C, Dima D, Yang H, Alvarez H, You MJ, Radovich M, Shpall E, Fabbri M, Rezvani K, Girnita L, Berindan-Neagoe I, Maitra A, Verstovsek S, Fodde R, Bueso-Ramos C, Gagea M, Manero GG, Calin GA. Cancer-associated rs6983267 SNP and its accompanying long noncoding RNACCAT2induce myeloid malignancies via unique SNP-specific RNA mutations. Genome Res 28(4):432-447, 2018. e-Pub 2018. PMID: 29567676.
- Kondo K, Shaim H, Thompson PA, Burger JA, Keating M, Estrov Z, Harris D, Kim E, Ferrajoli A, Daher M, Basar R, Muftuoglu M, Imahashi N, Alsuliman A, Sobieski C, Gokdemir E, Wierda W, Jain N, Liu E, Shpall EJ, Rezvani K. Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathway. Leukemia 32(4):960-970, 2018. e-Pub 2018. PMID: 28972595.
- Milgrom SA, Pinnix CC, Chi TL, Vu TH, Gunther JR, Sheu T, Fowler N, Westin JR, Nastoupil LJ, Oki Y, Fayad LE, Neelapu S, Rodriguez MA, Hagemeister FB, Fanale MA, Lee HJ, Hosing C, Ahmed S, Nieto Y, Shpall EJ, Dabaja BS. Radiation Therapy as an Effective Salvage Strategy for Secondary CNS Lymphoma. Int J Radiat Oncol Biol Phys 100(5):1146-1154, 2018. e-Pub 2018. PMID: 29452771.
- Oran B, Saliba RM, Carmazzi Y, de Lima M, Rondon G, Ahmed S, Alousi A, Andersson BS, Anderlini P, Alvarez M, Bashir Q, Ciurea S, Fernandez-Vina M, Hosing C, Kebriaei P, Korbling M, Cano P, Khouri I, Marin D, Nieto Y, Olson A, Popat U, Rezvani K, Qazilbash M, Shpall EJ, Champlin RE, Cao K. Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion. Blood 131(11):1248-1257, 2018. e-Pub 2018. PMID: 29386198.
- Ragon BK, Mehta RS, Gulbis AM, Saliba RM, Chen J, Rondon G, Popat UR, Nieto Y, Oran B, Olson AL, Patel K, Hosing CM, Qazilbash MH, Shah N, Kebriaei P, Shpall EJ, Champlin RE, Alousi AM. Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit. Bone Marrow Transplant 53(3):315-325, 2018. e-Pub 2018. PMID: 29269797.
- Liu E, Tong Y, Dotti G, Shaim H, Savoldo B, Mukherjee M, Orange J, Wan X, Lu X, Reynolds A, Gagea M, Banerjee P, Cai R, Bdaiwi MH, Basar R, Muftuoglu M, Li L, Marin D, Wierda W, Keating M, Champlin R, Shpall E, Rezvani K. Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent anti-tumor activity. Leukemia 32(2):520-531, 2018. e-Pub 2018. PMID: 28725044.
- Shaim H, Estrov Z, Harris D, Hernandez Sanabria M, Liu Z, Ruvolo P, Thompson PA, Ferrajoli A, Daher M, Burger J, Muftuoglu M, Imahashi N, Li L, Liu E, Alsuliman AS, Basar R, Nassif Kerbauy L, Sobieski C, Gokdemir E, Kondo K, Wierda W, Keating M, Shpall EJ, Rezvani K. The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide. Front Immunol 8(JAN):1773, 2018. e-Pub 2018. PMID: 29379494.
- Khoder A, Alsuliman A, Basar R, Sobieski C, Kondo K, Alousi AM, Szydlo R, Muftuoglu M, Shaim H, Apperley JF, Gokdemir E, Cooper N, Mehta RS, Marin D, Champlin R, Shpall E, Rezvani K. Evidence for B Cell Exhaustion in Chronic Graft-versus-Host Disease. Front Immunol 8(JAN):1937, 2018. e-Pub 2018. PMID: 29375566.
- Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, Cogdill AP, Zhao L, Hudgens CW, Hutchinson DS, Manzo T, Petaccia de Macedo M, Cotechini T, Kumar T, Chen WS, Reddy SM, Szczepaniak Sloane R, Galloway-Pena J, Jiang H, Chen PL, Shpall EJ, Rezvani K, Alousi AM, Chemaly RF, Shelburne S, Vence LM, Okhuysen PC, Jensen VB, Swennes AG, McAllister F, Marcelo Riquelme Sanchez E, Zhang Y, Le Chatelier E, Zitvogel L, Pons N, Austin-Breneman JL, Haydu LE, Burton EM, Gardner JM, Sirmans E, Hu J, Lazar AJ, Tsujikawa T, Diab A, Tawbi H, Glitza IC, Hwu WJ, Patel SP, Woodman SE, Amaria RN, Davies MA, Gershenwald JE, Hwu P, Lee JE, Zhang J, Coussens LM, Cooper ZA, Futreal PA, Daniel CR, Ajami NJ, Petrosino JF, Tetzlaff MT, Sharma P, Allison JP, Jenq RR, Wargo JA. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359(6371):97-103, 2018. e-Pub 2018. PMID: 29097493.
- Rondón G, Saliba RM, Chen J, Ledesma C, Alousi AM, Oran B, Hosing CM, Kebriaei P, Khouri IF, Shpall EJ, Popat UR, Champlin RE, Ciurea SO. Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem-Cell Transplant Outcomes. Biol Blood Marrow Transplant 23(12):2166-2171, 2017. e-Pub 2017. PMID: 28844946.
- Shah N, Cornelison AM, Saliba R, Ahmed S, Nieto YL, Bashir Q, Parmar S, Hosing C, Popat U, Shpall EJ, Champlin RE, Qazilbash M. Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma. Eur J Haematol 99(6):532-535, 2017. e-Pub 2017. PMID: 28895206.
- Im JS, Abraham SC, Saliba RM, Rondon G, Ross WA, Rashid A, Shpall EJ, Popat U, Qazilbash MH, Hosing C, Oran B, Shah N, Tewari P, Nieto Y, Kebriaei P, Champlin RE, Alousi AM. Histologic Grade 1 is Associated With Increased Nonrelapsed Mortality in Lower Gastrointestinal Graft Versus Host Disease. Am J Surg Pathol 41(11):1483-1490, 2017. e-Pub 2017. PMID: 28834808.
- Ciurea SO, Schafer JR, Bassett R, Denman CJ, Cao K, Willis D, Rondon G, Chen J, Soebbing D, Kaur I, Gulbis A, Ahmed S, Rezvani K, Shpall EJ, Lee DA, Champlin RE. Phase 1 clinical trial using mbIL21 ex-vivo expanded donor-derived NK cells after haploidentical transplantation. Blood 130(16):1857-68, 2017. e-Pub 2017. PMID: 28835441.
- Veltri LW, Milton DR, Delgado R, Shah N, Patel K, Nieto Y, Kebriaei P, Popat UR, Parmar S, Oran B, Ciurea S, Hosing C, Lee HC, Manasanch E, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH, Bashir Q. Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myeloma. Cancer 123(18):3568-3575, 2017. e-Pub 2017. PMID: 28513828.
- Hwang JP, Suarez-Almazor ME, Cantor SB, Barbo A, Lin HY, Ahmed S, Chavez-MacGregor M, Donato-Santana C, Eng C, Ferrajoli A, Fisch MJ, McLaughlin P, Simon GR, Rondon G, Shpall EJ, Lok AS. Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy. Cancer 123(17):3367-3376, 2017. e-Pub 2017. PMID: 28518219.
- Srour SA, Li S, Popat UR, Qazilbash MH, Lozano-Cerrada S, Maadani F, Alousi A, Kebriaei P, Anderlini P, Nieto Y, Jones R, Shpall E, Champlin RE, Hosing C. A randomized phase II study of standard-dose versus high-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term results. Br J Haematol 178(4):561-570, 2017. e-Pub 2017. PMID: 28485023.
- Mehta RS, Saliba RM, Cao K, Kaur I, Rezvani K, Chen J, Olson A, Parmar S, Shah N, Marin D, Alousi A, Hosing C, Popat U, Kebriaei P, Champlin R, de Lima M, Skerrett D, Burke E, Shpall EJ, Oran B. Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery. Biol Blood Marrow Transplant 23(8):1359-1366, 2017. e-Pub 2017. PMID: 28506845.
- Yucel OK, Saliba RM, Rondon G, Ahmed S, Alousi A, Bashir Q, Ciurea SO, Popat U, Khouri I, Marin D, Rezvani K, Kebriaei P, Shpall EJ, Champlin RE, Oran B. Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning. Cancer 123(14):2661-2670, 2017. e-Pub 2017. PMID: 28324640.
- Battula VL, Le PM, Sun JC, Nguyen K, Yuan B, Zhou X, Sonnylal S, McQueen T, Ruvolo V, Michel KA, Ling X, Jacamo R, Shpall E, Wang Z, Rao A, Al-Atrash G, Konopleva M, Davis RE, Harrington MA, Cahill CW, Bueso-Ramos C, Andreeff M. AML-induced osteogenic differentiation in mesenchymal stromal cells supports leukemia growth. JCI Insight 2(13), 2017. e-Pub 2017. PMID: 28679949.
- Dave H, Luo M, Blaney JW, Patel S, Barese C, Cruz CR, Shpall EJ, Bollard CM, Hanley PJ. Toward a Rapid Production of Multivirus-Specific T Cells Targeting BKV, Adenovirus, CMV, and EBV from Umbilical Cord Blood. Mol Ther Methods Clin Dev 5:13-21, 2017. e-Pub 2017. PMID: 28480300.
- Bayraktar UD, Milton DR, Shpall EJ, Rondon G, Price KJ, Champlin RE, Nates JL. Prognostic Index for Critically Ill Allogeneic Transplantation Patients. Biol Blood Marrow Transplant 23(6):991-996, 2017. e-Pub 2017. PMID: 28263919.
- Huang XJ, Liu K, Ritchie D, Andersson B, Lu J, Hou J, Burguera AF, Wang J, Yeoh A, Yan C, Zhou D, Tan D, Kim DW, Wu D, Shpall E, Kornblau S, Neelapu S, Hongeng S, Li J, Hu J, Zhang LS, Wang M, Malhotra P, Jiang Q, Qin Y, Wong R, Champlin R, Hagemeister F, Westin J, Iyer S, Mathews V, Wang Y, Hu Y, Xiao Z, Shao Z, Orlowski RZ, Chim CS, Mulligan S, Sanz M, Ozawa K, Parmar S, Issaragrisil S. Hematology oncology practice in the Asia-Pacific APHCON survey results from the 6th international hematologic malignancies conference: bridging the gap 2015, Beijing, China. Oncotarget 8(25):41620-41630, 2017. e-Pub 2017. PMID: 28404929.
- Thompson PA, Stingo F, Keating MJ, Wierda WG, O'Brien SM, Estrov Z, Ledesma C, Rezvani K, Qazilbash M, Shah N, Parmar S, Popat U, Anderlini P, Yago N, Ciurea SO, Kebriaei P, Champlin R, Shpall EJ, Hosing CM. Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse risk and inferior survival. Br J Haematol 177(4):567-577, 2017. e-Pub 2017. PMID: 28295181.
- Shah N, Li L, McCarty J, Kaur I, Yvon E, Shaim H, Muftuoglu M, Liu E, Orlowski RZ, Cooper L, Lee D, Parmar S, Cao K, Sobieiski C, Saliba R, Hosing C, Ahmed S, Nieto Y, Bashir Q, Patel K, Bollard C, Qazilbash M, Champlin R, Rezvani K, Shpall EJ. Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma. Br J Haematol 177(3):457-466, 2017. e-Pub 2017. PMID: 28295190.
- Gaballa S, Saliba R, Oran B, Brammer JE, Chen J, Rondon G, Alousi AM, Kebriaei P, Marin D, Popat UR, Andersson BS, Shpall EJ, Jabbour E, Daver N, Andreeff M, Ravandi F, Cortes J, Patel K, Champlin RE, Ciurea SO. Relapse risk and survival in patients with FLT3 mutated acute myeloid leukemia undergoing stem cell transplantation. Am J Hematol 92(4):331-337, 2017. e-Pub 2017. PMID: 28052408.
- Andersson BS, Thall PF, Valdez BC, Milton DR, Al-Atrash G, Chen J, Gulbis A, Chu D, Martinez C, Parmar S, Popat U, Nieto Y, Kebriaei P, Alousi A, de Lima M, Rondon G, Meng QH, Myers A, Kawedia J, Worth LL, Fernandez-Vina M, Madden T, Shpall EJ, Jones RB, Champlin RE. Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients. Bone Marrow Transplant 52(4):580-587, 2017. e-Pub 2017. PMID: 27991894.
- Beers DR, Zhao W, Wang J, Zhang X, Wen S, Neal D, Thonhoff JR, Alsuliman AS, Shpall EJ, Rezvani K, Appel SH. ALS patients' regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity. JCI Insight 2(5):e89530, 2017. e-Pub 2017. PMID: 28289705.
- Kaur I, Zulovich JM, Gonzalez M, McGee KM, Ponweera N, Thandi D, Alvarez EF, Annandale K, Flagge F, Rezvani K, Shpall E. Comparison of two methodologies for the enrichment of mononuclear cells from thawed cord blood products: The automated Sepax system versus the manual Ficoll method. Cytotherapy 19(3):433-439, 2017. e-Pub 2017. PMID: 28034522.
- Galloway-Peña JR, Smith DP, Sahasrabhojane P, Wadsworth WD, Fellman BM, Ajami NJ, Shpall EJ, Daver N, Guindani M, Petrosino JF, Kontoyiannis DP, Shelburne SA. Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients. Genome Med 9(1):21, 2017. e-Pub 2017. PMID: 28245856.
- Alsuliman A, Muftuoglu M, Khoder A, Ahn YO, Basar R, Verneris MR, Muranski P, Barrett AJ, Liu E, Li L, Stringaris K, Armstrong-James D, Shaim H, Kondo K, Imahashi N, Andersson B, Marin D, Champlin RE, Shpall EJ, Rezvani K. A subset of virus-specific CD161+ T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML. Blood 129(6):740-758, 2017. e-Pub 2017. PMID: 27821506.
- Kebriaei P, Bassett R, Lyons G, Valdez B, Ledesma C, Rondon G, Oran B, Ciurea S, Alousi A, Popat U, Patel K, Ahmed S, Olson A, Bashir Q, Shah N, Jones R, Marin D, Rezvani K, Nieto Y, Khouri I, Qazilbash M, Hosing C, Shpall E, Champlin RE, Andersson BS. Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results. Biol Blood Marrow Transplant 23(2):285-292, 2017. e-Pub 2017. PMID: 27816651.
- Abudayyeh A, Hamdi A, Abdelrahim M, Lin H, Page VD, Rondon G, Andersson BS, Afrough A, Martinez CS, Tarrand JJ, Kontoyiannis DP, Marin D, Gaber AO, Oran B, Chemaly RF, Ahmed S, Abudayyeh I, Olson A, Jones R, Popat U, Champlin RE, Shpall EJ, Rezvani K. Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients. Transpl Infect Dis 19(1), 2017. e-Pub 2017. PMID: 27862740.
- Robinson SN, Thomas MW, Simmons PJ, Lu J, Yang H, Javni JA, Shpall EJ, Zweidler-Mckay PA. Non-fucosylated CB CD34(+) cells represent a good target for enforced fucosylation to improve engraftment following cord blood transplantation. Cytotherapy 19(2):285-292, 2017. e-Pub 2017. PMID: 27919572.
- Nikiforow S, Li S, Snow K, Liney D, Kao GS, Haspel R, Shpall EJ, Glotzbecker B, Sica RA, Armand P, Koreth J, Ho VT, Alyea EP, Ritz J, Soiffer RJ, Antin JH, Dey B, McAfee S, Chen YB, Spitzer T, Avigan D, Cutler CS, Ballen K. Lack of impact of umbilical cord blood unit processing techniques on clinical outcomes in adult double cord blood transplant recipients. Cytotherapy 19(2):272-284, 2017. e-Pub 2017. PMID: 27939176.
- Oran B, Jorgensen JL, Marin D, Wang S, Ahmed S, Alousi AM, Andersson BS, Bashir Q, Bassett R, Lyons G, Chen J, Rezvani K, Popat U, Kebriaei P, Patel K, Rondon G, Shpall EJ, Champlin RE. Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia. Haematologica 102(1):110-117, 2017. e-Pub 2017. PMID: 27540139.
- Stringaris K, Marin D, Barrett AJ, Hills R, Sobieski C, Cao K, Saltarrelli JG, Daher M, Shaim H, Smith N, Linch D, Gale R, Allen C, Sekine T, Mehta R, Champlin R, Shpall EJ, Kantarjian H, Garcia-Manero G, Rezvani K. KIR gene haplotype: an independent predictor of clinical outcome in MDS patients. Blood 128(24):2819-2823, 2016. e-Pub 2016. PMID: 27760759.
- Mian I, Milton DR, Shah N, Nieto Y, Popat UR, Kebriaei P, Parmar S, Oran B, Shah JJ, Manasanch EE, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH, Bashir Q. Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma. Cancer 122(24):3831-3837, 2016. e-Pub 2016. PMID: 27680710.
- Najjar AM, Manuri PR, Olivares S, Flores L, Mi T, Huls H, Shpall EJ, Champlin RE, Turkman N, Paolillo V, Roszik J, Rabinovich B, Lee DA, Alauddin M, Gelovani J, Cooper LJ. Imaging of Sleeping Beauty-Modified CD19-Specific T Cells Expressing HSV1-Thymidine Kinase by Positron Emission Tomography. Mol Imaging Biol 18(6):838-848, 2016. e-Pub 2016. PMID: 27246312.
- Gaballa S, Ge I, El Fakih R, Brammer JE, Kongtim P, Tomuleasa C, Wang SA, Lee D, Petropoulos D, Cao K, Rondon G, Chen J, Hammerstrom A, Lombardi L, Alatrash G, Korbling M, Oran B, Kebriaei P, Ahmed S, Shah N, Rezvani K, Marin D, Bashir Q, Alousi A, Nieto Y, Qazilbash M, Hosing C, Popat U, Shpall EJ, Khouri I, Champlin RE, Ciurea SO. Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation. Cancer 122(21):3316-3326, 2016. e-Pub 2016. PMID: 27404668.
- Alatrash G, Thall PF, Valdez BC, Fox PS, Ning J, Garber HR, Janbey S, Worth LL, Popat U, Hosing C, Alousi AM, Kebriaei P, Shpall EJ, Jones RB, de Lima M, Rondon G, Chen J, Champlin RE, Andersson BS. Long-Term Outcomes after Treatment with Clofarabine ± Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome. Biol Blood Marrow Transplant 22(10):1792-800, 2016. e-Pub 2016. PMID: 27377901.
- Alsuliman A, Appel SH, Beers DR, Basar R, Shaim H, Kaur I, Zulovich J, Yvon E, Muftuoglu M, Imahashi N, Kondo K, Liu E, Shpall EJ, Rezvani K. A robust, good manufacturing practice-compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy. Cytotherapy 18(10):1312-24, 2016. e-Pub 2016. PMID: 27497700.
- El-Haddad D, El Chaer F, Vanichanan J, Shah DP, Ariza-Heredia EJ, Mulanovich VE, Gulbis AM, Shpall EJ, Chemaly RF. Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience. Antiviral Res 134:58-62, 2016. e-Pub 2016. PMID: 27582067.
- Sarvaria A, Basar R, Mehta RS, Shaim H, Muftuoglu M, Khoder A, Sekine T, Gokdemir E, Kondo K, Marin D, Daher M, Alousi AM, Alsuliman A, Liu E, Oran B, Olson A, Jones RB, Popat U, Hosing C, Champlin R, Shpall EJ, Rezvani K. IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation. Blood 128(10):1346-61, 2016. e-Pub 2016. PMID: 27439912.
- Nieto Y, Valdez BC, Thall PF, Jones RB, Wei W, Myers A, Hosing C, Ahmed S, Popat U, Shpall EJ, Qazilbash M, Gulbis A, Anderlini P, Shah N, Bashir Q, Alousi A, Oki Y, Fanale M, Dabaja B, Pinnix C, Champlin R, Andersson BS. Double epigenetic modulation of high-dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor-risk relapsed lymphoma. Cancer 122(17):2680-8, 2016. e-Pub 2016. PMID: 27203405.
- Langman LJ, Nesher L, Shah DP, Azzi JM, Shpall EJ, Rezvani K, Black JL, Chemaly RF. Challenges in Determining Genotypes for Pharmacogenetics in Allogeneic Hematopoietic Cell Transplant Recipients. J Mol Diagn 18(5):638-42, 2016. e-Pub 2016. PMID: 27371869.
- Kebriaei P, Singh H, Huls MH, Figliola MJ, Bassett R, Olivares S, Jena B, Dawson MJ, Kumaresan PR, Su S, Maiti S, Dai J, Moriarity B, Forget MA, Senyukov V, Orozco A, Liu T, McCarty J, Jackson RN, Moyes JS, Rondon G, Qazilbash M, Ciurea S, Alousi A, Nieto Y, Rezvani K, Marin D, Popat U, Hosing C, Shpall EJ, Kantarjian H, Keating M, Wierda W, Do KA, Largaespada DA, Lee DA, Hackett PB, Champlin RE, Cooper LJ. Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells. J Clin Invest 126(9):3363-76, 2016. e-Pub 2016. PMID: 27482888.
- Ma Q, Garber HR, Lu S, He H, Tallis E, Ding X, Sergeeva A, Wood MS, Dotti G, Salvado B, Ruisaard K, Clise-Dwyer K, John LS, Rezvani K, Alatrash G, Shpall EJ, Molldrem JJ. A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells. Cytotherapy 18(8):985-94, 2016. e-Pub 2016. PMID: 27265873.
- St John LS, Wan L, He H, Garber HR, Clise-Dwyer K, Alatrash G, Rezvani K, Shpall EJ, Bollard CM, Ma Q, Molldrem JJ. PR1-specific cytotoxic T lymphocytes are relatively frequent in umbilical cord blood and can be effectively expanded to target myeloid leukemia. Cytotherapy 18(8):995-1001, 2016. e-Pub 2016. PMID: 27378343.
- Galloway-Peña JR, Smith DP, Sahasrabhojane P, Ajami NJ, Wadsworth WD, Daver NG, Chemaly RF, Marsh L, Ghantoji SS, Pemmaraju N, Garcia-Manero G, Rezvani K, Alousi AM, Wargo JA, Shpall EJ, Futreal PA, Guindani M, Petrosino JF, Kontoyiannis DP, Shelburne SA. The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia. Cancer 122(14):2186-96, 2016. e-Pub 2016. PMID: 27142181.
- Sekine T, Marin D, Cao K, Li L, Mehta P, Shaim H, Sobieski C, Jones R, Oran B, Hosing C, Rondon G, Alsuliman A, Paust S, Andersson B, Popat U, Kebriaei P, Muftuoglu M, Basar R, Kondo K, Nieto Y, Shah N, Olson A, Alousi A, Liu E, Sarvaria A, Parmar S, Armstrong-James D, Imahashi N, Molldrem J, Champlin R, Shpall EJ, Rezvani K. Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation. Blood 128(2):297-312, 2016. e-Pub 2016. PMID: 27247137.
- Thompson PA, Perera T, Marin D, Oran B, Popat U, Qazilbash M, Shah N, Parmar S, Rezvani K, Olson A, Kebriaei P, Anderlini P, Rondon G, Alousi A, Ciurea S, Champlin RE, Bajel A, Szer J, Shpall EJ, Ritchie D, Hosing CM. Double umbilical cord blood transplant is effective therapy for relapsed or refractory Hodgkin lymphoma. Leuk Lymphoma 57(7):1-9, 2016. e-Pub 2016. PMID: 26472485.
- Oran B, Cortes J, Beitinjaneh A, Chen HC, de Lima M, Patel K, Ravandi F, Wang X, Brandt M, Andersson BS, Ciurea S, Santos FP, de Padua Silva L, Shpall EJ, Champlin RE, Kantarjian H, Borthakur G. Allogeneic Transplantation in First Remission Improves Outcomes Irrespective of FLT3-ITD Allelic Ratio in FLT3-ITD-Positive Acute Myelogenous Leukemia. Biol Blood Marrow Transplant 22(7):1218-26, 2016. e-Pub 2016. PMID: 27058617.
- Anderlini P, Saliba RM, Ledesma C, Plair T, Alousi AM, Hosing CM, Khouri IF, Nieto Y, Popat UR, Shpall EJ, Fanale MA, Hagemeister FB, Oki Y, Neelapu S, Romaguera JE, Younes A, Champlin RE. Gemcitabine, Fludarabine, and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma. Biol Blood Marrow Transplant 22(7):1333-7, 2016. e-Pub 2016. PMID: 27064056.
- Lee DA, Denman CJ, Rondon G, Woodworth G, Chen J, Fisher T, Kaur I, Fernandez-Vina M, Cao K, Ciurea S, Shpall EJ, Champlin RE. Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial. Biol Blood Marrow Transplant 22(7):1290-8, 2016. e-Pub 2016. PMID: 27090958.
- Nesher L, Shah DP, Ariza-Heredia EJ, Azzi JM, Siddiqui HK, Ghantoji SS, Marsh LY, Michailidis L, Makedonas G, Rezvani K, Shpall EJ, Chemaly RF. Utility of the ELISPOT interferon-γ release assay to predict the risk of CMV infection in hematopoietic cell transplant recipients. J Infect Dis 213(11):1701-1707, 2016. e-Pub 2016. PMID: 26908740.
- Naik S, Nicholas SK, Martinez CA, Leen AM, Hanley PJ, Gottschalk SM, Rooney CM, Hanson IC, Krance RA, Shpall EJ, Cruz CR, Amrolia P, Lucchini G, Bunin N, Heimall J, Klein OR, Gennery AR, Slatter MA, Vickers MA, Orange JS, Heslop HE, Bollard CM, Keller MD. Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes. J Allergy Clin Immunol 137(5):1498-1505.e1, 2016. e-Pub 2016. PMID: 26920464.
- Aung FM, Lichtiger B, Rondon G, Yin CC, Alousi A, Ahmed S, Andersson BS, Bashir Q, Ciurea SO, Hosing C, Jones R, Kebriaei P, Khouri I, Nieto Y, Oran B, Parmar S, Qazilbash M, Shah N, Shpall EJ, Champlin RE, Popat U. Pure Red Cell Aplasia in Major ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Severe Pancytopenia. Biol Blood Marrow Transplant 22(5):961-5, 2016. e-Pub 2016. PMID: 26921820.
- Mehta RS, Saliba RM, Chen J, Rondon G, Hammerstrom AE, Alousi A, Qazilbash M, Bashir Q, Ahmed S, Popat U, Hosing C, Khouri I, Shpall EJ, Champlin RE, Ciurea SO. Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation. Br J Haematol 173(3):444-55, 2016. e-Pub 2016. PMID: 26947769.
- Abudayyeh A, Hamdi A, Lin H, Abdelrahim M, Rondon G, Andersson BS, Afrough A, Martinez CS, Tarrand JJ, Kontoyiannis DP, Marin D, Gaber AO, Salahudeen A, Oran B, Chemaly RF, Olson A, Jones R, Popat U, Champlin RE, Shpall EJ, Winkelmayer WC, Rezvani K. Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients. Am J Transplant 16(5):1492-502, 2016. e-Pub 2016. PMID: 26608093.
- Rouce RH, Shaim H, Sekine T, Weber G, Ballard B, Ku S, Barese C, Murali V, Wu MF, Liu H, Shpall EJ, Bollard CM, Rabin KR, Rezvani K. The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia. Leukemia 30(4):800-11, 2016. e-Pub 2016. PMID: 26621337.
- Lukianova-Hleb EY, Yvon ES, Shpall EJ, Lapotko DO. All-in-one processing of heterogeneous human cell grafts for gene and cell therapy. Mol Ther Methods Clin Dev 3:16012, 2016. e-Pub 2016. PMID: 27006970.
- Torikai H, Mi T, Gragert L, Maiers M, Najjar A, Ang S, Maiti S, Dai J, Switzer KC, Huls H, Dulay GP, Reik A, Rebar EJ, Holmes MC, Gregory PD, Champlin RE, Shpall EJ, Cooper LJ. Genetic editing of HLA expression in hematopoietic stem cells to broaden their human application. Sci Rep 6:21757, 2016. e-Pub 2016. PMID: 26902653.
- Kongtim P, Popat U, Jimenez A, Gaballa S, El Fakih R, Rondon G, Chen J, Bueso-Ramos C, Borthakur G, Pemmaraju N, Garcia-Manero G, Kantarjian H, Alousi A, Hosing C, Anderlini P, Khouri IF, Kebriaei P, Andersson BS, Oran B, Rezvani K, Marin D, Shpall EJ, Champlin RE, Ciurea SO. Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia. Biol Blood Marrow Transplant 22(1):47-53, 2016. e-Pub 2016. PMID: 26343946.
- Kellner J, Wierda W, Shpall E, Keating M, McNiece I. Isolation of a novel chronic lymphocytic leukemic (CLL) cell line and development of an in vivo mouse model of CLL. Leuk Res 40:54-9, 2016. e-Pub 2016. PMID: 26601610.
- Hosing C, Bassett R, Dabaja B, Talpur R, Alousi A, Ciurea S, Popat U, Qazilbash M, Shpall EJ, Oki Y, Nieto Y, Pinnix C, Fanale M, Maadani F, Donato M, Champlin R, Duvic M. Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution. Ann Oncol 26(12):2490-5, 2015. e-Pub 2015. PMID: 26416896.
- Shelburne SA, Ajami NJ, Chibucos MC, Beird HC, Tarrand J, Galloway-Peña J, Albert N, Chemaly RF, Ghantoji SS, Marsh L, Pemmaraju N, Andreeff M, Shpall EJ, Wargo JA, Rezvani K, Alousi A, Bruno VM, Futreal PA, Petrosino JF, Kontoyiannis DP. Implementation of a Pan-Genomic Approach to Investigate Holobiont-Infecting Microbe Interaction: A Case Report of a Leukemic Patient with Invasive Mucormycosis. PLoS One 10(11):e0139851, 2015. e-Pub 2015. PMID: 26556047.
- Lee HC, Saliba RM, Rondon G, Chen J, Charafeddine Y, Medeiros LJ, Alatrash G, Andersson BS, Popat U, Kebriaei P, Ciurea S, Oran B, Shpall E, Champlin R. Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes. Biol Blood Marrow Transplant 21(11):1948-1954, 2015. e-Pub 2015. PMID: 26183077.
- Nieto Y, Valdez BC, Thall PF, Ahmed S, Jones RB, Hosing C, Popat U, Shpall EJ, Qazilbash M, Gulbis A, Anderlini P, Alousi A, Shah N, Bashir Q, Liu Y, Oki Y, Hagemeister F, Fanale M, Dabaja B, Pinnix C, Champlin R, Andersson BS. Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas. Biol Blood Marrow Transplant 21(11):1914-20, 2015. e-Pub 2015. PMID: 26071868.
- Kumaresan P, Figliola M, Moyes JS, Huls MH, Tewari P, Shpall EJ, Champlin R, Cooper LJ. Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System. J Vis Exp 2015(104), 2015. e-Pub 2015. PMID: 26484782.
- Oran B, Cao K, Saliba RM, Rezvani K, de Lima M, Ahmed S, Hosing CM, Popat UR, Carmazzi Y, Kebriaei P, Nieto Y, Rondon G, Willis D, Shah N, Parmar S, Olson A, Moore B, Marin D, Mehta R, Fernández-Viña M, Champlin RE, Shpall EJ. Better allele-level matching improves transplant-related mortality after double cord blood transplantation. Haematologica 100(10):1361-70, 2015. e-Pub 2015. PMID: 26250579.
- Oran B, Jimenez AM, De Lima M, Popat UR, Bassett R, Andersson BS, Borthakur G, Bashir Q, Chen J, Ciurea SO, Jabbour E, Cortes J, Kebriaei P, Khouri IF, Qazilbash MH, Ravandi F, Rondon G, Lu X, Shpall EJ, Champlin RE. Age and Modified European LeukemiaNet Classification to Predict Transplant Outcomes: An Integrated Approach for Acute Myelogenous Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant 21(8):1405-1412, 2015. e-Pub 2015. PMID: 25840338.
- Konopleva M, Benton CB, Thall PF, Zeng Z, Shpall E, Ciurea S, Kebriaei P, Alousi A, Popat U, Anderlini P, Nieto Y, Parmar S, Qiao W, Chen J, Rondon G, McMullin B, Wang RY, Lu H, Schober W, Woodworth G, Gulbis A, Cool R, Andreeff M, Champlin R. Leukemia cell mobilization with G-CSF plus plerixafor during busulfan-fludarabine conditioning for allogeneic stem cell transplantation. Bone Marrow Transplant 50(7):939-946, 2015. e-Pub 2015. PMID: 25867648.
- Saliba RM, Rezvani K, Leen A, Jorgensen J, Shah N, Hosing C, Parmar S, Oran B, Olson A, Rondon G, Chen J, Martinez C, Hamdi A, Mehta RS, Chemaly RF, Saunders IM, Bollard CM, Shpall EJ. General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation. Biol Blood Marrow Transplant 21(7):1284-1290, 2015. e-Pub 2015. PMID: 25708219.
- Thompson PA, Rezvani K, Hosing CM, Oran B, Olson AL, Popat UR, Alousi AM, Shah ND, Parmar S, Bollard C, Hanley P, Kebriaei P, Cooper L, Kellner J, McNiece IK, Shpall EJ. Umbilical cord blood graft engineering: challenges and opportunities. Bone Marrow Transplant 50 Suppl 2:S55-62, 2015. e-Pub 2015. PMID: 26039209.
- Rozovski U, Benjamini O, Jain P, Thompson PA, Wierda WG, O'Brien S, Burger JA, Ferrajoli A, Faderl S, Shpall E, Hosing C, Khouri IF, Champlin R, Keating MJ, Estrov Z. Outcomes of Patients With Chronic Lymphocytic Leukemia and Richter's Transformation After Transplantation Failure. J Clin Oncol 33(14):1557-63, 2015. e-Pub 2015. PMID: 25847930.
- Popat U, Mehta RS, Rezvani K, Fox P, Kondo K, Marin D, McNiece I, Oran B, Hosing C, Olson A, Parmar S, Shah N, Andreeff M, Kebriaei P, Kaur I, Yvon E, de Lima M, Cooper LJ, Tewari P, Champlin RE, Nieto Y, Andersson BS, Alousi A, Jones RB, Qazilbash MH, Bashir Q, Ciurea S, Ahmed S, Anderlini P, Bosque D, Bollard C, Molldrem JJ, Chen J, Rondon G, Thomas M, Miller L, Wolpe S, Simmons P, Robinson S, Zweidler-McKay PA, Shpall EJ. Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation. Blood 125(19):2885-92, 2015. e-Pub 2015. PMID: 25778529.
- Alousi AM, Brammer JE, Saliba RM, Andersson B, Popat U, Hosing C, Jones R, Shpall EJ, Khouri I, Qazilbash M, Nieto Y, Shah N, Ahmed S, Oran B, Al Atrash G, Ciurea S, Kebriaei P, Chen J, Rondon G, Champlin RE. Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies. Biol Blood Marrow Transplant 21(5):906-12, 2015. e-Pub 2015. PMID: 25667989.
- Simmons PJ, Robinson SN, Munsell MF, Thomas MW, Javni JA, Brouard N, Zweidler-McKay PA, Shpall EJ. Expression of a Surface Antigen (MA6) by Peripheral Blood CD34(+) Cells Is Correlated with Improved Platelet Engraftment and May Explain Delayed Platelet Engraftment Following Cord Blood Transplantation. Stem Cells Dev 24(9):1066-72, 2015. e-Pub 2015. PMID: 25674667.
- Hanley PJ, Melenhorst JJ, Nikiforow S, Scheinberg P, Blaney JW, Demmler-Harrison G, Cruz CR, Lam S, Krance RA, Leung KS, Martinez CA, Liu H, Douek DC, Heslop HE, Rooney CM, Shpall EJ, Barrett AJ, Rodgers JR, Bollard CM. CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo. Sci Transl Med 7(285):285ra63, 2015. e-Pub 2015. PMID: 25925682.
- Kellner J, Li S, Zweidler-McKay PA, Shpall EJ, McNiece I. Phenotypic and functional comparison of mobilized peripheral blood versus umbilical cord blood megakaryocyte populations. Cytotherapy 17(4):418-27, 2015. e-Pub 2015. PMID: 25532425.
- Ballen KK, Logan BR, Laughlin MJ, He W, Ambruso DR, Armitage SE, Beddard RL, Bhatla D, Hwang WY, Kiss JE, Koegler G, Kurtzberg J, Nagler A, Oh D, Petz LD, Price TH, Quinones RR, Ratanatharathorn V, Rizzo JD, Sazama K, Scaradavou A, Schuster MW, Sender LS, Shpall EJ, Spellman SR, Sutton M, Weitekamp LA, Wingard JR, Eapen M. Effect of Cord Blood Processing on Transplantation Outcomes after Single Myeloablative Umbilical Cord Blood Transplantation. Biol Blood Marrow Transplant 21(4):688-95, 2015. e-Pub 2015. PMID: 25543094.
- Parmar S, Liu X, Najjar A, Shah N, Yang H, Yvon E, Rezvani K, McNiece I, Zweidler-McKay P, Miller L, Wolpe S, Blazar BR, Shpall EJ. Ex vivo fucosylation of 3rd party human regulatory T cells enhances anti-graft versus host disease potency in vivo. Blood 125(9):1502-6, 2015. e-Pub 2015. PMID: 25428215.
- Martin-Antonio B, Najjar A, Robinson SN, Chew C, Li S, Yvon E, Thomas MW, Mc Niece I, Orlowski R, Muñoz-Pinedo C, Bueno C, Menendez P, Fernández de Larrea C, Urbano-Ispizua A, Shpall EJ, Shah N. Transmissible cytotoxicity of multiple myeloma cells by cord blood-derived NK cells is mediated by vesicle trafficking. Cell Death Differ 22(1):96-107, 2015. e-Pub 2015. PMID: 25168239.
- Maude SL, Shpall EJ, Grupp SA. Chimeric antigen receptor T-cell therapy for ALL. Hematology Am Soc Hematol Educ Program 2014(1):559-64, 2014. e-Pub 2014. PMID: 25696911.
- Di Stasi A, Milton DR, Poon LM, Hamdi A, Rondon G, Chen J, Pingali SR, Konopleva M, Kongtim P, Alousi A, Qazilbash MH, Ahmed S, Bashir Q, Al-atrash G, Oran B, Hosing CM, Kebriaei P, Popat U, Shpall EJ, Lee DA, de Lima M, Rezvani K, Khouri IF, Champlin RE, Ciurea SO. Similar Transplantation Outcomes for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with Haploidentical versus 10/10 Human Leukocyte Antigen-Matched Unrelated and Related Donors. Biol Blood Marrow Transplant 20(12):1975-81, 2014. e-Pub 2014. PMID: 25263628.
- Munoz J, Shah N, Rezvani K, Hosing C, Bollard CM, Oran B, Olson A, Popat U, Molldrem J, McNiece IK, Shpall EJ. Concise review: umbilical cord blood transplantation: past, present, and future. Stem Cells Transl Med 3(12):1435-43, 2014. e-Pub 2014. PMID: 25378655.
- Oran B, Kongtim P, Popat U, de Lima M, Jabbour E, Lu X, Chen J, Rondon G, Kebriaei P, Ahmed S, Andersson B, Alousi A, Ciurea S, Shpall E, Champlin RE. Cytogenetics, Donor Type and use of Hypomethylating Agents in Myelodysplastic Syndrome with Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant 20(10):1618-25, 2014. e-Pub 2014. PMID: 24953017.
- Khoder A, Sarvaria A, Alsuliman A, Chew C, Sekine T, Cooper N, Mielke S, de Lavallade H, Muftuoglu M, Fernandez Curbelo I, Liu E, Muraro PA, Alousi A, Stringaris K, Parmar S, Shah N, Shaim H, Yvon E, Molldrem J, Rouce R, Champlin R, McNiece I, Mauri C, Shpall EJ, Rezvani K. Regulatory B-Cells Are Enriched Within the IgM Memory and Transitional Subsets in Healthy Donors but Deficient In Chronic Graft-Versus-Host Disease. Blood 124(13):2034-45, 2014. e-Pub 2014. PMID: 25051962.
- Shah N, Rezvani K, Hosing C, Kebriaei P, Wierda W, Cooper L, Shpall E. Progress in Novel Cellular Therapy Options for Chronic Lymphocytic Leukemia: The MD Anderson Perspective. Clin Lymphoma Myeloma Leuk 14S:S18-S22, 2014. e-Pub 2014. PMID: 25486950.
- Bear AS, Hanley PJ, Bosque DM, Cruz CR, Kaur I, Liu H, Kebriaei P, Hosing C, Rezvani K, Oran B, De Lima MJ, Bollard CM, Shpall EJ. Low rate of infusional toxicity after expanded cord blood transplantation. Cytotherapy 16(8):1153-7, 2014. e-Pub 2014. PMID: 24582458.
- Zhou Y, Slack R, Jorgensen JL, Wang SA, Rondon G, de Lima M, Shpall E, Popat U, Ciurea S, Alousi A, Qazilbash M, Hosing C, O'Brien S, Thomas D, Kantarjian H, Medeiros LJ, Champlin RE, Kebriaei P. The Effect of Peritransplant Minimal Residual Disease in Adults With Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. Clin Lymphoma Myeloma Leuk 14(4):319-26, 2014. e-Pub 2014. PMID: 24548609.
- Tang X, Alatrash G, Ning J, Jakher H, Stafford P, Zope M, Shpall EJ, Jones RB, Champlin RE, Thall PF, Andersson BS. Increasing Chimerism Following Allogeneic Stem Cell Transplantation is Associated with Longer Survival Time. Biol Blood Marrow Transplant 20(8):1139-44, 2014. e-Pub 2014. PMID: 24727332.
- El-Mabhouh AA, Ayres ML, Shpall EJ, Baladandayuthapani V, Keating MJ, Wierda WG, Gandhi V. Evaluation of bendamustine in combination with fludarabine in primary chronic lymphocytic leukemia cells. Blood 123(24):3780-9, 2014. e-Pub 2014. PMID: 24747434.
- Liu X, Robinson SN, Setoyama T, Tung SS, D'Abundo L, Shah MY, Yang H, Yvon E, Shah N, Yang H, Konopleva M, Garcia-Manero G, McNiece I, Rezvani K, Calin GA, Shpall EJ, Parmar S. FOXP3 is a direct target of miR15a/16 in umbilical cord blood regulatory T cells. Bone Marrow Transplant 0(6):793-9, 2014. e-Pub 2014. PMID: 24710569.
- Mehta RS, Di Stasi A, Hosing C, Shah N, Rezvani K, Alousi A, O'Brien S, Wierda W, Keating M, Shpall EJ. Lenalidomide-induced graft-vs.-Leukemia effect in a patient with chronic lymphocytic leukemia who relapsed after allogeneic stem cell transplant. Clin Lymphoma Myeloma Leuk 14(3):e105-9, 2014. e-Pub 2014. PMID: 24502832.
- Stringaris K, Sekine T, Khoder A, Alsuliman A, Razzaghi B, Sargeant R, Pavlu J, Brisley G, de Lavallade H, Sarvaria A, Marin D, Mielke S, Apperley JF, Shpall EJ, Barrett AJ, Rezvani K. Leukemia-induced phenotypic and functional defects in natural killercells predict failure to achieve remission in acute myeloid leukemia. Haematologica 99(5):836-47, 2014. e-Pub 2014. PMID: 24488563.
- Jacamo R, Chen Y, Wang Z, Ma W, Zhang M, Spaeth EL, Wang Y, Battula VL, Mak PY, Schallmoser K, Ruvolo P, Schober WD, Shpall EJ, Nguyen MH, Strunk D, Bueso-Ramos CE, Konoplev S, Davis RE, Konopleva M, Andreeff M. Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance. Blood 123(17):2691-702, 2014. e-Pub 2014. PMID: 24599548.
- Perissinotti AJ, Gulbis A, Shpall EJ, Howell J. Characterizing human herpes virus 6 following hematopoietic stem cell transplantation. J Oncol Pharm Pract 21(2):85-92, 2014. e-Pub 2014. PMID: 24407957.
- Bollard CM, Gottschalk S, Torrano V, Diouf O, Ku S, Hazrat Y, Carrum G, Ramos C, Fayad L, Shpall EJ, Pro B, Liu H, Wu MF, Lee D, Sheehan AM, Zu Y, Gee AP, Brenner MK, Heslop HE, Rooney CM. Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins. J Clin Oncol 32(8):798-808, 2014. e-Pub 2014. PMID: 24344220.
- Robinson SN, Thomas MW, Simmons PJ, Lu J, Yang H, Parmar S, Liu X, Shah N, Martín-Antonio B, Bollard C, Dotti G, Savoldo B, Cooper LJ, Najjar A, Rezvani K, Kaur I, McNiece IK, Champlin RE, Miller LP, Zweidler-McKay PA, Shpall EJ. Fucosylation with fucosyltransferase VI or fucosyltransferase VII improves cord blood engraftment. Cytotherapy 16(1):84-9, 2014. e-Pub 2014. PMID: 24094497.
- Oran B, Shpall EJ. Allele-level HLA cord blood matching matters. Blood 123(1):8-9, 2014. e-Pub 2014. PMID: 24385496.
- Parmar S, Liu X, Tung SS, Robinson SN, Rodriguez G, Cooper LJ, Yang H, Shah N, Yang H, Konopleva M, Molldrem JJ, Garcia-Manero G, Najjar A, Yvon E, McNiece I, Rezvani K, Savoldo B, Bollard CM, Shpall EJ. Third-party umbilical cord blood-derived regulatory T cells prevent xenogenic graft-versus-host disease. Cytotherapy 16(1):90-100, 2014. e-Pub 2014. PMID: 24480547.
- Bayraktar UD, Shpall EJ, Liu P, Ciurea SO, Rondon G, de Lima M, Cardenas-Turanzas M, Price KJ, Champlin RE, Nates JL. Hematopoietic Cell Transplantation-Specific Comorbidity Index Predicts Inpatient Mortality and Survival in Patients Who Received Allogeneic Transplantation Admitted to the Intensive Care Unit. J Clin Oncol 31(33):4207-14, 2013. e-Pub 2013. PMID: 24127454.
- Cruz CR, Micklethwaite KP, Savoldo B, Ramos CA, Lam S, Ku S, Diouf O, Liu E, Barrett AJ, Ito S, Shpall EJ, Krance RA, Kamble RT, Carrum G, Hosing CM, Gee AP, Mei Z, Grilley BJ, Heslop HE, Rooney CM, Brenner MK, Bollard CM, Dotti G. Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study. Blood 122(17):2965-73, 2013. e-Pub 2013. PMID: 24030379.
- Shah N, Martin-Antonio B, Yang H, Ku S, Lee DA, Cooper LJ, Decker WK, Li S, Robinson SN, Sekine T, Parmar S, Gribben J, Wang M, Rezvani K, Yvon E, Najjar A, Burks J, Kaur I, Champlin RE, Bollard CM, Shpall EJ. Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity. PLoS One 8(10):e76781, 2013. e-Pub 2013. PMID: 24204673.
- Benjamini O, Jain P, Konoplev SN, Yin CC, Abruzzo L, Wotherspoon AC, Dearden C, Shpall EJ, Estrov Z, Keating MJ. CD4(-)/CD8(-) Variant of T-Cell Large Granular Lymphocytic Leukemia or Hepatosplenic T-Cell Lymphoma: A Clinicopathologic Dilemma. Clin Lymphoma Myeloma Leuk 13(5):610-3, 2013. e-Pub 2013. PMID: 23800602.
- Bashir Q, Khan H, Thall PF, Liu P, Shah N, Kebriaei P, Parmar S, Oran B, Ciurea S, Nieto Y, Jones R, Hosing CM, Popat UR, Dinh YT, Rondon G, Orlowski RZ, Shah JJ, De Lima M, Shpall E, Champlin R, Giralt S, Qazilbash MH. A Randomized Phase II Trial of Fludarabine/Melphalan 100 versus Fludarabine/Melphalan 140 Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Multiple Myeloma. Biol Blood Marrow Transplant 19(10):1453-8, 2013. e-Pub 2013. PMID: 23872222.
- Hart JW, Shiue LH, Shpall EJ, Alousi AM. Extracorporeal photopheresis in the treatment of graft-versus-host disease: evidence and opinion. Ther Adv Hematol 4(5):320-34, 2013. e-Pub 2013. PMID: 24082993.
- Yilmaz M, Chemaly RF, Han XY, Thall PF, Fox PS, Tarrand JJ, De Lima MJ, Hosing CM, Popat UR, Shpall E, Champlin RE, Qazilbash MH. Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience. Bone Marrow Transplant 48(9):1218-23, 2013. e-Pub 2013. PMID: 23503529.
- Sasaki K, Lu G, Saliba RM, Bashir Q, Hosing C, Popat U, Shah N, Parmar S, Dinh Y, Ahmed S, Shpall EJ, Kebriaei P, Shah JJ, Orlowski RZ, Champlin R, Qazilbash MH. Impact Of t(11;14)(q13;q32) On The Outcome Of Autologous Hematopoietic Cell Transplantation In Multiple Myeloma. Biol Blood Marrow Transplant 19(8):1227-32, 2013. e-Pub 2013. PMID: 23733001.
- Battula VL, Chen Y, Cabreira Mda G, Ruvolo V, Wang Z, Ma W, Konoplev S, Shpall E, Lyons K, Strunk D, Bueso-Ramos C, Davis RE, Konopleva M, Andreeff M. Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftment. Blood 122(3):357-66, 2013. e-Pub 2013. PMID: 23741006.
- Poon LM, Hamdi A, Saliba R, Rondon G, Ledesma C, Kendrick M, Qazilbash M, Hosing C, Jones RB, Popat UR, Nieto Y, Alousi A, Ciurea S, Shpall EJ, Champlin RE, Kebriaei P. Outcomes of adults with acute lymphoblastic leukemia (ALL) following relapse post allogeneic hematopoietic stem cell transplantation (HSCT). Biol Blood Marrow Transplant 19(7):1059-64, 2013. e-Pub 2013. PMID: 23644077.
- de Lavallade H, Khoder A, Hart M, Sarvaria A, Sekine T, Alsuliman A, Mielke S, Bazeos A, Stringaris K, Ali S, Milojkovic D, Foroni L, Chaidos A, Cooper N, Gabriel I, Apperley J, Belsey S, Flanagan RJ, Goldman J, Shpall EJ, Kelleher P, Marin D, Rezvani K. Tyrosine kinase inhibitors impair B cell immune responses in CML through off-target inhibition of kinases important for cell signaling. Blood 122(2):227-38, 2013. e-Pub 2013. PMID: 23719297.
- Weber G, Gerdemann U, Caruana I, Savoldo B, Hensel NF, Rabin KR, Shpall EJ, Melenhorst JJ, Leen AM, Barrett AJ, Bollard CM. Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplant. Leukemia 27(7):1538-47, 2013. e-Pub 2013. PMID: 23528871.
- Leen AM, Bollard CM, Mendizabal AM, Shpall EJ, Szabolcs P, Antin JH, Kapoor N, Pai SY, Rowley SD, Kebriaei P, Dey BR, Grilley BJ, Gee AP, Brenner MK, Rooney CM, Heslop HE. Multicenter study of banked third party virus-specific T-cells to treat severe viral infections after hematopoietic stem cell transplantation. Blood 121(26):5113-23, 2013. e-Pub 2013. PMID: 23610374.
- Poon LM, Bassett R, Rondon G, Hamdi A, Qazilbash M, Hosing C, Jones RB, Shpall EJ, Popat UR, Nieto Y, Worth LL, Cooper L, De Lima M, Champlin RE, Kebriaei P. Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia. Bone Marrow Transplant 48(5):666-70, 2013. e-Pub 2013. PMID: 23085830.
- Petz LD, Redei I, Bryson Y, Regan D, Kurtzberg J, Shpall E, Gutman J, Querol S, Clark P, Tonai R, Santos S, Bravo A, Spellman S, Gragert L, Rossi J, Li S, Li H, Senitzer D, Zaia J, Rosenthal J, Forman S, Chow R. Hematopoietic Cell Transplantation with Cord Blood for Cure of HIV Infections. Biol Blood Marrow Transplant 19(3):393-7, 2013. e-Pub 2013. PMID: 23089564.
- Nieto Y, Popat U, Anderlini P, Valdez B, Andersson B, Liu P, Hosing C, Shpall EJ, Alousi A, Kebriaei P, Qazilbash M, Parmar S, Bashir Q, Shah N, Khouri I, Rondon G, Champlin R, Jones RB. Autologous Stem Cell Transplantation for Refractory or Poor-Risk Relapsed Hodgkin Lymphoma: Effect of the Specific High-Dose Chemotherapy Regimen on Outcome. Biol Blood Marrow Transplant 19(3):410-7, 2013. e-Pub 2013. PMID: 23128322.
- Hosing C, Kebriaei P, Wierda W, Jena B, Cooper LJ, Shpall E. CARs in Chronic Lymphocytic Leukemia - Ready to Drive. Curr Hematol Malig Rep 8(1):60-70, 2013. e-Pub 2013. PMID: 23225251.
- Bart T, Boo M, Balabanova S, Fischer Y, Nicoloso G, Foeken L, Oudshoorn M, Passweg J, Tichelli A, Kindler V, Kurtzberg J, Price T, Regan D, Shpall EJ, Schwabe R. Impact of selection of cord blood units from the United States and swiss registries on the cost of banking operations. Transfus Med Hemother 40(1):14-20, 2013. e-Pub 2013. PMID: 23637645.
- Scaradavou A, Brunstein CG, Eapen M, Le-Rademacher J, Barker JN, Chao N, Cutler C, Delaney C, Kan F, Isola L, Karanes C, Laughlin MJ, Wagner JE, Shpall EJ. Double Unit Grafts Successfully Extend the Application of Umbilical Cord Blood Transplantation in Adults with Acute Leukemia. Blood 121(5):752-8, 2013. e-Pub 2013. PMID: 23223509.
- Kebriaei P, Madden T, Wang X, Thall PF, Ledesma C, de Lima M, Shpall EJ, Hosing C, Qazilbash M, Popat U, Alousi A, Nieto Y, Champlin RE, Jones RB, Andersson BS. Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL. Bone Marrow Transplant 48(1):26-31, 2013. e-Pub 2013. PMID: 22732703.
- Delaney C, Bollard CM, Shpall EJ. Cord Blood Graft Engineering. Biol Blood Marrow Transplant 19(1 Suppl):S74-8, 2013. e-Pub 2013. PMID: 23084956.
- Huls MH, Figliola MJ, Dawson MJ, Olivares S, Kebriaei P, Shpall EJ, Champlin RE, Singh H, Cooper LJ. Clinical application of sleeping beauty and artificial antigen presenting cells to genetically modify T cells from peripheral and umbilical cord blood. J Vis Exp(72):e50070, 2013. e-Pub 2013. PMID: 23407473.
- Decker WK, Shah N, Xing D, Lapushin R, Li S, Robinson SN, Yang H, Parmar S, Halpert MM, Keating MJ, Gribben JG, Molldrem JJ, Shpall EJ, Wierda WG. Generation of Functional CLL-Specific Cord Blood CTL Using CD40-Ligated CLL APC. PLoS One 7(12):e51390, 2012. e-Pub 2012. PMID: 23284688.
- Radvanyi LG, Bernatchez C, Zhang M, Fox PS, Miller P, Chacon J, Wu R, Lizee G, Mahoney S, Alvarado G, Glass M, Johnson VE, McMannis JD, Shpall E, Prieto V, Papadopoulos N, Kim K, Homsi J, Bedikian A, Hwu WJ, Patel S, Ross MI, Lee JE, Gershenwald JE, Lucci A, Royal R, Cormier JN, Davies MA, Mansaray R, Fulbright OJ, Toth C, Ramachandran R, Wardell S, Gonzalez A, Hwu P. Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients. Clin Cancer Res 18(24):6758-70, 2012. e-Pub 2012. PMID: 23032743.
- de Lima M, McNiece I, Robinson SN, Munsell M, Eapen M, Horowitz M, Alousi A, Saliba R, McMannis JD, Kaur I, Kebriaei P, Parmar S, Popat U, Hosing C, Champlin R, Bollard C, Molldrem JJ, Jones RB, Nieto Y, Andersson BS, Shah N, Oran B, Cooper LJ, Worth L, Qazilbash MH, Korbling M, Rondon G, Ciurea S, Bosque D, Maewal I, Simmons PJ, Shpall EJ. Cord Blood Engraftment With Ex-vivo Mesenchymal Cell Co- Culture. N Engl J Med 367(24):2305-15, 2012. e-Pub 2012. PMID: 23234514.
- Kebriaei P, Basset R, Ledesma C, Ciurea S, Parmar S, Shpall EJ, Hosing C, Khouri I, Qazilbash M, Popat U, Alousi A, Nieto Y, Jones RB, de Lima M, Champlin RE, Andersson BS. Clofarabine Combined with Busulfan Provides Excellent Disease Control in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 18(12):1819-26, 2012. e-Pub 2012. PMID: 22750645.
- Jelinek J, Liang S, Lu Y, He R, Ramagli LS, Shpall EJ, Estecio MR, Issa JP. Conserved DNA methylation patterns in healthy blood cells and extensive changes in leukemia measured by a new quantitative technique. Epigenetics 7(12):1368-78, 2012. e-Pub 2012. PMID: 23075513.
- Ballen K, Mendizabal AM, Cutler C, Politikos I, Jamieson K, Shpall EJ, Dey BR, Attar E, McAfee S, Delaney C, McCarthy P, Ball ED, Kamble R, Avigan D, Maziarz RT, Ho VT, Koreth J, Alyea E, Soiffer R, Wingard JR, Boussiotis V, Spitzer TR, Antin JH. Phase II Trial of Parathyroid Hormone following Double Umbilical Cord Blood Transplantation. Biol Blood Marrow Transplant 18(12):1851-8, 2012. e-Pub 2012. PMID: 22766223.
- Ciurea SO, Mulanovich V, Saliba RM, Bayraktar UD, Jiang Y, Bassett R, Wang SA, Konopleva M, Fernandez-Vina M, Montes N, Bosque D, Chen J, Rondon G, Alatrash G, Alousi A, Bashir Q, Korbling M, Qazilbash M, Parmar S, Shpall E, Nieto Y, Hosing C, Kebriaei P, Khouri I, Popat U, de Lima M, Champlin RE. Improved Early Outcomes Using a T-cell Replete Graft Compared with T-cell Depleted Haploidentical Hematopoietic Stem-Cell Transplantation. Biol Blood Marrow Transplant 18(12):1835-44, 2012. e-Pub 2012. PMID: 22796535.
- Nieto Y, Thall P, Valdez B, Andersson B, Popat U, Anderlini P, Shpall EJ, Bassett R, Alousi A, Hosing C, Kebriaei P, Qazilbash M, Frazier E, Gulbis A, Chancoco C, Bashir Q, Ciurea S, Khouri I, Parmar S, Shah N, Worth L, Rondon G, Champlin R, Jones RB. High-Dose Infusional Gemcitabine Combined with Busulfan and Melphalan with Autologous Stem-Cell Transplant in Patients with Refractory Lymphoid Malignancies. Biol Blood Marrow Transplant 18(11):1677-86, 2012. e-Pub 2012. PMID: 22643322.
- Ji Y, Feng L, Liu P, Shpall EJ, Kebriaei P, Champlin R, Berry D, Cooper LJ. Bayesian continual reassessment method for dose-finding trials infusing T cells with limited sample size. J Biopharm Stat 22(6):1206-19, 2012. e-Pub 2012. PMID: 23075018.
- Pillai RN, Chen LS, Ayres ML, Nowak BJ, Thomas MW, Shpall EJ, Keating MJ, Gandhi V. Multifaceted actions of 8-amino-adenosine kill BCR-ABL positive cells. Leuk Lymphoma 53(10):2024-32, 2012. e-Pub 2012. PMID: 22448923.
- Lee DW, Futami M, Carroll M, Feng Y, Wang Z, Fernandez M, Whichard Z, Chen Y, Kornblau S, Shpall EJ, Bueso-Ramos CE, Corey SJ. Loss of SHIP-1 protein expression in high-risk myelodysplastic syndromes is associated with miR-210 and miR-155. Oncogene 31(37):4085-94, 2012. e-Pub 2012. PMID: 22249254.
- Frolova O, Samudio I, Benito JM, Jacamo R, Kornblau SM, Markovic A, Schober W, Lu H, Qiu YH, Buglio D, McQueen T, Pierce S, Shpall E, Konoplev S, Thomas D, Kantarjian H, Lock R, Andreeff M, Konopleva M. Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment. Cancer Biol Ther 13(10):858-70, 2012. e-Pub 2012. PMID: 22785211.
- Robinson SN, Simmons PJ, Thomas MW, Brouard N, Javni JA, Trilok S, Shim JS, Yang H, Steiner D, Decker WK, Xing D, Shultz LD, Savoldo B, Dotti G, Bollard CM, Miller L, Champlin RE, Shpall EJ, Zweidler-McKay PA. Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2Rγnull (NSG) mice. Exp Hematol 40(6):445-56, 2012. e-Pub 2012. PMID: 22306295.
- Hanley PJ, Lam S, Shpall EJ, Bollard CM. Expanding cytotoxic T lymphocytes from umbilical cord blood that target cytomegalovirus, Epstein-Barr virus, and adenovirus. J Vis Exp(63):e3627, 2012. e-Pub 2012. PMID: 22588077.
- Ciurea SO, Saliba RM, Hamerschlak N, Karduss Aurueta AJ, Bassett R, Fernandez-Vina M, Petropoulos D, Worth LL, Chan KW, Couriel DR, Rondon G, Sharma M, Qazilbash M, Jones RB, Kebriaei P, McMannis J, Hosing CM, Nieto Y, Champlin RE, Shpall EJ, de Lima M. Fludarabine, Melphalan, Thiotepa and ATG Conditioning for Unrelated Cord Blood Transplantation. Leuk Lymphoma 53(5):901-6, 2012. e-Pub 2012. PMID: 21988645.
- Kebriaei P, Huls H, Jena B, Munsell M, Jackson R, Lee DA, Hackett PB, Rondon G, Shpall E, Champlin RE, Cooper LJ. Infusing CD19-Directed T Cells to Augment Disease Control in Patients Undergoing Autologous Hematopoietic Stem-Cell Transplantation for Advanced B-Lymphoid Malignancies. Hum Gene Ther 23(5):444-50, 2012. e-Pub 2012. PMID: 22107246.
- Kebriaei P, Saliba R, Rondon G, Chiattone A, Luthra R, Anderlini P, Andersson B, Shpall E, Popat U, Jones R, Worth L, Ravandi F, Thomas D, O'Brien S, Kantarjian H, de Lima M, Giralt S, Champlin R. Long-Term Follow-up of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Impact of Tyrosine Kinase Inhibitors on Treatment Outcomes. Biol Blood Marrow Transplant 18(4):584-92, 2012. e-Pub 2012. PMID: 21867666.
- Ciurea SO, Thall PF, Wang X, Wang SA, Hu Y, Cano P, Aung F, Rondon G, Molldrem JJ, Korbling M, Shpall EJ, de Lima M, Champlin RE, Fernandez-Vina M. Donor-specific anti-HLA antibodies and graft failure in matched unrelated donor hematopoietic stem cell transplantation. Blood 118(22):5957-64, 2011. e-Pub 2011. PMID: 21967975.
- Muralidharan S, Hanley PJ, Liu E, Chakraborty R, Bollard C, Shpall E, Rooney C, Savoldo B, Rodgers J, Dotti G. Activation of Wnt signaling arrests effector differentiation in human peripheral and cord blood-derived T lymphocytes. J Immunol 187(10):5221-32, 2011. e-Pub 2011. PMID: 22013128.
- Muralidharan S, Hanley PJ, Liu E, Chakraborty R, Bollard C, Shpall EJ, Rooney C, Savoldo B, Rodgers J, Dotti G. Activation of Wnt Signaling Arrests Eector Dierentiation in Human Peripheral and Cord Blood-Derived T Lymphocytes. J Immunology 187(10):5221-5232, 2011. e-Pub 2011.
- Kojima K, McQueen T, Chen Y, Jacamo R, Konopleva M, Shinojima N, Shpall E, Huang X, Andreeff M. p53 activation of mesenchymal stromal cells partially abrogates microenvironment-mediated resistance to FLT3 inhibition in AML through HIF-1{alpha}-mediated down-regulation of CXCL12. Blood 118(16):4431-9, 2011. e-Pub 2011. PMID: 21868571.
- Khan H, Oberoi S, Mahvash A, Sharma M, Rondon G, Alousi A, Shpall EJ, Kontoyiannis DP, Champlin RE, Ciurea SO. Reversible Ureteral Obstruction due to Polyomavirus Infection after Precutaneous Nephrostomy Catheter Placement. Biol Blood Marrow Transplant 17(10):1551-5, 2011. e-Pub 2011. PMID: 21396475.
- Perin EC, Tian M, Marini FC, Silva GV, Zheng Y, Baimbridge F, Quan X, Fernandes MR, Gahremanpour A, Young D, Paolillo V, Mukhopadhyay U, Borne AT, Uthamanthil R, Brammer D, Jackson J, Decker WK, Najjar AM, Thomas MW, Volgin A, Rabinovich B, Soghomonyan S, Jeong HJ, Rios JM, Steiner D, Robinson S, Mawlawi O, Pan T, Stafford J, Kundra V, Li C, Alauddin MM, Willerson JT, Shpall E, Gelovani JG. Imaging long-term fate of intramyocardially implanted mesenchymal stem cells in a porcine myocardial infarction model. PLoS One 6(9):e22949, 2011. e-Pub 2011. PMID: 21912635.
- Gonzalez G, Park S, Chen D, Armitage S, Shpall E, Behringer R. Identification and frequency of CCR5?32/?32 HIV-resistant cord blood units from Houston area hospitals. HIV Med 12(8):481-486, 2011. e-Pub 2011. PMID: 21375684.
- Ciurea SO, Mulanovich V, Jiang Y, Bassett R, Rondon G, McMannis J, de Lima M, Shpall EJ, Champlin RE. Lymphocyte Recovery Predicts Outcomes in Cord Blood and T Cell-Depleted Haploidentical Stem Cell Transplantation. Biol Blood Marrow Transplant 17(8):1169-75, 2011. e-Pub 2011. PMID: 21126598.
- Yang H, Robinson SN, Nieto Y, Jones RJ, Gocke CD, Lu J, Giralt SA, Jones RB, Decker WK, Xing D, Steiner D, Champlin RE, McMannis JD, Ng J, Thomas MW, Shah N, Andersson BS, Parmar S, Shpall EJ. Ex vivo graft purging and expansion of autologous blood progenitor cell products from patients with Multiple Myeloma. Cancer Res 71(14):5040-9, 2011. e-Pub 2011. PMID: 21646477.
- Bashir Q, Andersson BS, Fernandez-Vina M, de Padua Silva L, Giralt S, Chiattone A, Wei W, Sharma M, Anderlini P, Shpall EJ, Popat U, Rodrigues M, Champlin RE, de Lima M. Unrelated Donor Transplantation for Acute Myelogenous Leukemia in First Remission. Biol Blood Marrow Transplant 17(7):1067-71, 2011. e-Pub 2011. PMID: 21087679.
- Shah N, Decker WK, Lapushin R, Xing D, Robinson SN, Yang H, Parmar S, Tung SS, O'Brien S, Fernandez-Viña M, Shpall EJ, Wierda WG. HLA homozygosity and haplotype bias among patients with chronic lymphocytic leukemia: implications for disease control by physiological immune surveillance. Leukemia 25(6):1036-9, 2011. e-Pub 2011. PMID: 21350559.
- Andersson BS, de Lima M, Worth LL, Popat U, Jones RB, Shpall EJ, Hosing C, Madden T, Kazerooni R, McAdams P, Alousi A, Kebriaei P, Champlin RE. Clofarabine (Clo) +/– Fludarabine (Flu) with IV Busulfan (Bu) and Allogeneic Stem Cell Transplantation (Allo-SCT) for Relapsed, Refractory Myeloid Leukemia (ML) and MDS. Blood 50th ASH Annual Meeting 112(11):4390, 2011. e-Pub 2011. PMID: 20946966.
- Andersson BS, Valdez BC, de Lima M, Wang X, Thall PF, Worth LL, Popat U, Madden T, Hosing C, Alousi A, Rondon G, Kebriaei P, Shpall EJ, Jones RB, Champlin RE. Clofarabine ± Fludarabine with Once Daily i.v. Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and MDS. Biol Blood Marrow Transplant 17(6):893-900, 2011. e-Pub 2011. PMID: 20946966.
- Kebriaei P, Madden T, Kazerooni R, Wang X, Thall PF, Ledesma C, Nieto Y, Shpall EJ, Hosing C, Qazilbash M, Popat U, Khouri I, Champlin RE, Jones RB, Andersson BS. Intravenous busulfan plus melphalan is a highly effective, well-tolerated preparative regimen for autologous stem cell transplantation in patients with advanced lymphoid malignancies. Biol Blood Marrow Transplant 17(3):412-20, 2011. e-Pub 2011. PMID: 20674757.
- Parmar S, Andersson BS, Couriel D, Munsell MF, Fernandez-Vina M, Jones RB, Shpall EJ, Popat U, Anderlini P, Giralt S, Alousi A, Cano P, Bosque D, Hosing C, Silva Lde P, Westmoreland M, Wathen JK, Berry D, Champlin RE, de Lima MJ. Prophylaxis of Graft-Versus-Host Disease in Unrelated Donor Transplantation With Pentostatin, Tacrolimus, and Mini-Methotrexate: A Phase I/II Controlled, Adaptively Randomized Study. J Clin Oncol 29(3):294-302, 2011. e-Pub 2011. PMID: 21149654.
- Cohen YC, Scaradavou A, Stevens CE, Rubinstein P, Gluckman E, Rocha V, Horowitz MM, Eapen M, Nagler A, Shpall EJ, Laughlin MJ, Daniely Y, Pacheco D, Barishev R, Olmer L, Freedman LS. Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries. Bone Marrow Transplant 46(1):70-6, 2011. e-Pub 2011. PMID: 20436518.
- Benito J, Shi Y, Szymanska B, Carol H, Boehm I, Lu H, Konoplev S, Fang W, Zweidler-McKay PA, Campana D, Borthakur G, Bueso-Ramos C, Shpall E, Thomas DA, Jordan CT, Kantarjian H, Wilson WR, Lock R, Andreeff M, Konopleva M. Pronounced Hypoxia in Models of Murine and Human Leukemia: High Efficacy of Hypoxia-Activated Prodrug PR-104. PLoS One 6(8):e23108, 2011. e-Pub 2011. PMID: 21853076.
- Westin JR, Saliba RM, De Lima M, Alousi A, Hosing C, Qazilbash MH, Khouri IF, Shpall EJ, Anderlini P, Rondon G, Andersson BS, Champlin R, Couriel DR. Steroid-Refractory Acute GVHD: Predictors and Outcomes. Adv Hematol 2011:601953, 2011. e-Pub 2011. PMID: 22110505.
- Mulanovich VE, Jiang Y, de Lima M, Shpall EJ, Champlin RE, Ciurea SO. Infectious complications in cord blood and T-cell depleted haploidentical stem cell transplantation. Am J Blood Res 1(1):98-105, 2011. e-Pub 2011. PMID: 22432070.
- Shpall EJ, Bollard CM, Brunstein C. Novel cord blood transplant therapies. Biol Blood Marrow Transplant 17(1 Suppl):S39-45, 2011. e-Pub 2011. PMID: 20951821.
- Anderlini P, Acholonu SA, Okoroji GJ, Bassett RE, Shpall EJ, Qazilbash MH, Popat UR, Worth LL, Giralt SA, Champlin RE. Fludarabine, cyclophosphamide, and antithymocyte globulin for matched related and unrelated allogeneic stem cell transplant in severe aplastic anemia. Leuk Lymphoma 52(1):137-41, 2011. e-Pub 2011. PMID: 20939697.
- Bashir Q, Robinson SN, de Lima MJ, Parmar S, Shpall E. Umbilical cord blood transplantation. Clin Adv Hematol Oncol 8(11):786-801, 2010. e-Pub 2010. PMID: 21326157.
- Xing D, Ramsay AG, Gribben JG, Decker WK, Burks JK, Munsell M, Li S, Robinson SN, Yang H, Steiner D, Shah N, McMannis JD, Champlin RE, Hosing C, Zweidler-McKay PA, Shpall EJ, Bollard CM. Cord Blood Natural Killer Cells Exhibit Impaired Lytic Immunological Synapse Formation That Is Reversed With IL-2 Exvivo Expansion. J Immunother 33(7):684-96, 2010. e-Pub 2010. PMID: 20664358.
- Bashir Q, De Lima MJ, McMannis JD, Garcia-Manero G, Shpall E, Kantarjian H, Cortes JE, O'Brien SM, Jones D, Qazilbash M, Wei W, Giralt SA, Champlin RE, Hosing C. Hematopoietic progenitor cell collection in patients with chronic myelogenous leukemia in complete cytogenetic remission after imatinib mesylate therapy. Leuk Lymphoma 51(8):1478-84, 2010. e-Pub 2010. PMID: 20658954.
- Silva Lde P, Patah PA, Saliba RM, Szewczyk NA, Gilman L, Neumann J, Han XY, Tarrand J, Ribeiro R, Gulbis A, Shpall EJ, Jones R, Popat U, Walker JA, Petropoulos D, Chiattone A, Stewart J, El-Zimaity M, Anderlini P, Giralt S, Champlin RE, de Lima M. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type. Haematologica 95(7):1183-90, 2010. e-Pub 2010. PMID: 20410183.
- Wang J, Zhang S, Rabinovich B, Bidaut L, Soghomonyan S, Alauddin MM, Bankson JA, Shpall E, Willerson JT, Gelovani JG, Yeh ET. Human CD34+ cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of action. Circ Res 106(12):1904-11, 2010. e-Pub 2010. PMID: 20448213.
- Yang H, Robinson SN, Lu J, Decker WK, Xing D, Steiner D, Parmar S, Shah N, Champlin RE, Munsell M, Leen A, Bollard C, Simmons PJ, Shpall EJ. CD3(+) and/or CD14(+) depletion from cord blood mononuclear cells before ex vivo expansion culture improves total nucleated cell and CD34(+) cell yields. Bone Marrow Transplant 45(6):1000-7, 2010. e-Pub 2010. PMID: 19838220.
- Ramos CA, Saliba RM, de Pádua Silva L, Khorshid O, Shpall EJ, Giralt S, Patah PA, Hosing CM, Popat UR, Rondon G, Nieto Y, Champlin RE, de Lima M. Resolved hepatitis B virus infection is not associated with worse outcomes after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 16(5):686-94, 2010. e-Pub 2010. PMID: 20056165.
- Micklethwaite KP, Savoldo B, Hanley PJ, Leen AM, Demmler-Harrison GJ, Cooper LJ, Liu H, Gee AP, Shpall EJ, Rooney CM, Heslop HE, Brenner MK, Bollard CM, Dotti G. Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation. Blood 115(13):2695-703, 2010. e-Pub 2010. PMID: 20110422.
- Marks LB, Cirrincione C, Fitzgerald TJ, Laurie F, Glicksman AS, Vredenburgh J, Prosnitz LR, Shpall EJ, Crump M, Richardson PG, Schuster MW, Ma J, Peterson BL, Norton L, Seagren S, Henderson IC, Hurd DD, Peters WP, Cancer and Leukemia Group B, Group SO, Trials Group NCIOCC. Impact of high-dose chemotherapy on the ability to deliver subsequent local-regional radiotherapy for breast cancer: analysis of Cancer and Leukemia Group B Protocol 9082. Int J Radiat Oncol Biol Phys 76(5):1305-13, 2010. e-Pub 2010. PMID: 19747781.
- Manuri PV, Wilson MH, Maiti SN, Mi T, Singh H, Olivares S, Dawson MJ, Huls H, Lee DA, Rao PH, Kaminski JM, Nakazawa Y, Gottschalk S, Kebriaei P, Shpall EJ, Champlin RE, Cooper LJ. PiggyBac transposon/transposase system to generate CD19-specific T cells for treatment of B-lineage malignancies. Hum Gene Ther 21(4):427-37, 2010. e-Pub 2010. PMID: 19905893.
- Ciurea SO, Saliba R, Rondon G, Pesoa S, Cano P, Fernandez-Vina M, Qureshi S, Worth LL, McMannis J, Kebriaei P, Jones RB, Korbling M, Qazilbash M, Shpall EJ, Giralt S, de Lima M, Champlin RE, Gajewski J. Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT. Bone Marrow Transplant 45(3):429-36, 2010. e-Pub 2010. PMID: 19668237.
- Hosing C, Munsell MF, Reuben JM, Popat U, Lee BN, Gao H, Körbling M, Shpall EJ, Kebriaei P, Alousi A, De Lima M, McMannis J, Qazilbash M, Anderlini P, Giralt S, Champlin RE, Khouri I. A randomized study comparing chemotherapy followed by G-CSF alone or in combination with GM-CSF for mobilization of peripheral blood stem cells in patients with non-Hodgkin's lymphomas. J Blood Med 1:49-55, 2010. e-Pub 2010. PMID: 22282683.
- Couriel DR, Saliba R, de Lima M, Giralt S, Andersson B, Khouri I, Hosing C, Ippoliti C, Shpall EJ, Champlin R, Alousi A. A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease. Biol Blood Marrow Transplant 15(12):1555-62, 2009. e-Pub 2009. PMID: 19896079.
- Ciurea SO, de Lima M, Cano P, Korbling M, Giralt S, Shpall EJ, Wang X, Thall PF, Champlin RE, Fernandez-Vina M. High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation. Transplantation 88(8):1019-24, 2009. e-Pub 2009. PMID: 19855248.
- Parmar S, Del Lima M, Zou Y, Patah PA, Liu P, Cano P, Rondon G, Pesoa S, de Padua Silva L, Qazilbash MH, Hosing C, Popat U, Kebriaei P, Shpall EJ, Giralt S, Champlin RE, Stastny P, Fernandez-Vina M. Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease. Blood 114(14):2884-7, 2009. e-Pub 2009. PMID: 19654407.
- Steiner D, Gelovani J, Savoldo B, Robinson SN, Decker WK, Brouard N, Najjar A, Xing D, Yang H, Li S, Marini F, Zweidler-McKay PA, Bollard CM, Shpall EJ, Dotti G, Simmons PJ. Noninvasive Bioluminescent Imaging Demonstrates Long-Term Multilineage Engraftment of Ex Vivo-Expanded CD34-Selected Umbilical Cord Blood Cells. Stem Cells 27(8):1932-1940, 2009. e-Pub 2009. PMID: 19544439.
- Hanley PJ, Cruz CR, Savoldo B, Leen AM, Stanojevic M, Khalil M, Decker W, Molldrem JJ, Liu H, Gee AP, Rooney CM, Heslop HE, Dotti G, Brenner MK, Shpall EJ, Bollard CM. Functionally active virus-specific T-cells that target CMV, adenovirus and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes. Blood 114(9):1958-67, 2009. e-Pub 2009. PMID: 19443656.
- Dotti G, Tian M, Savoldo B, Najjar A, Cooper LJ, Jackson J, Smith A, Mawlawi O, Uthamanthil R, Borne A, Brammer D, Paolillo V, Alauddin M, Gonzalez C, Steiner D, Decker WK, Marini F, Kornblau S, Bollard CM, Shpall EJ, Gelovani JG. Repetitive Noninvasive Monitoring of HSV1-tk-Expressing T Cells Intravenously Infused into Nonhuman Primates Using Positron Emission Tomography and Computed Tomography with 18F-FEAU. Mol Imaging 8(4):230-7, 2009. e-Pub 2009. PMID: 19728977.
- Martin PJ, Bachier CR, Klingemann HG, McCarthy PL, Szabolcs P, Uberti JP, Schuster MW, Weisdorf D, Chao NJ, Kebriaei P, Shpall EJ, Macmillan ML, Soiffer RJ. Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement. Biol Blood Marrow Transplant 15(7):777-84, 2009. e-Pub 2009. PMID: 19539208.
- Popat U, Saliba R, Thandi R, Hosing C, Qazilbash M, Anderlini P, Shpall E, McMannis J, Körbling M, Alousi A, Andersson B, Nieto Y, Kebriaei P, Khouri I, de Lima M, Weber D, Thomas S, Wang M, Jones R, Champlin R, Giralt S. Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma. Biol Blood Marrow Transplant 15(6):718-23, 2009. e-Pub 2009. PMID: 19450756.
- Jabbour E, Giralt S, Kantarjian H, Garcia-Manero G, Jagasia M, Kebriaei P, de Padua L, Shpall EJ, Champlin R, de Lima M. Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia. Cancer 115(9):1899-905, 2009. e-Pub 2009. PMID: 19235255.
- Decker WK, Xing D, Li S, Robinson SN, Yang H, Steiner D, Komanduri KV, Shpall EJ. Th-1 polarization is regulated by dendritic cell comparison of MHC class I and class II antigens. Blood 113(18):4213-23, 2009. e-Pub 2009. PMID: 19171878.
- Safdar A, Decker WK, Li S, Xing D, Robinson SN, Yang H, Steiner D, Rodriguez G, Shpall EJ, Bollard C. De novo T-lymphocyte responses against baculovirus-derived recombinant influenzavirus hemagglutinin generated by a naive umbilical cord blood model of dendritic cell vaccination. Vaccine 27(10):1479-84, 2009. e-Pub 2009. PMID: 19185049.
- Singh H, Najjar AM, Olivares S, Nishii R, Mukhopadhyay U, Alauddin M, Manuri PR, Huls H, Lee DA, Dotti G, Bollard C, Simmons PJ, Shpall EJ, Champlin RE, Gelovani JG, Cooper LJ. PET imaging of T cells derived from umbilical cord blood. Leukemia 23(3):620-2, 2009. e-Pub 2009. PMID: 18830258.
- Ramos CA, Saliba RM, de Pádua L, Khorshid O, Shpall EJ, Giralt S, Patah PA, Hosing CM, Popat UR, Rondon G, Khouri IF, Nieto YL, Champlin RE, de Lima M. Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Haematologica 94(2):249-57, 2009. e-Pub 2009. PMID: 19144658.
- De Assis RA, Kerbauy FR, Rodrigues M, Seguro FS, Aranha LF, Fayad L, Shpall EJ, de Lima M, Hamerschlak N. Mycobacterium tuberculosis infection: a rare late complication after cord blood hematopoietic SCT. Bone Marrow Transplant 43(8):667-8, 2009. e-Pub 2009. PMID: 19029968.
- Ni X, Richmond HM, Liao XM, Decker WK, Shiue LH, Shpall EJ, Duvic M. Induction of T-cell responses against cutaneous T-cell lymphomas ex vivo by autologous dendritic cells transfected with amplified tumor mRNA. J Invest Dermatol 128(11):2631-9, 2008. e-Pub 2008. PMID: 18480841.
- Rondón G, Saliba RM, Khouri I, Giralt S, Chan K, Jabbour E, McMannis J, Champlin R, Shpall E. Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysis. Biol Blood Marrow Transplant 14(8):859-66, 2008. e-Pub 2008. PMID: 18640568.
- Andersson BS, de Lima M, Thall PF, Wang X, Couriel D, Korbling M, Roberson S, Giralt S, Pierre B, Russell JA, Shpall EJ, Jones RB, Champlin RE. Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS. Biol Blood Marrow Transplant 14(6):672-84, 2008. e-Pub 2008. PMID: 18489993.
- de Lima M, McMannis J, Gee A, Komanduri K, Couriel D, Andersson BS, Hosing C, Khouri I, Jones R, Champlin R, Karandish S, Sadeghi T, Peled T, Grynspan F, Daniely Y, Nagler A, Shpall EJ. Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Bone Marrow Transplant 41(9):771-8, 2008. e-Pub 2008. PMID: 18209724.
- Singh H, Manuri PR, Olivares S, Dara N, Dawson MJ, Huls H, Hackett PB, Kohn DB, Shpall EJ, Champlin RE, Cooper LJ. Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system. Cancer Res 68(8):2961-71, 2008. e-Pub 2008. PMID: 18413766.
- Decker WK, Li S, Xing D, Robinson SN, Yang H, Steiner D, Komanduri KV, Bollard CM, Shpall EJ. Deficient T(H)-1 responses from TNF-alpha-matured and alpha-CD40-matured dendritic cells. J Immunother 31(2):157-65, 2008. e-Pub 2008. PMID: 18481385.
- de Lima M, Champlin RE, Thall PF, Wang X, Martin TG, Cook JD, McCormick G, Qazilbash M, Kebriaei P, Couriel D, Shpall EJ, Khouri I, Anderlini P, Hosing C, Chan KW, Andersson BS, Patah PA, Caldera Z, Jabbour E, Giralt S. Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome. Leukemia 22(2):258-64, 2008. e-Pub 2008. PMID: 17989720.
- Shpall EJ, Clarke-Pearson D, Soper JT, Berchuck A, Jones RB, Jr BR, Ross M, Lidor Y, Vanacek K, Tyler T, al E. High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer. Gynecol Oncol 38(3):386-91, 2008. e-Pub 2008.
- Komanduri KV, St John LS, de Lima M, McMannis J, Rosinski S, McNiece I, Bryan SG, Kaur I, Martin S, Wieder ED, Worth L, Cooper LJ, Petropoulos D, Molldrem JJ, Champlin RE, Shpall EJ. Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T cell skewing. Blood 110(13):4543-51, 2007. e-Pub 2007. PMID: 17671230.
- Safdar A, Rodriguez GH, De Lima MJ, Petropoulos D, Chemaly RF, Worth LL, Shpall EJ, Rolston KV, Raad II, Chan KW, Champlin RE. Infections in 100 cord blood transplantations: spectrum of early and late posttransplant infections in adult and pediatric patients 1996-2005. Medicine 86(6):324-333, 2007. e-Pub 2007. PMID: 18004177.
- Nieto Y, Nawaz F, Jones RB, Shpall EJ, Nawaz S. Prognostic significance of overexpression and phosphorylation of epidermal growth factor receptor (EGFR) and the presence of truncated EGFRvIII in locoregionally advanced breast cancer. J Clin Oncol 25(28):4405-13, 2007. e-Pub 2007. PMID: 17906204.
- Sims CR, Thompson K, Chemaly RF, Shpall EJ, Champlin RE, Safdar A. Oral topical cidofovir: novel route of drug delivery in a severely immunosuppressed patient with refractory multidrug-resistant herpes simplex virus infection. Transpl Infect Dis 9(3):256-9, 2007. e-Pub 2007. PMID: 17605730.
- Nieto Y, Woods J, Nawaz F, Baron A, Jones RB, Shpall EJ, Nawaz S. Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy. Br J Cancer 97(3):391-397, 2007. e-Pub 2007. PMID: 17609662.
- Jabbour E, Cortes J, Kantarjian H, Giralt S, Andersson BS, Giles F, Shpall E, Kebriaei P, Champlin R, de Lima M. Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia: no evidence for increased transplant-related toxicity. Cancer 110(2):340-4, 2007. e-Pub 2007. PMID: 17559140.
- Ozdemir E, Saliba RM, Champlin RE, Couriel DR, Giralt SA, de Lima M, Khouri IF, Hosing C, Kornblau SM, Anderlini P, Shpall EJ, Qazilbash MH, Molldrem JJ, Chemaly RF, Komanduri KV. Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies. Bone Marrow Transplant 40(2):125-36, 2007. e-Pub 2007. PMID: 17530009.
- Ballen KK, Shpall EJ, Avigan D, Yeap BY, Fisher DC, McDermott K, Dey BR, Attar E, McAfee S, Konopleva M, Antin JH, Spitzer TR. Phase I trial of parathyroid hormone to facilitate stem cell mobilization. Biol Blood Marrow Transplant 13(7):838-843, 2007. e-Pub 2007. PMID: 17580262.
- Oran B, Donato M, Aleman A, Hosing C, Korbling M, Detry MA, Wei C, Anderlini P, Popat U, Shpall E, Giralt S, Champlin RE. Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment. Biol Blood Marrow Transplant 13(4):469-477, 2007. e-Pub 2007. PMID: 17382253.
- Shpall EJ, Zhang S, Willerson JT. Fusion of human hematopoietic progenitor cells and murine cardiomyocytes is mediated by alpha 4 beta 1 integrin/vascular cell adhesion molecule-1 interaction. Circulation Research 100(5):693-702, 2007. e-Pub 2007. PMID: 17303762.
- Safdar A, Rodriguez G, Rolston KV, O'Brien S, Khouri IF, Shpall EJ, Keating MJ, Kantarjian HM, Champlin RE, Raad II, Kontoyiannis DP. High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation. Bone Marrow Transplant 39(3):157-64, 2007. e-Pub 2007. PMID: 17245424.
- Madden T, de Lima M, Thapar N, Nguyen J, Roberson S, Couriel D, Pierre B, Shpall EJ, Jones RB, Champlin RE, Andersson BS. Pharmacokinetics of once-daily IV busulfan as part of pretransplantation preparative regimens: a comparison with an every 6-hour dosing schedule. Biol Blood Marrow Transplant 13(1):56-64, 2007. e-Pub 2007. PMID: 17222753.
- Wang S, Hong S, Yang J, Qian J, Zhang X, Shpall E, Kwak LW, Yi Q. Optimizing immunotherapy in multiple myeloma: Restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cells. Blood 108(13):4071-7, 2006. e-Pub 2006. PMID: 16917008.
- Lekakis L, Giralt S, Couriel D, Shpall EJ, Hosing C, Khouri IF, Anderlini P, Korbling M, Martin T, Champlin RE, de Lima M. Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies. Bone Marrow Transplant 38(6):421-6, 2006. e-Pub 2006. PMID: 16892072.
- Safdar A, Rodriguez GH, Lichtiger B, Dickey BF, Kontoyiannis DP, Freireich EJ, Shpall EJ, Raad, II, Kantarjian HM, Champlin RE. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions. Cancer 106(12):2664-71, 2006. e-Pub 2006. PMID: 16691620.
- Hosing C, Qazilbash MH, Kebriaei P, Giralt S, Davis MS, Popat U, Anderlini P, Shpall EJ, McMannis J, Korbling M, Champlin RE. Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma. Br J Haematol 133(5):533-7, 2006. e-Pub 2006. PMID: 16681642.
- Xing D, Decker WK, Li S, Robinson SN, Yang H, Segal H, O'Connor S, Yao X, Komanduri KV, McMannis JD, Jones RB, de Lima M, Champlin RE, Shpall EJ. AML-loaded DC generate Th1-type cellular immune responses in vitro. Cytotherapy 8(2):95-104, 2006. e-Pub 2006. PMID: 16698683.
- Parmar S, Robinson SN, Komanduri K, St John L, Decker W, Xing D, Yang H, McMannis J, Champlin R, de Lima M, Molldrem J, Rieber A, Bonyhadi M, Berenson R, Shpall EJ. Ex vivo expanded umbilical cord blood T cells maintain naive phenotype and TCR diversity. Cytotherapy 8(2):149-57, 2006. e-Pub 2006. PMID: 16698688.
- Couriel DR, Hosing C, Saliba R, Shpall EJ, Anderlini P, Rhodes B, Smith V, Khouri I, Giralt S, de Lima M, Hsu Y, Ghosh S, Neumann J, Andersson B, Qazilbash M, Hymes S, Kim S, Champlin R, Donato M. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood 107(8):3074-80, 2006. e-Pub 2006. PMID: 16368882.
- Decker WK, Xing D, Li S, Robinson SN, Yang H, Yao X, Segall H, McMannis JD, Komanduri KV, Champlin RE, Shpall EJ. Double loading of dendritic cell MHC class I and MHC class II with an AML antigen repertoire enhances correlates of T-cell immunity in vitro via amplification of T-cell help. Vaccine 24(16):3203-16, 2006. e-Pub 2006. PMID: 16480795.
- Yang H, Eaves C, de Lima M, Lee MS, Champlin RE, McMannis JD, Robinson SN, Niu T, Decker WK, Xing D, Ng J, Li S, Yao X, Eaves AC, Jones R, Andersson BS, Shpall EJ. A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts. Bone Marrow Transplant 37(6):575-82, 2006. e-Pub 2006. PMID: 16435011.
- Thall PF, Wooten LH, Shpall EJ. A Geometric Approach to Comparing Treatments for Rapidly Fatal Diseases. Biometrics 62(1):193-201, 2006. e-Pub 2006. PMID: 16542246.
- Robinson SN, Ng J, Niu T, Yang H, McMannis JD, Karandish S, Kaur I, Fu P, Del Angel M, Messinger R, Flagge F, de Lima M, Decker W, Xing D, Champlin R, Shpall EJ. Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells. Bone Marrow Transplant 37(4):359-66, 2006. e-Pub 2006. PMID: 16400333.
- Nieto Y, Patton N, Hawkins T, Spearing R, Bearman SI, Jones RB, Shpall EJ, Rabinovitch R, Zeng C, Baron A, McSweeney PA. Tacrolimus and mycophenolate mofetil after nonmyeloablative matched-sibling donor allogeneic stem-cell transplantations conditioned with fludarabine and low-dose total body irradiation. Biol Blood Marrow Transplant 12(2):217-25, 2006. e-Pub 2006. PMID: 16443519.
- Vredenburgh JJ, Coniglio D, Broadwater G, Jones RB, Ross M, Shpall EJ, Hussein A, Rizzieri D, Marks LB, Gilbert C, Affronti ML, Moore S, McDonald C, Petros WP, Peters WP. Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chemotherapy alone. Biol Blood Marrow Transplant 12(2):195-203, 2006. e-Pub 2006. PMID: 16443517.
- Gutman, J, Shpall, E, Nieto, Y, McSweeney, PA, McNiece, I. Long-term follow-up of patients with breast cancer transplanted with autologous ex vivo expanded peripheral blood progenitor cells. Cell Preservation Technology 4(1):4-8, 2006. e-Pub 2006.
- Peppercorn J, Herndon J, 2nd, Kornblith AB, Peters W, Ahles T, Vredenburgh J, Schwartz G, Shpall E, Hurd DD, Holland J, Winer E. Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066. Cancer 104(8):1580-9, 2005. e-Pub 2005. PMID: 16118805.
- Rosinski SL, McNiece IK, Shpall EJ, Clough N, Russell P, Blunk B, Nieto Y. Prognostic analysis of pre-transplant peripheral T-cell levels in patients receiving an autologous hematopoietic progenitor-cell transplant. Bone Marrow Transplant 36(5):425-30, 2005. e-Pub 2005. PMID: 15980880.
- Gutman JA, Bearman SI, Nieto Y, Sweetenham JW, Jones RB, Shpall EJ, Zeng C, Baron A, McSweeney PA. Autologous transplantation followed closely by reduced-intensity allogeneic transplantation as consolidative immunotherapy in advanced lymphoma patients: a feasibility study. Bone Marrow Transplant 36(5):443-51, 2005. e-Pub 2005. PMID: 15995712.
- Nieto Y, Shpall EJ, Bearman SI, Jones RB. Evaluation of the effect of age on treatment-related mortality and relapse in patients with high-risk primary breast cancer receiving high-dose chemotherapy. Am J Clin Oncol 28(3):248-54, 2005. e-Pub 2005. PMID: 15923796.
- Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, Shpall EJ, McCarthy P, Atkinson K, Cooper BW, Gerson SL, Laughlin MJ, Loberiza FR, Jr, Moseley AB, Bacigalupo A. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 11(5):389-98, 2005. e-Pub 2005. PMID: 15846293.
- Peters WP, Rosner GL, Vredenburgh JJ, Shpall EJ, Crump M, Richardson PG, Schuster MW, Marks LB, Cirrincione C, Norton L, Henderson IC, Schilsky RL, Hurd DD. Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13. J Clin Oncol 23(10):2191-200, 2005. e-Pub 2005. PMID: 15767638.
- Nieto Y, Shpall EJ, Bearman SI, McSweeney PA, Cagnoni PJ, Matthes S, Gustafson D, Long M, Baron AE, Jones RB. Phase I and pharmacokinetic study of docetaxel combined with melphalan and carboplatin, with autologous hematopoietic progenitor cell support, in patients with advanced refractory malignancies. Biol Blood Marrow Transplant 11(4):297-306, 2005. e-Pub 2005. PMID: 15812395.
- Khouri IF, Saliba RM, Hosing C, Okoroji GJ, Acholonu S, Anderlini P, Couriel D, De Lima M, Donato ML, Fayad L, Giralt S, Jones R, Korbling M, Maadani F, Manning JT, Pro B, Shpall E, Younes A, McLaughlin P, Champlin RE. Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas. J Clin Oncol 23(10):2240-7, 2005. e-Pub 2005. PMID: 15800314.
- Korbling M, Robinson S, Estrov Z, Champlin R, Shpall E. Umbilical cord blood-derived cells for tissue repair. Cytotherapy 7(3):258-61, 2005. e-Pub 2005. PMID: 16081352.
- Weinberg A, Enomoto L, Li S, Shen D, Coll J, Shpall EJ. Risk of transmission of herpesviruses through cord blood transplantation. Biol Blood Marrow Transplant 11(1):35-8, 2005. e-Pub 2005. PMID: 15625542.
- Robinson S, Niu T, de Lima M, Ng J, Yang H, McMannis J, Karandish S, Sadeghi T, Fu P, del Angel M, O'Connor S, Champlin R, Shpall E. Ex vivo expansion of umbilical cord blood. Cytotherapy 7(3):243-50, 2005. e-Pub 2005. PMID: 16081350.
- Cheng YC, Rondon G, Yang Y, Smith TL, Gajewski JL, Donato ML, Shpall EJ, Jones R, Hortobagyi GN, Champlin RE, Ueno NT. The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy. Biol Blood Marrow Transplant 10(11):794-804, 2004. e-Pub 2004. PMID: 15505610.
- Nieto Y, Vredenburgh JJ, Shpall EJ, Bearman SI, McSweeney PA, Chao N, Rizzieri D, Gasparetto C, Matthes S, Baron AE, Jones RB. Phase II feasibility and pharmacokinetic study of concurrent administration of trastuzumab and high-dose chemotherapy in advanced HER2+ breast cancer. Clin Cancer Res 10(21):7136-43, 2004. e-Pub 2004. PMID: 15534084.
- Nieto Y, Shpall EJ, McNiece IK, Nawaz S, Beaudet J, Rosinski S, Pellom J, Slat-Vasquez V, McSweeney PA, Bearman SI, Murphy J, Jones RB. Prognostic analysis of early lymphocyte recovery in patients with advanced breast cancer receiving high-dose chemotherapy with an autologous hematopoietic progenitor cell transplant. Clin Cancer Res 10(15):5076-86, 2004. e-Pub 2004. PMID: 15297410.
- de Lima M, Couriel D, Thall PF, Wang X, Madden T, Jones R, Shpall EJ, Shahjahan M, Pierre B, Giralt S, Korbling M, Russell JA, Champlin RE, Andersson BS. Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS. Blood 104(3):857-64, 2004. e-Pub 2004. PMID: 15073038.
- Stiff PJ, Shpall EJ, Liu PY, Wilczynski SP, Callander NS, Scudder SA, Jazieh AR, Samlowski W, McCoy J, Alberts DS. Randomized Phase II trial of two high-dose chemotherapy regimens with stem cell transplantation for the treatment of advanced ovarian cancer in first remission or chemosensitive relapse: a Southwest Oncology Group study. Gynecol Oncol 94(1):98-106, 2004. e-Pub 2004. PMID: 15262126.
- Nieto Y, Franklin WA, Jones RB, Berman SI, Pellom J, Baron AE, Shpall EJ. Prognostic significance of occult tumor cells in the apheresis products of patients with advanced breast cancer receiving high-dose chemotherapy and autologous hematopoietic progenitor cell support. Biol Blood Marrow Transplant 10(6):415-25, 2004. e-Pub 2004. PMID: 15148495.
- Nieto Y, Nawaz S, Shpall EJ, Bearman SI, Murphy J, Jones RB. Long-term analysis and prospective validation of a prognostic model for patients with high-risk primary breast cancer receiving high-dose chemotherapy. Clin Cancer Res 10(8):2609-17, 2004. e-Pub 2004. PMID: 15102662.
- Peled T, Mandel J, Goudsmid RN, Landor C, Hasson N, Harati D, Austin M, Hasson A, Fibach E, Shpall EJ, Nagler A. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine. Cytotherapy 6(4):344-55, 2004. e-Pub 2004. PMID: 16146887.
- McNiece I, Harrington J, Turney J, Kellner J, Shpall EJ. Ex vivo expansion of cord blood mononuclear cells on mesenchymal stem cells. Cytotherapy 6(4):311-7, 2004. e-Pub 2004. PMID: 16146883.
- Suratt BT, Cool CD, Serls AE, Chen L, Varella-Garcia M, Shpall EJ, Brown KK, Worthen GS. Human pulmonary chimerism after hematopoietic stem cell transplantation. Am J Respir Crit Care Med 168(3):318-22, 2003. e-Pub 2003. PMID: 12724127.
- Medeiros BC, Kolhouse JF, Cagnoni PJ, Ryder J, Nieto Y, Rabinovitch R, Shpall EJ, Bearman SI, Jones RB, McSweeney PA. Nonmyeloablative allogeneic hematopoietic stem cell transplantation for congenital sideroblastic anemia. Bone Marrow Transplant 31(11):1053-5, 2003. e-Pub 2003. PMID: 12774059.
- De Lima, M, Shpall, E. Cord blood transplantation. Current Opinion in Organ Transplantation 7(3):286-293, 2002. e-Pub 2002.
- Parikh, CR, McSweeney, PA, Korular, D, Ecder, T, Merouani, A, Taylor, J, Slat-Vasquez, V, Shpall, E, Jones, R, Bearman, SI, Schrier, RW. Renal dysfunction in allogeneic hematopoietic cell transplantation. Kidney International 62(2):566-573, 2002. e-Pub 2002. PMID: 12110019.
- McNiece IK, Almeida-Porada G, Shpall EJ, Zanjani E. Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential. Exp Hematol 30(6):612-6, 2002. e-Pub 2002. PMID: 12063029.
- Nieto Y, Nawaz S, Jones RB, Shpall EJ, Cagnoni PJ, McSweeney PA, Baron A, Razook C, Matthes S, Bearman SI. Prognostic model for relapse after high-dose chemotherapy with autologous stem-cell transplantation for stage IV oligometastatic breast cancer. J Clin Oncol 20(3):707-18, 2002. e-Pub 2002. PMID: 11821452.
- Hogan CJ, Shpall EJ, Keller G. Differential long-term and multilineage engraftment potential from subfractions of human CD34+ cord blood cells transplanted into NOD/SCID mice. Proc Natl Acad Sci U S A 99(1):413-8, 2002. e-Pub 2002. PMID: 11782553.
- Shpall EJ, Quinones R, Giller R, Zeng C, Baron AE, Jones RB, Bearman SI, Nieto Y, Freed B, Madinger N, Hogan CJ, Slat-Vasquez V, Russell P, Blunk B, Schissel D, Hild E, Malcolm J, Ward W, McNiece IK. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 8(7):368-76, 2002. e-Pub 2002. PMID: 12171483.
- Nieto Y, Bearman SI, Shpall EJ, Jones RB, Cagnoni PJ, Rabinovitch RA, McSweeney PA. Intensive chemotherapy for progressive chronic lymphocytic leukemia administered early after a nonmyeloablative allograft. Bone Marrow Transplant 28(11):1083-6, 2001. e-Pub 2001. PMID: 11781620.
- Shpall E, Adkins D, Appelbaum F, Keating A, LeMaistre CF, Mangen K, Smith F. American Society for Blood and Marrow Transplantation guidelines for training. Biol Blood Marrow Transplant 7(10):577, 2001. e-Pub 2001. PMID: 12659107.
- Howrey RP, Martin PL, Driscoll T, Szabolcs P, Kelly T, Shpall EJ, Bearman SI, Slat-Vasquez V, Rubinstein P, Stevens CE, Kurtzberg J. Graft-versus-leukemia-induced complete remission following unrelated umbilical cord blood transplantation for acute leukemia. Bone Marrow Transplant 26(11):1251-4, 2000. e-Pub 2000. PMID: 11149743.
- McNiece I, Jones R, Bearman SI, Cagnoni P, Nieto Y, Franklin W, Ryder J, Steele A, Stoltz J, Russell P, McDermitt J, Hogan C, Murphy J, Shpall EJ. Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood 96(9):3001-7, 2000. e-Pub 2000. PMID: 11049977.
- McNiece I, Kubegov D, Kerzic P, Shpall EJ, Gross S. Increased expansion and differentiation of cord blood products using a two-step expansion culture. Exp Hematol 28(10):1181-6, 2000. e-Pub 2000. PMID: 11027837.
- Nieto Y, Russ P, Everson G, Bearman SI, Cagnoni PJ, Jones RB, Shpall EJ. Acute pancreatitis during immunosuppression with tacrolimus following an allogeneic umbilical cord blood transplantation. Bone Marrow Transplant 26(1):109-11, 2000. e-Pub 2000. PMID: 10918414.
- Nieto Y, Cagnoni PJ, Nawaz S, Shpall EJ, Yerushalmi R, Cook B, Russell P, McDermit J, Murphy J, Bearman SI, Jones RB. Evaluation of the predictive value of Her-2/neu overexpression and p53 mutations in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplantation. J Clin Oncol 18(10):2070-80, 2000. e-Pub 2000. PMID: 10811672.
- Stiff P, Chen B, Franklin W, Oldenberg D, Hsi E, Bayer R, Shpall E, Douville J, Mandalam R, Malhotra D, Muller T, Armstrong RD, Smith A. Autologous transplantation of ex vivo expanded bone marrow cells grown from small aliquots after high-dose chemotherapy for breast cancer. Blood 95(6):2169-74, 2000. e-Pub 2000. PMID: 10706891.
- Shpall EJ, Quinones R, Giller R, Jones RB, Bearman SI, Nieto Y, McSweeney P, Cagnoni P, Baron A, Zeng C, Madinger N, Hogan C, Ward B, Slat-Vasquez V, Russell P, Blunk B, Solzan M, McNiece I. Transplantation of adult and pediatric cancer patients with cord blood progenitors expanded ex vivo. Blood (mtg abstract) 96(11):207a, 2000. e-Pub 2000.
- Nieto Y, Champlin RE, Wingard JR, Vredenburgh JF, Elias AD, Richardson P, Glaspy J, Jones RB, Stiff PJ, Bearman SI, Cagnoni PJ, McSweeney PA, LeMaistre CF, Pecora AL, Shpall EF. Status of high-dose chemotherapy for breast cancer: a review. Biol Blood Marrow Transplant 6(5):476-95, 2000. e-Pub 2000. PMID: 11063377.
- Warkentin PI, Nick L, Shpall EJ. FAHCT accreditation: common deficiencies during on-site inspections. Cytotherapy 2(3):213-20, 2000. e-Pub 2000. PMID: 12042044.
- Nieto Y, Cagnoni PJ, Bearman SI, Shpall EJ, Matthes S, Jones RB. Cardiac toxicity following high-dose cyclophosphamide, cisplatin, and BCNU (STAMP-I) for breast cancer. Biol Blood Marrow Transplant 6(2A):198-203, 2000. e-Pub 2000. PMID: 10816028.
- Nieto Y, Cagnoni PJ, Shpall EJ, Xu X, Murphy J, Vredenburgh J, Chao NJ, Bearman SI, Jones RB. A predictive model for relapse in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplant. Clin Cancer Res 5(11):3425-31, 1999. e-Pub 1999. PMID: 10589754.
- Rizzieri DA, Vredenburgh JJ, Jones R, Ross M, Shpall EJ, Hussein A, Broadwater G, Berry D, Petros WP, Gilbert C, Affronti ML, Coniglio D, Rubin P, Elkordy M, Long GD, Chao NJ, Peters WP. Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support. J Clin Oncol 17(10):3064-74, 1999. e-Pub 1999. PMID: 10506601.
- Johnson DW, Cagnoni PJ, Schossau TM, Stemmer SM, Grayeb DE, Baron AE, Shpall EJ, Bearman SI, McDermitt J, Jones RB. Optic disc and retinal microvasculopathy after high-dose chemotherapy and autologous hematopoietic progenitor cell support. Bone Marrow Transplant 24(7):785-92, 1999. e-Pub 1999. PMID: 10516683.
- Nieto Y, Shpall EJ. Autologous stem-cell transplantation for solid tumors in adults. Hematol Oncol Clin North Am 13(5):939-68, vi, 1999. e-Pub 1999. PMID: 10553256.
- Bearman SI, Vredenburgh J, Cagnoni P, Shpall E, Nieto Y, Ross M, Peters W, Jones R. High-dose therapy with autologous hematopoietic cell support as salvage treatment for patients with breast cancer who have relapsed after previous high-dose chemotherapy. Bone Marrow Transplant 24(5):491-5, 1999. e-Pub 1999. PMID: 10482932.
- Nieto Y, Cagnoni PJ, Shpall EJ, Matthes S, Baron A, Jones RB, Bearman SI. Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease. Clin Cancer Res 5(7):1731-7, 1999. e-Pub 1999. PMID: 10430076.
- Cagnoni PJ, Matthes S, Day TC, Bearman SI, Shpall EJ, Jones RB. Modification of the pharmacokinetics of high-dose cyclophosphamide and cisplatin by antiemetics. Bone Marrow Transplant 24(1):1-4, 1999. e-Pub 1999. PMID: 10435726.
- Franklin WA, Glaspy J, Pflaumer SM, Jones RB, Hami L, Martinez C, Murphy JR, Shpall EJ. Incidence of tumor-cell contamination in leukapheresis products of breast cancer patients mobilized with stem cell factor and granulocyte colony-stimulating factor (G-CSF) or with G-CSF alone. Blood 94(1):340-7, 1999. e-Pub 1999. PMID: 10381531.
- Nieto Y, Ross M, Gianani R, Shpall EJ, Cagnoni PJ, Bearman SI, Jones RB. Post-mortem incidental finding of cytomegalovirus oophoritis after an allogeneic stem cell transplant. Bone Marrow Transplant 23(12):1323-4, 1999. e-Pub 1999. PMID: 10414924.
- Shpall EJ. The utilization of cytokines in stem cell mobilization strategies. Bone Marrow Transplant 23 Suppl 2:S13-9, 1999. e-Pub 1999. PMID: 10335872.
- Shpall EJ, Wheeler CA, Turner SA, Yanovich S, Brown RA, Pecora AL, Shea TC, Mangan KF, Williams SF, LeMaistre CF, Long GD, Jones R, Davis MW, Murphy-Filkins R, Parker WR, Glaspy JA. A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients. Blood 93(8):2491-501, 1999. e-Pub 1999. PMID: 10194427.
- Nieto Y, Xu X, Cagnoni PJ, Matthes S, Shpall EJ, Bearman SI, Murphy J, Jones RB. Nonpredictable pharmacokinetic behavior of high-dose cyclophosphamide in combination with cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea. Clin Cancer Res 5(4):747-51, 1999. e-Pub 1999. PMID: 10213208.
- McNiece I, Jones R, Cagnoni P, Bearman S, Nieto Y, Shpall EJ. Ex-vivo expansion of hematopoietic progenitor cells: preliminary results in breast cancer. Hematol Cell Ther 41(2):82-6, 1999. e-Pub 1999. PMID: 10344558.
- Bachier CR, Gokmen E, Teale J, Lanzkron S, Childs C, Franklin W, Shpall E, Douville J, Weber S, Muller T, Armstrong D, LeMaistre CF. Ex-vivo expansion of bone marrow progenitor cells for hematopoietic reconstitution following high-dose chemotherapy for breast cancer. Exp Hematol 27(4):615-23, 1999. e-Pub 1999. PMID: 10210319.
- Shpall EJ, Jones RB, Bearman SI, Cagnoni PJ, Nieto Y, McNiece IK. Peripheral blood stem cell transplantation in breast cancer. Baillieres Best Pract Res Clin Haematol 12(1-2):219-32, 1999. e-Pub 1999. PMID: 11000995.
- Nieto Y, Cagnoni PJ, Bearman SI, Shpall EJ, Matthes S, DeBoom T, Baron A, Jones RB. Acute encephalopathy: a new toxicity associated with high-dose paclitaxel. Clin Cancer Res 5(3):501-6, 1999. e-Pub 1999. PMID: 10100699.
- Nieto Y, Ross M, Gianani RCagnoni PJ, Shpall EJ, Bearman SI, Jones RB. Isolated cytomegalovirus oophoritis after allogeneic peripheral blood progenitor cell transplant. Bone Marrow Transplant 23:1323-1324, 1999. e-Pub 1999.
- Berenson RJ, Heimfeld S, Auditore-Hargreaves K, Krieger M, Jacobs C, Shpall EJ. Hematopoietic stem cell transplantation. J Hematotherapy, 1999. e-Pub 1999.
- Banda NK, Simon GR, Sipple JD, Terrell KL, Archer P, Shpall EJ, Akkina RK, Myers AM, Harrison GS. Depletion of CD34+ CD4+ cells in bone marrow from HIV-1-infected individuals. Biol Blood Marrow Transplant 5(3):162-72, 1999. e-Pub 1999. PMID: 10392962.
- McNiece, I, Jones, R, Bearman, SI, Cagnoni, P, Nieto, Y, Shpall, E. Ex Vivo Expansion of Hematopoietic Cells. Keio Journal of Medicine 48:A32-A36, 1999. e-Pub 1999.
- Gladstone, DE, Bedi, A, Miller, C, Noga, SJ, Griffin, C, Piantadosi, S, Cagnoni, P, Brodsky, RA, Smith, BD, Douglas, TT, Shpall, E, JONES, RJ. Philadelphia chromosome-negative engraftment after autologous transplantation with granulocyte-macrophage colony-stimulating factor for chronic myeloid leukemia. Biology of Blood and Marrow Transplantation 5(6):394-399, 1999. e-Pub 1999. PMID: 10595817.
- Banda NK, Akkina RK, Terrell K, Shpall EJ, Tomczak J, Campain J, Claman H, Cagle L, Harrison GS. Diphtheria toxin A gene-mediated HIV-1 protection of cord blood-derived T cells in the SCID-hu mouse model. J Hematother 7(4):319-31, 1998. e-Pub 1998. PMID: 9735863.
- Cagnoni PJ, Nieto Y, Shpall EJ, Bearman SI, Baron AE, Ross M, Matthes S, Dunbar SE, Jones RB. High-dose chemotherapy with autologous hematopoietic progenitor-cell support as part of combined modality therapy in patients with inflammatory breast cancer. J Clin Oncol 16(5):1661-8, 1998. e-Pub 1998. PMID: 9586876.
- Pugh RE, Bitter MA, Shpall EJ, Hami LS, Wolf DM, Franklin WA. CD19 selection improves the sensitivity of B cell lymphoma detection. J Hematother 7(2):159-68, 1998. e-Pub 1998. PMID: 9597573.
- Hayward A, Ambruso D, Battaglia F, Donlon T, Eddelman K, Giller R, Hobbins J, Hsia YE, Quinones R, Shpall E, Trachtenberg E, Giardina P. Microchimerism and tolerance following intrauterine transplantation and transfusion for alpha-thalassemia-1. Fetal Diagn Ther 13(1):8-14, 1998. e-Pub 1998. PMID: 9605609.
- Glick HA, Shpall EJ, LeMaistre CF, McCarron TJ, Lu ZJ, Erder MH, Glaspy JA. Empirical criteria for the selection of quality-of-life instruments for the evaluation of peripheral blood progenitor cell transplantation. Int J Technol Assess Health Care 14(3):419-30, 1998. e-Pub 1998. PMID: 9780529.
- Shpall EJ, Champlin R, Glaspy JA. Effect of CD34+ peripheral blood progenitor cell dose on hematopoietic recovery. Biol Blood Marrow Transplant 4(2):84-92, 1998. e-Pub 1998. PMID: 9763111.
- Shpall EJ, LeMaistre CF, Holland K, Ball E, Jones RB, Saral R, Jacobs C, Heimfeld S, Berenson R, Champlin R. A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy. Blood 90(11):4313-20, 1997. e-Pub 1997. PMID: 9373242.
- Bearman SI, Overmoyer BA, Bolwell BJ, Taylor CW, Shpall EJ, Cagnoni PJ, Mechling BE, Ronk B, Baron AE, Purdy MH, Ross M, Jones RB. High-dose chemotherapy with autologous peripheral blood progenitor cell support for primary breast cancer in patients with 4-9 involved axillary lymph nodes. Bone Marrow Transplant 20(11):931-7, 1997. e-Pub 1997. PMID: 9422471.
- Hogan CJ, Shpall EJ, McNiece I, Keller G. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells. Biol Blood Marrow Transplant 3(5):236-46, 1997. e-Pub 1997. PMID: 9450918.
- Glaspy JA, Shpall EJ, LeMaistre CF, Briddell RA, Menchaca DM, Turner SA, Lill M, Chap L, Jones R, Wiers MD, Sheridan WP, McNiece IK. Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients. Blood 90(8):2939-51, 1997. e-Pub 1997. PMID: 9376574.
- Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood. Exp Hematol 25(11):1125-39, 1997. e-Pub 1997. PMID: 9328449.
- Shpall EJ. Foundation for the Accreditation of Hematopoietic Cell Therapy (FAHCT) response to FDA (Docket no. 97N-0068). FAHCT Board of Directors. J Hematother 6(4):287-9, 1997. e-Pub 1997. PMID: 9377066.
- Hogan CJ, Shpall EJ, McNulty O, McNiece I, Dick JE, Shultz LD, Keller G. Engraftment and development of human CD34(+)-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice. Blood 90(1):85-96, 1997. e-Pub 1997. PMID: 9207442.
- Banda NK, Tomczak JA, Shpall EJ, Sipple J, Akkina RK, Steimer KS, Hami L, Curiel TJ, Singer Harrison G. HIV-gp120 induced cell death in hematopoietic progenitor CD34+ cells. Apoptosis 2(1):61-8, 1997. e-Pub 1997. PMID: 14646565.
- Nieto Y, Cagnoni PJ, Shpall EJ, Bearman SI, Ross M, Sedlacek S, Jones RB. High-dose chemotherapy (HDC) with autologous stem cell transplant (ASCT) for inflammatory breast cancer. Breast Cancer Res Treat 46(1):72, 1997. e-Pub 1997.
- Gehline, UM, Ryder, J, Hogan, C, McNiece, I, Franklin, W, Shpall, E. Ex vivo expansion of megakaryocyte (MK) progenitors. Infusionstherapie und Transfusionsmedizin 24(4):243, 1997. e-Pub 1997.
- Cagnoni PJ, Shpall EJ, Bearman SI, Matthes S, Ross M, Taffs S, Jones RB. Paclitaxel-containing high-dose chemotherapy: the University of Colorado experience. Semin Oncol 23(6 Suppl 15):43-8, 1996. e-Pub 1996. PMID: 8996598.
- Merouani A, Shpall EJ, Jones RB, Archer PG, Schrier RW. Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer. Kidney Int 50(3):1026-31, 1996. e-Pub 1996. PMID: 8872980.
- Cagnoni PJ, Shpall EJ, Bearman SI, Ross M, Jones RB. High-dose chemotherapy with AHPCS for the treatment of breast cancer. The University of Colorado results. Bone Marrow Transplant 18 Suppl 1(SUPPL. 1):S26-9, 1996. e-Pub 1996. PMID: 8899166.
- Cagnoni PJ, Jones RB, Bearman SI, Ross M, Hami L, Franklin WA, Capizzi R, Schein PS, Shpall EJ. Use of amifostine in bone marrow purging. Semin Oncol 23(4 Suppl 8):44-8, 1996. e-Pub 1996. PMID: 8783666.
- Stemmer SM, Cagnoni PJ, Shpall EJ, Bearman SI, Matthes S, Dufton C, Day T, Taffs S, Hami L, Martinez C, Purdy MH, Arron J, Jones RB. High-dose paclitaxel, cyclophosphamide, and cisplatin with autologous hematopoietic progenitor-cell support: a phase I trial. J Clin Oncol 14(5):1463-72, 1996. e-Pub 1996. PMID: 8622060.
- Shpall EJ, Gee AP, Hogan C, Cagnoni P, Gehling U, Hami L, Franklin W, Bearman SI, Ross M, Jones RB. Bone marrow metastases. Hematol Oncol Clin North Am 10(2):321-43, 1996. e-Pub 1996. PMID: 8707758.
- Conneally E, Bardy P, Eaves CJ, Thomas T, Chappel S, Shpall EJ, Humphries RK. Rapid and efficient selection of human hematopoietic cells expressing murine heat-stable antigen as an indicator of retroviral-mediated gene transfer. Blood 87(2):456-64, 1996. e-Pub 1996. PMID: 8555466.
- Emerman JT, Stingl J, Petersen A, Shpall EJ, Eaves CJ. Selective growth of freshly isolated human breast epithelial cells cultured at low concentrations in the presence or absence of bone marrow cells. Breast Cancer Res Treat 41(2):147-59, 1996. e-Pub 1996. PMID: 8944333.
- Hussein AM, Petros WP, Ross M, Vredenburgh JJ, Affrontil ML, Jones RB, Shpall EJ, Rubin P, Elkordy M, Gilbert C, Gupton C, Egorin MJ, Soper J, Berchuck A, Clarke-Person D, Berry DA, Peters WP. A phase I/II study of high-dose cyclophosphamide, cisplatin, and thioTEPA followed by autologous bone marrow and granulocyte colony-stimulating factor-primed peripheral-blood progenitor cells in patients with advanced malignancies. Cancer Chemother Pharmacol 37(6):561-8, 1996. e-Pub 1996. PMID: 8612310.
- Shpall EJ. Peripheral blood progenitor cells harvesting. Hematopoietic Therapy Index & Reviews 3(2), 1996. e-Pub 1996.
- Franklin WA, Shpall EJ, Archer P, Johnston CS, Garza-Williams S, Hami L, Bitter MA, Bast RC, Jones RB. Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support. Breast Cancer Res Treat 41(1):1-13, 1996. e-Pub 1996. PMID: 8932871.
- Pugh RE, Bitter MA, Kami L, Shpall EJ, Franklin W. CD19 column preselection increases sensitivity of lymphoma cell detection by pcr for the t(14;18) breakpoint. FASEB Journal 10(6):A1132, 1996. e-Pub 1996.
- Purdy, MH, Hogan, C, Hami, L, McNiece, I, Franklin, W, Jones, R, Bearman, SI, Berenson, R, Cagnoni, P, Heimfeld, S, Shpall, E. Large Volume Ex Vivo Expansion of CD34-Positive Hematopoietic Progenitor Cells for Transplantation. Journal of Hematotherapy and Stem Cell Research 4(6):515-525, 1995. e-Pub 1995. PMID: 8846011.
- Harrison GS, Wang Y, Tomczak J, Hogan C, Shpall EJ, Curiel TJ, Felgner PL. Optimization of gene transfer using cationic lipids in cell lines and primary human CD4+ and CD34+ hematopoietic cells. Biotechniques 19(5):816-23, 1995. e-Pub 1995. PMID: 8588922.
- Appelbaum F, Fay J, Herzig G, Kersey J, Parkman R, Petersdorf E, Przepiorka D, Saral R, Shpall E, Wolf J. American Society for Blood and Marrow Transplantation guidelines for training. Biol Blood Marrow Transplant 1(1):56, 1995. e-Pub 1995. PMID: 9118292.
- Schrier DM, Stemmer SM, Johnson T, Kasliwal R, Lear J, Matthes S, Taffs S, Dufton C, Glenn S, Butchko G, Ceriani R, Rovira D, Bunn P, Shpall EJ, Bearman SI, Purdy M, Cagnoni P, Jones RB. High-dose 90Y Mx-DTPA-BrE-3 and autologous hematopoietic stem cell support (AHSCS) for the treatment of advanced breast cancer: A Phase I Trial. Cancer Research (Suppl) 55(23):5921-24s, 1995. e-Pub 1995.
- Schrier, DM, Stemmer, SM, Johnson, T, Kasliwal, R, Lear, J, Matthes, S, Taffs, S, Dufton, C, Glenn, SD, Butchko, G, Ceriani, RL, Rovira, D, Bunn, P, Shpall, E, Bearman, SI, Purdy, MH, Cagnoni, P, Jones, R. High-dose 90Y Mx-diethylenetriaminepentaacetic acid (DTPA)-BrE-3 and autologous hematopoietic stem cell support (AHSCS) for the treatment of advanced breast cancer. Cancer Research 55(23 SUPPL):5921S-5924S, 1995. e-Pub 1995. PMID: 7493371.
- Berenson, R, Heimfeld, S, Auditore-Hargreaves, K, Krieger, M, Jacobs, C, Shpall, E. Hematopoietic stem cell transplantation. Bone marrow transplantation 15(SUPPL. 1):S21-S27, 1995. e-Pub 1995.
- Shpall EJ, Gehling U, Cagnoni P, Purdy M, Hami L, Gee AP. Isolation of CD34-positive hematopoietic progenitor cells. Immunomethods 5(3):197-203, 1994. e-Pub 1994. PMID: 7540099.
- Shpall EJ, Jones RB, Bearman SI, Purdy MP. Future strategies for the treatment of advanced epithelial ovarian cancer using high-dose chemotherapy and autologous bone marrow support. Gynecol Oncol 54(3):357-61, 1994. e-Pub 1994. PMID: 8088613.
- Bitter MA, Fiorito D, Corkill ME, Huffer WE, Stemmer SM, Shpall EJ, Archer PG, Franklin WA. Bone marrow involvement by lobular carcinoma of the breast cannot be identified reliably by routine histological examination alone. Hum Pathol 25(8):781-8, 1994. e-Pub 1994. PMID: 7520018.
- Purdy MH, Shpall EJ. The role and methodology for purging tumor from autologous bone marrow and peripheral blood progenitor cells. Med Oncol 11(2):47-51, 1994. e-Pub 1994. PMID: 7531586.
- Shpall EJ, Stemmer SM, Hami L, Franklin WA, Shaw L, Bonner HS, Bearman SI, Peters WP, Bast RC, Jr, McCulloch W, al E. Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow support. Blood 83(11):3132-7, 1994. e-Pub 1994. PMID: 8193351.
- Shpall EJ, Jones RB, Bearman SI, Franklin WA, Archer PG, Curiel T, Bitter M, Claman HN, Stemmer SM, Purdy M, al E. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 12(1):28-36, 1994. e-Pub 1994. PMID: 7505806.
- Shpall EJ, Jones RB, Bearman SI, Purdy MH, Franklin WA, Heimfeld S, Berenson RJ. Transplantation of CD34+ hematopoietic progenitor cells: Implications for removal of tumor cells. . Hematology/Oncology Annals 2(1):78-84, 1994. e-Pub 1994.
- Shpall EJ, Jones RB, Bearman SI, Purdy MH, Franklin WA, Heimfeld S, Berenson RJ. Transplantation of CD34+ hematopoietic progenitor cells. J Hematother 3(2):145-7, 1994. e-Pub 1994. PMID: 7522899.
- Shpall EJ, Franklin WA, Jones RB, Bearman SI, Purdy MH, Cagnoni P, Heimfeld S, Berenson RJ. Transplantation of CD34 positive (+) marrow and/or peripheral blood progenitor cells (PBPCS) into breast cancer patients following high- dose chemotherapy. Blood 84(10):396a, 1994. e-Pub 1994.
- Petsche D, Hami L, Purdy M, Myers S, Hogan C, Messner H, Briddell R, Heimfeld S, Berenson R, Shpall E. Comparative assays of megakaryocyte progenitors in CD34+ peripheral blood progenitor cell fractions. Prog Clin Biol Res 389:415-20, 1994. e-Pub 1994. PMID: 7535450.
- Morstyn G, Glaspy J, Shpall EJ, LeMaistre F, Briddell R, Menchaca D, Lill M, Jones RB, Tami J, Brown S, Yan XQ, McNiece I. Clinical applications of filgrastim and stem cell factor in vivo and in vitro. J Hematother 3(4):353-5, 1994. e-Pub 1994. PMID: 7537611.
- Jones, R, Shpall, E. Response to Editorial Reply. Journal of Hematotherapy and Stem Cell Research 3(4):251, 1994. e-Pub 1994.
- Bearman, SI, Jones, R, Shpall, E, Stemmer, SM, Purdy, MH, Myers, SE. New approaches in progenitor cell-supported chemotherapy for stage IV breast cancer. Bone marrow transplantation 14(SUPPL. 1):S28, 1994. e-Pub 1994.
- Shpall, E. ABMT using high dose cyclophosphamide, cisplatin, BCNU (CPA/cDDP/BCNU) for patients with high risk breast cancer. Bone marrow transplantation 14(SUPPL. 2):S19, 1994. e-Pub 1994.
- Berenson, R, Heimfeld, S, Auditore-Hargreaves, K, Krieger, M, Jacobs, C, Shpall, E. Hematopoietic stem cells transplantation. Bone marrow transplantation 14(SUPPL. 1):S8-S9, 1994. e-Pub 1994.
- Shpall, E, Jones, R, Bearman, SI, Purdy, MH, Franklin, W, Heimfeld, S, Berenson, R. Transplantation of CD34+ marrow and/or PBPCS into breast cancer patients following high-dose chemotherapy. Bone marrow transplantation 14(SUPPL. 2):S12, 1994. e-Pub 1994.
- Shpall EJ, Jones RB, Bearman SI, Stemmer SM, Purdy MH, Heimfeld S, Berenson RJ. Positive selection of CD34+ hematopoietic progenitor cells for transplantation. Stem Cells 11 Suppl 3(3 S):48-9, 1993. e-Pub 1993. PMID: 7507756.
- Meisenberg BR, Ross M, Vredenburgh JJ, Jones R, Shpall EJ, Seigler HF, Coniglio DM, Wu K, Peters WP. Randomized trial of high-dose chemotherapy with autologous bone marrow support as adjuvant therapy for high-risk, multi-node-positive malignant melanoma. J Natl Cancer Inst 85(13):1080-5, 1993. e-Pub 1993. PMID: 8515495.
- Peters WP, Ross M, Vredenburgh JJ, Meisenberg B, Marks LB, Winer E, Kurtzberg J, Bast RC, Jr, Jones R, Shpall E. High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol 11(6):1132-43, 1993. e-Pub 1993. PMID: 8501500.
- Jones RB, Matthes S, Shpall EJ, Fisher JH, Stemmer SM, Dufton C, Stephens JK, Bearman SI. Acute lung injury following treatment with high-dose cyclophosphamide, cisplatin, and carmustine: pharmacodynamic evaluation of carmustine. J Natl Cancer Inst 85(8):640-7, 1993. e-Pub 1993. PMID: 8468721.
- Shpall EJ, Jones RB, Bearman S, Franklin WA, Stemmer S, Archer PA. Transplantation of autologous CD34+ hematopoietic progenitor cells into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral blood progenitors and growth factors on engraftment. J Clin Oncol 12:28-36, 1993. e-Pub 1993.
- Jones RB, Matthes S, Dufton C, Bearman SI, Stemmer SM, Meyers S, Shpall EJ. Pharmacokinetic/pharmacodynamic interactions of intensive cyclophosphamide, cisplatin, and BCNU in patients with breast cancer. Breast Cancer Res Treat 26 Suppl(1):S11-7, 1993. e-Pub 1993. PMID: 8400329.
- Shpall EJ, Stemmer SM, Bearman SI, Myers S, Purdy M, Jones RB. New strategies in marrow purging for breast cancer patients receiving high-dose chemotherapy with autologous bone marrow transplantation. Breast Cancer Res Treat 26 Suppl(1):S19-23, 1993. e-Pub 1993. PMID: 7691269.
- Berenson, R, Heimfeld, S, Hallagan, J, Jones, R, Shpall, E. Human Stem Cell Transplantation. Journal of Hematotherapy and Stem Cell Research 2(1):114-116, 1993. e-Pub 1993.
- Vandemark RM, Shpall EJ, Affronti ML. Bone metastases from breast cancer: value of CT bone windows. J Comput Assist Tomogr 16(4):608-14, 1992. e-Pub 1992. PMID: 1629422.
- Shpall EJ, Jones RB, Johnston C. Purified cd34-positive (+) marrow progenitor cells provide effective reconstitution for breast cancer (ca) and non-Hodgkin’s lymphoma (nhl) patients receiving high dose chemotherapy with autologous bone marrow support (hdc/abms): recombinant granulocyte colony stimulating factor (g-csf) accelerates hematopoietic recovery. Proc Amer Soc Clin Oncol 11:A61, 1992. e-Pub 1992.
- Shpall EJ, Stemmer SM, Johnston CF, Hami L, Bearman SI, Berenson R, Jones RB. Purging of autologous bone marrow for transplantation: the protection and selection of the hematopoietic progenitor cell. J Hematother 1(1):45-54, 1992. e-Pub 1992. PMID: 1365017.
- Shpall EJ. New developments in bone marrow purging strategy: The protection and selection of the Hematopoietic progenitor cell. Intl Autologous Bone Marrow Transplant Registry Reviews 5:7-9, 1992. e-Pub 1992.
- Hami LS, Shpall EJ, Johnston CS, Berenson R, Jones RB. The effect of PIXY-321 on 4-hydroperoxycyclophosphamide purged and CD34+ positively selected bone marrow. Prog Clin Biol Res 377:321-5, 1992. e-Pub 1992. PMID: 1279709.
- Antman K, Corringham R, De Vries E, Elfenbein G, Gianni AM, Gisselbrecht C, Herzig R, Juttner C, Kaizer H, Kennedy MJ, Kessinger A, Kotasek D, Lazarus H, Ljungman P, Maraninchi D, Nabholtz J, Niederwieser D, Ogawa M, Patrone F, Peters W, Rosti G, Rouesse J, Schilcher R, Selby G, Shea T, Shpall E, Spitzer G, Sweet D, Tajima T, Vaughan W, Williams S, Wolff S. Dose-intensive therapy in breast cancer. Bone Marrow Transplantation: Current Controversies 10:67-73, 1992. e-Pub 1992.
- Johnston CS, Shpall EJ, Williams S, Hami L, Jones RB, Bast RC, Ceriani RL, Franklin W. Detection of minimal residual breast cancer in bone marrow. Prog Clin Biol Res 377:637-42, 1992. e-Pub 1992. PMID: 1438446.
- Lidor YJ, Shpall EJ, Peters WP, Bast RC, Jr. Synergistic cytotoxicity of different alkylating agents for epithelial ovarian cancer. Int J Cancer 49(5):704-10, 1991. e-Pub 1991. PMID: 1937956.
- Kanj SS, Sharara AI, Shpall EJ, Jones RB, Peters WP. Myocardial ischemia associated with high-dose carmustine infusion. Cancer 68(9):1910-2, 1991. e-Pub 1991. PMID: 1655228.
- O'Briant KC, Shpall EJ, Houston LL, Peters WP, Bast RC, Jr. Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclophosphamide, monoclonal antibodies, and magnetic microspheres. Cancer 68(6):1272-8, 1991. e-Pub 1991. PMID: 1873781.
- Shpall EJ, Bast RC, Jr, Joines WT, Jones RB, Anderson I, Johnston C, Eggleston S, Tepperberg M, Edwards S, Peters WP. Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation. Bone Marrow Transplant 7(2):145-51, 1991. e-Pub 1991. PMID: 2049558.
- Shpall EJ, Jones RB, Bast RC, Jr, Rosner GL, Vandermark R, Ross M, Affronti ML, Johnston C, Eggleston S, Tepperburg M, al E. 4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial. J Clin Oncol 9(1):85-93, 1991. e-Pub 1991. PMID: 1985173.
- Shpall EJ, Jones RB, Johnston C. Amifostine (WR-2721) shortens recovery of bone purged with 4-HC in breast cancer patients receiving intensive chemotherapy with an autologous bone marrow transplant (ABMT). Blood 78:192a, 1991. e-Pub 1991.
- Shpall EJ, Jones RB, Johnston C, Hami L, Morgan MJ, Stemmer S, Bunn P, Shaw L, McCulloch W, Schein P. WR-2721 (Amifostine) shortens the engraftment period of 4- hydroperoxycyclophosphamide (4-HC) purged bone marrow patients receiving high-dose chemotherapy with autologous bone marrow support (ABMS). Blood 78:192a, 1991. e-Pub 1991.
- Shpall EJ, Clarke-Pearson D, Soper JT, Berchuck A, Jones RB, Bast RC, Jr, Ross M, Lidor Y, Vanacek K, Tyler T, Peters WP. High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer. Gynecol Oncol 38(3):386-91, 1990. e-Pub 1990. PMID: 2121627.
- Jones RB, Shpall EJ, Shogan J, Affronti ML, Coniglio D, Hart L, Halperin E, Iglehart JD, Moore J, Gockerman J, al E. The Duke AFM Program. Intensive induction chemotherapy for metastatic breast cancer. Cancer 66(3):431-6, 1990. e-Pub 1990. PMID: 2364358.
- Leslie DS, Johnston WW, Daly L, Ring DB, Shpall EJ, Peters WP, Bast RC, Jr. Detection of breast carcinoma cells in human bone marrow using fluorescence-activated cell sorting and conventional cytology. Am J Clin Pathol 94(1):8-13, 1990. e-Pub 1990. PMID: 2193508.
- Jones RB, Shpall EJ, Ross M, Coniglio D, Affronti ML, Peters WP. High-dose carboplatin, cyclophosphamide, and BCNU with autologous bone marrow support: excessive hepatic toxicity. Cancer Chemother Pharmacol 26(2):155-6, 1990. e-Pub 1990. PMID: 2189592.
- Peters WP, Kurtzberg J, Atwater S, Borowitz M, Rao M, Currie M, Gilbert C, Shpall EJ, Jones RB, Ross M. The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation. Prog Clin Biol Res 338:121-8, 1990. e-Pub 1990. PMID: 2189135.
- Shpall EJ, Jones RB, Johnston C, Schein P, Peters WP, Seigler H. Purging of breast cancer cells from bone marrow using WR2721 and 4- hydroperoxycyclophosphamide (meeting abstract). Proc Annual meeting Amer Assoc Cancer Research 31:A1994, 1990. e-Pub 1990.
- Shpall EJ, Anderson IC, Bast RC, Jr, Joines WT, Jones RB, Ross M, Edwards S, Eggleston S, Johnston C, Tepperberg M, al E. Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantation. Prog Clin Biol Res 333(321-35):discussion 336, 1990. e-Pub 1990. PMID: 2308989.
- Shpall EJ, Bast RC, Joines W, Jones RB, Ross M, Johnston C, Eggleston S, Tepperberg M, Peters WP. Immunopharmacologic Bone Marrow Purging in Metastatic Breast Cancer (CA) patients (pts) Receiving High-Dose Chemotherapy with Autologous Marrow Support (meeting abstract). . Proc Annual Mtg Amer Soc Clin. Oncol 9:A29, 1990. e-Pub 1990.
- Anderson IC, Shpall EJ, Leslie DS, Nustad K, Ugelstad J, Peters WP, Bast RC, Jr. Elimination of malignant clonogenic breast cancer cells from human bone marrow. Cancer Res 49(16):4659-64, 1989. e-Pub 1989. PMID: 2663144.
- Peters WP, Stuart A, Klotman M, Gilbert C, Jones RB, Shpall EJ, Gockerman J, Bast RC, Jr, Moore JO. High-dose combination cyclophosphamide, cisplatin, and melphalan with autologous bone marrow support. A clinical and pharmacologic study. Cancer Chemother Pharmacol 23(6):377-83, 1989. e-Pub 1989. PMID: 2653660.
- Peters WP, Atwater S, Kurtzberg J, Borowitz M, Brandt SJ, Coleman RE, Kim CS, Gilber C, Shpall EJ, Jones RB, Shogan J, Oette D, Stuart A, Coniglio D, Affronti ML, Evans S. The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation. Bone Marrow Transplantation: Current Controversies:595-606, 1989. e-Pub 1989.
- Shpall EJ, Bast RC, Joines W, Jones R, Edwards S, Eggleston S, Johnston C, Peters WP. Large-scale Immunopharmacologic purging of clonogenic cancer cells from bone marrow for autologous bone marrow transplantation (ABMT). Proc Amer Assoc. Cancer Research 30:35, 1989. e-Pub 1989.
- Peters WP, Kurtzberg J, Rao M, Atwater S, Coleman RE, Jones RB, Shpall EJ, Ross M, Affronti ML, Gilbert C, Garnick M. Effects of recombinant human macrophage colony stimulating factor (rHuM-CSF) on hematopoiesis following high-dose chemotherapy (HDC) and autologous bone marrow support (ABMS). Blood 74:269-70, 1989. e-Pub 1989.
- Peters WP, Shpall EJ, Jones RB, Olsen GA, Bast RC, Gockerman JP, Moore JO. High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol 6(9):1368-76, 1988. e-Pub 1988. PMID: 3047332.
- Brandt SJ, Peters WP, Atwater SK, Kurtzberg J, Borowitz MJ, Jones RB, Shpall EJ, Bast RC, Jr, Gilbert CJ, Oette DH. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med 318(14):869-76, 1988. e-Pub 1988. PMID: 3281007.
- Shpall EJ, Jones RB, Holland JF, Bhardwaj S, Paciucci PA, Wilfinger CL, Strashun A. Intensive single-agent mitoxantrone for metastatic breast cancer. J Natl Cancer Inst 80(3):204-8, 1988. e-Pub 1988. PMID: 3279218.
- Shpall E, Jones R, Egorin M, Gockerman J, Moore J, Bast R, Olsen G, Coniglio D, Brophy L, Walsh B, Peters W. A phase I trial of high dose combination cyclophosphamide (C), cisplatin (P) and thiotepa (T), with autologous bone marrow support (ABMS) in the treatment of resistant solid tumors. Proc Amer Soc Clin Oncol 6:139, 1987. e-Pub 1987.
- Shpall EJ, Holland JF. Update on understanding the causes of cancer. Compr Ther 12(8):9-14, 1986. e-Pub 1986. PMID: 3742998.
- Shpall EJ, Efremidis AP, Kasambalides E, Sedlin E, Hermann G. Case report 352: Osteonecrosis of the femoral shaft (probably steroid-induced). Skeletal Radiol 15(2):170-4, 1986. e-Pub 1986. PMID: 3961525.
- Shpall EJ, Efremidis AP, Kasmbalides E, Sedlin E, Hermann G. Osteonecrosis of the femoral head. Skeletal Radiol 15(2):170-4, 1986. e-Pub 1986.
Invited Articles
- Ueno NT, Shpall EJ, Champlin RE, Jones RB. raft-vs-Breast Cancer Effect by Allogeneic Hematopoietic Stem Cell Transplantation: A Possible New Frontier. Journal of Clinical Oncology, 2004. e-Pub 2004.
- de Lima M, Shpall EJ. Cord Blood Transplantation. Curr Opin Organ Transplant 7:186-293, 2002. e-Pub 2002.
- Shpall EJ, Gee A, Cagnoni PJ, Hogan C, Gehling U, Hami L, Franklin W, Bearman SI, Ross M, Jones RB. Stem cell isolation. Curr Opin Hematol 2(6):452-9, 1995. e-Pub 1995. PMID: 9372035.
- Auditore-Hargreaves K, Heimfeld S, Krieger M, Jacobs C, Shpall EJ, Berenson RJ. Selection and transplantation of hematopoietic stem cells. Hematology Reviews 9:73-83, 1995. e-Pub 1995.
- Shpall EJ, Cagnoni PJ, Bearman SI, Purdy MP, Jones RB. High-dose therapy with autologous hematopoietic support for the treatment of high-risk breast cancer. ASCO Education Book 31st Annual Meeting May 20-23, 1995 Los Angeles, California:347-51, 1995. e-Pub 1995.
- Shpall EJ. Peripheral Blood Progenitor Cell Harvesting. Hematopoietic Therapy: Index & Reviews 3(2), 1994. e-Pub 1994.
- Demetri GD, Dale DC, Andrews RB, Shpall EJ, Brenner MK. Cytokines, Science and the Therapeutic Context: Current Practice, Controversies, and Future Applications 2:12-5, 1994. e-Pub 1994.
Review Articles
- Fan AE, Vasconez WA, Ramakrishnan R, Tewari P, Olson A, Shpall EJ, Sheikh IN. Post-Transplant Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Pediatric Stem Cell Transplantation. Pediatr Blood Cancer 72(12), 2025. e-Pub 2025. PMID: 40985530.
- Smallbone, PI, Kebriaei, P, Mendt Vilchez, MC, Shpall, E, Olson, AL, Fingrut, WB. Mesenchymal stem cells in hematology: Therapeutic initiatives and future directions. Best Pract Res Clin Haematol 38(1):101613, 2025. e-Pub 2025. PMID: 40274341.
- Chen GL, Shpall EJ. Another tool against cytomegalovirus after allogeneic hematopoietic cell transplantation. J Clin Invest 133(10), 2023. e-Pub 2023. PMID: 37183817.
- Sanchez-Petitto G, Rezvani K, Daher M, Rafei H, Kebriaei P, Shpall EJ, Olson A. Umbilical Cord Blood Transplantation: Connecting Its Origin to Its Future. Stem Cells Transl Med 12(2):55-71, 2023. e-Pub 2023. PMID: 36779789.
- Pasvolsky O, Daher M, Alatrash G, Marin D, Daver N, Ravandi F, Rezvani K, Shpall E, Kebriaei P. CARving the Path to Allogeneic CAR T Cell Therapy in Acute Myeloid Leukemia. Front Oncol 11:800110, 2022. e-Pub 2022. PMID: 35083154.
- Ragoonanan D, Khazal SJ, Abdel-Azim H, McCall D, Cuglievan B, Tambaro FP, Ahmad AH, Rowan CM, Gutierrez C, Schadler K, Li S, Di Nardo M, Chi L, Gulbis AM, Shoberu B, Mireles ME, McArthur J, Kapoor N, Miller J, Fitzgerald JC, Tewari P, Petropoulos D, Gill JB, Duncan CN, Lehmann LE, Hingorani S, Angelo JR, Swinford RD, Steiner ME, Hernandez Tejada FN, Martin PL, Auletta J, Choi SW, Bajwa R, Dailey Garnes N, Kebriaei P, Rezvani K, Wierda WG, Neelapu SS, Shpall EJ, Corbacioglu S, Mahadeo KM. Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. Nat Rev Clin Oncol 18(7):435-453, 2021. e-Pub 2021. PMID: 33608690.
- Greenbaum U, Kebriaei P, Srour SA, Olson A, Bashir Q, Neelapu SS, Rezvani K, Shpall EJ. Chimeric antigen receptor T-cell therapy toxicities. Br J Clin Pharmacol 87(6):2414-2424, 2021. e-Pub 2021. PMID: 32463929.
- Greenbaum U, Yalniz FF, Srour SA, Rezvani K, Singh H, Olson A, Jr BG, Hong DS, Shpall EJ, Kebriaei P. Chimeric Antigen Receptor Therapy: How Are We Driving in Solid Tumors?. Biol Blood Marrow Transplant 26(10):1759-1769, 2020. e-Pub 2020. PMID: 32623078.
- Greenbaum U, Mahadeo KM, Kebriaei P, Shpall EJ, Saini NY. Chimeric Antigen Receptor T-Cells in B-Acute Lymphoblastic Leukemia: State of the Art and Future Directions. Front Oncol 10(10):1594, 2020. e-Pub 2020. PMID: 32984022.
- Mendt M, Rezvani K, Shpall E. Mesenchymal stem cell-derived exosomes for clinical use. Bone Marrow Transplant 54(Suppl 2):789-792, 2019. e-Pub 2019. PMID: 31431712.
- Mehta RS, Rezvani K, Shpall EJ. Cord Blood Expansion: A Clinical Advance. J Clin Oncol 37(5):JCO1801789, 2019. e-Pub 2019. PMID: 30576267.
- Mahadeo KM, Khazal SJ, Abdel-Azim H, Fitzgerald JC, Taraseviciute A, Bollard CM, Tewari P, Duncan C, Traube C, McCall D, Steiner ME, Cheifetz IM, Lehmann LE, Mejia R, Slopis JM, Bajwa R, Kebriaei P, Martin PL, Moffet J, McArthur J, Petropoulos D, O'Hanlon Curry J, Featherston S, Foglesong J, Shoberu B, Gulbis A, Mireles ME, Hafemeister L, Nguyen C, Kapoor N, Rezvani K, Neelapu SS, Shpall EJ, (PALISI) Network PALIASI. Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy. Nat Rev Clin Oncol 16(1):45-63, 2019. e-Pub 2019. PMID: 30082906.
- Neelapu SS, Tummala S, Kebriaei P, Wierda W, Gutierrez C, Locke FL, Komanduri KV, Lin Y, Jain N, Daver N, Westin J, Gulbis AM, Loghin ME, de Groot JF, Adkins S, Davis SE, Rezvani K, Hwu P, Shpall EJ. Chimeric Antigen Receptor T-cell therapy - Assessment and Management of Toxicities. Nat Rev Clin Oncol 15(1):47-62, 2018. e-Pub 2018. PMID: 28925994.
- Hill L, Alousi A, Kebriaei P, Mehta R, Rezvani K, Shpall E. New and emerging therapies for acute and chronic graft versus host disease. Ther Adv Hematol 9(1):21-46, 2018. e-Pub 2018. PMID: 29317998.
- Rezvani K, Rouce R, Liu E, Shpall E. Engineering Natural Killer Cells for Cancer Immunotherapy. Mol Ther 25(8):1769-1781, 2017. e-Pub 2017. PMID: 28668320.
- Barker JN, Kurtzberg J, Ballen K, Boo M, Brunstein C, Cutler C, Horwitz M, Milano F, Olson A, Spellman S, Wagner JE, Delaney C, Shpall E. Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies. Biol Blood Marrow Transplant 23(6):882-896, 2017. e-Pub 2017. PMID: 28279825.
- Bachegowda LS, Saliba RM, Ramlal R, Kongtim P, Chen J, Rondon G, Wallis W, Alousi A, Ahmed S, Hosing CM, Parmar S, Qazilbash M, Khouri IF, Bashir Q, Oran B, Popat U, Shpall EJ, Marin D, Rezvani K, Kebriaei P, Champlin RE, Ciurea SO. Predictive model for survival in patients with AML/MDS receiving haploidentical stem cell transplantation. Blood 129(22):3031-3033, 2017. e-Pub 2017. PMID: 28351938.
- Mehta RS, Dave H, Bollard CM, Shpall EJ. Engineering cord blood to improve engraftment after cord blood transplant. Stem Cell Investig 4:41, 2017. e-Pub 2017. PMID: 28607915.
- Parmar S, Shpall EJ. Treg adoptive therapy: is more better?. Blood 127(8):962-3, 2016. e-Pub 2016. PMID: 26917738.
- Petz LD, Burnett JC, Li H, Li S, Tonai R, Bakalinskaya M, Shpall EJ, Armitage S, Kurtzberg J, Regan DM, Clark P, Querol S, Gutman JA, Spellman SR, Gragert L, Rossi JJ. Progress toward curing HIV infection with hematopoietic cell transplantation. Stem Cells Cloning 8:109-16, 2015. e-Pub 2015. PMID: 26251620.
- Lund TC, Boitano AE, Delaney CS, Shpall EJ, Wagner JE. Advances in umbilical cord blood manipulation-from niche to bedside. Nat Rev Clin Oncol 12(3):163-174, 2015. e-Pub 2015. PMID: 25511187.
- Thompson PA, Shpall EJ, Keating MJ. Shifting paradigms in the treatment of chronic lymphocytic leukemia. Future Oncol 11(4):641-57, 2015. e-Pub 2015. PMID: 25686119.
- Mehta RS, Shpall EJ, Rezvani K. Cord Blood as a Source of Natural Killer Cells. Front Med (Lausanne) 2:93, 2015. e-Pub 2015. PMID: 26779484.
- Mehta RS, Rezvani K, Olson A, Oran B, Hosing C, Shah N, Parmar S, Armitage S, Shpall EJ. Novel Techniques for Ex Vivo Expansion of Cord Blood: Clinical Trials. Front Med (Lausanne) 2:89, 2015. e-Pub 2015. PMID: 26697430.
- Kebriaei P, Kelly SS, Manuri P, Jena B, Jackson R, Shpall E, Champlin R, Cooper LJ. Chimeric antibody receptors (CARs): Driving T-cell specificity to enhance anti-tumor immunity. Frontiers in Bioscience - Scholar 4(2):520-31, 2012. e-Pub 2012. PMID: 22202074.
- Oran B, Shpall E. Umbilical cord blood transplantation: a maturing technology. Hematology Am Soc Hematol Educ Program 2012:215-22, 2012. e-Pub 2012. PMID: 23233584.
- Raval M, Gulbis A, Bollard C, Leen A, Chemaly R, Shpall E, Lahoti A, Kebriaei P. Evaluation and Management of BK Virus-Associated Nephropathy following Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 17(11):1589-93, 2011. e-Pub 2011. PMID: 21767514.
- Robinson SN, Simmons PJ, Yang H, Alousi AM, Marcos de Lima J, Shpall EJ. Mesenchymal stem cells in ex vivo cord blood expansion. Best Pract Res Clin Haematol 24(1):83-92, 2011. e-Pub 2011. PMID: 21396596.
- Wierda WG, Chiorazzi N, Dearden C, Brown JR, Montserrat E, Shpall E, Stilgenbauer S, Muneer S, Grever M. Chronic lymphocytic leukemia: new concepts for future therapy. Clin Lymphoma Myeloma Leuk 10(5):369-78, 2010. e-Pub 2010. PMID: 21030350.
- Hanley PJ, Cruz CR, Shpall EJ, Bollard CM. Improving clinical outcomes using adoptively transferred immune cells from umbilical cord blood. Cytotherapy 12(6):713-20, 2010. e-Pub 2010. PMID: 20818913.
- Tung SS, Parmar S, Robinson SN, De Lima M, Shpall EJ. Ex vivo expansion of umbilical cord blood for transplantation. Best Pract Res Clin Haematol 23(2):245-57, 2010. e-Pub 2010. PMID: 20837337.
- Kelly SS, Parmar S, De Lima M, Robinson S, Shpall E. Overcoming the barriers to umbilical cord blood transplantation. Cytotherapy 12(2):121-30, 2010. e-Pub 2010. PMID: 20196692.
- Kelly SS, Sola CB, de Lima M, Shpall E. Ex vivo expansion of cord blood. Bone Marrow Transplant 44(10):673-81, 2009. e-Pub 2009. PMID: 19802023.
- Nieto Y, Shpall EJ. High-dose chemotherapy for high-risk primary and metastatic breast cancer: is another look warranted?. Curr Opin Oncol 21(2):150-7, 2009. e-Pub 2009. PMID: 19532017.
- Champlin R, de Lima M, Kebriaei P, Rondon G, Fisher T, Jabbour E, Cortés JE, Kantarjian H, Anderlini P, Alousi A, Hosing C, Shpall E, Popat U, Qazilbash M, Andersson B, Giralt S. Nonmyeloablative allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era. Clin Lymphoma Myeloma 9 Suppl 3:S261-5, 2009. e-Pub 2009. PMID: 19778850.
- Gonzalez G, Shpall EJ, Gathe JC, Behringer RR. Cord blood stem cell therapy for acquired immune deficiency syndrome. Stem Cells Dev 18(1):1-2, 2009. e-Pub 2009. PMID: 19018697.
- Patah PA, Parmar S, McMannis J, Sadeghi T, Karandish S, Rondon G, Tarrand J, Champlin R, de Lima M, Shpall EJ. Microbial contamination of hematopoietic progenitor cell products: Clinical outcome. Bone Marrow Transplant 40(4):365-368, 2007. e-Pub 2007. PMID: 17572714.
- Decker WK, Xing D, Shpall EJ. Dendritic cell immunotherapy for the treatment of neoplastic disease. Biol Blood Marrow Transplant 12(2):113-25, 2006. e-Pub 2006. PMID: 16443510.
- Couriel D, Hosing C, Saliba R, Shpall EJ, Andelini P, Popat U, Donato M, Champlin R. Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?. Biol Blood Marrow Transplant 12(1 Suppl 2):37-40, 2006. e-Pub 2006. PMID: 16399600.
- Nieto Y, Jones RB, Shpall EJ. Stem-cell transplantation for the treatment of advanced solid tumors. Springer Semin Immunopathol 26(1-2):31-56, 2004. e-Pub 2004. PMID: 15368078.
- de Lima M, Shpall EJ. Ex-vivo purging of hematopoietic progenitor cells. Curr Hematol Rep 3(4):257-64, 2004. e-Pub 2004. PMID: 15217555.
- Ueno, NT, Yee, CC, Shpall, E, Champlin, RE. Autologous hematopoietic stem cell transplantation in breast cancer. Breast Diseases 15(2):113-117, 2004. e-Pub 2004.
- Nieto Y, Jones RB, Shpall EJ. High-dose chemotherapy for breast cancer: is another look warranted?. Curr Opin Oncol 16(2):114-9, 2004. e-Pub 2004. PMID: 15075901.
- Nieto Y, Shpall EJ. High-dose chemotherapy for breast cancer. Cancer Treat Res 103:77-114, 2000. e-Pub 2000. PMID: 10948443.
- Beaudet, J, McNiece, I, Jones, R, Bearman, SI, Cagnoni, P, Nieto, Y, McSweeney, PA, Shpall, E. The use of hematopoietic growth factors to support patients with breast cancer recovering from dose intensive theraphies. Seminars in Breast Disease 3(3):144-152, 2000. e-Pub 2000.
- Nieto Y, Cagnoni PJ, Shpall EJ. High-dose chemotherapy in gynecologic malignancies. Cancer Treat Res 95:277-85, 1998. e-Pub 1998. PMID: 9619289.
- Chen CS, Seidel K, Armitage JO, Fay JW, Appelbaum FR, Horowitz MM, Shpall EJ, Weiden PL, Antman KS, Champlin RE, Kersey JH, Sullivan KM. Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant 3(6):331-40, 1997. e-Pub 1997. PMID: 9502301.
- Campain JA, Terrell KL, Tomczak JA, Shpall EJ, Hami LS, Harrison GS. Comparison of retroviral-mediated gene transfer into cultured human CD34+ hematopoietic progenitor cells derived from peripheral blood, bone marrow, and fetal umbilical cord blood. Biol Blood Marrow Transplant 3(5):273-81, 1997. e-Pub 1997. PMID: 9450923.
- Shpall EJ, Cagnoni PJ. High-dose chemotherapy for the treatment of breast and ovarian cancer. Curr Opin Oncol 9(2):122-5, 1997. e-Pub 1997. PMID: 9161788.
- Shpall EJ, Cagnoni PJ, Bearman SI, Ross M, Jones RB. Peripheral blood stem cells for autografting. Annu Rev Med 48:241-51, 1997. e-Pub 1997. PMID: 9046959.
- Shpall EJ, Cagnoni PJ, Bearman SI, Ross M, Nieto Y, Jones RB. Peripheral blood stem cell harvesting and CD34-positive cell selection. Cancer Treat Res 77:143-57, 1997. e-Pub 1997. PMID: 9071502.
- Shpall EJ, Cagnoni PJ. Mobilization and selection of CD34-positive hematopoietic progenitors. Blood Rev 10(1):1-7, 1996. e-Pub 1996. PMID: 8861273.
- Bearman SI, Shpall EJ, Jones RB, Cagnoni PJ, Ross M. High-dose chemotherapy with autologous hematopoietic progenitor cell support for metastatic and high-risk primary breast cancer. Semin Oncol 23(1 Suppl 2):60-7, 1996. e-Pub 1996. PMID: 8614848.
- Berenson RJ, Shpall EJ, Auditore-Hargreaves K, Heimfeld S, Jacobs C, Krieger MS. Transplantation of CD34+ hematopoietic progenitor cells. Cancer Invest 14(6):589-96, 1996. e-Pub 1996. PMID: 8951362.
- Auditore-Hargreaves, K, Heimfeld, S, Krieger, M, Jacobs, C, Shpall, E, Berenson, R. Selection and transplantation of hematopoietic stem cells. Hematology Reviews and Communications 9(2):73-83, 1995. e-Pub 1995.
- Shpall EJ, Jones RB, Bearman S. High-dose therapy with autologous bone marrow transplantation for the treatment of solid tumors. Curr Opin Oncol 6(2):135-8, 1994. e-Pub 1994. PMID: 8011690.
- Shpall EJ, Stemmer SM, Bearman SI, Jones RB. Role of autotransplantation in treatment of other solid tumors. Hematol Oncol Clin North Am 7(3):663-86, 1993. e-Pub 1993. PMID: 8344885.
Other Articles
- Uryu, H, Saeki, K, Haeno, H, Kapadia, C, Furudate, D.M.D., Ph.D., K, Nangalia, J, Spencer Chapman, M, Zhang, L, Padilla, J, Zhao, L, Hsu, JI, Zhao, C, Chen, S, Tanaka, T, Li, Z, Ogata, S, Hanache, S, Yang, H, DiNardo, C, Daver, N, Pemmaraju, N, Jain, N, Ravandi-Kashani, F, Zhang, J, Song, X, Thompson, EJ, Tang, H, Little, L, Gumbs, C, Orlowski, R, Qazilbash, MH, Bhalla, K, Colla, S, Kantarjian, HM, Kanagal Shamanna, R, Bueso-Ramos, CE, Nakada, D, Al-Atrash, G, Molldrem, JJ, Futreal, A, Shpall, E, Goodell, MA, Garcia-Manero, G, Takahashi, K Author Correction. Nature Genetics 57(9):2339, 2025. PMID: 40789920.
- Nieto Y, Banerjee P, Kaur I, Basar R, Li Y, Daher M, Rafei H, Kerbauy LN, Kaplan M, Marin D, Griffin L, Barnett M, Bassett R, Uprety N, Shrestha R, Silva FR, Islam S, Ganesh C, Borneo Z, Ramdial J, Ramirez A, Hosing C, Alousi A, Popat U, Qazilbash M, Ahmed S, Iyer S, Sainz TP, Vega F, Fowlkes NW, Alexis K, Emig M, Harstrick A, Overesch A, Shpall EJ, Rezvani K Author Correction: Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial. Nat Med 31(8):2816, 2025. PMID: 40571757.
- Alkhunaizi M, Patel B, Bueno L, Bhan N, Ahmed T, Arain MH, Saliba R, Rondon G, Dickey BF, Bashoura L, Ost DE, Li L, Wang S, Shpall E, Champlin RE, Mehta R, Popat UR, Hosing C, Alousi AM, Sheshadri A Corrigendum to 'Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell Transplantation' [Transplantation and Cellular Therapy 29/3 (2023) 204-204]. Transplant Cell Ther, 2024. PMID: 39561968.
- Li Y, Basar R, Wang G, Liu E, Moyes JS, Li L, Kerbauy LN, Uprety N, Fathi M, Rezvan A, Banerjee PP, Muniz-Feliciano L, Laskowski TJ, Ensley E, Daher M, Shanley M, Mendt M, Acharya S, Liu B, Biederstadt A, Rafei H, Guo X, Melo Garcia L, Lin P, Ang S, Marin D, Chen K, Bover L, Champlin RE, Varadarajan N, Shpall EJ, Rezvani K Author Correction: KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape. Nat Med 30(3):906, 2024. PMID: 38182787.
- Meraz IM, Majidi M, Fang B, Meng F, Gao L, Shao R, Song R, Li F, Lissanu Y, Chen H, Ha MJ, Wang Q, Wang J, Shpall E, Jung SY, Haderk F, Gui P, Riess JW, Olivas V, Bivona TG, Roth JA Author Correction: 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib. Commun Biol 6(1):608, 2023. PMID: 37280434.
- Ragoonanan D, Khazal SJ, Abdel-Azim H, McCall D, Cuglievan B, Tambaro FP, Ahmad AH, Rowan CM, Gutierrez C, Schadler K, Li S, Di Nardo M, Chi L, Gulbis AM, Shoberu B, Mireles ME, McArthur J, Kapoor N, Miller J, Fitzgerald JC, Tewari P, Petropoulos D, Gill JB, Duncan CN, Lehmann LE, Hingorani S, Angelo JR, Swinford RD, Steiner ME, Tejada FNH, Martin PL, Auletta J, Choi SW, Bajwa R, Garnes ND, Kebriaei P, Rezvani K, Wierda WG, Neelapu SS, Shpall EJ, Corbacioglu S, Mahadeo KM Author Correction: Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer. Nat Rev Clin Oncol 18(7):468, 2021. PMID: 33731864.
- Andermann TM, Peled JU, Ho C, Reddy P, Riches M, Storb R, Teshima T, van den Brink MRM, Alousi A, Balderman S, Chiusolo P, Clark WB, Holler E, Howard A, Kean LS, Koh AY, McCarthy PL, McCarty JM, Mohty M, Nakamura R, Rezvani K, Segal BH, Shaw BE, Shpall EJ, Sung AD, Weber D, Whangbo J, Wingard JR, Wood WA, Perales MA, Jenq RR, Bhatt AS, Trials Network BAMTC Microbiome-Host Interactions in Hematopoietic Stem Cell Transplant Recipients. Biol Blood Marrow Transplant 24(7):1322-1340, 2018. PMID: 29471034.
- Hanley, PJ, Melenhorst, J, Nikiforow, S, Scheinberg, P, Blaney, JW, Demmler-Harrison, GJ, Cruz, CR, Lam, S, Krance, RA, Leung, KS, Martinez, CA, Liu, H, Douek, DC, Heslop, H, Rooney, CM, Shpall, E, Barrett, AJ, Rodgers, J, Bollard, CM Erratum. Science translational medicine 8(321), 2016. PMID: 26764153.
- Mehta RS, Di Stasi A, Andersson BS, Nieto Y, Jones R, de Lima M, Hosing C, Popat U, Kebriaei P, Oran B, Alousi A, Rezvani K, Qazilbash M, Bashir Q, Bollard C, Cooper L, Worth L, Tewari P, McNiece I, Willhelm K, Champlin R, Shpall EJ The Development of a Myeloablative, Reduced-Toxicity, Conditioning Regimen for Cord Blood Transplantation. Clin Lymphoma Myeloma Leuk 14(1):e1-5, 2014. PMID: 24169268.
- McNiece I, Shpall E Does plerixafor destroy the hematopoietic progenitor cell/mesenchymal stromal cell niche?. Cytotherapy 16(1):1-2, 2014. PMID: 24373524.
- Nieto Y, Shpall EJ High-dose chemotherapy with autologous stem cell transplant for breast cancer: what have we learned 25 years later?. Biol Blood Marrow Transplant 18(1):3-5, 2012. PMID: 22146617.
- de Lima M, Fernandez-Vina M, Shpall EJ HLA matching of CB: it's complicated. Blood 118(14):3761-2, 2011. PMID: 21980049.
- Shah N, Shpall EJ NK antibody therapy: KIR-ative intent. Blood 114(13):2567-8, 2009. PMID: 19779042.
- Decker WK, Shpall EJ Progress in dendritic cell immunotherapy: elucidating the enigma of Th-1 polarization. Hum Vaccin 4(2):162-4, 2008. PMID: 18382128.
- Shpall, E, De Lima, M, Jones, R, Champlin, RE Are 2 cords better than 1?. Blood 110(8):2789-2790, 2007.
Editorials
- Kansagra AJ, Frey NV, Bar M, Laetsch TW, Carpenter PA, Savani BN, Heslop HE, Bollard CM, Komanduri KV, Gastineau DA, Chabannon C, Perales MA, Hudecek M, Aljurf M, Andritsos L, Barrett JA, Bachanova V, Bonini C, Ghobadi A, Gill SI, Hill J, Kenderian S, Kebriaei P, Nagler A, Maloney D, Liu HD, Shah NN, Kharfan-Dabaja MA, Shpall EJ, Mufti GJ, Johnston L, Jacoby E, Bazarbachi A, DiPersio JF, Pavletic SZ, Porter DL, Grupp SA, Sadelain M, Litzow MR, Mohty M, Hashmi SK. Clinical Utilization of Chimeric Antigen Receptors T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation. Bone Marrow Transplant 54(11):1868-1880, 2019. PMID: 30576834.
- Heslop HE, Shpall EJ. Harmonizing Immune Effector Toxicity Reporting. Biol Blood Marrow Transplant 25(4):e121-e122, 2019. PMID: 30615980.
- Robinson S, Simmons PJ, Thomas MW, Brouard N, Javni JA, Trilok S, Shim JS, Yang H, Steiner D, Decker WK, Xing D, Shultz LD, Savoldo B, Dotti G, Bollard CM, Miller L, Champlin RE, Shpall EJ, Zweidler-McKay PA. Reply to Sackstein. Exp Hematol 7(40):519-20, 2012.
- Shpall EJ. The 2011 education supplement on hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 17(1 Suppl):S1, 2011. PMID: 20977943.
- Shpall E, Marcos DL, Roy J. Are two cords better than one?. Blood 110:2789-2790, 2007.
- de Lima M, Shpall E. Strategies for widening the use of cord blood in hematopoietic stem cell transplantation. Haematologica 91(5):584-7, 2006. PMID: 16670062.
- Ueno NT, Shpall EJ, Champlin RE, Jones RB. Graft--versus--breast cancer effect by allogeneic hematopoietic stem-cell transplantation: a possible new frontier. J Clin Oncol 22(19):3846-7, 2004. PMID: 15314060.
- Suratt BT, Cool CD, Serls AE, Chen L, Varella-Garcia M, Shpall EJ, Brown KK, Worthen G. Cellular Alchem. American Journal of Respiratory and Critical Care Medicine 168:267-268, 2003.
- Collins N, Gee A, Rowley S, Shpall E. Are we ready for regulation? ISHAGE Regulatory Action Group. International Society for Hematotherapy and Graft Engineering. J Hematother 4(1):1-2, 1995. PMID: 7757394.
- Shpall EJ, Jones RB. Release of tumor cells from bone marrow. Blood 83(3):623-5, 1994. PMID: 7905297.
- Jones RB, Shpall EJ. Dissemination and commercialization of hematopoietic progenitor cell transplantation. J Hematother 3(2):93-4, 1994. PMID: 7922017.
- Jones RB, Shpall EJ. Treatment of breast cancer in the 1990s. What does the future hold?. Drugs 43(2):141-5, 1992. PMID: 1372213.
Abstracts
- Magenau J, Hamadani M, Martens MJ, Arai S, Jurdi NE, Oshima MU, Solomon SR, Geller N, Henderson L, Reddy P, McGuirk J, Mendizabal A, Hill LC, Qayed M, Wang Y, Lee LA, Deeg H, Alousi AM, BAi L, Abedin S, Ponce DM, Choe HK, Pidala J, Chojecki AL, DiFronzo N, Shpall EJ, Pritchard T, Romeril J, Hamilton BK, Koreth J, Schroeder MA, Preiss R, Morrison L, Yanik GA. LBA-2 - A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Alpha-1-Antitrypsin for Treatment of High Risk Acute Gvhd (BMT CTN 1705). 2025 Tandem Meetings of ASTCT and CIBMTR.
Book Chapters
- Rafei, H, Mehta, RS, Oran, B, Rezvani, K, Shpall, E, Olson, AL. Umbilical Cord Blood Transplantation, 101-114, 2023.
- Greenbaum, U, Ramdial, JL, Afrough, A, Alsfeld, LC, Ghanem, S, Daher, M, Olson, AL, Kebriaei, P, Strati, P, Steiner, RE, Ahmed, S, Tanner, MR, Neelapu, SS, Rezvani, K, Shpall, E. Cytokine Release Syndrome Following CD19 Directed Chimeric Antigen Receptor T-Cell Therapy, 509-524, 2023.
- Wilson, JM, Eaton, EN, Pool, K, Reioux, D, Fontenot, M, Marin, D, Champlin, RE, Rezvani, K, Shpall, E, Hosing, C. Design and Licensure of an American Cord Blood Bank, 301-338, 2021.
- Gehling, U, Hogan, CH, Gee, AP, Cagnoni, P, Franklin, W, Jones, R, Bearman, SI, Ross, M, Shpall, E. Marrow contamination, 103-113, 2020.
- Jones, R, Cagnoni, P, Bearman, SI, Shpall, E. Pharmacology of high-dose therapy with bone marrow transplantation, 81-88, 2020.
- Khan, M, Siddiqi, R, Shpall, E, Olson, AL. Principles and applications of cellular therapy in the setting of hematopoietic cell transplant, 395-416, 2019.
- Mehta, RS, Olson, AL, Ponce, DM, Shpall, E. Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies, 1633-1649.e4, 2017.
- Nieto, Y, Shpall, E. Autologous Hematopoietic Cell Transplantation for Breast Cancer and Germ-cell Tumors, 739-750, 2016.
- Warkentin, P, Shpall, E. Hematopoietic Cell Procurement, Processing, and Transplantation, 414-424, 2016.
- Olson, AL, Shpall, E. Cord blood cells for clinical use, 141-152, 2015.
- Lee, DA, Neil Cooper, LJ, Shpall, E. Nk-cell immunotherapy for aml, 737-755, 2015.
- McNiece, I, Robinson, SN, Shpall, E. MSC for ex vivo expansion of umbilical cord blood cells, 485-501, 2013.
- McNiece I, Robinson, Shpall E. MSC for Ex Vivo Expansion of Umbilical Cord Blood Cells. In: Mesenchymal Stromal Cells. Springer Science, 485-501, 2013.
- Kebriaei, P, Robinson, SN, McNiece, I, Shpall, E. Mesenchymal stem cells as therapy for graft versus host disease, 173-190, 2013.
- Hosing, C, De Lima, M, Shpall, E. Mesenchymal stromal cells and umbilical cord blood transplantation, 33-47, 2012.
- Robinson S, Simmons P, Zweidler-McKay P, Shpall E. Fucosylation for improved Engraftment. In: Cord Blood Biology Transplantation, Banking and Regulation, 2011.
- Shpall E, de Lima M. Clinical Aspects of Hematopoietic Stem Cell Transplantation. In: Neoplastic Hematopathology. Humana Press, 505-511, 2010.
- De Padua Silva, L, De Lima, M, Shpall, E, Armitage, S. Cord blood transplantation, 453-461, 2009.
- Nieto, Y, Shpall, E. Hematopoietic Cell Transplantation for Breast Cancer, 931-947, 2009.
- Warkentin, P, Shpall, E. Hematopoietic Cell Procurement, Processing, and Transplantation, 533-543, 2009.
- McNiece, I, Shpall, E. Ex vivo expansion of cord blood, 91-96, 2009.
- Warketin P, Shpall E. Hematopoietic Cell Procurement, Processing, and Transplantation: Standards, Accreditation, and Regulation. In: Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation, Fourth Edition. Blackwell Publishing, 2009.
- Appelbaum F. Hematopoietic Cell Transplantation for Breast cancer. In: Thomas’ Hematopoetic Cell Transplantation. Wiley-Blackwell, 931-947, 2009.
- Murphy M. Cord blood Transplantation. In: Practical Transfusion Medicine. Wiley, Blackwell, 453-461, 2009.
- Warkentin PI, Nick L, Shpall EJ. Hematopoietic Cell Procurement, Processing and Transplantation: Regulation and Accreditation (Chapter 41. In: Thomas Hematopoietic Cell Transplantation Third Edition, 2002.
- Roman-Unfer S, Shpall EJ, Nieto Y, Cook B. Negative and positive hematopoietic cell collection. In: High-Dose Cancer Therapy: Pharmacology, Hematopoietins, Stem Cells. Lippincott, William & Wilkins, 331-354, 2000.
- Nieto Y, Shpall EJ. Autologous stem cell transplantation for solid tumors in adults. In: Hematology/Oncology Clinics of North America. W.B. Saunders Company, 939-968, 1999.
- Roman-Unfer S, Shpall EJ. The use of cytokines to enhance collection of stem cells for marrow and blood transplantation. In: Clinical Applications of Cytokines and Growth Factors. Kluwer Academic Publishers, 369-380, 1999.
- Jones RB, Matthes SM, Dufton C, Shpall EJ, Bearman SI, Ross M, Cagnoni P. Nitrosoureas. In: A Clinician’s Guide to Chemotherapy, Pharmacokinetics, and Pharmacodynamics. Williams & Wilkins, 331-44, 1998.
- Shpall EJ, Warkentin PI, Jones RB. Guidelines for the procurement and manipulation of stem cells for transplantation. In: Hematopoietic Cell Transplantation, Second Edition. Blackwell Science, Inc, 417-20, 1998.
- Roman-Unfer S, Jones RB, Bearman SI, Cagnoni PJ, Nieto Y, Shpall EJ. Autologous hematopoietic progenitor cell transplantation. In: Cellular Support for the Oncology Pt. Baxter Healthcare Corporation, 9-22, 1998.
- Roman-Unfer S Shpall EJ. Negative and Positive Hematopoietic Cell Selection (in press). In: High-dose cancer therapy: pharmacology, hematopoietins, stem cells. Williams & Wilkins, 1998.
- Nieto Y, Cagnoni PJ, Shpall EJ, Bearman SI, McSweeney P, Matthes S, Holter S, Razook C, Russell P, Cook B, Yerushalmi R, Jones RB. High-dose chemotherapy in gynecologic malignancies. In: Cancer Treatment and Research, Boston, Kluwer Academic Publishers, 277-85, 1998.
- Cagnoni PJ Shpall EJ. High-dose chemotherapy for the treatment of breast cancer. In: The Clinical Practice of Stem Cell Transplantation. Isis Medical Media Ltd, 191-203, 1998.
- Nieto Y, Shpall EJ, Bearman SI, Jones RB. Clinical results of autologous bone marrow transplantation for solid tumors in adults (in press). In: Hematology: Basic Principles and Practice. New York, 1998.
- Roman-Unfer S Shpall EJ. The use of cytokines to enhance collection of stem cells for marrow and blood transplantation (in press). In: Clinical Applications of Cytokines and Growth Factors. Kluwer Academic Publishers, 1998.
- Shpall EJ, Jones RB, Bearman SI, Cagnoni PJ, Nieto Y, McNiece IK. Peripheral blood stem cell transplantation. In: Baillière’s Clinical Hematology, 1998.
- Nieto Y, Shpall EJ, Bearman SI, Jones RB. CD34+ blood stem cell transplantation. In: Blood Stem Cell Transplantation. Martin Dunitz Ltd, 187-201, 1998.
- Shpall EJ, Cagnoni PJ, Bearman SI, Ross M, Jones RB. Peripheral blood stem cells for autografting. In: Annual Review of Medicine. Annual Reviews Inc, 241-51, 1997.
- Nieto Y, Shpall EJ, Bearman SI, Jones RB. Ex vivo stem cell expansion. In: Bone Marrow Transplantation. Churchill Livingstone, 1997.
- Shpall EJ. Peripheral blood progenitor cell graft engineering. In: Apheresis: Principles and Practice. AABB Press, 465-74, 1997.
- Shpall EJ, Cagnoni PJ, Bearman SI, Ross M, Nieto Y, Jones RB. Peripheral Blood Stem Cell Harvesting and CD34-Positive Cell Selection. In: Cancer Treat Res: Blood Stem Cell Transplantation. Kluwer Academic Publishers, 143-57, 1997.
- Shpall EJ, Gehling U, Cagnoni PJ, Hogan C, Bearman SI, Jones RB. Sources of Hemopoietic Progenitor Cells for Transplantation. In: Cancer Clinical Sciences in Practice: Cell Therapy. Cambridge University Press, 113-129, 1996.
- Shpall EJ, Gee AP, Hogan C, Cagnoni P, Gehling U, Hami L, Franklin W, Bearman SI, Ross M, Jones RB. Bone marrow metastases. In: Hem/Onc Clinics of North America, Haemtologic Complications of Cancer. W.B. Saunders, 321-43, 1996.
- Jones RB, Stemmer SM, Kasliwal R, Johnson T, Glenn S, Bunn P, Shpall EJ, Bearman SI, Ceriani R. Intensive radiolabeled anti-breast monoclonal antibody 90Y-BrE-3 with autologous hematopoietic cell support preliminary results. In: Autologous Marrow and Blood Transplantation. Proceedings of the Seventh International Symposium Cancer Treatment Research Education Fund, 727-33, 1995.
- Jones RJ, Cagnoni PJ, Bearman SI, Shpall EJ. Pharmacology of High-Dose Therapy with Bone Marrow Transplantation. In: Autologous Stem Cell Transplantation: Biological and Clinical Results in Malignancies. Harwood Academic Publishers, 81-8, 1995.
- Shpall EJ, Cagnoni PJ, Gehling U, Hami LS, Hogan CJ. Bone Marrow Purging. In: High-Dose Cancer Therapy: Pharmacology, Hematopoietins, Stem Cells, Second Edition. Williams & Wilkins, 249-79, 1995.
- Cagnoni PJ, Jones RB, Bearman SI, Shpall EJ. The Treatment of Ovarian Cancer. In: Expert Consultations in Gynecologic Malignancies, 317-20, 1995.
- Gehling UM, Hogan CJ, Gee A, Cagnoni P, Franklin W, Jones RB, Bearman SI, Ross M, Shpall EJ. Marrow Contamination: Detection and significance. In: Autologous Stem Cell Transplantation: Biological and Clinical Results in Malignancies. Harwood Academic Publishers, 103-13, 1995.
- Stiff P, Shpall EJ, Tan S, Camarda M, Bayer R. High-dose combination chemotherapy and bone marrow rescue for ovarian carcinoma: Current status in the United States. In: Autologous Bone Marrow Transplantatio. Proceedings of the Seventh International Symposium Cancer Treatment Research Education, 453-58, 1994.
- Berenson RJ, Heimfeld S, Krieger MS, Jacobs C, Auditore-Hargreaves K, Shpall EJ. Selection and Transplantation of Autologous Hematopoietic Progenitor Cells. In: Hematopoietic Stem Cells: Biology & Therapeutic Applications. Marcel Dekker, Inc.,, 519-33, 1994.
- Shpall EJ, Jones RB, Bast R, Shogan J, Ross M, Edwards S, Eggleston S, Johnston C, Affronti M, Coniglio D, Peters WP. Mobilization and Collection of Peripheral Blood Progenitor Cells for Support of High-dose Cancer Therapy. In: Bone Marrow Transplantation. Blackwell Scientific Publications, 913-18, 1994.
- Jacobs CA, Shpall EJ, Ball ED, Champlin RE, LeMaistre CF, Holland HK, Saral R, Berenson RJ. A prospective, randomized Phase III study using the ceprate SC stem cell concentrator to isolate CD34+ hematopoietic progenitors for autologous marrow transplantation after high dose chemotherapy. In: Autologous Bone Marrow Transplantation. Proceedings of the Seventh International Symposium Cancer Treatment Research Education Fund, 669-78, 1994.
- Jones RB, Matthes S, Dufton C, Bearman SI, Stemmer SM, Myers SE, Shpall EJ. The pharmacology of intensive cyclophosphamide, cisplatin, and BCNU (CPA/cDDP/BCNU) in patients with breast cancer. In: Autologous Bone Marrow Transplantation. Proceedings of the Sixth International Symposium Cancer Treatment Research Education Fund, 124-28, 1993.
- McGlave P, Horowitz M, Weisdorf D, Shpall E. Clinical marrow transplantation. In: Hematology. The Education Program of the American Society of Hematology, 152-62, 1993.
- Shpall EJ, Stemmer SM, Bearman SI, Bast RC, Peters WP, Ross M, Jones RB. High-dose chemotherapy with autologous bone marrow support for the treatment of epithelial ovarian cancer. In: Cancer of the Ovary. Williams and Wilkins, 327-38, 1993.
- Shpall EJ, Stemmer SM, Bearman SI, Jones RB. Role of autotransplantation in treatment of other solid tumors. In: Hematology/Oncology Clinics of North America: Autologous Bone Marrow Transplantation. W.B. Saunders, 663-86, 1993.
- Stiff P, Antman K, Broun R, Collins R, Fields K, Kessinger A, Shea T, Shpall E, Spitzer G. Bone marrow transplantation for ovarian carcinoma in the United States: A survey of active programs. In: Autologous Bone Marrow Transplantation. Proceedings of the Sixth International Symposium Cancer Treatment Research Education Fund, 192-98, 1993.
- Shpall EJ, Johnston C, Hami L. Bone Marrow Purging. In: High-Dose Therapy: Pharmacology, Hematopoietins, and Stem Cells. Williams and Wilkins, 249-75, 1992.
- Shpall EJ, Bast RC, Johnston CS, Peters WP, Jones RB. Immunopharmacologic purging of breast cancer from bone marrow. In: Breast Epithelial Antigens: Molecular Biology to Clinical Applications. Plenum Press, 211-14, 1991.
- Shpall EJ, Bast RC, Johnston CS, Peters WP, Jones RB. Combined purging approaches in autologous transplantation. In: Bone Marrow Processing and Purging: A Practical Guide. CRC Press, 307-28, 1991.
- Shpall EJ, Jones RB, Bast RC, Johnston CS, Ross M, Anderson I, bone marrow PWIPOBCF. Immunopharmacologic purging of breast cancer from bone marrow. In: Autologous Bone Marrow Transplantation: Proceedings of the Fifth International Symposium Cancer Treatment Research Education Fund, 379-84, 1991.
- Shpall EJ, Anderson IC, Bast, JrR, Joines W, Jones RB, Ross M, Edwards S, Eggleston S, Johnston C, Tepperberg M, Affronti ML, Coniglio D, Mathias B, Peters W. Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantation. In: Bone Marrow Purging and Processing. Wiley-Liss Inc.,, 321-36, 1990.
- Peters WP, Atwater S, Kurtzberg J, Borowitz M, Brandt SJ, Coleman RE, Kim CS, Gilbert C, Shpall EJ, Jones RB, Shogan J, Bast RC, Oette D, Stuart A, Coniglio D, Affronti ML, Evans S. The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation. In: Autologous Bone Marrow Transplantation. Proc. of the Fourth International Symposium Cancer Treatment Research Education Fund, Arlington, Texas, 657-67, 1989.
- Shpall EJ, Jones RB, Bast R, Shogan J, Ross M, Edwards S, Eggleston S, Johnston C, Affronti M, Coniglio D, Peters WP. 4-hydroperoxycyclophosphamide (4-HC) purging of the ficolled mononuclear cell fraction (FMNCF) of bone marrow. In: Proc of the 2nd International Symposium on Bone Marrow Processing and Purging. Wiley-Liss, 1989.
- Peters WP, Jones RB, Shpall EJ, Gockerman J, Kurtzberg J, Moore J, Bast RC, Gilbert C, Blackburn B, Coniglio D, Brophy L, Edwards S. Strategies in the treatment of breast cancer with intensive chemotherapy and autologous bone marrow support. In: Autologous Bone Marrow Transplantation. Proceedings of the Second International Symposium Cancer Treatment Research Education Fund, Arlington, Texas, 657-67, 1987.
- Peters WP, Shpall EJ, Jones RB, Olsen G, Gockerman J, Eder JP, Antman K, Kurtzberg J, Bast RC, Moore JO, Egorin MJ. Critical factors in the design of high-dose combination chemotherapy regimens. In: Advances in Cancer Chemotherapy: Symposium on High-Dose Thiotepa and Autologous Transplantation. Park Row, 43-52, 1987.
- Nieto, Yago, Shpall, Elizabeth. Autologous Hematopoietic Cell Transplantation for Breast Cancer and Germ-Cell Tumors. In: Thomas’ Hematopoietic Cell Transplantation, 5th edition. Fred Appelbaum, Joseph Antin and Stephen Forman.
- Shpall EJ. Elizabeth Shpall, MD. In: Legends and Legacies Book Chapters. OpenWorks @ MD Anderson.
Books (edited and written)
- Bashir, Q, Shpall, E, Champlin, RE. Manual of Hematopoietic Cell Transplantation and Cellular Therapies, 2023.
- Bashir, Q, Shpall, E, Champlin, RE. Manual of Hematopoietic Cell Transplantation and Cellular Therapies, 2023.
Letters to the Editor
- Marvin-Peek J, Kantarjian H, Jen WY, Daver N, Short N, Borthakur G, Bazinet A, Maiti A, Abbas H, Yilmaz M, Issa G, Macfarland M, Alvarado Y, Garcia-Manero G, Alousi A, Popat U, Shpall E, Ravandi F, DiNardo C, Kadia TM. Evaluating the Impact of Fewer Frontline Intensive Chemotherapy Plus Venetoclax Consolidation Cycles on Outcomes in AML. Am J Hematol, 2026.
- Subramanian NG, Guffey D, Avery J, Garcia D, Basom R, Lee SJ, Klein K, Kebriaei P, Rondon G, Shpall E, Jin S, Young E, Rojas Hernandez CM, Li A. Clinical Factors Associated With Catheter-Related VTE in Patients Undergoing Hematopoietic Cell Transplantation: A Multi-Center Study. Am J Hematol 100: 1463-1466, 2025.
- Senapati J, Garcia-Manero G, DiNardo CD, Deshmukh I, Borthakur G, Kadia TM, Jabbour E, Short NJ, Abbas HA, Pemmaraju N, Jain N, Haddad FG, Issa GC, Maiti A, Shpall E, Popat U, Loghavi S, Tang G, Yilmaz M, Alvarado Y, Montalban-Bravo G, Ravandi F, Kantarjian HM, Daver NG. Barriers to allogeneic stem cell transplantation in responding patients with TP53-mutated acute myeloid leukemia. Bone Marrow Transplant 60: 910-913, 2025.
- Smallbone, PI, Sekhar, M, Srour, S, Ramdial, JL, Carmicheal Kusy, CL, Shpall, E, Popat, UR. Hematopoietic Stem Cell Transplantation in Patients With Myelofibrosis and Splanchnic Vein Thrombosis. American journal of hematology 100: 305-309, 2025.
- Marcoux C, Pasyar S, Milton DR, Khan HN, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Neupane N, Lee HC, Patel KK, Tang G, Aljawai Y, Kebriaei P, Thomas SK, Orlowski RZ, Shpall EJ, Champlin R, Qazilbash MH, Pasvolsky O. Impact of body mass index on outcomes of multiple myeloma patients undergoing upfront autologous stem cell transplant. Br J Haematol 206: 763-765, 2025.
- Smallbone P, Sekhar M, Srour SA, Ramdial JL, Carmicheal Kusy CL, Shpall EJ, Popat UR. Hematopoietic Stem Cell Transplantation in Patients With Myelofibrosis and Splanchnic Vein Thrombosis: A Case Series. Am J Hematol 100: 305-309, 2025.
- Rafaeli N, Costa DM, Ledesma C, Jain N, Tewari P, Khouri I, Alatrash G, Short N, Jabbour E, Rezvani K, Alousi A, Popat U, Champlin R, Shpall E, Kebriaei P. Allogeneic Hematopoietic Stem Cell Transplantation Following CAR T Therapy in Relapsed/Refractory Acute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk 25: e374-e377, 2025.
- Senapati J, Jabbour E, Short NJ, Jain N, Haddad F, Bathala T, Kovalenko I, Bidikian A, Ravandi F, Khouri I, Kadia TM, Garris R, Montalban Bravo G, Chien K, Shpall E, Kebriaei P, Kantarjian HM. Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin. Blood Cancer J 14: 129, 2024.
- Saliba RM, Lee SJ, Carpenter PA, Hill GR, Lee CJ, Alousi A, Daher M, Chen G, Champlin RE, Rezvani K, Shpall EJ, Mehta RS. Mycophenolate mofetil is associated with inferior overall survival in cytomegalovirus-seropositive patients with acute myeloid leukemia undergoing hematopoietic cell transplantation. Haematologica 109: 2321-2325, 2024.
- Ramdial J, Kebriaei P, Champlin RE, Popat U, Rezvani K, Shpall EJ, Mehta RS. Improved survival with younger HLA-matched unrelated donors versus older matched sibling donor HCT with PTCy-prophylaxis. Leukemia 38: 1432-1434, 2024.
- Malek AE, Al-Juhaishi T, Milton DR, Ramdial JL, Daher M, Olson AL, Srour SA, Alatrash G, Oran B, Mehta RS, Khouri IF, Bashir Q, Shah N, Ciurea SO, Rondon G, Maadani F, Hosing C, Marin D, Kebriaei P, Rezvani K, Nieto Y, Anderlini P, Alousi AM, Faisal MS, Qazilbash MH, Popat UR, Champlin RE, Shpall EJ, Mulanovich VE, Ahmed S. Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis. Bone Marrow Transplant 59: 699-704, 2024.
- Mamlouk O, Strati P, Feng L, Sun R, Ayers A, Steiner RE, Nair R, Flowers C, Ramdial JL, Saini N, Srour SA, Champlin RE, Kebriaei P, Nastoupil LJ, Rodriguez MA, Shpall EJ, Nieto Y, Westin J, Neelapu SS, Mandayam S, Ahmed S. Real-world analysis of safety and efficacy of CAR T-cell therapy in lymphoma patients with decreased kidney function. Br J Haematol 204: e11-e16, 2024.
- Pasvolsky O, Saliba RM, Masood A, Mohamedi AH, Tanner MR, Bashir Q, Srour S, Saini N, Ramdial J, Nieto Y, Lee HC, Patel KK, Kebriaei P, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Impact of gender on outcomes of patients with multiple myeloma undergoing autologous Haematopoietic stem cell transplant. Br J Haematol 201: e37-e41, 2023.
- Koller P, Saliba RM, Ledesma C, Rondon G, Popat U, Alousi A, Mehta R, Oran B, Olson A, Hosing C, Qazilbash M, Khouri I, Ciurea S, Shpall E, Jorgensen J, Wang S, Jain N, Jabbour E, Kantarjian H, Champlin R, Konopleva M, Kebriaei P. Outcomes in patients with CRLF2 overexpressed acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 56: 1746-1749, 2021.
- Saini NY, Marin D, Ledesma C, Delgado R, Rondon G, Popat U, Bashir Q, Hosing C, Nieto Y, Alousi A, Qazilbash MH, Ciurea SO, Shpall EJ, Khouri IF, Kantarjian HM, Jabbour E, Ravandi F, Champlin R, Kebriaei P. Impact of TKIs post-allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive ALL. Blood 136: 1786-1789, 2020.
- Kongtim P, Bittencourt M, Srour SA, Ramdial J, Rondon G, Chen J, Khouri I, Betul O, Popat U, Olson A, Bashir Q, Shpall EJ, Kebriaei P, Champlin RE, Ciurea SO. Haploidentical transplants for patients with relapse after the first allograft. Am J Hematol 95: E267-E269, 2020.
- John TM, Malek AE, Mulanovich VE, Adachi JA, Raad II, Hamilton AR, Shpall EJ, Rezvani K, Aitken SL, Jain N, Klein K, Martinez F, Jacob CN, Cherian SV, Manzano JM, Muthu M, Wegner R. Migratory Pulmonary Infiltrates in a Patient With COVID-19 Infection and the Role of Corticosteroids. Mayo Clin Proc 95: 2038-2040, 2020.
- Strati P, Ahmed S, Kebriaei P, Nastoupil LJ, Claussen CM, Watson G, Horowitz SB, Brown ART, Do B, Rodriguez MA, Nair R, Shpall EJ, Green MR, Neelapu SS, Westin JR. Clinical efficacy of anakinra to mitigate CAR T-cell therapy-associated toxicity in large B-cell lymphoma. Blood Adv 4: 3123-3127, 2020.
- Kohorst MA, Nunez CA, Tewari P, Petropoulos D, Mahadeo KM, Neelapu SS, Shpall EJ, Khazal S. Primary mediastinal large B‐cell lymphoma in paediatric and adolescent patients: emerging questions in the era of immunotherapy. Br J Haematol 190: e114-e117, 2020.
- Rezvani K, Shpall EJ, Marin D. CAR-Transduced Natural Killer Cells. Reply. N Engl J Med 382: 1866-1867, 2020.
- Mehta RS, Bassett R, Olson A, Chen J, Ahmed S, Alousi AM, Anderlini P, Al-Atrash G, Bashir Q, Ciurea SO, Hosing CM, Im JS, Kebriaei P, Khouri I, Marin D, Molldrem JJ, Nieto Y, Oran B, Rezvani K, Qazilbash MH, Srour SA, Shpall EJ, Andersson BS, Champlin RE, Popat UR. Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: long term results of a prospective phase II clinical trial. Haematologica 104: e555-e557, 2019.
- Nevo N, Zuckerman T, Gur-Cohen S, Kollet O, Avemaria F, Shpall EJ, Mendt MC, Nagler A, Brenner B, Ben Arush M, Lapidot T. PAR1 Expression Predicts Clinical G-CSF CD34+ HSPC Mobilization and Repopulation Potential in Transplanted Patients. Hemasphere 3: e288, 2019.
- Marsilio S, Khiabanian H, Fabbri G, Vergani S, Scuoppo C, Montserrat E, Shpall EJ, Hadigol M, Marin P, Rai KR, Rabadan R, Devereux S, Pasqualucci L, Chiorazzi N. Somatic CLL mutations occur at multiple distinct hematopoietic maturation stages: Documentation and cautionary note regarding cell fraction purity. Leukemia 32: 1041-1044, 2018.
- Neelapu SS, Tummala S, Kebriaei P, Wierda W, Locke FL, Lin Y, Jain N, Daver N, Gulbis AM, Adkins S, Rezvani K, Hwu P, Shpall EJ. Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'. Nat Rev Clin Oncol 15: 218, 2018.
- Lu J, Hou J, Liu KY, Parmar S, De La Fuente A, Andersson B, Yan C, Zhou D, Tan D, Ritchie D, Wu D, Shpall E, Laport GG, Li J, Hu J, Zhang LS, Wang M, Malhotra P, Jiang Q, Qin Y, Wong R, Champlin R, Issaragrisil S, Iyer S, Mathews V, Wang Y, Hu Y, Xiao Z, Shao Z, Rosengarten R, Steuernagle J, Xiao JH, Orlowski R, Chim CS. Asia-Pacific Hematology Consortium Report on approach to multiple myeloma. Survey results from the 6th International Hematologic Malignancies Conference: Bridging the Gap 2015, Beijing, China. Leuk Lymphoma 57: 1534-8, 2016.
- Varma A, Saliba RM, Torres HA, Afrough A, Hosing C, Khouri IF, Nieto Y, Shah ND, Parmar S, Bashir Q, Ahmed S, Jones RB, Kebriaei P, Olson AL, Shpall EJ, Alousi AM, Qazilbash MH, Champlin RE, Popat U. Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation. Bone Marrow Transplant 51: 999-1001, 2016.
- Cornelison AM, Saliba RM, Afrough A, Dinh Y, Nieto Y, Bashir Q, Shah N, Parmar S, Hosing C, Popat U, Shpall E, Champlin R, Qazilbash MH. Autologous hematopoietic stem cell transplantation in light chain amyloidosis (AL) with renal involvement. Bone Marrow Transplant 51: 307-9, 2016.
- Shah N, Thall PF, Fox PS, Bashir Q, Shah JJ, Parmar S, Lin P, Kebriaei P, Nieto Y, Popat UR, Hosing CM, Cornelison A, Shpall EJ, Orlowski RZ, Champlin RE, Qazilbash MH. Phase I/II trial of lenalidomide and high dose melphalan with autologous stem cell transplantation for relapsed myeloma. Leukemia 29: 1945-8, 2015.
- Gul Z, Bashir Q, Cremer M, Yusuf SW, Gunaydin H, Arora S, Slone S, Nieto Y, Sherwani N, Parmar S, Shah N, Dinh YT, Hosing CM, Popat UR, Kebriaei P, Shpall EJ, Giralt SA, Champlin RE, Qazilbash MH. Short-term cardiac toxicity of autologous hematopoietic stem cell transplant for multiple myeloma. Leuk Lymphoma 56: 1-3, 2015.
- Parmar S, de Lima M, Worth L, Petropoulos D, Lee D, Cooper L, Kongtim P, Alousi A, Hosing C, Popat U, Kebriaei P, McNiece I, Shpall E, Rondon G, Champlin R. Is there an expiration date for a cord blood unit in storage?. Bone Marrow Transplant 49: 1109-12, 2014.
- Chakraborty S, Lin YH, Leng X, Miranda RN, Medeiros LJ, Shpall E, Arlinghaus RB. Activation of Jak2 in patients with blast crisis chronic myelogenous leukemia: inhibition of Jak2 inactivates Lyn kinase. Blood Cancer J 3: e142, 2013.
- Robinson, SN, Simmons, PJ, Thomas, MW, Brouard, N, Javni, JA, Trilok, S, Shim, JS, Yang, H, Steiner, D, Decker, WK, Xing, D, Shultz, L, Savoldo, B, Dotti, G, Bollard, CM, Miller, LP, Champlin, RE, Shpall, E, Zweidler-McKay, PA. Reply to Sackstein. Experimental Hematology 40: 519-520, 2012.
- Anderlini P, Saliba RM, Ledesma C, Chancoco C, Alousi AM, Shpall EJ, Popat UR, Hosing CM, Khouri IF, Nieto Y, Ciurea S, Younes A, Fanale MA, Acholonu S, Valverde R, Champlin RE. Gemcitabine, fludarabine and melphalan (G-FM) as a reduced-intensity conditioning regimen for allogeneic stem cell transplantation in relapsed and refractory hodgkin lymphoma: preliminary results. Leuk Lymphoma 53: 499-502, 2012.
- Hurton LV, Siddik RI, Singh H, Olivares S, Rabinovich BA, Tian R, Mojsilovic D, Hildebrand W, Lee DA, Kelly SS, Champlin R, Shpall EJ, Fernandez-Viña M, Cooper LJ. Identifying candidate allogeneic NK-cell donors for hematopoietic stem-cell transplantation based on functional phenotype. Leukemia 24: 1059-62, 2010.
- Burger, JA, Velev, N, Jabbour, EJ, Wierda, WG, Ravandi-Kashani, F, Cortes, JE, Kantarjian, HM, Nieto, Y, Shpall, E, Jorgensen, JL. Failure is not fatal. Leukemia 24: 666-668, 2010.
- Oran B, Giralt S, Couriel D, Hosing C, Shpall EJ, de Meis E, Khouri IF, Qazilbash M, Anderlini P, Kebriaei P, Popat U, Carrasco-Yalan A, Champlin RE, de Lima M. Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation. Leukemia 21: 2540-4, 2007.
- Khorshid O, de Meis E, Martin T, Jones RB, Shpall EJ, Nieto Y, Khouri I, Shahjahan M, Gajewski J, Giralt S, Champlin R, de Lima M. Unrelated umbilical cord blood stem cell transplant after failure of haploidentical or matched unrelated donor hematopoietic stem cell transplant. Leukemia 17: 2538-40, 2003.
- Peters WP, Shogan J, Shpall EJ, Jones RB, Kim CS. Recombinant human granulocyte-macrophage colony-stimulating factor produces fever. Lancet 1: 950, 1988.
Patents
- Decker W, Shpall E. Methods and compositions related to TH-1 dendritic cells. Patent Number: 8,728,806.
- Rezvani K, Shpall E, Liu E. Methods of treatment with Natural Killer cells matched for killer immunoglobulin receptor type. Patent Number: UTSCP1271USP1.
Patient Reviews
CV information above last modified March 10, 2026